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Abstract 
In 2012 Oh and co-workers reported the isolation of the tricyclic macrolactam 
tripartilactam 1.1 from a Streptomyces sp. found in the brood ball of the dung bettle Copris 
tripartitus. The compound proved to be a moderate inhibitor of Na+/K+ ATPase (IC50 of 16.6 
μg/mL). The unique and rather complex structure embodies a cyclobutane fused, on its 
opposing faces, to both an 8- and an 18-membered ring. These architecturally novel features 
prompted the author to pursue a total synthesis of it. 
 
Chapter One provides a brief introduction to the isolation, structural elucidation and 
proposed biogenesis of tripartilactam. This section also provides details of selected organic 
reactions that played important roles in the synthetic studies of the author, in particular the 
Stille cross-coupling, olefin metathesis and olefination reactions. 
Chapter Two describes two distinct sets of manipulations of the enantiomerically pure 
chloro cis-1,2-dihydrocatechol 2.3, readily obtained through the whole-cell biotransformation 
of chlorobenzene, into a terminal allene/carbonyl-conjugated alkene 2.5 and a polyoxygenated 
cyclooctenone 2.7 embodying the Eastern Hemisphere of the non-natural enantiomeric form 
of tripartilactam 1.1. Attempts to elaborate intermediates 2.5 and 2.7 to the 
bicyclo[6.2.0]decane ent-2.4 via both intra- and inter-molecular [2+2]-cycloaddition reactions 
are also discussed. 
 vi 
 
 
The research detailed in Chapters Three, Four and Five is focused on the synthesis of 
compound 1.7 that it was thought could engage in a transannular [2+2] cycloaddition reaction. 
If successful, this reaction would mimic the final step in the proposed biogenesis of 
tripartilactam 1.1. Three different approaches were investigated and these involved masking 
the Z-double bonds between C14-C15 and/or C16-C17 as alkynes that could each be revealed 
via stereocontrolled (Z-selective) semi-reduction.  
 
Macrolactone 6.1 was identified as a potential precursor to tripartilactam 1.1 and 
attempts to prepare the former compound are described in Chapter Six.  
 
 vii 
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1.1. The Macrocyclic Natural Product Tripartilactam 
1.1.1. Isolation and Assignment of Structure to Tripartilactam 
In recent years, investigations into the symbiotic relationships between insects and 
microbes have led to the discovery of natural products with pharmaceutical potential. 
Sceiliphrolactam, an antifungal polyene macrocyclic lactam, represents one natural product 
discovered in this way.1 In 2012, Oh and co-workers investigated the selective isolation of 
actinomycete type microbes from the brood ball of dung beetle Copris tripartitus, a soil-
dwelling insect, and showed both the diversity of the actinomycetes population and their 
potentially bioactive metabolites. Over the course of this study, Oh discovered a Streptomyces 
strain, SNA112, that produces a secondary metabolite displaying a distinctive UV spectrum 
(λmax at 277 nm).2 This yellowish powder was named tripartilactam and assigned structure 1.1 
and thus embodying a cyclobutane core substituted on its opposing faces by an 8-membered 
carbocyclic ring and a 14-membered lactam. 
 
Figure 1.1.  A Dung Beetle with a Brood Ball and the Structure of Tripartilactam 1.1. 
The molecular formula of tripartilactam was established through a combination of 1H 
and 13C NMR spectroscopic methods as well as mass spectrometry. A protonated molecular 
ion was observed at m/z = 482.2542 which corresponds to the molecular formula C28H35NO6 
(calculated m/z = 482.2543). Furthermore, the 13C NMR spectrum showed twelve signals 
ranging from δ 147.0 to 121.7 ppm that were attributed to sp2-hybridised and olefinic carbons. 
Three resonances due to carbonyl carbons appeared at δ 210.0, 191.2 and 164.4 ppm with the 
last of these arising from an amide carbon. The presence of an IR absorption band at 1677 cm−1 
provided further evidence for the presence of such a unit. The three carbon resonances observed 
at δ 78.7, 74.2 and 70.2 ppm were attributed to oxygenated sp3-hybridised carbons. The 
remaining ten resonances appeared in the up-field region of the 13C NMR spectrum as would 
be expected for a compound with structure 1.1. The 1H NMR spectrum displayed signals 
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consistent with a poly-unsaturated compound containing ten olefinic protons with these 
resonating in the range δ 7.10 to 5.23 ppm. Two resonances due to the protons of allylic methyl 
groups appeared at δ 1.49 and 1.26 ppm and the signal due to the amide proton appeared at 
δ 7.99 ppm. The presence of three hydroxyl group protons was confirmed using deuterium 
exchange techniques while a broad absorption band appearing at 3361 cm−1 in the IR spectrum 
provided additional evidence for the presence of these moieties. Further analysis of the 1H 
NMR spectrum revealed the presence of a secondary methyl group at δ 0.93 ppm (d, J = 6.5 
Hz), as well as nine other proton resonances ranging from δ 3.54 to 2.32 ppm. Analyses of both 
NMR spectra as well as the IR spectrum led to the identification of six double bonds and three 
carbonyl groups. The remaining three degrees of “unsaturation” requires the presence of three 
rings. COSY correlations and an assessment of 1H-1H couplings led to the identification of a 
connectivity from C19 to the NH group of the lactam moiety as well as one between C28 and 
C24. The presence of a cyclobutane ring with two “pendant” alkenyl groups on C8 and C16 of 
the four-membered carbocycle was also supported by such studies. An isolated methylene (C2-
H2), a discrete double bond (C14/C15) and a triol moiety (C11/12/13) were also revealed in 
this way. The HMBC and ROESY correlations observed for the constituent atoms of both the 
four- and eight-membered rings are shown in Figure 1.2 and these also served to reveal the 
details of the structure of tripartilactam.  
 
Figure 1.2.  Key COSY, HMBC and ROESY Correlations Used to Establish the Structure of Tripartilactam. 
The configurations of the stereogenic centers on both the cyclobutane and the 
cyclooctene rings were determined via a modified Mosher method employing (R) and (S)-α-
methoxy-α-(trifluoromethyl)phenylacetyl chloride as derivatizing agents. The preparation of 
the C13-MTPA ester led to the assignment of this center as R and from the relative 
configurations established using the ROESY experiments, the configurations at C8, C9, C11, 
C12, C16 and C17 were assigned as R, R, R, R, R and S, respectively. Indeed, it was observed 
that the difference in chemical shifts for the R and S diastereoisomers, as established using the 
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formula ΔδSR= δ (S-MTPA ester)-δ (R-MTPA ester), gave negative values for C11 and C12 
while positive values were obtained for C14 and C15. This result strongly suggested that C11 
was part of R2 and C16 part of R1 (Figure 1.3) and therefore led to the assignment of the R 
configuration at C13.  
 
Figure 1.3.  Application of the Mosher Ester Method in the Determination of the Absolute Configuration of 
C13 of Tripartilactam. 
Finally, and as depicted in Scheme 1.1, the absolute stereochemistry at C24 was 
determined from β–amino-acid 1.2, which was prepared through a multistep chemical 
degradation of tripartilactam that started with ozonolysis and acid hydrolysis steps. Reaction 
of this degradation product with the Sanger reagent followed by derivatisation using either (S)- 
or (R)-phenylglycine methyl ester (PGME) gave the amides 1.4a and 1.4b, respectively. 1H 
NMR spectroscopic analyses of these products then led to assignment of R-stereochemistry at 
C24. 
C ΔδS-R (ppm) 
11 −0.036 
12 −0.157 
13 −0.016 
14 +0.028 
15 +0.063 
Chapter One  Introduction 
 
 
6 
 
 
Scheme 1.1.  Chemical Degradation Steps Applied to Tripartilactam that Led to the Assignment of the 
R-Configuration at C24. 
 
1.1.2. The Biogenesis of Tripartilactam 
Oh and co-workers suggested that the biogenesis of tripartilactam occurs via an initial 
cascade of condensation/dehydration reactions involving one molecule of 3-amino-2-
methylpropanoyl CoA, nine of acetyl-CoA and two of propionyl-CoA to afford the crucial 
acyclic precursor 1.5. Lactamisation of this last species would then release the cofactor and 
lead to diol 1.6 that it was suggested would undergo oxidation to give the tricarbonyl compound 
1.7. A transannular and possibly photochemically promoted [2+2]-cycloaddition then takes 
place as illustrated and as the final chemical event to afford tripartilactam 1.1 (see Scheme 
1.2). Support for such a proposal stems from the earlier isolation of sceiliphrolactam (see inset, 
stereochemistry undefined) from another insect-associated Streptomyces species reported by 
the Oh group.  
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Scheme 1.2.  Proposed Biogenesis of Tripartilactam 1.1. 
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1.2. Overview of the Contents of the Remaining Parts of this Thesis 
The work described in this thesis was directed towards establishing a total synthesis of 
tripartilactam (1.1), a target natural product that has yet to be realised by any group. Two 
distinct strategies were investigated. The first sought to construct the cyclobutane-containing 
Eastern Hemisphere and then add the Western one to it. The other involved approaches to the 
assembly of macrolactam 1.7 with the intention of then effecting a transannular [2+2]-
cycloaddition reaction in an effort to mimic the proposed bio-synthetic pathway. Chapter Two 
details the author’s work involved in pursuing the former strategy, while the three different 
approaches to macrolactam 1.7 are presented in Chapters Three, Four and Five, respectively. 
A model macrolactone was also studied and the author’s work in this area is described in 
Chapter Six. The remaining parts of this Chapter (One) highlight the general utilities and 
mechanisms that operate in key reactions used by the author in her studies. These include the 
Stille cross-coupling, olefin metathesis and olefination reactions. 
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1.3. General Description of Key Organic Reactions Used in Synthetic Approaches 
to Tripartilactam  
1.3.1. The Stille Cross-Coupling Reaction 
1.3.1.1.   Introduction 
Carbon-carbon bond-forming reactions have played a pivotal role in the evolution of 
organic chemistry. Prominent classical examples of such processes include the Grignard, Diels-
Alder cycloaddition and Wittig reactions. More recently, palladium-catalysed cross-coupling 
reactions have emerged as powerful tools in the assembly of complex molecular frameworks. 
The reports of the first-generation variants of palladium-catalysed cross-coupling reactions 
emerged in the mid-1970s.3 In the intervening period, such processes have become widely 
known, especially in the forms of the Heck,4 Sonogashira,5 Stille,6 Suzuki,7 and Negishi8 cross-
coupling reactions. This section focuses on the Stille reaction due to its utility in the author’s 
studies as delineated in certain of the following chapters. 
The first example of a palladium-catalysed cross-coupling reaction involving organotin 
compounds was reported by Eaborn in 1976.9 A year later, Kosugi and Migita described the 
reaction of an allyltin compound with either an aromatic halide or acyl chloride in the presence 
of a palladium catalyst.6a,b This process was studied both synthetically and mechanistically in 
1978 by Stille and co-workers as part of their establishment of a new route to ketones.6c,d By 
the early 1980s Stille was recognised as a pioneer in the use of this method. Over the years, the 
Migita-Kosugi-Stille reaction, the name originally given to palladium-catalysed couplings of 
organostannanes with organic electrophiles to form a new carbon-carbon bond, has become 
known as the Stille cross-coupling reaction, the general form of which is shown in Scheme 1.3. 
 
Scheme 1.3.  The Stille Cross-Coupling Reaction. 
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Almost forty years later, this reaction remains one of the most widely applied methods for the 
formation of carbon-carbon bonds due to the normally mild reaction conditions involved and 
its tolerance to the presence of various sensitive functionalities as well as air and moisture. The 
ease of handling of organotin compounds compared to other organometallic substrates is a 
further attraction of the process. 
 
1.3.1.2. Mechanism 
A mechanistic rationalisation of the Stille cross-coupling reaction was first proposed 
by its namesake in 1979.6d More detailed information has since emerged including a knowledge 
of the geometry of the palladium center in the relevant intermediates and the roles of the 
different ligands employed as part of the catalytic system. In the case of chiral halides, the 
matter of inversion versus retention of configuration at the relevant stereogenic center(s) is 
dictated by the nature of the oxidative addition step and shown to depend on the nature of both 
the solvent and the metal-bound ligand.10 In those instances involving chiral stannanes, the 
transmetalation step dictates whether retention or inversion of the configuration is observed.11 
In general, the catalytic cycle proceeds as illustrated in Scheme 1.4.12 The active catalytic 
species is believed to be a Pd0L2 complex that can be generated in situ from a pre-catalyst, for 
example, a preformed palladium(0) system [such as tetrakis(triphenylphosphine)palladium or 
bis(dibenzylideneacetone)palladium] or from a palladium(II) complex [such as palladium 
acetate or bis(triphenylphosphine)palladium(II) chloride]. These latter complexes are reduced 
to the relevant Pd(0) species by the organostannanes. The first step, namely the oxidative 
addition, involves reaction of a PdL2 complex with an organic electrophile R
1-X in a three-
atom centered transition state to form complex I. The cis-[R1PdXL2] complex is believed to 
form initially and then isomerise to the more stable trans-isomer. The latter species is the only 
observable intermediate in the catalytic cycle, a feature that suggests the next (transmetalation) 
step involving reaction with the organostannane is the slow or rate limiting one. Two possible 
transition states for this process have been proposed and involve either a cyclic or open-chain 
species.13 In the former pathway, the generation of the Pd-X-Sn-containing species is assisted 
by the exchange of one ligand (L) for R2 to give the complex II that then delivers a cis R1/R2 
arrangement as shown in the cis T-shaped IV species. The open mechanism proceeds via an 
exchange of X for R2 to form the trans-complex III that itself isomerises to the cis-complex V. 
Both cis complexes IV and V would be expected to undergo reductive elimination to deliver 
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the observed product. A study by Amatore and Jutand14 showed that in a coordinating solvent, 
the replacement of X by a solvent molecule could occur to form the stabilised complex VI from 
the dominant trans-[R1PdXL2] species. It is noteworthy that this pathway also leads to the 
generation of trans-complex III. 
 
Scheme 1.4.  Generally Accepted Mechanism for the Stille Cross-Coupling Reaction. 
 
1.3.1.3. Effects of Added Copper 
Several significant variations on the original Stille cross-coupling protocol have been 
developed. Perhaps the most remarkable of these involves the recognition of the co-catalytic 
effect encountered upon addition of copper(I) salts. This phenomenon was first studied by 
Liebeskind15 who suggested two reasons for the observed and highly valuable rate 
accelerations: 
i. Copper(I) acts as a free-ligand scavenger such that when strong ones (such as PPh3) 
are present it helps dissociation of trans-[PdR1XL2] in the transmetalation step. 
Specifically, the copper “captures” the neutral ligand released during the oxidative 
addition of PdL4 to trans-[PdR
1XL2] and so reducing the concentration of free 
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ligand in the solution. The addition of a copper(I) salt results in minimal rate 
enhancements when a soft ligand (such as AsPh3) is involved as these are readily 
dissociated from palladium(II) anyway. 
ii. In polar solvents, tin-to-copper transmetalation of the tin reagents takes place to 
give the more nucleophilic organocopper species. 
In 1996, Corey16 described the beneficial exploitation of a tetrakis(triphenylphosphine)- 
palladium/copper chloride/lithium chloride combination in a Stille cross-coupling reaction 
between a range of sterically hindered 1-substituted alkenyl stannanes and aryl perfluoroalkane 
sulfonates or halides. These reactions were conducted at 60 °C in dimethyl sulfoxide. Lithium 
chloride was presumed to suppress the homocoupling of the alkenyl copper intermediate. 
Again, the rate enhancement was attributed to the conversion of alkenyl stannanes into the 
alkenylcopper(I) species R2CuLiCl that themselves react rapidly with R1PdXL2. The tin/copper 
exchange was thought to be reversible and, therefore, an increased reversion would delay the 
positive influence of copper due to the accumulation of R3SnX in the reaction medium (Scheme 
1.5). This hypothesis was supported by Liebeskind’s observations17 that the reaction was 
initially rapid but slowed as it approached 50% conversion. 
 
Scheme 1.5.  Co-Catalytic Effect of Copper Additive in Polar Media - the Formation of a More Nucleophilic 
Organocopper Species. 
Several methods have been devised to ensure the desired effect of the added copper is 
actually observed. Those involve either choosing the type of copper(I) salt so that the R3SnX 
would be less prone to participate in the reverse process or removing the R3SnX from the 
equilibrium. Copper(I) thiophene-2-carboxylate17 (CuTC) was recommended for the first 
purpose. In 2005, Baldwin reported the use of either tetra-n-butylammonium fluoride (TBAF) 
or cesium fluoride as a fluoride source to remove the R3SnX by-product from the equilibrium 
mixture as polymeric R3SnF and so shifting the equilibrium towards the more reactive 
organocopper species. However, using such fluoride additives was found to be incompatible 
with some late-stage Stille coupling reactions associated with natural product syntheses due to 
their basicities and their capacity to effect unwanted desilylation reactions. As a result, 
Fürstner18 attempted to use the neutral tin scavenging phosphinate salt [Ph2PO2][NBu4] instead 
and in combination with copper(I) thiophene-2-carboxylate as the copper(I) source. This 
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protocol proved very effective in all the reactions involved, with the desired reaction often 
going to completion in less than an hour at ambient temperatures and providing the requisite 
products in good yield. 
 
1.3.1.4. Preparation of Alkenyl Stannanes via a Hydrostannylation Reaction 
The hydrostannylation of alkynes is perhaps the most straightforward method for 
preparing alkenyl stannanes required in Stille cross-coupling reactions. This palladium-
catalysed process proceeds under mild conditions and two commonly used catalysts are 
tetrakis(triphenylphosphine)palladium and bis(triphenylphosphine)palladium(II) chloride, the 
latter being reduced in situ to give the palladium(0) species as illustrated in Scheme 1.6.a  
 
Scheme 1.6.  Proposed Mechanism for the Palladium-Catalysed Hydrostannylation Reaction. 
                                                 
a A propargylic alcohol was chosen as a substrate in this mechanistic illustration because of its relevant to the 
work detailed in Chapter Four and Five. 
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Thus, the catalytic cycle starts with the oxidative addition of tri-n-butyltin hydride to the metal 
center (complex I) and this is followed by coordination of the triple bond to form complex II 
that itself undergoes hydrometallation to give one or both of the regio-isomeric 
hydrostannylation products IIIα and IIIβ.19 As a consequence of the operation of a syn-addition 
process, reductive elimination within these two alkenyl complexes will lead to the E-isomeric 
form of organostannanes. The relative steric bulk as well as the electronic nature of R will 
dictate the mode of addition (the n-Bu3Sn fragment can attach to either the sp-hybridised carbon 
proximal or distal to R). In an overall sense, then, the regioselectivity of this transformation is 
dictated by the nature of the substrate. Table 1.1 provides some examples of the variation in 
regioselectivity that can be observed in such processes. In 1999, Alami20 reported an extensive 
study involving aryl-substituted alkyne substrates and found that an electron-withdrawing 
group in the para-position gave exclusively the α-isomer (entry 1) while the regioselectivity 
decreased when an electron-donating group was present at the same position (entry 2). Little 
selectivity was found for 1-octyne (entry 3), but the β-isomer was obtained exclusively upon 
increasing the steric bulk at the sp3-hybridised carbon attached to the sp-carbon of the alkyne.21 
So, the primary propargylic alcohol22 gave a 62:38 ratio of α/β isomers while the secondary 
alcohol began to show some preference for formation of the β-isomer (25:75 α/β ratio of 
products).21 Complete selectivity for β-isomer formation was observed for tertiary alcohols, 
such as shown in entry 7.23 Kazmaier24 developed a molybdenum-based catalyst that could 
improve the selectivity for the α-isomer as shown in entry 8 with the α/β ratio rising to 91:9 as 
compared with the 62:38 ratio observed earlier (entry 5). Alami20 also noticed that the reverse 
selectivity was engendered by changing the solvent. So, for example, switching from 
dichloromethane to tetrahydrofuran led to a change in the α/β ratio from 33:67 to 80:20, 
respectively.  
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Table 1.1.  Controlling the Regioselectivity of the Hydrostannylation Reaction of Substituted Alkynes. 
Entry Substrate Catalyst Ratio Ref. 
α-isomer β-isomer 
1 
 
Pd(PPh3)2Cl2 100 - 
20 
2 
 
Pd(PPh3)2Cl2 76 24 
20 
3 
 
Pd(PPh3)2Cl2 57 43 
21 
4 
 
Pd(PPh3)2Cl2 0 100 
21 
5 
 
Pd(PPh3)4 62 38 
22 
6 
 
Pd(PPh3)2Cl2 25 75 
21 
7 
 
Pd(PPh3)2Cl2 - 100 
23 
8 
 
Mo(CO)3(tBuNC)3 91 9 
24 
9 
 
Pd(PPh3)2Cl2, 
DCM 
33 67 20 
10 
 
Pd(PPh3)2Cl2, 
THF 
80 20 20 
  
Chapter One  Introduction 
 
 
16 
 
1.3.1.5. Application in Natural Product Synthesis 
Stille cross-coupling reactions have provided particularly reliable means for effecting 
both inter- and intra-molecular carbon-carbon bond formation (the latter mode leading to 
carbocyclic ring-formation). A wide variety of ring sizes is available via such means. Besides 
being tolerant of the presence of a range of functional groups that are often present in the 
complex substrates required for natural product synthesis, the reaction provides remarkable 
levels of chemo- and stereo-selectivity. The synthesis of novel immunosuppressant agent 
sanglifehrin A reported by Nicolaou25 (Scheme 1.7) emphasises such matters. 
 
Scheme 1.7.  Chemoselective Intra- and Inter-molecular Stille Cross-Coupling Reactions in a Total 
Synthesis of Sanglifehrin A. 
The late-stage and regio-selective intramolecular Stille cross-coupling reaction 
involving the alkenyl stannane and alkenyl iodide residues within substrate 1.8 provided the 
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22-membered macrocycle 1.9 in 62% yield. A subsequent intermolecular Stille cross-coupling 
reaction between the hindered alkenyl iodide embodied within this product and alkenyl 
stannane 1.10 delivered compound 1.11 incorporating the full carbon framework of the target 
natural product. Indeed, when this last compound was subjected to acetal-deprotection, 
sanglifehrin A was obtained. 
A so-called “stitching” cyclisation strategy featuring a double Stille cross-coupling 
reaction has also been employed by various research groups including those of Nicolaou26 (in 
the total synthesis of rapamycin), Panek27 (in the construction of (+)-mycotrienol and (+)-
mycotrienin I) and Danishefsky28 [in the preparation of the racemic modification of the 
enediyne anticancer antibiotic dynemicin (Scheme 1.8)]. The pivotal step in this last synthesis 
was the coupling of bis(iodoalkyne) 1.12 with the cis-1,2-distannyl ethylene thus leading to 
formation of the highly strained 10-membered ring-containing compound 1.13 in 81% yield. 
 
Scheme 1.8.  Double-Stille Cross-Coupling Strategy Leading to the Enediyne Core Associated with the 
Danishefsky’s Synthesis of Dynemicin. 
In 2007, Fürstner29 reported formal total syntheses of amphidinolides H and G in which 
the crucial intermolecular Stille cross-coupling reaction between alkenyl iodide 1.14 and the 
hindered stannane 1.15 was performed with the assistance of copper(I) thiophene-2-
carboxylate and conducted in presence of the neutral tin scavenger phosphinate salt 
[Ph2PO2][NBu4] (Scheme 1.9). The desired product 1.16 was obtained in 89% yield at ambient 
temperatures and, notably, in the presence of an unprotected alcohol residue, a sensitive β-
hydroxyketone unit and various O-silyl groups. 
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Scheme 1.9.  Crucial Stille Cross-Coupling Reaction Used in a Synthesis of Amphidinolide H. 
The Stille reaction has the capacity to generate species that can engage, in situ, in the 
next step of a reaction cascade. Thus, in Martin’s synthesis of manzamine A,30 Scheme 1.10, 
treatment of bromide 1.17 with vinyl stannane in refluxing toluene using a catalytic amount of 
tetrakis(triphenylphosphine)palladium provided the coupling product 1.18 that underwent an 
in situ and intramolecular Diels-Alder reaction to furnish the tricyclic core containing 
compound 1.19 in 68% yield. This process delivered three new carbon-carbon bonds and three 
new stereocenters with full control. Over sixteen additional steps, product 1.19 was carried 
forward to manzamine A. 
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Scheme 1.10.  Tandem Intermolecular Stille Coupling/Intramolecular Diels-Alder Cycloaddition Processes 
Leading to the Tricyclic Core of Manzamine A. 
It is clear from the foregoing that, the Stille cross-coupling reaction has become one of 
the most popular and effective transition metal-catalysed processes available for carbon-carbon 
bond formation. It has evolved, since its inception, from a relatively demanding method into 
an extremely mild and flexible one. Its versatility has been increased tremendously through the 
discovery of the co-catalytic effect of copper and the optimisation of the ligand set used. There 
is even a palladium-free method available now involving the use of copper(I) thiophene-2-
carboxylate.17 This reaction proceeds at room temperature. 
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1.3.2. Metathesis Reactions 
In recent decades, metathesis reactions have also contributed dramatically to the 
repertoire of carbon-carbon bond forming processes now available, particularly by allowing 
the reorganisation-transformation of simple molecules into target systems that are often 
structurally complex, highly functionalised and difficult to obtain by other means. This section 
highlights some of the features and applications of such processes in total syntheses. Metathesis 
reactions are no longer restricted to olefins. Now they can also involve enynes and alkynes as 
substrates. In fact, the rate of development in this area has been rather dramatic, especially in 
regards to the matter of catalyst design. As a result, synthetic chemists now have access to 
transformations that would have, until recently, been thought almost impossible. Furthermore, 
such processes often show exceptional tolerance for a broad range of substrates. 
1.3.2.1. Alkene Metathesis 
The alkene metathesis reaction has a fascinating history, starting with its discovery in 
1955.31 Its potential utility has attracted global attention. As a result, a wide range of readily 
available catalyst systems with high activity and functional group tolerance have led it to 
becoming the most commonly used method among the metathesis-based carbon-carbon bond 
forming processes. Figure 1.4 shows the most commonly utilised, commercially available 
catalysts. The molybdenum-based complex 1.20 was introduced by Schrock32 in 1990 and 
represents the first advanced catalyst containing a tetra-coordinated alkylidene species with 
bulky substituents on the imido and alkoxide ligands. The complex is a well behaved metathesis 
initiator even for sterically hindered systems.33 It is, however, quite sensitive to oxygen and 
moisture as well as being relatively intolerant of the presence of protons on heteroatoms (such 
as encountered in carboxylic acids, alcohols, amines, amides, etc). In 1995 Grubbs34 disclosed 
the ruthenium carbene complex 1.21 as initiator system exhibiting greater functional group 
tolerance. Although less reactive than Schrock’s molybdenum alkylidene 1.20, this so-called 
first-generation Grubbs’ catalyst is reasonably stable to oxygen, water and minor impurities in 
the reaction solvent. The replacement of one of the phosphine ligands with an N-heterocyclic 
carbene (NHC) ligand provides complex 1.22 which is known as the second-generation 
Grubbs’ catalyst.35 The introduction of this last catalyst expanded the scope of the olefin/alkene 
metathesis process significantly. It is not only stable and tolerant of various functional groups 
but also more reactive with sterically demanding substrates. Another remarkable contribution 
to the field of ruthenium-based catalysts involved the introduction of iso-propoxystyrene-
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coordinated complex 1.23 by Hoveyda36 in 2000. This system is now known as the second-
generation Hoveyda-Grubbs’ catalyst. The complex contains an NHC ligand that imparts 
significant reactivity and a styrenyl ether residue that allows the recovery of the catalyst by 
conventional flash chromatography. The origin of such useful features is the presence of the 
iso-propoxy group on the phenylcarbene unit. This stabilises the complex while continuing to 
provide an accessible coordination site for the substrate. Despite these significant innovations, 
the search for increasingly efficient, as well as selective catalysts continues unabated.37 
 
Figure 1.4.  Commonly Used Alkene Metathesis Catalysts. 
Alkene metatheses can be divided in five important subtypes. As shown in Scheme 
1.11 these are the ring-closing metathesis (RCM), ring-opening metathesis (ROM), ring-
opening polymerisation metathesis (ROMP), acyclic diene metathesis polymerisation 
(ADMET) and cross metathesis (CM) processes.38 
 
Scheme 1.11.  Five Different Types of Alkene Metathesis Reaction. 
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Among them, the ring-closing metatheses of acyclic dienes have probably received the 
greatest attention as they provide a highly effective method for the construction of medium to 
large carbocycles and heterocycles. Ring-opening polymerisation metatheses provide the 
capacity to prepare functionalised polymers. Cross metatheses, on the other hand, are found to 
be the most challenging processes because of the frequent lack of selectivity between those 
reactions leading to the desired “heterodimer” and those producing the normally undesired 
“homodimers”. Scheme 1.12 shows the mechanism that most likely operates in the ring-closing 
metathesis process. Thus, the now generally accepted mechanism for alkene metathesis was 
first proposed by Chauvin39 in 1970. It proceeds through coordination of the alkene with a 
metal alkylidene to generate a metallacyclobutane intermediate that then fragments in the 
reverse manner to that by which it was formed. As such, it involves sequential [2+2]-
cycloaddition and cycloreversion events. Since all the individual steps of the catalytic cycle are 
reversible, it is important to shift the equilibrium in one direction in order to obtain a productive 
outcome. For example, in the case of the ring-closing metathesis, the catalytic cycle 
commences with an initiation phase involving a [2+2]-cycloaddition reaction between the 
catalyst and one of the two olefins present in the substrate so as to deliver the 
metallacyclobutane I which then ruptures to furnish the active alkylidene metal II. Formation 
of the second metallacyclobutane III and its disintegration generates the cyclic product and the 
metal carbene IV, that serves as the active complex to promote the next catalytic cycle. The 
release of the volatile ethylene by-product formed at this stage is the driving force that allows 
for the complete formation of the desired cycloalkene product (provided the ethylene is vented 
properly). 
 
Scheme 1.12.  General Catalytic Cycle Associated with the Ring-Closing Metathesis of Dienes. 
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The situation is different for ring-opening metatheses or ring-opening polymerisation 
metatheses. Ring-strain release is normally the driving force for these transformations. Any 
potential competition between ring-closing metathesis and acyclic diene metathesis 
polymerisation events can be controlled through the application of high-dilution techniques. 
The total synthesis of ingenol reported by Wood and co-workers represents a 
remarkable application of the alkene metathesis reaction.40 Ingenol is the parent compound 
associated with a class of naturally occurring compound called ingenanes. They all share the 
same carbon framework. Ingenol has attracted the attention of synthetic chemists not only 
because of its highly oxygenated polycyclic structure, which features a distinctive bridged ring 
system, but also because of its interesting biological profile. By using a ring-opening/cross 
metathesis tactic involving the first-generation Grubbs’ catalyst, the authors were able to 
convert the spiro compound 1.24 into diene 1.25 in almost quantitative yield under an ethylene 
atmosphere (Scheme 1.13).41 The derived diene 1.26 itself served as the substrate for the 
pivotal ring-closing metathesis step. Delightfully, it was found that by using the second-
generation Hoveyda-Grubbs’ catalyst 1.23 then compound 1.27 could be generated (in 76% 
yield) and then elaborated to ingenol, albeit over a further twenty steps. 
 
Scheme 1.13.  Ring-Opening/Cross Metathesis and Ring-Closing Metathesis Reactions Used in a Total 
Synthesis of Ingenol. 
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Difficulties sometimes encountered with steric hindrance and/or electronic deactivation 
within a substrate can be circumvented through the application of a “relay ring-closing 
metathesis” approach. Since such problems often derive from a difficult initiation process, a 
solution would be the installation of a temporary tether containing a sterically unencumbered 
alkene that would initiate the catalytic cycle. One such an example is illustrated in Scheme 
1.14 and involves the synthesis of oximidine III by the Porco group.42 Thus, on submitting 
diene 1.28 to conventional ring-closing metathesis only a 15% yield of the desired product 1.30 
was obtained. It was presumed that the stabilised alkylidene 1.28a did not undergo ready 
reaction with the hindered alkenyl epoxide. Accordingly, a so-called relay moiety was 
introduced as seen in compound 1.29 and its presence allowed the ruthenium alkylidene 
catalyst to react, initially, with this less hindered terminal double bond to form intermediate 
1.29a. The kinetically favorable ring-closing metathesis then occurred to form, through the 
extrusion of a molecule of cyclopentene, complex 1.29b that itself underwent another ring-
closing metathesis reaction to afford the target macrolactone 1.30 in 71% yield. 
 
Scheme 1.14.  Relay Ring-Closing Metathesis in a Total Synthesis of Oximidine III. 
Alkene cross metatheses are also important processes and could be considered, in some 
instances, as useful alternatives to cross-coupling reactions. The most challenging issue in this 
type of metathesis is the chemo- and stereo-selective formation of the desired heterodimeric 
product. An interesting tactic involves temporary connection through silicon-based tethers so 
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as to enable a ring-closing metathesis reaction to be employed instead. Such an approach was 
employed in the total synthesis of the antitumor agent (−)-mucocin by Evans and co-workers 
(Scheme 1.15).43 Since, the cross metathesis of allylic alcohols 1.31 and 1.32 did not seem to 
be a promising approach for a selective “heterodimerisation” process, a temporary silicon tether 
as seen in substrate 1.33, was installed and a ring-closing metathesis reaction then took place 
to provide alkene 1.34 in 83% yield although an excess of catalyst (180 mol%) was required to 
drive the reaction to completion. Finally, sequential global deprotection and diimide reduction 
steps revealed the natural product (−)-mucocin. 
 
Scheme 1.15.  Use of a Temporary Silicon Tether in a Synthesis of (−)-Mucocin. 
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In 2003, Grubbs and co-workers described a general model for predicting the outcomes 
of alkene cross metatheses.44 Their investigations revealed that olefins can be ranked (in terms 
of their reactivity in cross-metatheses) by considering their relative ability to undergo 
homodimerisation and examining the reactivity of these “homodimers” in a secondary 
metathesis process. As a result, four different olefin types were identified as shown in Scheme 
1.16. The selectivity of such reactions can be tuned by decreasing the rate of 
“homodimerisation” of one component, something that can be achieved by altering either the 
steric or electronic properties of the substituents near the reacting alkenes. In other words, 
selective cross metatheses would be achieved by engaging two different types of olefins. So, 
for example, Crowe and Zhang45 showed a chemoselective cross metathesis could be achieved 
between a type I terminal olefin 1.35 and so-called type II styrene to form product 1.36 
possessing the E-configuration about the newly established double bond (normally the products 
of such reactions are mixtures of E- and Z-isomers). High Z-selectivities are realised when the 
coupling partner bears a substituent incorporating an sp-hybridised carbon as seen, for 
example, in acrylonitrile.46 
 
Scheme 1.16.  Chemoselective Cross Metathesis Using Schrock’s Catalyst 1.20. 
The lack of methods that selectively furnish Z-alkenes captured the attention of 
Hoveyda (a pioneer in the field) who developed structurally distinct catalysts to address this 
matter (Scheme 1.17). So, the Z-olefin 1.39 was obtained upon treatment of oxabicycle 1.37 
with styrene and 1 mol% molybdenum catalyst 1.38 (generated in situ from adamantylimido 
bispyrolide 1.40 and alcohol 1.41).47 The ring-opening/cross metathesis sequence proceeded 
within an hour to afford the desired product in 80% yield. It is presumed that the sterically 
demanding but fully rotatable around Mo-O bond to the aryloxide ligand, together with a 
smaller imido substituent (relative to the aryloxide), allows for the formation of the key cis-
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metallacyclobutane I, that likely involves in the formation of the Z-configured product. The 
bromo-derivative of complex 1.38 also proved to be an efficient and highly stereoselective 
catalyst for reactions involving enol ethers.48 
 
Scheme 1.17.  Selective Z-Alkene Formation Using a Molybdenum Catalyst. 
A general accepted mechanism for the ring-opening/cross metathesis process is shown 
in Scheme 1.18. First, a [2+2]-cycloaddition reaction between the cyclo-olefinic substrate and 
the alkylidene catalyst generates metallacyclobutane I that collapses to form the ring-opened 
metal complex II. This intermediate then participates in a cross metathesis reaction with 
another acyclic olefin to yield an acyclic metallacyclobutane III, that itself ruptures to deliver 
both the product and the active metal-carbene IV, the latter being capable of participating in 
subsequent catalytic cycles. 
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Scheme 1.18.  General Mechanism for Catalytic Ring-Opening/Cross Metathesis. 
Although Z-alkenes are generated exclusively when small or medium rings are formed 
in ring-closing metatheses, this is not the case for larger rings wherein mixtures of E- and Z-
isomers are observed in most cases. Further investigations of ring-closing metathesis reactions 
show that the use of tungsten alkylidene 1.43 delivers even higher Z-alkene selectivity than the 
molybdenum-based systems, as seen, for example in the synthesis of the 15-membered ring of 
nakadomarin A.49 Thus, the desired pentacycle, 1.44, was isolated in 90% yield by exposing 
substrate 1.42 to 5 mol% of catalyst 1.43 (Scheme 1.19). Only 3% of the corresponding E-
isomer was obtained. 
 
Catalyst Schrock’s cat. 
1.20 (5 mol%) 
2nd-Grubbs’ cat. 
1.22 (10 mol%)  
2nd-Hoveyda-Grubbs’ 
cat. 1.23 (10 mol%) 
Molybdenum cat. 1.38 
(Br derivative) (6 mol%) 
Yield  67%  70%  66%  71%  
Z/E 38:62 38:62 36:64 69:31 
Scheme 1.19.  Z-Selective Ring-Closing Metathesis Reaction Employed as the Key Step in a Synthesis of 
Nakadomarin A and Results Using Other Catalysts. 
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Examination of the ability of different catalysts to promote the Z-selective ring-closing 
metathesis of substrate 1.42 revealed that some of the E-isomer was normally obtained with 
most catalysts. The bromine analogue of the molybdenum-based catalyst 1.38 provided a 69:31 
ratio of Z- and E-isomers. Another advantage of catalyst 1.43 is its high stability towards air 
and moisture compared with its molybdenum-based counterpart. Ruthenium based-catalysts 
have been studied by Grubbs and found to deliver useful Z/E ratios.50 These catalysts are also 
found to be more functional group tolerant than molybdenum- and tungsten-based systems and 
capable of ca. 1000 turnovers in several cross metathesis reactions at low loadings and without 
requiring low pressures or high temperatures. As such, they offer significant advantages from 
an industrial point-of-view. Nevertheless, the search for even better catalyst continues. 
 
1.3.2.2. Enyne Metathesis 
Although less-studied than alkene metatheses, enyne metatheses, especially 
intramolecular variants, have proven to be a powerful method for the construction of 1,3-
dienes. This enyne reorganisation reaction involves the migration of the terminal alkylidene 
moiety from an alkene to an alkyne carbon and delivers a semi-cyclic diene product.51 The first 
use of a ruthenium carbene complex in such a transformation was reported by Mori (Scheme 
1.20).52 This author proposed a mechanism in which the active metal alkylidene A first 
associates with the terminal alkyne B. This pathway would lead to two metallacyclobutenes, 
Ia and Ib, that collapse to the ring-opened metal complexes IIa and IIb, respectively. A ring-
closing metathesis of the latter species would then deliver the 1,2-disubstituted product IVa 
and the 1,3-disubstituted product IVb. It was later noted that it was advantageous to effect the 
enyne-metathesis macrocyclisation under an atmosphere of ethylene.53 Such observations 
suggested a second mechanistic pathway could be operational wherein the active metal 
alkylidene first reacts with the alkene moiety. The ensuing metal carbene intermediate V can 
then engage in two different modes of ring closure, namely either an exo or an endo one, to 
generate the metallacyclobutenes VIa and VIb, respectively. The alkylidene complexes 
derived from these intermediates would then react with ethylene to produce the same products, 
IVa and IVb, arising from the operation of the other pathway. Indeed, intermediate VIIa can 
participate in a cross metathesis reaction with another enyne substrate B to afford the exo 
product and, simultaneously, release the metal carbene V. A systematic study by Lee et al.54 
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based on the analysis of literature data55 revealed a correlation between the ring size and the 
exo/endo selectivity. The authors showed that the exo-products predominated for ring-closing 
metatheses of enynes leading to ten-membered and smaller rings, while endo-products were 
obtained preferentially when the formation of twelve-membered or larger rings was involved. 
For eleven-membered rings 1:1 mixtures of exo and endo products were observed. 
 
Scheme 1.20.  Two Possible Mechanistic Pathways Associated with Intramolecular Enyne Metatheses. 
In 2009, Schrock and Hoveyda demonstrated the capacity of the stereogenic-at-Mo 
complex 1.45 (Scheme 1.21) to promote the formation of endo-products for five-, six-, and 
seven-membered rings.56 The reaction is presumed to proceed through initial catalyst 
association with the alkyne and, given the preference of the sterically demanding molybdenum 
centre to form the metallacyclobutene Ib, thus leading to the selective formation of 1,3-
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disubstituted and endo, ring-closed metathesis products. As illustrated, the formation of exo-
1.46 and endo-1.46 could be controlled by appropriate choice of catalysts. 
 
Scheme 1.21.  Catalyst Control of the Endo/Exo Nature of the Ring-Closing Enyne Metathesis Reaction. 
Further investigations have led to several new catalysts that not only promote efficient 
endo-selective reactions but also provide enantiomerically enriched products. For example, the 
cyclic triene 1.50 (Scheme 1.22) is obtained in 96% ee by exposing compound 1.47 to the 
chiral catalyst 1.48. The isolation of tetraene 1.49 in the course of this reaction revealed the 
first association of an alkylidene complex with the alkyne moiety that subsequently participates 
in enyne cross metathesis with ethylene. Exposure of compound 1.49 to catalyst 1.48 under a 
nitrogen atmosphere gave rise to product 1.50 in 92% yield. In fact, this two-step sequence 
could be performed as a one-pot process wherein treatment of substrate 1.47 with 10 mol% of 
catalyst 1.48 under ethylene atmosphere for ten minutes was followed by stirring for twelve 
hours after the ethylene atmosphere was removed. Under such conditions, product 1.50 was 
obtained in 62% yield and 90% ee.  
 
Scheme 1.22.  An Example of endo-Selective Ring-Closing Enyne Metathesis Reaction. 
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The use of enyne metatheses in cascade processes is one of the most powerful 
applications of this type of reaction. The metal carbenoid arising from the initial ring-closing 
metathesis reaction can participate in a second intramolecular event with an appropriately 
tethered olefin to generate another ring and a new metal carbene species. So, for example, 
during the course of the formation of key intermediate associated with Danishefsky’s 
guanacastepene A synthesis57a (Scheme 1.23), Hanna’s group57b reported that exposure of 
enyne 1.51 (as a 1:1 mixture of epimers at C9) to the second-generation Grubbs’ catalyst (1.22) 
afforded the tricyclic core 1.52 in 82% yield. The selectivity of this cascade process was due to 
the programed initiation at the least hindered (substituted) alkene in precursor 1.51 which 
ensured the correct regiochemical outcome. Indeed, the initially formed metal carbene directed 
the first enyne ring-closing metathesis so as to generate the seven-membered ring and the co-
produced metal carbene that participated in the second ring-closing metathesis with the more 
hindered alkene.38b  
 
Scheme 1.23.  Tandem Ring-Closing Metathesis Reaction Used in a Total Synthesis of Guanacastepene A. 
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1.3.2.3.  Alkyne Metathesis 
The first alkyne metathesis reaction was reported in 1968 by Penella and catalysed by 
a heterogeneous mixture of tungsten oxide and silica at very high temperatures (200-450 °C).58 
Following this observation, Mortreux and Blanchard reported that a combination of 
molybdenum hexacarbonyl and resorcinol was able to effect the disproportionation of p-
tolylphenylacetylene to diphenylacetylene.59 Ten years later, the report of the well-defined 
tungsten alkylidyne catalyst 1.54 by Schrock was considered as the major breakthrough in 
catalyst design.60 Reactions involving terminal alkynes, however, suffered from catalyst 
deactivation and polymerisation. As such, this type of metathesis has found only rather limited 
application in organic synthesis. In 1998, the first ring-closing alkyne metathesis (Scheme 
1.24) between two methyl-substituted alkyne moieties was reported by Fürstner61 and heralded 
a new era for this process. So, treatment of diyne 1.53 with Schrock’s catalyst (1.54) in 
chlorobenzene at 80 °C smoothly generated macrocycle 1.55 in 73% yield. 
 
Scheme 1.24.  First Example of an Alkyne Ring-Closing Metathesis. 
The favoured mechanism for alkyne ring-closing metatheses is shown in Scheme 1.25 
and follows the “logic” of the Chauvin cycle for alkene metathesis.62 So, the catalytic cycle 
starts with the combining of the metal alkylidyne A and one of the methyl-capped alkyne units 
of the substrate via a [2+2]-cycloaddition reaction so as to form the metallacyclobutadiene Ia 
that is converted into isomer Ib. Cycloreversion of the latter complex releases intermediate II 
and another competent metal species B. The steric hindrance associated with substrate II directs 
the association of B to the remaining methyl-capped alkyne to deliver a second 
metallacyclobutadiene, IIIa, that itself isomerises to congener IIIb that, in turn, ruptures to 
give the metal-carbon triple bond complex IV and 2-butyne. In line with events proposed for 
the alkene ring-closing metathesis, the release of this volatile product (viz 2-butyne) is the 
driving force for the reaction. Finally, a [2+2]-cycloaddition reaction of intermediate IV and 
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cycloreversion within the resulting adduct would deliver the product cycloalkyne and 
regenerate catalyst A. 
 
Scheme 1.25.  General Catalytic Cycle Associated with Alkyne Ring-Closing Metathesis reaction. 
The most interesting application of this transformation, however, was the 
stereoselective semi-reduction of the product cycloalkyne to generate either naturally occurring 
E- or Z-configured cycloalkenes. As already noted, alkene ring-closing metatheses usually 
provide an unpredictable and often uncontrollable mixture of geometrical isomers. This 
situation was highlighted in the first three syntheses of epothilones A and C by Nicolaou,63 
Danishefski,64 and Schinzer65 wherein the alkene metathesis was successfully exploited despite 
suffering from little or no selectivity for the required Z-isomer. Upon revisiting the issue, in 
2001, Fürstner’s group66 reported the first stereoselective synthesis through alkyne ring-closing 
metathesis of diyne 1.56 (Scheme 1.26) followed by semi-reduction of the cycloalkyne product 
using hydrogen in the presence of Lindlar’s catalyst so as to generate the Z-configured alkene 
1.59, which was itself converted into epothilone C by cleavage of the associated silyl ether. 
The 16-membered cycloalkyne was isolated in 80% yield upon exposure to molybdenum 
amido catalyst precursor 1.57 that was converted, in situ, into the active species through 
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reaction with gem-dihalides, for example, dichloromethane.67 Ten years later, Schrock and 
Hoveyda49 were able to obtain macrolactone 1.59 in a highly Z-selective alkene ring-closing 
metathesis reaction (85% yield with a 96:4 Z/E ratio) by treating diene 1.60 with the tungsten-
based catalyst 1.43. 
 
Scheme 1.26.  Alkyne Ring-Closing Metathesis/Semi-Reduction and Z-Selective Alkene Ring-Closing 
Metathesis in the Syntheses of Epothilone C. 
The alkyne ring-closing metathesis/semi-reduction tactic developed by Fürstner was 
rapidly applied to the synthesis of various other natural products.68 Although it might never 
reach the breadth of alkene metatheses, the potential of this reaction is significant. Therefore, 
it is important to note the recent development of more stable, reactive, and functional group 
tolerant catalysts. Although the Schrock alkylidyne 1.54 and the molybdenum complex 1.57 
were found to be reactive and surprisingly functional group tolerant, they are very air and 
moisture sensitive. Inspired by the work of John et al,69 that had focused on novel nitride 
molybdenum and tungsten complexes capable of generating active alkylidynes in situ, further 
investigations by Fürstner’s group resulted in the identification of the highly active species 
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1.61 (Scheme 1.27), one that is compatible with many polar groups save for epoxides, 
aldehydes and acid chlorides [due to the reactions with the nitride residue of the catalyst].70 
Although this complex requires handling in an inert atmosphere, it can be generated by heating 
the corresponding pyridine adduct 1.62, which is sufficiently stable to be weighed in air, and 
used at temperatures up to 80 °C. Inert atmosphere storage is, however, still required for 
catalyst 1.62 because of its eventual hydrolysis. Gratifyingly, replacement of the pyridine 
ligand with 1,10-phenanthroline provided an indefinitely air stable and crystalline pre-catalyst 
1.63 that delivers, in situ, the reactive species on treatment with manganese chloride or related 
salts. At the present time, a molybdenum alkylidyne complex carrying ancillary silanolate 
ligands is considered the most effective catalyst. It is possible to choose between the air 
sensitive ether form 1.64, which is superbly active and selective at ambient temperature, or the 
more robust phenanthroline adduct 1.65 (inert gas storage required), which can be activated by 
treatment with manganese chloride at 80 °C for thirty minutes. For example, by using 2 mol% 
of catalyst 1.64, the product macrolactone 1.58 (Scheme 1.26) was obtained in 91% yield at 
room temperature and thus providing ready access to a key intermediate associated with a new 
route to epothilone C.70 
 
Scheme 1.27.  Molybdenum Nitride/Alkylidyne Complexes with Ancillary Silanolate Ligands and their 
Precursors. 
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1.3.3. Some Stereoselective Olefination Reactions 
1.3.3.1. The Wittig Reaction 
The “classic” Wittig reaction between a phosphorous ylide and an aldehyde or ketone 
to afford the corresponding alkene and phosphine oxide was first described in 1953.71 Since 
then, it has become one of the most important methods for carbon-carbon bond formation. A 
number of investigations have sought to understand and control the E- and Z-stereoselectivity 
of such reactions. This has, in turn, led to diverse modifications.72 The active species in this 
reaction is the phosphorous ylide, which is usually prepared from triphenylphosphine and a 
primary or secondary halide followed by deprotonation with a suitable base. The ylide 
chemoselectively and rapidly reacts with aldehydes and more slowly with ketones while the 
other carbonyl-containing functionalities such as esters, amides and acids etc. remain 
unaffected. Generally, there are two pathways by which the aldehyde can approach the ylide 
(in the rate limiting step) and so leading to either the cis- or trans-oxaphosphetanes that engage 
in a cycloreversion process to afford the corresponding Z- and E- alkenes, respectively 
(Scheme 1.28).  
 
Scheme 1.28.  General Mechanism for the Wittig Reaction. 
The Z-product is normally the kinetically favoured one, while the E-isomer, although initially 
suffering from steric clashes between the R2 of the aldehyde and the triphenylphosphonium 
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group is favoured under thermodynamic conditions due to the formation of the more stable 
trans-oxaphosphetane. The selectivity of the Wittig reaction can be tuned through careful 
choice of the particular ylide and the solvent. Indeed, in polar aprotic solvents, the less reactive, 
stabilised ylides, formed by treatment with an alkali metal hydroxide, usually react with an 
aldehyde to afford E-alkenes under conditions of thermodynamic control. In contrast, when 
non-stabilised ylides are involved (and thus requiring the use of strong bases such as n-
butyllithium for their formation) they react with either aldehydes or ketones to produce the 
corresponding Z-alkenes. Furthermore, the addition of lithium salts and a second equivalent of 
a strong base, such as an alkyl lithium, followed by quenching with a proton source under 
kinetic control facilitates the formation of the E-alkene from non-stabilised ylides. This 
important procedure is known as Schlosser’s modification of the Wittig reaction.73  
 
1.3.3.2. The Horner-Wadsworth-Emmons Reaction 
The olefination reaction involving a phosphonate stabilised carbanion and an 
aldehyde/ketone is referred to as the Horner-Wadsworth-Emmons (HWE) reaction.74 The 
starting alkyl phosphonates are easily prepared by using a Michaelis-Arbuzov reaction between 
a trialkylphosphite and an organic halide. The phosphonate carbanions generated by 
deprotonation of the resulting phosphonates are more nucleophilic than the corresponding 
phosphorous ylides and produce water-soluble dialkyl phosphates as by-products that are, 
therefore, much easier to remove than the triphenylphosphine oxide by-product produced in 
the Wittig reaction. Generally, this HWE olefination reaction proceeds with high E-selectivity 
when stabilizing groups are attached to the phosphonate-substituted carbon (COO−, CO2R, CN, 
aryl, vinyl, SO2R, OR, NR2). The non-stabilised phosphonates result in low yields of the 
desired products due to the formation of β-hydroxyphosphonates.75 The commonly accepted 
mechanism for such reactions is depicted in Scheme 1.29. Thus, as with the Wittig reaction, 
there are two possible modes of the addition of the carbanion to the carbonyl group although 
this is not the rate limiting step due to the higher activity of phosphonate carbanions compared 
to phosphorous ylides (this is rate limiting step in Wittig reaction). The cis- and trans-
oxaphosphetanes are in equilibrium with one another and, as a result, the elimination reaction 
normally provides the E-alkene as the major product. However, high Z-selectivity can be 
achieved using the Still-Gennari modification that involves a stabilised bis(trifluoroalkyl)-
phosphonate with a well-dissociated base such as potassium bis(trimethylsilyl)amide.76 
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Subsequently, Masamune and Roush77 reported a protocol employing both lithium chloride and 
an amine base that proceeds at ambient temperature and thus allows for the olefination of 
relatively base-sensitive substrates. The reaction also proceeds with high E-selectivity when 
stabilised phosphonates (viz. those carrying electron withdrawing groups at the phosphonate 
substituted-carbon) are used. Relevant examples from the author’s own work are presented in 
Chapter Four. 
 
Scheme 1.29.  Mechanism for the Horner-Wadsworth-Emmons Reaction. 
 
1.3.3.3. The Julia Reaction 
The Julia olefination reaction involves the condensation of an aryl sulfone with an 
aldehyde or ketone. The initial protocol, reported in 1973, involved a three-step sequence 
starting with the addition of an α-metalated 
phenylsulfone to a carbonyl group, followed by 
trapping of the resulting β-alkoxysulfone as an 
acetate, benzylate, mesylate or tosylate and, 
finally, a reductive elimination of the resulting β-
acyloxysulfone, or equivalent, with a one-
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electron donor such as samarium iodide to yield the alkene.78 Although the reaction proceeds 
with high E-selectivity, the classic procedure is quite a tedious one. Second generation variants 
involving a heteroarylsulfone, benzothiazoyl (BT)79 or phenyltetrazoyl (PT)80 sulfone (Figure 
1.5) provide a more convenient process. Indeed, they allow for a one-pot reaction that proceeds 
via an in situ reductive elimination reaction involving a Smiles rearrangement. The widely 
accepted mechanism involving the BT-sulfone is shown in Scheme 1.30.  
 
Scheme 1.30.  General Accepted Mechanism for Julia Olefination Reaction. 
There are two possible modes of addition of carbanion I to the carbonyl-containing substrate 
and thus affording either or both of the anti-II and syn-II adducts, which then undergo a series 
of transformations, including Smiles rearrangement and elimination, to release sulphur dioxide 
and a metal derivative of 1,3-benzothiazol-2-one.  Concomitant alkene production also takes 
place. The elimination reaction is presumed to occur through a concerted, anti-periplanar 
process to give the E- or Z-olefin from the corresponding anti- or syn-sulfinate, respectively. 
Generally, the stereochemical outcome is highly dependent on the nature of the reactants as 
well as the solvent and the counter-ion to the base. Although reactions with aliphatic aldehydes 
furnish the corresponding alkenes with almost no stereochemical bias, aromatic aldehydes 
show some E-selectivity. Robiette and Pospίšil81 demonstrated that with aromatic aldehydes 
syn-periplanar elimination reaction occurred preferentially within the syn-sulfinate to afford 
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the E-olefin. Kocienski also reported the influence of the solvent and the base on the 
stereoselectivity of the reaction, most particularly in those variants involving a large counter-
ion (potassium) in a polar solvent (1,2-dimethoxyethane). In such circumtances, the E-alkene 
product predominates.80 
 
1.3.3.4.  Applications of Olefination Reactions to the Syntheses of Natural Products 
Olefinations have been used extensively as early steps in preparing many compounds 
for natural product synthesis. A proper choice among the different types of olefination 
reactions, in addition to proper substrate design, can provide the required product with high 
stereoselectivity. For example, in their synthesis of unnatural or (−)-discodermolide, Smith and 
co-workers were able to effect a highly Z-selective Wittig reaction between phosphonium salt 
1.66 and the hindered aldehyde 1.67 (Scheme 1.31).82 Product 1.68 was thus obtained in 76% 
yield (with 98:2 ratio of Z- and E-isomers) when sodium bis(trimethylsilyl)amide was used as 
a base. 
 
Scheme 1.31.  Highly Z-Selective Wittig Reaction in a Synthesis of (−)-Discodermolide. 
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In contrast, en route to establishing an asymmetric total synthesis of ISP-I, as a potent 
immunosuppressive compound (Scheme 1.32), 83 on applying the Schlosser modification of 
the Wittig reaction to substrates 1.69 and 1.70 in the presence of phenyllithium, compound 
1.71 was obtained in 82% yield with high E-selectivity (with 96:4 ratio of E- and Z- isomers)  
 
Scheme 1.32.  Use of a Highly E-Selective Wittig-Schlosser Modification Reaction in a Synthesis of ISP-I. 
In 2007, Nicolaou and co-workers84 reported a highly convergent and flexible strategy 
for the construction of the key precursor, 1.73, associated with a synthesis of palmerolide A 
(Scheme 1.33). Under the appropriate conditions (namely those involved in applying the 
Masamune-Roush protocol) the desired E-alkene was obtained from substrate 1.72 in 73% 
yield.  
 
Scheme 1.33.  The Highly E-Selective HWE Reaction with Massamune-Rouch Protocol for the 
Macrocylisation Step in a Synthesis of Palmerolide A. 
In contrast, in the synthesis of phorboxazole reported by Forsyth,85 an intramolecular 
Horner-Wadsworth-Emmons (involving the Still-Gennari modification) was employed using 
bis(trifluoroethoxy)phosphonate-aldehyde 1.74 as substrate (Scheme 1.34) and the desired 
intermediate macrolactone 1.75 was obtained in 77% yield (with 4:1 ratio of Z- and E-isomers) 
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upon exposure to potassium carbonate and 18-crown-6 in toluene for five hours at −40 to  
−5 °C.  
 
Scheme 1.34.  Z-Selective HWE Reaction (Still-Gennari Modification) Used in Forsyth’s Synthesis of 
Phorboxazole A. 
In 2006, Bonini86 reported using a benzothiazol TMS-propargylic sulfone in a one-pot 
Julia olefination reaction to effect a predominantly Z-selective process when a variety of 
aliphatic and aromatic aldehydes was employed. The tactic was then applied in the synthesis 
of lactimidomycin by Fürstner87 wherein reduction of amide 1.76 with lithium aluminum 
hydride followed by reaction of the product aldehyde with sulfone 1.78 under the one-pot Julia 
olefination reaction conditions gave the product Z-1.79 in isomerically pure form and in 59% 
yield over the two steps (Scheme 1.35). Esterification of this last compound with 2-octynoic 
acid provided the ester diyne 1.80 (in high yield), and this was then subjected to alkyne ring-
closing metathesis and so-forming the cyclic enyne in 95% yield. Selective semi-reduction of 
this cycloalkyne using a trans-hydrosilylation/protodesilylation protocol then delivered the 
required E,Z-configured diene 1.81, a key intermediate associated with a synthesis of 
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lactimidomycin. This one-pot Julia olefination and alkyne ring-closing metathesis strategy 
served as an inspiration for the author’s pursuit of a tripartilactam synthesis by the pathway 
detailed in Chapter Four. 
 
Scheme 1.35.  Application of the Z-Selective Julia Reaction to a Synthesis of Lactimidomycin.
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2.1. cis-1,2-Dihydrocatechols  
Enzymes have been exploited in the production, through fermentation, of food and 
beverages such as cheese, bread, vinegar, soy sauce, beer, and wine for more than a thousand 
years. The first modern enzyme study was conducted around 1833 by Payen and Persoz88 and 
involved the isolation of a substance from malt extract that has since been shown to be a 
mixture of lipases. In 1857 the reducing nature of yeast was first noted by Pasteur during the 
production of alcohol by fermentation then in 1874, by Duma, during the conversion of sulfur 
to hydrosulfide and by Lintner and von Liebig in 1911 during the reduction of furfural to 
furfuryl alcohol.88 Today, biocatalysis provides a remarkable means for conducting chemical 
syntheses, especially in an enantioselective manner. These capacities were recognised some 
one hundred years ago. In 1908, for example, Störmer et al.88 established that aromatic 
compounds such as toluene and xylene could be consumed by Bacillus hexacarovorum. Then, 
in 1968 Gibson et al.89 described the enzymatic dihydroxylation of p-chlorotoluene to the 
corresponding cis-dihydrocatechol by toluene dioxygenase, an enzyme obtained from the soil 
bacterium Pseudomonas putida F1. Further studies established that the lack of catechol 
dehydrogenase expression in Gibson’s chemically-induced mutant Pseudomonas putida 39D90 
results in the accumulation of the cis-1,2-dihydrocatechol in the fermentation broth. The 
recombinant strain of Escherichia coli JM 109 (pDTG601), which harbors encoding genes for 
toluene dioxygenase, is now the most widely used biocatalyst for this purpose and allows for 
the production, in high enantiomeric purity (> 98% ee), of up to 35 g of metabolite 2.2 per litre 
of fermentation broth (Scheme 2.1).91  
 
Scheme 2.1.  Generation of cis-1,2-Dihydrocatechol Derivatives through the Biotransformation of the 
Corresponding Arene. 
cis-1,2-Dihydrocatechols have been recognised as versatile building blocks for the 
enantioselective synthesis of a range of complex and homochiral natural products. Several 
groups have highlighted the utility of these metabolites as seen, for example, in Taylor’s 
polyphenylene92 synthesis in 1983, Ley’s synthesis of racemic (±)-pinitol93 in 1987, Hudlicky’s 
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enantioselective syntheses of prostaglandin E2α
94 (PGE2α) in 1988, zeylena
95 in 1989 and 
specionin96 in 1992 (Figure 2.1). 
 
Figure 2.1.  Early Examples of Compounds Prepared from Enzymatically-Derived cis-1,2-Dihydrocatechols. 
The novel combination of functionalities and reactive sites associated with the cis-1,2-
dihydrocatechols have been exploited in the Banwell group over the years to prepare a variety 
of target compounds (Figure 2.2). Among the notable functionalities associated with these 
compounds, the 1,3-diene unit often readily participates in intermolecular Diels-Alder 
cycloaddition reactions to deliver enantiomerically pure bicyclo[2.2.2]octenes that can, for 
example, be elaborated into linear triquinanes such as (+)-connatusin B97 or the non-natural or 
(−)-enantiomer of hirsutene.98 In the case of the halogenated cis-1,2-dihydrocatechols, the 
more electron-rich (non-halogenated) double bond can be selectively converted, via 
electrophilic addition process, into the corresponding bromohydrin and this then engaged in a 
3-exo-tet cyclisation reaction, or a vinylogous variant, to afford a single epoxide, a process 
exploited during the course of the formation of (+)-hexacyclinol,99 an inhibitor of Plasmodium 
falciparum (and thus a possible lead compound for the development of new antimalarial drugs). 
When the halogenated double bond is oxidatively cleaved by treatment with ozone, then 
various open-chain compounds are obtained, as highlighted in the total synthesis of (−)-
cladospolide A.100 These halogenated systems can also engage in palladium(0)-catalysed cross-
coupling reactions with organometallic species or participate in transmetallation process that 
can then followed by halide couplings. The successful completion of the total synthesis of (−)-
platencin101 provides an illustrative example in which a Negishi cross-coupling reaction then a 
thermally-promoted and intramolecular Diels-Alder (IMDA) reaction were performed to 
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deliver the tricyclic framework of this important new antibiotic.  When 3-chloro-cis-1,2-
dihydrocatechol (2.1, X = Cl) was employed as the starting material, it was possible to 
accomplish the first total synthesis of the alkaloid (+)-nangustine102 using, as a pivotal step, an 
unusual radical addition-elimination process. 
 
Figure 2.2.  Selective Manipulations of the cis-1,2-Dihydrocatechols Leading to Natural Products 
Undertaken in the Banwell Group. 
On the basis of such examples, it was envisioned that 3-chloro-cis-1,2-dihydrocatechol 
could be used as an effective starting material in developing approaches to the synthesis of the 
Eastern Hemisphere of tripartilactam. 
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2.2. Synthetic Strategy Leading to a Substructure of ent-Tripartilactam  
The synthesis of highly functionalised eight-membered carbocycles is known to be 
challenging owing to strain induced by transannular interactions.103 An even more challenging 
objective, then, would be the assembly of an eight-membered ring fused to a cyclobutane as 
encountered in the Eastern Hemisphere of tripartilactam. Thus, the author’s first efforts in this 
area focused on the synthesis of the chiral polyoxygenated bicyclo[6.2.0]decane 2.4. The 
retrosynthetic plan shown in Scheme 2.2 highlights two distinct approaches, both of which 
exploit the enantiomerically pure 3-chloro-cis-1,2-dihydrocatechol 2.3 as the starting material. 
The use of this readily available compound in the reaction sequence would lead to the optical 
antipodes of the relevant substructures, namely ent-2.4, in the first instance. However, since 
the enantiomer of compound 2.3 is also available any successful synthetic sequence 
automatically allows for access to the equivalent “natural” enantiomeric forms of the relevant 
compounds. 
In the first approach, an intramolecular [2+2]-cycloaddition reaction between a terminal 
allene and an enone as embodied in compound 2.5 was expected to deliver adduct 2.6 in which 
the associated eight- and four-membered rings would have been assembled in a biomimetic 
fashion through simultaneous formation of the C8–C17 and C9–C16 bonds. The choice of an 
allene moiety was inspired by the recently reported approaches to the synthesis of various 
cyclobutane-containing compounds,104 most notably bielschowskysin.105 Although, according 
to the Woodward-Hoffmann rules, [2+2]-cycloaddition reactions of allenes are “forbidden” 
under thermal conditions, these processes have been effected both thermally and 
photochemically. Diradical intermediates are presumed to be involved. More recently, 
transition metal catalysts have been employed for the same purpose.105 In addition, an 
intramolecular process could be more effective in terms of providing a capacity to control the 
regio- and/or stereo-selectivities of these reactions. In this approach the tether was designed to 
include an acetonide and a bulky TBS-ether protecting group on the basis that these would 
favourably influence the entropics of the process. 
In the contrasting second approach, it was envisaged that an intermolecular [2+2]-
cycloaddition reaction between cyclooctenone 2.7 and a suitable alkene would allow for the 
formation of the requisite four-membered ring as embodied within adduct 2.8. The key eight-
membered ring-containing compound 2.7 could be constructed using a ring closing metathesis 
reaction as the pivotal step.106 Once again, the formation of this challenging medium-sized ring 
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would be assisted by the presence of both the acetonide and a bulky TBS-ether protecting 
groups. 
The outcomes of the relevant sets of studies are presented in the following sections. 
 
Scheme 2.2.  Synthetic Approaches to the Eastern Hemisphere of ent-Tripartilactam. 
 
Chapter Two Synthetic Approaches to the Eastern Hemisphere of Tripartilactam 
 
 
52 
 
2.3. Exploring an Intramolecular [2+2]-Cycloaddition Approach 
2.3.1. Preparation of an Allene Precursor 
In order to investigate the possibility of performing an intramolecular [2+2]-
cycloaddition reaction as the means for obtaining the bicyclo[6.2.0]decane moiety associated 
with the Eastern Hemisphere of tripartilactam, the necessary substrates were prepared as 
delineated in Schemes 2.3–2.5 shown immediately below. First, 3-chloro-cis-1,2-
dihydrocatechol 2.3 was treated (Scheme 2.3) with N-bromosuccinimide in aqueous 
tetrahydrofuran and the resulting bromotriol converted into the corresponding acetonide 2.9107 
(74% from 2.3) by treating it with 2,2-dimethoxypropane and a catalytic amount of p-
toluenesulfonic acid. Reaction of bromohydrin 2.9 thus formed with sodium hydride then 
provided epoxide 2.10107 in 85% yield. Regioselective reductive cleavage of this epoxide using 
di-iso-butylaluminium hydride (DIBAl-H), wherein hydride added to the allylic carbon, 
afforded the homoallylic alcohol 2.11 (95%) as a crystalline solid, the structure of which was 
secured by single-crystal X-ray analysis (Figure 2.3). Protection of this alcohol as the 
corresponding TBS-ether 2.12 (using tert-butyldimethylsilyl chloride and imidazole, 97%) and 
submission of the latter to oxidative cleavage through exposure to ozone in the presence of 
methanol then reductive work-up (with triphenylphosphine) provided the ω-oxo-ester 2.13 in 
77% yield.  
 
Scheme 2.3.  Reagents and Conditions (i) a) NBS, THF/H2O (4:1 v/v), 0 to 18 °C, 4 h; b) (MeO)2CMe2, p-
TsOH, THF, 18 °C , 2 h; (ii) NaH, THF, 0 to 18 °C, 2 h; (iii) DIBAl-H, Et2O, −40 to 0 °C, 3 h; (iv) TBS-Cl, 
imidazole, DMF, 18 °C, 4 h; (v) O3, pyridine, DCM/MeOH (4:1 v/v) then PPh3, 18 °C, 2 h. 
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The manner in which the ozonolytic cleavage of unsaturated compounds proceeds was 
originally suggested by Criegee108 and involves three discrete steps. In the case of compound 
2.13, 1,3-dipolar cycloaddition of ozone to the double bond (Scheme 2.4) results in the primary 
ozonide (molozonide) 2.12a. Due to the presence of the chlorine atom, the fragmentation of 
the molozonide probably occurs through the indicated pathway to give carbonyl oxide 2.12b. 
In the presence of methanol, this last species reacts to give hyperoxide 2.12c and elimination 
of the elements of hydrochloric acid from this then gives intermediate 2.12d.  
An intramolecular 1,3-dipolar cycloaddition reaction of the carbonyl oxide moiety to the 
tethered aldehyde then affords the secondary ozonide 2.12e. Finally, on treatment with 
triphenylphosphine this ozonide fragments to give the observed ω-oxo-ester 2.13. 
 
Scheme 2.4.  Reaction Pathway for the Ozonolytic Cleavage of Chlorocyclohexene 2.12 to give Product 2.13. 
A single-crystal X-ray analysis of ω-oxo-ester 2.13 served to confirm the assigned 
structure. The derived ORTEP is shown in Figure 2.3. 
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(black = C, red = O, purple = Si, green = Cl, grey = H) 
Figure 2.3.  Plots Arising from the Single-Crystal X-ray Analyses of Alcohol 2.11 and ω-oxo-Ester 2.13. 
Treatment of compound 2.13 with ethynylmagnesium bromide at −78 °C (Scheme 2.5) 
gave a 1:0.4 mixture of the epimeric and chromatographically separable α- and β- forms of 
propargylic alcohol 2.14 in 95% combined yield. An increase in the reaction temperature from 
−78 to −15 °C led to an erosion of the preference for the formation of epimer 2.14α (1:0.7 ratio 
of α/β epimers). Further increases in temperature were not investigated due to the possibility 
of the newly formed alcohol adding to the pendant methyl ester given that such a lactonisation 
process was observed in the reaction of this aldehyde with vinylmagnesium bromide.b On the 
basis that each of these epimers could, in principle, be exploited in the proposed synthetic 
sequence (since the alcohol would be oxidised to the corresponding ketone at a later stage) 
subsequent studies were carried out on each of the diastereomerically pure compounds 2.14α 
and 2.14β. This needed to commence with protection of the propargylic alcohol residue. The 
protecting group to be used had to be orthogonal to the ones already present and not 
exceedingly bulky as it might otherwise inhibit the foreshadowed cycloaddition process. 
Furthermore, this same group should be capable of installation without the need to use a strong 
base (in order to prevent lactonisation and/or the isomerisation of the acetonide moiety). The 
p-methoxybenzyl ether (PMB) group was thus chosen as it could be installed under mild 
conditions using p-methoxybenzyl trichloroacetimidate (2.15, PMBTCA)109 in combination 
with catalytic amounts of Ph3C
+BF4
−. Unfortunately, the reaction proved to be very slow and 
low yielding (25–30%) at 18 °C and the temperature could not be increased to accelerate the 
process due to the instability of the reagent. In contrast, when 2-(4-methoxybenyloxy)-4-
methylquinoline 2.16 (PMBO-lepidine)110 (Scheme 2.6) was used in combination with (+)-
                                                 
b Such lactonisation processes are discussed in Section 3.4 
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camphor-10-sulfonic acid (CSA) (cat.) in refluxing dichloromethane, the desired and protected 
alcohol 2.17 was readily obtained (in 90% yield for 2.17α and 83% yield for 2.17β). 
 
Scheme 2.5.  Reagents and Conditions (i) HC≡CMgBr, Et2O, −78 to −15 °C, 1 h; (ii) PMBO-lepidine (2.16), 
CSA (cat.), DCM, 40 °C, 16 h. 
The use of 2-((4-methoxybenzyl)oxy)-4-methylquinoline (PMBO-lepidine), 2.16, 
(Scheme 2.6) as an acetimidate surrogate for transferring the p-methoxybenzyl protecting 
group onto an hydroxyl center was established by Dudley110 in 2006. The reagent is easily 
prepared by heating (at reflux for one hour) a mixture of p-methoxybenzyl alcohol, 2-
chlorolepidine and potassium hydroxide with accompanying (azeotropic) removal of water. 
Lepidine ether 2.16 is more stable and easier to handle than its PMBTCA-containing 
counterpart 2.15. The in situ activation of PMBO-lepidine 2.16 (into 2.16a) is effected in the 
presence of a catalytic amount of camphorsulfonic acid, an event that is followed by 
nucleophilic substitution of the alcohol to provide the desired product (along with lepidone that 
can be easily removed by flash chromatography). 
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Scheme 2.6.  Preparation of PMBO-Lepidine (2.16) and the Likely Mechanism for its Use in the Introduction 
of PMB-Ether Protecting Group.  
To advance the synthesis, each of the terminal alkynes 2.17α and 2.17β was subjected 
to the Searles-Crabbé allene-forming protocol111 (Scheme 2.7) using paraformaldehyde, 
copper(I) iodide and di-iso-propylamine and so providing the target allenes 2.18α and 2.18β in 
78% and 85% yields, respectively. Interestingly, the use of copper(I) bromide led to dimeric 
coupling of the terminal alkyne starting material and thus giving diyne 2.19α/2.19β as the major 
product under such conditions.112 
 
Scheme 2.7.  Reagents and Conditions (i) (CHO)n, CuI, i-Pr2NH, dioxane, 100 °C, 24 h. 
Although the mechanism for such dimerisation reactions is not fully understood, the 
one proposed by Bohlmann et al. is the most widely accepted.113 This pathway starts with the 
copper(I) ion activation of the terminal alkyne through deprotonation to form a monomeric π-
Chapter Two Synthetic Approaches to the Eastern Hemisphere of Tripartilactam 
 
 
57 
 
complex. The combination of two of these gives dimer 2.19a (Scheme 2.8) that, while 
stabilised by the added amine, eventually collapses to the homocoupled product. By using 
copper(I) iodide that is minimally contaminated with a copper(II) species, allene formation 
occurs, presumably via the illustrated two-step mechanism (Scheme 2.8). The first step 
involves reaction of the cuprous acetylene with the iminium ion derived from the reaction of 
di-iso-propylamine with paraformaldehyde and so affording intermediate 2.18a. Next, a 1,5-
sigmatropic shift of the α-hydrogen from the N-isopropyl group onto the π-complexed 
copper(I) 2.18b takes place and this is converted into intermediate 2.18c that itself fragments 
in the indicated manner to give the observed allene.  
 
Scheme 2.8.  Mechanism for the Formation of Dimerisation and Allene Products. 
Separate treatment of the methyl esters 2.18α and 2.18β with N,O-
dimethylhydroxylamine hydrochloride salt in the presence of iso-propylmagnesium chloride at 
−15 °C (Scheme 2.9) produced the corresponding and crystalline Weinreb amides 2.20α (86%) 
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and 2.20β (77%) and the structures of both of these were confirmed by single-crystal X-ray 
analyses (Figure 2.4). 
 
Scheme 2.9.  Reagents and Conditions (i) HCl•HN(OMe)Me, i-PrMgCl, THF, −15 to 0 °C, 1 h. 
 
 
 
 
(black = C, red = O, purple = Si, blue = N, grey = H) 
Figure 2.4.  Plots Arising from the Single-Crystal X-ray Analyses of Weinreb Amides 2.20α and 2.20β. 
Reaction of Weinreb amide 2.20α with vinyl magnesium bromide (Scheme 2.10) 
delivered, after work up of the reaction mixture with a saturated aqueous solution of ammonium 
chloride, the target enone 2.5α (21%) as a minor product, the major one being β-aminoketone 
2.21α which was isolated in 57% yield. The latter product is no doubt formed through the 
conjugate addition of the N,O-dimethylhydroxylamine by-product to the enone moiety of the 
initially produced enone. Consistent with this, when the epimeric amide 2.20β was submitted 
to the same reaction conditions but 1.0 M aqueous hydrochloric acid was now used in the work-
up, then the desired enone 2.5β (71%) was isolated as the major product, although the related 
aminoketone 2.21β was still obtained in 14% yield. 
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Scheme 2.10.  Reagents and Conditions (i) H2C=CHMgBr, THF, −78 °C, 1 h. 
Figure 2.5 provides a comparison of the 1H NMR spectra of compounds 2.5α and 2.5β. 
These epimers share the same characteristic signals (four CH protons in the aromatic region 
and two germinal protons with large coupling constant, around 11.0 Hz) due to the presence of 
PMB-ether residues, the enone systems (three mutually coupling protons with two distinct 
coupling constant corresponding for trans coupling around 17.4 Hz and cis coupling around 
10.5 Hz), and the allene moieties (wherein the C16-H appeared as a quartet and the two 
germinal protons coupled around 11.0 Hz). The major differences between the two spectra are 
in the regions associated with the resonances arising from C15-H and C14-H2 (appearing as a 
quartet and an overlapped doublet of triplets, respectively, for 2.5α and appearing as a doublet 
of triplets and doublet of doublets of doublets, respectively, for 2.5β).  
 
Chapter Two Synthetic Approaches to the Eastern Hemisphere of Tripartilactam 
 
 
60 
 
 
Figure 2.5.  400 MHz 1H NMR Spectra of Enones 2.5α above and 2.5β below (each recorded in d-
chloroform). 
2.3.2. Attempts to Effect an Intramolecular [2+2]-Cycloaddition Reaction 
With allene-enone 2.5 finally in hand, the foreshadowed intramolecular [2+2]-
cycloaddition reaction was attempted under various conditions. However, all of these failed to 
produce the desired bicyclo[6.2.0]decane. Instead, when compound 2.5α was submitted to 
heating at 150 °C in N,N-dimethylformamide some decomposition was observed while a 
significant quantity of starting material was recovered. Microwave irradiation of an acetonitrile 
solution of substrate 2.5β failed to effect any reaction at 150 °C even after four hours while 
heating at 180 °C only led to decomposition. Successful thermally induced [2+2]-cycloaddition 
reactions of allenes have been rationalised as proceeding via a stepwise, diradical mechanism104 
and these usually require high temperatures (160 to 200 °C) as well as long reaction times in 
order to proceed. In the present case, due to the complex nature of the substrate, decomposition 
occurred when the temperatures normally required for the desired transformation were reached. 
Upon irradiation with a high-pressure mercury lamp, compound 2.5α remained unchanged 
while decomposition was observed for congener 2.5β under the same conditions. When 
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compound 2.5α was treated with Echavarren’s gold catalyst the associated PMB group was 
cleaved and the secondary alcohol so-formed cyclized to give the corresponding dihydrofuran.  
 
2.4. Exploring an Intermolecular [2+2]-Cycloaddition Approach 
Although compounds 2.5α/2.5β bear some resemblance to the Eastern Hemisphere of 
the putative biogenetic precursor, 1.7,c of tripartilactam, neither epimer could be elaborated, 
through an intramolecular [2+2]-cycloaddition reaction, to the targeted bicyclo[6.2.0]decane 
ent-2.4. Therefore, an alternate route to a chiral, polyoxygenated cyclooctenone incorporating 
the Eastern Hemisphere of tripartilactam was pursued wherein the eight-membered ring would 
be assembled first, and the cyclobutane ring then annulated via an intermolecular [2+2]-
cycloaddition process (see Scheme 2.2).  
2.4.1. Preparation of Cyclooctenone 2.25 
The starting point for this new approach to the Eastern Hemisphere began with the 
readily prepared ω-oxo-ester 2.13 obtained as described earlier (see Scheme 2.3). Thus, 
compound 2.13 was first subjected to Wittig olefination reaction (Scheme 2.11) with the ylide 
obtained by deprotonation of methyl triphenylphosphonium bromide and so affording the 
unsaturated ester 2.22 (76%) that was then converted into the corresponding Weinreb amide 
2.23 (92%) under standard conditions (as described in Section 2.3.1). Treatment of this amide 
with allylmagnesium bromide provided the rather sensitive β,γ-unsaturated ketone 2.24 which 
was partially isomerised to its conjugated counterpart 2.24’ during the course of attempted flash 
chromatographic purification. Accordingly, the crude ketone 2.24 was immediately engaged in 
a ring closing metathesis reaction (RCM) by treating it with the second-generation Grubbs’ 
catalyst,114 and so affording the expected cyclooctenone 2.25 (78% from 2.23). The illustrated 
assignments of the signals observed in the 1H NMR spectrum of 2.25 (Figure 2.6) were 
established using 1H/1H correlation spectroscopic (COSY) techniques while the 13C NMR 
spectrum (Figure 2.7) shows the expected eight signals corresponding to cyclooctenone moiety 
as well as the resonances arising from the protecting groups. The structure of this eight-
membered ring-containing compound was finally confirmed by single-crystal X-ray analysis 
(Figure 2.8).  
                                                 
c Described in Scheme 1.2, Chapter One. 
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Scheme 2.11.  Reagents and Conditions (i) (Ph3P+CH3)Br−, LiHMDS, THF, 0 to 18 °C, 2 h; (ii) 
HCl•HN(OMe)Me, i-PrMgCl, THF, −15 to 0 °C, 1 h; (iii) H2C=CHCH2MgBr, THF, −78 °C., 1h; (iv) Grubbs’ 
(II) cat., DCM, 40 °C, 16 h. 
 
Figure 2.6.  400 MHz 1H NMR Spectrum of Compound 2.25 (recorded in d-chloroform). 
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Figure 2.7.  100 MHz 13C NMR Spectrum of Compound 2.25 (recorded in d-chloroform). 
 
 
(black = C, red = O, purple = Si, grey = H) 
Figure 2.8.  Plots Derived from the Single-Crystal X-ray Analyses of Cyclooctenone 2.25.  
Having successfully established the polyoxygenated cyclooctenone core of 
tripartilactam, attention was now turned toward the elaboration of this material into a desired 
substrate for the pivotal [2+2]-cycloaddition reaction. 
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2.4.2. Elaboration of Cyclooctenone 2.25 
The substrate required for the [2+2]-cycloaddition reaction was sought by a two-step 
reaction sequence involving isomerisation of the β,γ-unsaturated ketone 2.25 to the conjugated 
enone 2.26 (Scheme 2.12) followed by allylic oxidation with selenium oxide to install a 
hydroxyl group at the γ-carbon. This hydroxyl group would eventually be eliminated so as to 
form the corresponding (Z)-alkene, a motif that would be retained in the final product. 
Unfortunately, treatment of ketone 2.25 with lithium hydroxide only led, in 90% yield, to an 
epimerisation product, namely compound 2.27,115 the structure of which was confirmed by 
single-crystal X-ray analysis (Figure 2.9).  
 
Scheme 2.12.  Reagents and Conditions (i) (LiOH, MeOH, 18 °C, 2 h; (ii) Pd(OAc)2, NaBO3.4H2O, Ac2O, ACN 
or 2.29, NaOAc, AcOH, Pd(OAc)2, O2, dioxane, 60 °C, 2 d. 
 
 
(black = C, red = O, purple = Si, grey = H) 
Figure 2.9.  Plots Derived from the Single-Crystal X-ray Analyses of Cyclooctenone 2.27.  
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As a result, palladium-acetate catalysed allylic C-H acetoxylation was attempted in the hope of 
obtaining the γ-acetate enone 2.28 (Scheme 2.12). However, no reaction occurred upon using 
sodium perborate as an oxidant and acetic anhydride as the source of nucleophile.116 
Furthermore, following the procedure of Stahl,117 using 4,5-diazafluorenone (2.29) as ligand, 
oxygen as the oxidant and a catalytic amount of sodium acetate, the epimerised product 2.27 
was once again the only observable product even after heating substrate 2.25 at 60 °C for two 
days.  
In order to prevent the unwanted epimerisation described above, a new route was 
pursued, this being inspired by a literature reports118 describing the formation of an epoxide 
from the alkene and then effecting its opening with a base. It was postulated that the opening 
of epoxide would be more favourable than the epimerisation of the acetonide. However, efforts 
to apply this process to compound 2.25 by subjecting it to various epoxidation conditions, only 
met with limited success. So, for example, epoxidation with m-chloroperoxybenzoic acid only 
gave 25 to 30% of the desired epoxide. Purification of the m-chloroperoxybenzoic acid before 
use or attempts to carry out the reaction in buffered media using sodium hydrogencarbonate 
also failed to improve matters. The use of hydrogen peroxide was also investigated but this 
only led to decomposition of the starting material.119 Gratifyingly, when cyclooctenone 2.25 
was treated (Scheme 2.13) with freshly prepared dimethyldioxirane (DMDO)120 a completely 
stereoselective and substrate-directed reaction ensued to give epoxide 2.30 (80%), the structure 
of which was confirmed by single-crystal X-ray analysis (Figure 2.10). Exposure of this 
epoxide to 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) resulted, presumably via an E1cb 
reaction pathway, in a fully regiocontrolled cleavage of the epoxide ring to form the γ-hydroxy-
α,β-unsaturated enone 2.31a. This product existed almost exclusively as the lactol 2.31b (as 
judged by the derived spectral data). Significantly, no epimerisation at the α-carbon appeared 
to have taken place during the conversion of epoxide 2.30 into lactol 2.31b. 
 
Scheme 2.13.  Reagents and Conditions (i) DMDO, DCM, 0 to 18 °C, 16 h; (ii) DBU, DCM, 18 °C, 4 h. 
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(black = C, red = O, purple = Si, grey = H) 
Figure 2.10.  Plots Derived from the Single-Crystal X-ray Analysis of Epoxide 2.30.  
It was envisioned that lactol 2.31b would serve as a precursor to a model substrate for 
an intramolecular photolysis reaction if it could be opened to reveal the enone moiety 
concurrently with derivatisation of the γ-hydroxyl group so as to install a chromophore. 
Accordingly, the lactol was heated in dichloromethane with cinnamoyl chloride and pyridine 
in the presence of 4-(N,N-dimethylamino)pyridine (DMAP) for two days. As hoped, the desired 
enone 2.32 (68%) (Scheme 2.14) was obtained as a major product (its structure was confirmed 
by single-crystal X-ray analysis - see Figure 2.11), although it was accompanied by the related 
acetal 2.33 (19%). Disappointingly, separate irradiation of each of these products in degassed 
acetonitrile in a quartz flask using a commercially available UV-C lamp for two hours did not 
afford any of the desired [2+2]-cycloaddition products. Decomposition was observed when 
enone 2.32 was used as the substrate and recovered starting material was obtained in the case 
of acetal 2.33. 
 
Scheme 2.14.  Reagents and Conditions (i) cinnamoyl chloride, DMAP, pyridine, DCM, 40 °C, 48 h; (ii) UV-
C, 18 °C, ACN, 2 h. 
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(black = C, red = O, purple = Si, grey = H) 
Figure 2.11.  Plot Derived from the Single-Crystal X-ray Analysis of Enone 2.32. 
For the purpose of preparing a substrate suitable for an intermolecular [2+2]-
cycloaddition reaction, lactol 2.31b was converted into acetate 2.36 (85%) (Scheme 2.15) 
under the same conditions as used for the formation of compound 2.32. The most significant 
features observed in the 1H NMR spectrum of compound 2.36 (Figure 2.12) were the 
resonances associated with the enone moiety. The lower field resonance was attributed to C16-
H and appeared at δ 6.24 as a doublet of doublets (J = 12.9 and 5.9 Hz) while the other doublet 
of doublets resonating at δ 6.05 (J = 12.9 and 2.2 Hz) was assigned to C9-H. The signal at δ 
5.85 was assigned to C15-H as expected for an oxymethine proton on an sp3-hybridised carbon 
bearing an acetate group. The 13C NMR spectrum (Figure 2.13) also provided strong evidence 
for the assigned structure, which was finally confirmed by single-crystal X-ray analysis. The 
derived ORTEP is shown in Figure 2.14. The possibility of effecting a thermal syn-elimination 
within compound 2.36 so as to generate the (Z)-alkene 2.38 was explored.121 However, the use 
of flash vacuum pyrolytic (FVP) techniques at 400 °C only led to the recovery of the starting 
material while raising the temperature to 500 °C resulted in the onset of decomposition 
processes. In an effort to investigate other modes of thermally-induced elimination, lactol 2.31b 
was treated with phenyl thionochloroformate. Although only a small amount of the anticipated 
thiocarbonate 2.37 was obtained this could be submitted to FVP at 300 °C. The product mixture 
obtained appeared to contain the desired dienenone 2.38 (as judged by 1H NMR analysis) and 
this is presumably formed by the pathway shown in the inset associated with Scheme 2.15.122 
Although this product could not be completely characterised, the possibility of installing the 
(Z)-olefin by such means had been established. Efforts were then undertaken to test the 
intermolecular [2+2]-cycloaddition reaction. 
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Scheme 2.15.  Reagents and Conditions (i) (CH3CO)2O, DMAP, pyridine, DCM, 40 °C, 24 h; (ii) 
thionochloroformate, DMAP, pyridine, DCM, 40 °C, 48 h.  
 
Figure 2.12.  400 MHz 1H NMR Spectrum of Acetate 2.36 (recorded in d-chloroform). 
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Figure 2.13.  100 MHz 13C NMR Spectrum of Acetate 2.36 (recorded in d-chloroform). 
 
 
(black = C, red = O, purple = Si, grey = H) 
Figure 2.14.  Plots Derived from the Single-Crystal X-ray Analysis of Acetate 2.36. 
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2.4.3. Attempts to Effect an Intermolecular [2+2]-Cycloaddition Reaction 
Notwithstanding the failure to effect an intramolecular [2+2]-cycloaddition as 
described in previous sections, an intermolecular photocycloaddition reaction was explored. 
To such ends, a solution of acetate 2.36 and ethyl vinyl ether in degassed acetonitrile contained 
in a quartz flask (Scheme 2.16) was irradiated with high-pressure mercury lamp (UV-C) for 
two hours. Disappointingly, neither of the hoped-for photoproducts 2.8a or 2.8b was detected. 
The substrate enone simply decomposed under the reaction conditions used.  
 
Scheme 2.16.  Reagents and Conditions (i) UV-C, 18 °C, ACN, 2 h. 
At this stage, it was decided to investigate the possibility of effecting a [2+2]-
cycloaddition reaction between an unconjugated alkene and a ketene. Cyclooctenone 2.25 was 
chosen as the substrate with which to explore this possible transformation. On heating at 110 
°C with propionyl chloride and triethylamine in toluene, no reaction was observed, even after 
a full day. When the same reagent/reactant combination was submitted to microwave 
irradiation in dichloromethane, the exo-methylenated product 2.40 (80%) was, rather 
unexpectedly, isolated instead of the desired adducts 2.39a or 2.39b (Scheme 2.17). A control 
experiment was undertaken in the absence of propionyl chloride and compound 2.40 was again 
obtained, this time in 87% yield. 
 
Scheme 2.17: Reagents and Conditions (i) propionyl chloride, Et3N, DCM, 100 °C, µW, 4 h. 
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There is some literature precedent for this methylenation reaction. Hon and co-workers 
have shown that on using 1,2-dibromomethane (CH2Br2) and diethylamine (Et2NH) in 
dichloromethane the α-methylenation of a range of substrates takes place in varying yields.123 
They rationalised this outcome as shown in Scheme 2.18 and wherein initial formation of an 
iminium ion, through reaction of diethylamine with dibromomethane occurs and this ion, in 
turn, reacts with the added and enolizable carbonyl compound to form a Mannich base. 
Following deamination of the resulting β-diethylamino ketone, the α-methylenated products 
are finally formed. Presumably a somewhat related but new pathway, involving formation of 
chlorocarbene (rather than an iminium ion), applies in the case of the conversion 2.25 → 2.40.  
 
Scheme 2.18.  Proposed Mechanism for the Formation Methylenation Product. 
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2.5. Conclusion 
The eight-membered ring-containing compounds 2.25, 2.32 and 2.36 (Figure 2.15), 
each of which embodies the polyoxygenated cyclooctene-containing Eastern Hemisphere of 
ent-tripartilactam, were synthesised from a readily available and homochiral 3-chloro-cis-1,2-
dihydrocatechol. Several X-ray structures were obtained to confirm the structures of these 
compounds. In light of the lack of the participation of these compounds, and the acyclic 
congener 2.5, in any productive inter- or intra-molecular [2+2]-cycloaddition process, an 
alternative strategy was required for the assembly of the Eastern Hemisphere of tripartilactam. 
Details of such a new approach are presented in the following Chapters. 
 
Figure 2.15.  Eight-Membered Ring-Containing Compounds Embodying Eastern Hemisphere of ent-
Tripartilactam. 
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3.1. The Basic Strategy 
Owing to the difficulties encountered with the approach to tripartilactam outlined in the 
preceding Chapter, a new one was considered necessary. The proposal that the macrolactam 
1.7 is transformed, during the course of the biogenesis of tripartilactam 1.1, through a 
transannular [2+2]-cycloadditon reaction into the natural product prompted the author to 
attempt to mimic this process.2 On this basis, the alkyne-containing lactam 3.1 (Scheme 3.1) 
was thought to be a logical precursor to macrolactam 1.7 in that semi-reduction of the alkyne 
moiety associated with the former compound (3.1) would deliver its dihydro-counterpart (1.7). 
 
Scheme 3.1.  Revised Synthetic Approach to Tripartilactam that Exploits a Transannular [2+2]-
Cycloaddition Reaction. 
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3.2. Retrosynthetic Analysis and Identification of Key Fragments 
The retrosynthetic plan formulated for the generation of compound 3.1 is outlined in 
Scheme 3.2. Disconnections of the lactam bond, the C7–C8 σ-bond, the C14–C15 (Z)-olefinic 
bond and the C21–C22 σ-bond reveal four sub-structures A, B, C and D. It was envisioned that 
a Suzuki cross-coupling reaction could be used to connect fragments A and B, thus providing 
a compound that embodies the Southern Hemisphere of the macrolactam 3.1. The Δ14,15-(Z)-
olefin associated with this target would be installed along with fragment C by employing a 
Julia olefination reaction,124 and the complete but uncyclised form of macrolactam 3.1 would 
finally arise from a Stille cross-coupling reaction involving fragment D and this would be 
followed by a thermally induced macrolactamisation reaction. In this plan, it is important to 
note that by using the same starting material as featured in the previous approach, namely the 
3-chloro-cis-1,2-dihydrocatechol 2.3, for the formation of fragment B then the natural 
enantiomeric form of macrolactam 3.1 should be accessible. It is also noteworthy that the 
configuration at C10 (in B) is not relevant as the alcohol at this position would be oxidised to 
the corresponding ketone at a later stage. The preparations of synthons A, B, C and D central 
to this approach are described in the following sections. 
 
Scheme 3.2.  Key Building Blocks (Fragments) Associated with the Assembly of Macrolactam 3.1. 
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3.3. Synthesis of Fragment A 
3.3.1.  Synthesis of the Corresponding Alkenyl Iodide 3.2 
The convergent assembly of this first key subunit appeared straightforward and was 
thought achievable via a Horner-Wadsworth-Emmons (HWE) olefination reaction between 
phosphonate 3.3 and aldehyde 3.4 (Scheme 3.3) so as to install the (E)-configured double bond 
between C4 and C5. Borylation of the alkenyl iodide 3.2 would then deliver fragment A. The 
1,3-dioxinone moiety associated with target 3.2 was chosen in the construction of this coupling 
partner because: 
i. the carbonyl moieties are protected in a manner that should allow for the use of 
lithium di-iso-propylamine to effect the necessary lithiation and chlorination steps 
required for the preparation of phosphonate 3.3. 
ii. thermolysis of this functionalised 1,3-dioxinone would generate, in situ, a highly 
reactive acylketene species that could be trapped by either added or internal 
nucleophiles.125 
 
Scheme 3.3: Retrosynthetic Analysis of Alkenyl Iodide 3.10. 
The synthesis began with the preparation of phosphonate 3.3 following the procedure 
of Boeckman and Thomas (Scheme 3.4).126 So, the known dioxinone 3.5 was deprotonated 
with lithium di-iso-propylamine (LDA) at −78 °C and the resulting anion quenched with 
hexachloroethane at −50 °C to afford chloride 3.6 in 72% yield. This last compound was 
converted into the corresponding phosphonate 3.3 (96%) by treating it with the sodium salt of 
diethyl phosphite at room temperature.  
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Scheme 3.4.  Reagents and Conditions (i) LDA, C2Cl6, THF, −78 to −50 °C; (ii) NaH, (EtO)2P(O)H, THF, 
DMF, 0 to 18 °C.  
The aldehyde 3.4 (Scheme 3.5) to be coupled with phosphonate 3.3 was prepared by 
first treating diethyl 2-methylmalonate (3.7) with diiodocarbene (generated in situ by reaction 
of iodoform and sodium hydride) in refluxing ether.127 The resulting carbene insertion product, 
namely diethyl di-iodomethylmethylmalonate (3.8), was itself converted into (E)-3-iodo-2-
methylacrylic acid (3.9) (79% over 2 steps) through successive saponification (with potassium 
hydroxide) and decarboxylation reactions, the latter being effected by refluxing the 
intermediate acid in ethanol-water. Reduction of compound 3.9 with lithium aluminium 
hydride furnished the allylic alcohol 3.10 (90%) that was oxidised with manganese dioxide to 
3-iodomethacrolein (3.4). This was obtained in 87% yield. The foreshadowed Horner-
Wadsworth-Emmons (HWE) olefination reaction involved generating the anion of 
phosphonate 3.3 (through reaction with sodium hydride) and then treating this with acrolein 
3.4 and so generating the alkenyl iodine 3.2 (76%). This product was obtained exclusively as 
the (E)-isomer, as evident from a 15.5 Hz coupling observed between C4-H and C5-H in the 
1H NMR spectrum (Figure 3.1). 
 
Scheme 3.5.  Reagents and Conditions (i) NaH, CHI3, Et2O, 35 °C, 20 h; (ii) KOH, EtOH-H2O, 100 °C, 16 h; 
(iii) LiAlH4, Et2O, 0 to 18 °C, 4 h; (iv) MnO2, DCM, 18 °C, 4 h; (v) NaH, THF, −78 to 18 °C, 1 h. 
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Figure 3.1.   400 MHz 1H NMR Spectrum of Alkenyl Iodide 3.2 (recorded in d-chloroform). 
 
3.3.2. Borylation of Alkenyl Iodide 3.2 
With alkenyl iodide 3.2 in hand, the Miyaura borylation of this material was 
investigated in efforts to prepare fragment A, namely 3.11, (Scheme 3.6) required in the Suzuki 
cross-coupling reaction planned for the assembly of the Southern Hemisphere of macrolactam 
3.1. This transformation turned out to be challenging. So, for example, heating a mixture of 
compound 3.2, pinacol borane, triethylamine, 1,1'-bis(diphenylphosphino)ferrocene-
palladium(II)-dichloride dichloromethane complex in dioxane at 80 °C for sixteen hours did 
not provide the desired product. Rather, a complex reaction mixture was observed. Similarly, 
using bis(pinacolato)-diboron and potassium acetate128 also only led to complex reaction 
mixtures under the same conditions. These outcomes may result from the sensitivity of the 1,3-
dioxinone moiety to both base and heat. 
 
Scheme 3.6.  Reagents and Conditions (i) pinacol borane, PdCl2(dppf)•CH2Cl2, Et3N, dioxane, 80 °C, 16 h; or 
bis(pinacolato)diboron, PdCl2(dppf)•CH2Cl2, KOAc, dioxane, 80 °C, 16 h. 
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In light of these difficulties, it was concluded that the Suzuki-Miyaura cross-coupling 
reaction could not be used to connect fragments A and B. As such, a Stille cross-coupling 
reaction was planned instead and wherein a stannane moiety could be associated with either 
fragment A or B (both options shown in Scheme 3.7). Accordingly, attention turned to the 
preparation of stannane B (see option 1) in the first instance. 
 
Scheme 3.7.  Stille Cross-Coupling Reaction for Connection of Fragments A and B. 
 
3.4. Synthesis of Fragment B 
3.4.1. Preparation of the Pivaloate-Protected Fragment B 
The synthesis of the revised form of fragment B started with the readily accessible 
epoxide 2.10 (prepared as described in Section 2.3.1) that was regioselectively opened with 
acetic acid and a catalytic amount of phosphoric acid to deliver diol mono-acetate 3.12 (73%) 
(Scheme 3.8). The associated alcohol was protected as a pivaloate 3.13 (82%) under 
conventional conditions and this was subjected to ozonolysis in the presence of methanol. After 
reductive work-up with triphenylphosphine the rather unstable aldehyde 3.14 was obtained. 
Immediate submission of this aldehyde to a Takai olefination reaction using anhydrous 
chromium chloride and iodoform then afforded the alkenyl iodide 3.15 in 45% yield (over the 
two steps from precursor 3.13).  
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Scheme 3.8.  Reagents and Conditions (i) H3PO4 cat., acetic acid, 18 °C, 4 h; (v) Piv-Cl, DMAP, Et3N, DCM, 
−0 to 18 °C, 16 h; (vi) ozone, pyridine, DCM/MeOH (4:1 v/v), −78 °C, then PPh3, 18 °C, 1 h; (vii) CrCl2, CHI3, 
THF, 18 °C, 16 h. 
With compound 3.15 in hand, it was decided to pursue a method for the formation of 
the Δ14,15-(Z)-olefinic residue within target 3.1 (see Scheme 3.1) before converting the alkenyl 
iodide into the alkenyl stannane. In order to do so, the methyl ester moiety within compound 
3.15 had to be reduced to the corresponding aldehyde, perhaps by using di-iso-butylaluminium 
hydride. Prior to carrying out such an operation, the acetate residue within compound 3.15 
needed to be replaced by another protecting group that was stable to the reducing conditions 
being contemplated. However, treatment of acetate 3.15 (Scheme 3.9) with potassium 
carbonate in methanol failed to give the selectively deprotected alcohol. Indeed, both the 
acetate and pivaloate ester units were cleaved when this reagent was employed and 
lactonisation then followed. While the use of aqueous ammonia led to the desired alcohol, the 
formation of this was accompanied by amide formation to give compound 3.16 (87%). 
Gratifyingly, it was found that using magnesium methoxide allowed for cleavage of the acetyl 
group, although this newly formed alcohol then cyclised to give lactone 3.17 in 70% yield and 
reaction of this lactone with di-iso-butylaluminium hydride led to the deprotected lactol 3.18 
(77%). The generation of lactone 3.17 and lactol 3.18 as just described established that the 
pivaloate could not serve as a suitable protecting group in this particular instance. Accordingly, 
the use of the TBS-ether was explored as an alternative. 
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Scheme 3.9.  Reagents and Conditions (i) NH4OH, MeOH, 18 °C, 4 h; (ii) Mg(OMe)2, THF, 18 °C, 4 h; (iii) 
DIBAl-H, DCM, −78 °C, 30 min.  
 
3.4.2. Preparation of the TBS-Ether-Protected Fragment B 
It was thought the lactonisation “issue” encountered during the course of the studies 
described immediately above could be circumvented by switching from an acetate to a PMB-
ether protecting group. Accordingly, regioselective ring-opening of the epoxide 2.10 (Scheme 
3.10) with p-methoxybenzyl alcohol and a catalytic amount of copper(II) tetrafluoroborate was 
carried out and the alcohol 3.19 (71%) so obtained was then protected as the TBS-ether 3.20 
(97%) under conventional conditions. Disappointingly, exposure of compound 3.20 to ozone 
only gave a complex reaction mixture even when using Sudan III dye as indicator to detect the 
point at which oxidative cleavage of olefin had taken place without the benzyl ether beginning 
to react.129  
 
Scheme 3.10.  Reagents and Conditions (i) PMB-OH, Cu(BF4)2, DCM, 18 °C, 6 h; (ii) TBS-Cl, imidazole, 
DMF, 18 °C, 2 h; (iii) ozone, pyridine, DCM/MeOH (4:1 v/v), −78 °C, then PPh3, 18 °C, 1 h. 
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Given the last result, it was decided to follow the previously established sequence 
starting with protection of the alcohol 3.12 (Scheme 3.11) as a TBS-ether 3.22 (94%) using 
conventional conditions. Submission of this product to ozonolysis followed by Takai 
olefination of the aldehyde so-formed furnished the alkenyl iodide 3.24 in 55% over the two 
steps. Finally, cleavage of the acetate followed by reduction of the ensuing lactone 3.25 
afforded the lactol 3.26 as a 3:7 mixture of diastereomers which was obtained in 91% combined 
yield.  
 
Scheme 3.11.  Reagents and Conditions (i) TBS-Cl, imidazole, DMF, 18 °C, 2 h; (ii) ozone, pyridine, 
DCM/MeOH (4:1 v/v), −78 °C, then PPh3, 18 °C, 1 h; (iii) CrCl2, CHI3, THF, 18 °C, 16 h; (iv) Mg(OMe)2, THF, 
18 °C, 4 h; (v) DIBAl-H, DCM, −78 °C, 30 min.  
 
3.4.3. Attempts to Manipulate Lactol 3.26 
Although the formation of lactol 3.26 was unexpected, it was still considered to have 
potential in the construction of fragment B. In particular, it could be deprotonated to reveal the 
corresponding alkoxy aldehyde that could then be quenched with pivaloyl chloride to provide 
compound 3.27 (Scheme 3.12). Unfortunately, when seemingly relevant conditions were 
employed only the “protected” lactol 3.28 (70%) was observed. Other attempts to open this 
lactol failed to give the desired product. For example, submission of it to a Wittig olefination 
reaction only led to the recovery of starting material rather than the formation of alkene 3.29. 
Attempted homologation of the lactol using trimethylsilyldiazomethane130 did not provide any 
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of the desired product, 3.30. Only small amounts of TMS-protected lactol 3.31 were observed. 
Using the Bestmann-Ohira reagent 3.32 only provided a minor amount of the desired product 
3.30, the major one being TBS-deprotected lactol 3.18.  
 
Scheme 3.12.  Reagents and Conditions (i) Piv-Cl, Et3N, DMAP, DCM; (ii) Ph3P=CH2, n-BuLi; THF (iii) 
TMSCHN2, LDA, THF; (iv) 3.32, K2CO3, MeOH. 
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5. Conclusion 
The alkenyl iodide 3.2 representing fragment A was successfully prepared by a 
straightforward sequence from two commercially available materials, namely dioxinone 3.5 
and diethyl 2-methylmalonate 3.7 (Scheme 3.13). During the course of efforts to prepare 
fragment B, an unwanted lactonisation reaction thwarted efforts to secure the target compound. 
An alternate approach to this key building block was required and one is detailed in the next 
Chapter. 
 
Scheme 3.13.  Summary of Work Described in this Chapter (Three). 
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4.1. Retrosynthetic Analysis 
The problems encountered during the course of the work described in Chapter Three 
prompted a re-evaluation of the approach to be taken in attempting to prepare lactam 1.7. 
Specifically, it was now planned to synthesise macrolactam 1.7 by a pathway in which the C14-
C15 (Z)-double bond, rather than the neighbouring (C16-C17) one, was obtained through a 
stereoselective semi-reduction of an acetylene linkage as seen, for example, in potential 
precursor 4.1 (Scheme 4.1). Such a step has some literature precedent.131 As with the first 
approach, the (Z,Z)-diene 1.7 would be used as the substrate with which to perform the pivotal 
transannular and biomimetic [2+2]-cycloaddition reaction. 
 
Scheme 4.1. Revised Strategy. 
A possible route to macrolactam 4.1 is shown in retrosynthetic form in Scheme 4.2. 
Thus, a Stille cross-coupling reaction would be used to establish the C7–C8 σ-bond and this 
would be followed by thermally-induced amide formation to attach fragment C and, finally, an 
alkyne ring-closing metathesis reaction to establish the macrocycle. This approach would 
require the synthesis of three key building blocks, namely alkenyl iodide A, alkenyl stannane 
B, and tetra-enyne C. The straightforward formation of fragment A (3.2) has already been 
described in Section 3.2.1. It was decided to employ an inexpensive and readily available 
starting material, D-ribose, for the preparation of fragment B as a replacement for 3-chloro-cis-
1,2-dihydrocatechol 2.3. A major motivation for doing so is that the natural enantiomeric form 
of macrolactam 4.1 would be accessible by this means. The constructions of the crucial 
synthons B and C associated with this approach are described in the following sections. 
 
Chapter Four Second-Generation Approach to a Substrate for Macrolactamisation  
 
 
90 
 
 
Scheme 4.2.  Key Building Blocks (Fragments) Associated with the Assembly of Macrolactam 4.1. 
 
4.2. Synthesis of Fragment B and its Connection to A 
4.2.1. From D-Ribose to Lactol 4.2 
As noted above, it was anticipated that the stannane-containing fragment B could be 
synthesised from D-ribose. The reaction sequence started with treatment of this inexpensive 
starting material with acetone in the presence of catalytic quantity of sulfuric acid and so giving 
acetonide 4.2 in quantitative yield (Scheme 4.3). Reduction of this lactol with sodium 
borohydride followed by oxidative cleavage of the ensuing vicinal diol residue using sodium 
periodate then provided the lactol 4.3132 in 75% yield. Lactol 4.3 is a well-known chiron that 
reacts with a range of nucleophiles to give adducts of value in natural product synthesis.133 It 
has, for example, been treated with vinylmagnesium bromide in the synthesis of (−)-gabosine 
C133a or with iso-propenylmagnesium bromide for the construction of tetracyclic core of 
resiniferatoxin.133b In addition, subjection of this masked aldehyde to Wittig olefination 
provided an intermediate employed in Bantu’s synthesis of sapinofuranone A.133c Moreover, 
treatment of this lactol with n-butylamine delivered a lactamine that underwent nucleophilic 
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addition with vinylmagnesium bromide to give an alcohol that could be further elaborated to 
1,4-dideoxy-1,4-imino-D-allitol.133d 
 
Scheme 4.3.  Preparation of Lactol 4.3 and Examples of its Application in Natural Product Synthesis. 
Reagents and Conditions (i) acetone, H2SO4 (cat.); 18 °C, 4 h (ii) a) NaBH4, MeOH, 0 to 18 °C, 16 h; b) NaIO4, 
t-BuOH-H2O, 18 °C, 16 h. 
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4.2.2. Preparation of Alkenyl Stannane 4.9 
As the first step in the synthesis of building block 4.9, lactol 4.3 was reacted (Scheme 
4.4) with 1-propynylmagnesium bromide to afford the ring-opened diol 4.4 as a single 
diastereoisomer. The newly generated stereocentre within compound 4.4 is anti-related to the 
adjacent acetonide-associated centre of chirality,d an outcome that can be accounted for by 
invoking the chelation-controlled addition process shown in the inset of Scheme 4.4. Thus, the 
first equivalent of the Grignard reagent acts as a base to reveal the corresponding carbonyl and 
γ-alkoxy groups with the latter chelating to magnesium bromide. The second equivalent of the 
1-propynyl anion attacks the carbonyl group from the less hindered face to deliver the observed 
diastereoisomer 4.4. Related arguments have been advanced by Moon134 and Rao135 to account 
for the diastereoselective reactions they observed in similar systems. 
 
Scheme 4.4.  Reagents and Conditions (i) H3CC≡CMgBr, THF, 0 °C, 1 h. 
The 1H NMR spectrum (Figure 4.1) of the product obtained from this reaction clearly 
indicated the formation of a single compound. The lowest field signal at δ 4.40 is a doublet of 
quartets (J = 6.7 and 2.2 Hz) and assigned to C13-H. This resonance couples to the signal at δ 
4.13 (due to C12-H) that appears as a doublet of doublets (J = 6.7 and 6.5 Hz). The spectrum 
also displays the ABX spin system anticipated for the C10-H2 methylene protons (JAB = 11.7 
Hz, JAX = 4.8 Hz, JBX = 6.5 Hz) which allowed for the assignment of the resonance at δ 4.30, 
that appears as a triplet of doublets (J = 6.5 and 4.8 Hz), to C11-H. The methyl doublet at δ 
                                                 
d The stereochemistry at this newly formed stereogenic center was confirmed by single-crystal X-ray analysis of 
derivative 5.3 (see Section 5.2.1). 
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1.88 (J = 2.2 Hz, long range coupling to C13-H) was assigned to the methyl capped-alkyne 
unit. The protons of the diastereotopic acetonide methyl groups resonate as separate three-
proton singlets at δ 1.49 and 1.40. 
 
Figure 4.1.  400 MHz 1H NMR Spectrum of Diol 4.4 (recorded in d4-methanol). 
The primary alcohol residue within compound 4.4 was selectively protected (Scheme 
4.5) as the corresponding pivaloate 4.5 [using pivaloate chloride, 4-(N,N)-dimethylamino-
pyridine (DMAP) and trimethylamine, 83%] while the secondary alcohol was then converted 
into TBS-ether 4.6 (using tert-butyldimethylsilyl chloride and imidazole, 83%). Removal of 
the pivaloate protecting group was achieved by treating compound 4.6 with di-iso-
butylaluminium hydride and so providing primary alcohol 4.7 in 98% yield. Compound 4.7 
was subjected to Swern oxidation and the product aldehyde immediately reacted with 
ethynylmagnesium bromide to afford an inseparable epimeric mixture of the α- and β- forms 
of the propargylic alcohol 4.8 (23:77 α/β, 78%). Both epimers should be usefully carried 
forward in the synthetic sequence as the C10 alcohol would be oxidised to the corresponding 
ketone at a later stage. Thus, submission of this epimeric mixture of alkynes to a 
hydrostannylation reaction using bis(triphenylphosphine)palladium(II) dichloride as catalyst 
and tri-n-butyltin hydride as the source of tin gave a mixture of alkenyl stannanes from which 
the pure β-isomer 4.9 was isolated (as the major product) in 43% yield.e 
                                                 
e An explanation for the selective formation of the β-epimer can be found in Section 5.3.2. 
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Scheme 4.5.  Reagents and Conditions (i) Piv-Cl, DMAP, Et3N, DCM, −78 °C, 1 h; (ii) TBS-Cl, imidazole, 
DMF, 18 °C, 2 h; (iii) DIBAl-H, DCM, −78 °C, 30 min; (iv) (COCl)2, DMSO, Et3N, DCM, −78 to 0 °C, 1 h; (v) 
HC≡CMgBr, THF, −15 °C, 1 h; (vi) Pd(PPh3)2Cl2, n-Bu3SnH, DCM, −78 to 0 °C, 30 min. 
 
4.2.3. The Stille Cross-Coupling Reaction 
Having obtained the targeted alkenyl stannane 4.9 as described above, the Stille cross-
coupling of this with the readily prepared alkenyl iodide fragment A (formed as described in 
Section 3.3.1) was investigated. The reaction was performed using tetrakis(triphenyl- 
phosphine)palladium(0), in combination with triphenylphosphine, a large excess of copper(I) 
iodide and lithium chloride under anaerobic conditions at 40 °C in N,N-dimethylformamide 
(Scheme 4.6).16 By such means, the desired product 4.10 was obtained in 52% yield.  
 
Scheme 4.6.  Reagents and Conditions (i) Pd(PPh3)4, PPh3, CuI, LiCl, DMF, 40 °C, 16 h. 
The 1H and 13C NMR spectral data obtained on the product arising from the union of 
fragments A and B, were consistent with the assigned structure 4.10 (Table 4.1). Thus, the 1H 
NMR spectrum (Figure 4.2) exhibits six resonances due to olefinic protons as would be 
expected for a compound containing four trans-configured double bonds that bear two 
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branching substituents. The 13C NMR spectrum (Figure 4.3) displays all of the expected 
twenty-nine signals, sixteen of which correspond to the carbons (C1-C15 and C26) of the 
Southern Hemisphere of macrolactam 4.1. 
 
Figure 4.2.  400 MHz 1H NMR Spectrum of Stille Coupling Product 4.10 (recorded in d-chloroform). 
 
Figure 4.3.  100 MHz 13C NMR Spectrum of Stille Coupling Product 4.10 (recorded in d-chloroform). 
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Table 4.1.  Assignment of 1H and 13C NMR Data for Compound 4.10*. 
C/H δH mult (J in Hz) δC  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
10-OH 
11, 12 
13 
14 
15 
15-methyl 
26 
-TBS 
 
 
-acetonide 
 
-dioxinone 
 
5.30 
 
6.95 
5.95 
 
6.36 
6.70 
6.02 
4.73 
3.63 
4.14-4.17 
4.82 
 
 
1.84 
1.89 
0.91 
0.18, 0.16 
 
1.52, 1.35 
 
1.71 
 
s 
 
d (15.5) 
d (15.5) 
 
d (11.4) 
dd (15.0, 11.4) 
dd (15.0, 5.8) 
m 
brs 
m 
m 
 
 
d (2.2) 
s 
m 
s, s 
 
s, s 
 
s 
 
162.3 
94.3 
164.0 
118.7 
138.4 
133.8 
138.0 
126.9 
142.6 
69.8 
 
80.1, 79.5 
62.3 
83.4 
77.3 
3.9 
12.7 
26.0 
−4.3, −4.8 
18.5 
26.7, 25.3 
109.0 
25.2 
106.4 
C 
CH 
C 
CH 
CH 
C 
CH 
CH 
CH 
CH 
 
2 x CH 
CH 
C 
C 
CH3 
CH3 
3 x CH3 
2 x CH3 
C 
2 x CH3 
C 
2 x CH3 
C 
* Data acquired in d-chloroform at 400 or 100 MHz (for 1H and 13C NMR data, respectively). 
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4.3. Synthesis of Fragment C 
4.3.1. Retrosynthetic Analysis  
The retrosynthetic analysis of polyenyne 4.11 shown below in Scheme 4.7, a 
specifically N-protected form of fragment C shown earlier (see Scheme 4.2), suggests this 
should be accessible from triene 4.12 through a sequence of standard functional group 
interconversions involving reduction, oxidation and Julia olefination steps. Sulfonamide 4.12 
itself would be generated from the tert-butyldiphenylsilyl (TBDPS) ether 4.13 which could, in 
turn, be assembled from aldehyde 4.14 and phosphonate 4.15 via a Horner-Wadsworth-
Emmons (HWE) olefination reaction. Attempts to implement this synthetic plan are detailed in 
the following sections. 
 
Scheme 4.7.  Retrosynthetic Analysis of Fragment C. 
 
4.3.2. Preparation of Triene 4.13 
The synthesis of sub-target 4.13 began with the preparation of aldehyde 4.14. Thus, 
commercially available (S)-3-hydroxy-2-methylpropionate [(S)-Roche ester] 4.16 (Scheme 
4.8) was first protected as the TBDPS-ether 4.17 (99%) by treating the alcohol with tert-
butyldiphenylsilyl chloride and imidazole.136 This product was converted into the 
corresponding aldehyde 4.18 (82%) through a DIBAl-H mediated reduction of the ester motif 
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using hexane as solvent. A slightly higher yielding, two-step sequence starting with a reduction 
using lithium borohydride and submission of the crude product to the Swern oxidation also 
delivered aldehyde 4.18, this time in 97% yield. A Horner-Wadsworth-Emmons reaction 
involving compound 4.18 and triethyl phosphonoacetate 4.19 was effected using the 
Masamune-Roush’s protocol77 [involving lithium chloride and 1,8-diazabicyclo[5.4.0]undec-
7-ene (DBU) as the key reagents] and so affording the conjugated ester 4.20137 (85%). This 
was converted, in 99% yield, into alcohol 4.21 by treating it with di-iso-butylaluminium 
hydride. Allylic oxidation of product 4.21 using manganese dioxide then provided the desired 
aldehyde 4.14 in 91% yield. 
 
Scheme 4.8.  Reagents and Conditions (i) TBDPS-Cl, imidazole, DMF, 0 to 18 °C, 16 h; (ii) LiBH4, MeOH-
Et2O, 0 to 18 °C, 2 h; (iii) (COCl)2, DMSO, Et3N, DCM, −78 to 0 °C, 1 h; (iv) LiCl, DBU, acetonitrile, 18 °C, 16 
h; (v) DIBAl-H, hexane, −78 °C, 2 h; (vi) MnO2, DCM, 18 °C, 3 h.  
The four-step synthetic sequence used to produce the previously reported138 
phosphonate 4.15 (Scheme 4.9) commenced with the commercially available methyl 2-
bromopropionate (4.22). Heating this material in acetonitrile with triphenylphospine generated 
a stabilised Wittig reagent that was condensed with glyoxylic acid monohydrate to deliver the 
E-configured acid 4.23 in 82% yield. Selective reduction of the carboxylic acid residue 
associated with this product (in the presence of the associated methyl ester) could be effected 
using the borane-tetrahydrofuran complex and this generated allylic alcohol 4.24 in 66% yield. 
An Apel reaction was employed to convert the latter alcohol into allylic bromide 4.25 which 
was obtained in 80% yield. Heating this bromide in neat triethyl phosphite, so as to effect a 
Michaelis-Arbuzov reaction, then gave the phosphonate 4.15139 in 96% yield. Finally, 
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condensation of this phosphonate and aldehyde 4.14 in the presence of n-butyl lithium 
furnished the all-E-triene 4.13 (80%). 
 
Scheme 4.9.  Reagents and Conditions (i) PPh3, ACN, 65 °C, 16 h; (ii) DIPEA, glyoxylic acid monohydrate, 0 
to 18 °C, 16 h; (iii) BH3.THF, THF, −15 to 18 °C, 16 h; (iv) CBr4, PPh3, DCM, 0 to 18 °C, 30 min; (v) P(OEt)3, 
110 °C, 2 h; (vi) n-BuLi, THF, −78 to 18 °C, 3.5 h. 
The most notable features observed in the 1H NMR spectrum of compound 4.13 
(Figure 4.4) were the resonances associated with the triene moiety. The signal appearing at δ 
7.22 was assigned to C19-H (tripartilactam numbering) and this is coupled (J = 11.0 Hz) with 
the signal due to the C20-H which appears at δ 6.40. This resonance, in turn, shows a coupling 
to the resonance at δ 6.50 that is 
attributed to C21-H. The other 
doublet of doublets (for C22- and 
C23-H) are centered at δ 6.21 and 
5.85, respectively. The observed 
coupling constants of 14.8 Hz 
(between C21- and C20-H) and 
15.3 Hz (between C22- and C23-H) 
C/H δH mult (J in Hz) 
19 
20 
21 
22 
23 
7.22 
6.40 
6.50 
6.21 
5.85 
d (11.0) 
dd (14.8, 11.0) 
dd (14.8, 10.2) 
dd (15.3, 10.2) 
dd (15.3, 7.4) 
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indicate an E-configuration about each of the associated double bonds. Table 4.2 shows the 
mutual couplings between these relevant protons. 
 
 
Figure 4.4.  400 MHz 1H NMR Spectrum of Triene 4.15 (recorded in d-chloroform). 
In order to install the amine residue required in fragment C, a tetra-n-butylammonium 
fluoride (TBAF)-mediated desilylation reaction was used to convert ether 4.13 into the free 
alcohol 4.26 (84%) (Scheme 4.10). Then, with this alcohol in hand, instead of following a 
three-step sequence involving conversion of the alcohol into the corresponding azide, reduction 
of this to the amine and, finally, protecting this amine (with possibility of over protection to 
form a tertiary amine with the same protecting group), Mitsunobu reactions using various 
different amine derivatives as nucleophiles were explored as a means of introducing a protected 
amine directly. Thus, a solution of alcohol 4.26, the relevant nitrogen-based nucleophile and 
triphenylphosphine in tetrahydrofuran was treated with di-iso-propyl azodicarboxylate 
(DIAD). The outcomes of these types of reactions are shown in Scheme 4.10. Unfortunately, 
no reaction was observed when using a primary amine such as p-methoxybenzylamine or p-
methoxyaniline as a nucleophile - only starting material was recovered. However, when the 
more acidic nitrogen-centred nucleophile phthalimide (pKa = 8.3) was used then product 4.27 
was obtained in 87% yield. Unfortunately, attempts to manipulate this product in various ways 
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only led to intractable mixtures. Accordingly, Fukuyama’s method140 was employed using N-
(4-methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 (prepared from p-methoxybenzylamine 
and 2-nitrobenzenesulfonyl chloride) as the nucleophile. Disappointedly, only the elimination 
product 4.29 was observed under these conditions. 
 
 
Entry Nucleophile Result/Product 
1 
 
No reaction, recovered SM 
2 
 
No reaction, recovered SM 
3 
 
 
 
4 
  
Scheme 4.10.  Reagents and Conditions (i) TBAF, THF, 18 °C, 2 h; (ii) nucleophile, DIAD, PPh3, THF, 18 °C, 
16 h.  
In light of the outcomes defined above, the reaction sequence shown in Scheme 4.11 
was followed. Thus, the (R)-Roche ester was protected as the TBDPS-ether 4.30141 (99%) and 
this was reduced with lithium borohydride in the presence of an equivalent amount of methanol 
to provide alcohol 4.31 (98%). Submission of this alcohol to a Mitsunobu reaction with 
sulfonamide 4.28 then gave the desired sulfonamide 4.32 in 96% yield. Fluoride-mediated 
deprotection of silyl-ether 4.32 provided alcohol 4.33 (90%) that was oxidised to the 
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corresponding aldehyde 4.34 (84%) using the Dess-Martin periodinane (DMP). 
Disappointingly, upon submission of compound 4.34 to reaction with triethyl 
phosphonoacetate, lithium chloride and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (as used 
successfully in the formation of  compound 4.20), only the simple sulfonamide 4.28 (almost 
certainly the product of an E1cb reaction) was isolated. None of the hoped-for ester 4.35 was 
obtained.  
 
Scheme 4.11.  Reagents and Conditions (i) TBDPS-Cl, imidazole, DMF, 0 to 18 °C, 16 h; (ii) LiBH4, MeOH-
Et2O, 0 to 18 °C, 2 h; (iii) DIAD, PPh3, THF, 18 °C, 16 h; (iv) TBAF, THF, 18 °C, 2 h; (v) DMP, pyridine, DCM, 
18 °C, 3 h; (vi) triethylphosphonoacetate, LiCl, DBU, acetonitrile, 18 °C, 16 h. 
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4.3.3. The Julia Olefination Reaction 
In order to address the difficulties detailed immediately above, ester 4.13 was reduced 
(Scheme 4.12), with di-iso-butylaluminium hydride, to the corresponding alcohol that was 
immediately oxidised to the corresponding aldehyde 4.36 (81% yield over two steps) using 
manganese dioxide. A Julia olefination reaction was then performed so as to install the key Z-
configured double bond (C16-C17) associated with fragment C. So. following the procedure 
of Bonini,86 which was later used by Fürstner87 as a part of total synthesis of lactimidomycin, 
sulfone 1.78 and potassium bis(trimethylsilyl)amide (KHMDS) were reacted with aldehyde 
4.36 at −55 °C and the desired product 4.37 was obtained, after two days, in 44% yield as an 
inseparable mixture with the corresponding E-isomer (85:15 Z/E). As observed by Bonini, the 
Z-isomer is favored in this case.f The 1H NMR spectrum of the mixture of tetra-ene 4.37 and 
its E-isomer is shown in Figure 4.5. The resonances due to both geometric isomers are quite 
evident. Thus, the signals at δ 5.58 (J = 15.9 and 2.5 Hz) and δ 5.39 (J = 11.8 and 2.8 Hz) were 
assigned to the C16 protons associated with the E- and Z- isomeric forms, respectively. Each 
is coupled, as a doublet, with C17-H. Coupling to the protons of the methyl “cap” of the alkyne 
was also observed in each instance. While deprotection of the TBDPS-ether 4.37 could be 
achieved using tetra-n-butylammonium fluoride, and thus providing alcohol 4.38 in 89% yield, 
additional proportions of the E-isomer were formed (Z/E ratio now 75:25). 
 
Scheme 4.12.  Reagents and Conditions (i) DIBAl-H, hexane, −78 °C, 2 h; (ii) MnO2, DCM, 18 °C, 3 h; (iii) 
KHMDS, THF, −55 °C, 48 h; (iv) TBAF, THF, 18 °C, 2 h. 
                                                 
f See Section 1.3.3.4 for more information. 
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Figure 4.5.  400 MHz 1H NMR Spectrum of Tetraenyne 4.37 (recorded in d-chloroform). 
 Reaction of N-(4-methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 with alcohol 4.38 
(Scheme 4.13) in the presence of triphenylphosphine and di-iso-propyl azodicarboxylate 
(DIAD) provided the sulfonamide 4.39 in 66% yield. Unfortunately, even more Z- to E- 
isomerisation was observed during this reaction as revealed by inspection of 1H NMR spectrum 
(Figure 4.6) of the product mixture. Specifically, the Z/E ratio was now 60:40 and thus 
constituting a synthetically unacceptable situation. It was envisioned that these difficulties 
could be addressed by replacing of the double bonds between C14-C15 and C16-C17 in lactam 
1.7 by triple bonds, a possibility that was now pursued as detailed in the following Chapter. 
 
Scheme 4.13.  Reagents and Conditions (i) DIAD, PPh3, THF, 18 °C, 16 h. 
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Figure 4.6.  400 MHz 1H NMR Spectrum of the E- and Z-Isomeric Forms of Sulfonamide 4.39 (recorded 
in d-chloroform). 
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4.4. Conclusion 
In the work described in this Chapter (Four), a synthetic sequence leading to the 
Southern Hemisphere of macrolactam 4.1 (as embodied in compound 4.10) has been 
established. The Stille cross-coupling reaction used for the connection of fragments A and B 
proved effective in generating polyene 4.10 (Scheme 4.14), even if only in modest yield. 
Attempts to enhance the effectiveness of this reaction are presented in the next Chapter. 
 
Scheme 4.14.  Summary of the Formation of Southern Hemisphere of Macrolactam 4.1. 
The polyene fragment C as manifest in compound 4.40, which embodies the Northern 
Hemisphere of macrolactam 4.1, was also constructed from the enantiomerically pure (S)-
Roche ester (Scheme 4.15). The use of N-(4-methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 
as a nucleophile in Mitsunobu reaction allowed for the conversion of a primary alcohol into a 
protected amine in one step. Unfortunately, the ready isomerisation of the (Z)-configured Δ16,17-
double bond within tetraene 4.40 to its E-isomer undermined the utility of this reaction 
sequence. 
 
Scheme 4.15.  Summary of the Synthetic Route to the Northern Hemisphere of Macrolactam 4.1. 
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5.1. Retrosynthetic Analysis 
In order to address the facile Z- to E-isomerisation process that had undermined the 
studies detailed in the preceding Chapter, another approach to macrolactam 1.7 was pursued 
wherein the stereo- and site-selective generation of the (Z,Z)-configured 1,3-diene moiety 
located between C14 and C17 would be established by semi-reduction of the corresponding 
1,3-diyne moiety embedded within lactam 5.1 (Scheme 5.1).142  
 
Scheme 5.1. Revised Strategy. 
In this third approach, the retrosynthetic analysis outlined in Scheme 5.2 was applied 
in efforts to construct macrolactam 5.1. A key feature would be to use a Cadiot-Chodkiewicz 
coupling reaction to connect C15 to C16 and wherein the precursor fragment C would contain 
either a terminal alkyne or a bromo-alkyne residue. Therefore, two possible routes to fragment 
C were pursued. As in the second approach detailed in the preceding Chapter, the truncated 
fragments A and B would be linked through a Stille cross-coupling reaction that establishes the 
C7–C8 σ-bond. The straightforward assembly of fragment A (3.2) has already been described 
(see Section 3.3.1). The synthetic pathway leading to the formation of a compound closely 
related to fragment B from inexpensive and readily available D-ribose has also been described 
(see Section 4.2.2). The modifications of these procedures for the purposes of constructing the 
“revised” fragments B and C are detailed in the following sections. 
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Scheme 5.2.  Key Building Blocks (Fragments) Associated with the Assembly of Macrolactam 5.1. 
 
5.2. Synthesis of the TMS-Capped Variant of Fragment B and its Connection to 
Fragment A 
5.2.1. Preparation of Alkenyl Stannane 5.8 
Following the reaction sequence established as described in Section 4.2.2, the known 
lactol 4.3 was treated (Scheme 5.3) with ethynylmagnesium bromide to afford the ring-opened 
diol 5.2 as a single-epimer in 89% yield. Confirmation of the illustrated configuration at the 
newly formed stereogenic center was obtained through the conversion of compound 5.2 into 
the corresponding pivaloate derivative 5.3 (69%), the structure of which was established by 
single-crystal X-ray crystallography (see Figure 5.1 for derived plot). The secondary alcohol 
moiety within the latter compound was converted into the corresponding TBS-ether 5.4 (95%) 
under standard conditions. Upon treatment with iso-propylmagnesium chloride, deprotonation 
of terminal alkyne occured and the resulting anion was reacted with trimethylsilyl chloride 
(TMS-Cl) to afford the TMS-capped acetylene 5.5 in 90% yield. Reduction of this last 
compound with di-iso-butylaluminium hydride then gave the primary alcohol 5.6 in 85% yield. 
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Scheme 5.3.  Reagents and Conditions (i) HC≡CMgBr, THF, 0 to 18 °C; (ii) Piv-Cl, DMAP, Et3N, DCM, −78 
°C, 1.5 h; (iii) TBS-Cl, imidazole, DMF, 18 °C, 2 h; (iv) i-PrMgCl, TMS-Cl, THF, 0 to 18 °C, 2 h; (v) DIBAl-H, 
hexane, −78 °C, 30 min. 
 
 
(black = C, red = O, grey = H) 
Figure 5.1.  Plot Derived from the Single-Crystal X-ray Analysis of Pivaloate 5.3.  
Oxidation of alcohol 5.6 using the Dess-Martin periodinane (Scheme 5.4) provided the 
corresponding aldehyde that was treated, without purification, with ethynylmagnesium 
bromide in the presence of zinc chloride at −15 °C and so delivering compound 5.7 as an 
inseparable 17:83 mixture of epimers. When the addition reaction was carried out at −40 °C a 
10:90 mixture of epimers was obtained although the reaction rate was much slower. Notably, 
in the absence of zinc chloride the addition reaction proceeded with reduced selectivity, a 40:60 
mixture of epimers being obtained, an outcome that could be attributed to the absence of 
chelation control. It is should be noted, at this point, that the two epimers are likely to be of 
equivalent value in the synthesis as each would eventually be oxidised to the corresponding 
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ketone. The mixture of the epimeric forms of alcohol 5.7 was subjected to hydrostannylation 
using bis(triphenylphosphine)palladium(II) dichloride and tri-n-butyltin hydride and thereby 
generating the corresponding and chromatographically separable alkenyl stannanes 5.8α and 
5.8β in 12 and 60% yield, respectively.g 
 
Scheme 5.4.  Reagents and Conditions (i) DMP, pyridine, DCM, 18 °C, 3 h; (ii) HC≡CMgBr, ZnCl2, THF, −15 
°C, 4 h; (iii) Pd(PPh3)2Cl2, n-Bu3SnH, DCM, −78 to 0 °C, 30 min. 
 
5.2.2. The Stille Cross-Coupling Reaction 
 With the more abundant alkenyl stannane 5.8β readily to hand, the pivotal Stille 
coupling reaction with the easily prepared alkenyl iodide fragment A (as described in Section 
3.3.1) (Scheme 5.5) was undertaken in the presence of tetrakis(triphenylphosphine)-
palladium(0), copper(I) iodide and lithium chloride. However, the desired coupling product 5.9 
was only obtained in 20% yield when the same conditions as applied in the synthesis of the 
methyl-capped stannane 4.9 were used (see Section 4.2.3). Various efforts to improve this 
outcome were pursued. These proved fruitless. For example, when a protocol reported by 
Fürstner18 was employed, and involving the use of copper(I) thiophene-2-carboxylate and a 
phosphinate salt [Ph2PO2][nBu4] at room temperature, only a complex mixture of products was 
produced. These disappointing outcomes were attributed to the lability of TMS-capped alkyne 
                                                 
g An explanation for the selective formation of the β-epimer can be found in Section 5.3.2. 
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moiety within compound 5.8β. Accordingly, an equivalent synthetic sequence involving the 
TIPS-capped compound was investigated. Details are provided in the following section. 
 
Scheme 5.5.  Reagents and Conditions (i) Pd(PPh3)4, PPh3, CuI, LiCl, DMF, 40 °C, 16 h. 
 
5.3. Synthesis of the TIPS-Capped Variant of Fragment B and its Connection to 
Fragment A 
5.3.1. Introduction of TIPS-Capped Alkyne 
Upon treating compound 5.4 with iso-propylmagnesium chloride and tri-iso-propylsilyl 
chloride (TIPS-Cl) (Scheme 5.6) only starting material was recovered. As a result of 
considering various protecting group compatibilities, alcohol 5.3 was treated with di-iso-
propylethylamine, 4-(N,N-dimethylamino)pyridine (DMAP) and 2-(trimethylsilyl)ethoxy- 
methyl chloride (SEM-Cl) to furnish the protected compound 5.11 (83%). However, upon 
exposure of this alkyne to n-butyl lithium and tri-iso-propylsilyl chloride (TIPS-Cl), the desired 
product 5.12 was only isolated in 38% yield and was accompanied by co-product 5.13 (25%). 
The conversion was found to be very slow at room temperature and the addition of an excess 
of tri-iso-propylsilyl chloride led to the formation of more of the TIPS-ether 5.13. Therefore, a 
different route was pursued wherein the lactol 4.3 was treated with the metallated acetylene 
formed, in situ, upon exposure of TIPS-acetylene to iso-propylmagnesium chloride. As a result 
of the operation of a chelation-controlled addition reaction, diol 5.14 was obtained in 98% yield 
and 87% de.h The derived 1H NMR spectrum of the product obtained from this reaction 
established that compound 5.14 was the major epimeric product (Figure 5.2). 
 
                                                 
h An explanation for the preferential formation of this diastereoisomer can be found in Section 4.2.2. 
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Scheme 5.6.  Reagents and Conditions (i) i-PrMgCl, TIPS-Cl, THF, 0 to 18 °C, 2 h; (ii) SEM-Cl, DIPEA, 
DMAP, DCM, reflux, 16 h; (iii) n-BuLi, TIPS-Cl, −78 to 18 °C, 16 h; (iv) i-PrMgCl, TIPS-C≡CH THF, 0 to 18 
°C, 3 h. 
 
 
Figure 5.2.  400 MHz 1H NMR Spectrum of Diol 5.14 (recorded in d4-methanol). 
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Efforts to selectively protect the primary alcohol moiety within compound 5.14 
(Scheme 5.7) as a pivaloate 5.16 (43%) were disappointingly low yielding because of the 
competitive formation of the secondary pivaloate 5.17 (43%). Changing the reaction 
temperature, equivalents of base used and/or the rates of addition of pivaloyl chloride to 
overcome the inherent bias in the formation of protected secondary alcohol failed to provide a 
workable solution to this problem. At this point, it was decided to carry the two products 
forward and, indeed, the pivaloate 5.17 was shown to be more useful as the two step protection 
and deprotection sequence originally envisaged for handling the protected primary alcohol 5.16 
was no longer required. 
 
Scheme 5.7.  Reagents and Conditions (i) Piv-Cl, DMAP, Et3N, DCM, −78 °C, 1.5 h. 
 
5.3.2. Advancing the Synthesis Using the Unprotected Propargylic Alcohol-Containing 
Fragment B 
The liberated primary alcohol residue within compound 5.17 (Scheme 5.8) was 
subjected to oxidation with the Dess-Martin periodinane and the product aldehyde treated with 
ethynylmagnesium bromide in the presence of zinc chloride to provide a 23:77 mixture of the 
epimeric forms of compound 5.18. This was obtained in 81% combined yield over the two 
steps involved. These two epimers could be separated by column chromatography and 
treatment of the major one with tetra-n-butylammonium fluoride provided an unsymmetrical 
and optically active diol 5.19β and thus establishing (R)-configuration at C10 in its precursor. 
The 13C NMR spectrum of diol 5.19β is shown in Figure 5.3. Compounds 5.18α and 5.18β 
were independently submitted to the hydrostannylation reaction. The major, β-epimer 5.18β 
provided the desired product 5.20β and its regioisomer 5.21β in 63 and 14% yields, 
respectively. The minor, α-epimer 5.18α, was also submitted to the same reaction and, once 
again, both the desired product 5.20α and its regioisomer 5.21α were obtained in 75 and 15% 
yields, respectively. 
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Scheme 5.8.  Reagents and Conditions (i) DMP, pyridine, DCM, 18 °C, 3 h then (ii) HC≡CMgBr, ZnCl2, THF, 
−40 °C, 4 h; (iii) Pd(PPh3)2Cl2, n-Bu3SnH, DCM, −78 to 0 °C, 30 min; (iv) TBAF, THF, 18 °C, 4 h. 
 
 
Figure 5.3:  100 MHz 13C NMR Spectrum of Diol 5.19β (recorded in d6-acetone). 
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The major isomer 5.20β was used for the initial investigation of the Stille cross-
coupling with fragment A (Scheme 5.9). Upon using Fürstner’s conditions,18 involving 
tetrakis(triphenylphosphine)palladium(0), triphenylphosphine, copper(I) thiophene and  
[Ph2PO2][nBu4] (as a tin scavenger) under anaerobic conditions at ambient temperatures in 
N,N-dimethylformamide, the desired connection of fragments A and B took place to give, in 
93% yield after thirty minutes, product 5.22. The 1H and 13C NMR spectral data derived from 
this product were completely consistent with the assigned structure 5.22 (see Figure 5.4, 
Figure 5.5 and Table 5.1). 
 
Scheme 5.9.  Reagents and Conditions (i) Pd(PPh3)4, PPh3, [Ph2PO2][NBu4], DMF, 18 °C, 30 min. 
Polyene 5.22 was found to be unstable, even on storage at low temperature or after 
further manipulation. Means for addressing this matter are detailed below. 
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Figure 5.4.  400 MHz 1H NMR Spectrum of Tetraenyne 5.22 (recorded in d-chloroform). 
 
 
Figure 5.5.  100 MHz 13C NMR Spectrum of Tetraenyne 5.22 (recorded in d-chloroform). 
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Table 5.1.  Assignment of 1H and 13C NMR Data for Compound 5.22*. 
C/H δH mult (J in Hz) δC  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
10-OH 
11 
12 
13 
14 
15 
26 
-TIPS 
 
-Piv 
 
 
-acetonide 
 
-dioxinone 
 
5.33 
 
6.96 
5.99 
 
6.34 
6.77 
5.96 
4.58 
2.64 
4.11 
4.32 
5.67 
 
 
1.91 
1.05 
 
1.20 
 
 
1.55, 1.38 
 
1.71 
 
s 
 
d (15.5) 
d (15.5) 
 
d (11.3) 
dd (15.0, 11.3) 
dd (15.0, 5.9) 
m 
brd (3.8) 
t (5.5) 
t (5.5) 
d (5.5) 
 
 
s 
m 
 
s 
 
 
s, s 
 
s 
 
162.1 
94.5 
163.7 
119.2 
137.0 
134.7 
135.8 
128.3 
142.2 
69.5 
 
79.8 
77.2 
63.0 
101.9 
89.1 
12.6 
18.6 
11.2 
27.0 
38.9 
176.4 
27.1, 25.3 
109.4 
25.2 
106.3 
C 
CH 
C 
CH 
CH 
C 
CH 
CH 
CH 
CH 
 
CH 
CH 
CH 
C 
C 
CH3 
6 x CH3 
3 x CH 
3 x CH3 
C 
CO 
2 x CH3 
C 
2 x CH3 
C 
* Data acquired in d-chloroform at 400 or 100 MHz (for 1H and 13C NMR data, respectively). 
 
5.3.3. Advancing the Synthesis Using the Protected Propargylic Alcohol-Containing 
Fragment B 
A synthetic route to key intermediate 5.25 from both alcohols 5.16 and 5.17 (Scheme 
5.10) was pursued as a means of obtaining a C-10 protected form of compound 5.22 that, in its 
OH unprotected form, was distinctly unstable. The route from alcohol 5.17 to sub-target 5.25 
was straightforward and involved conventional steps through propagylic alcohol 5.18, PMB-
ether 5.23, and alcohol 5.24. By changing the order of reactions, alcohol 5.16 could also be 
converted into the same key compound 5.25 over the same number of conventional steps. The 
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only difference between the two routes rested in choosing the reaction conditions required for 
the protection of the newly installed propargylic alcohol as the PMB-ether. Indeed, in the case 
of compound 5.18 and owing to the presence of the pivaloate group, non-basic conditions were 
employed involving 2-(4-methoxybenyloxy)-4-methylquinoline (PMBO-lepidine) (2.16)i in 
the presence of (+)-camphor-10-sulfonic acid (cat.), while p-methoxybenzyl chloride and 
sodium hydride was the reagent combination applied to congener 5.28. 
 
Scheme 5.10.  Reagents and Conditions (i) DMP, pyridine, DCM, 18 °C, 3 h then (ii) HC≡CMgBr, ZnCl2, THF, 
−40 °C, 4 h; (iii) PMBO-lepidine (2.16), CSA, DCM, 40 °C, 16 h; (iv) DIBAl-H, hexane, −78 °C, 30 min; (v) 
SEM-Cl, DIPEA, DMAP, DCM, reflux, 16 h; (vi) (COCl)2, DMSO, Et3N, DCM, −78 to 0 °C, 1 h then (ii) 
HC≡CMgBr, THF, −15 °C, 1 h, 95% over two steps; (vii) PMB-Cl, NaH, TBAI, THF, 18 °C, 16 h. 
The PMB-protected analogue, 5.30, (Scheme 5.11) of compound 5.22 was readily 
prepared from the epimeric mixture of ethers 5.25 by treating this with 
bis(triphenylphosphine)palladium(II) dichloride and tri-n-butyltin hydride and thus forming 
                                                 
i See Scheme 2.6, Section 2.3.1 for more information. 
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alkenyl stannanes 5.29α and 5.29β in 19 and 52% yields, respectively. Although the 
regioisomeric stannanes were not isolated and characterised, the presence of these by-products 
was detected by thin layer chromatography. When the major, β-epimer 5.29β was submitted to 
the crucial Stille cross-coupling reaction with fragment A, 3.2, using the same conditions as 
employed for the synthesis of congener 5.22, then target 5.30 was obtained in 87% yield. The 
structure of this product was confirmed by both 1H and 13C NMR spectroscopies (see Figure 
5.6, Figure 5.7 and Table 5.2). 
 
Scheme 5.11. Reagents and Conditions (i) Pd(PPh3)2Cl2, n-Bu3SnH, DCM, −78 to 0 °C, 30 min; (ii) Pd(PPh3)4, 
PPh3, CuTC, [Ph2PO2][NBu4], DMF, 18 °C, 30 min. 
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Figure 5.6.  400 MHz 1H NMR Spectrum of Compound 5.30 (recorded in d-chloroform). 
 
 
Figure 5.7.  100 MHz 1H NMR Spectrum of Compound 5.30 (recorded in d-chloroform). 
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Table 5.2.  Assignment of 1H and 13C NMR Data for Compound 5.30*. 
C/H δH mult (J in Hz) δC  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
26 
-TIPS 
 
-SEM 
 
 
 
-acetonide 
 
-PMB 
 
 
 
-dioxinone 
 
 
5.35 
 
6.97 
6.03 
 
6.37 
6.73 
5.91 
4.45 
4.27 
4.19 
4.63 
 
 
1.91 
1.09 
 
4.95, 4.69 
3.60, 3.55 
0.89–0.73 
−0.04 
1.58, 1.38 
 
7.26, 6.58 
4.51 
 
3.79 
1.72, 1.71 
 
s 
 
d (15.5) 
d (15.5) 
 
d (11.3) 
dd (15.2, 11.3) 
dd (15.2, 7.7) 
t (7.7) 
t (6.8) 
dd (6.8, 5.0) 
d (5.0) 
 
 
s 
m 
 
d, d (6.7) 
ddd (11.1, 9.1, 5.8) 
complex m 
s 
s 
 
d (8.6) 
ABq (11.4)  
 
s 
s 
162.0 
94.7 
163.6 
119.6 
136.6 
135.1 
134.2 
130.5 
141.9 
78.2 
79.7 
78.0 
65.4 
103.4 
89.8 
12.6 
18.7 
11.3 
91.9 
66.0 
18.2 
−1.3 
27.0, 25.3 
109.4 
129.2, 113.8 
70.6 
159.2, 130.7 
55.3 
25.2 
106.4 
C 
CH 
C 
CH 
CH 
C 
CH 
CH 
CH 
CH 
CH 
CH 
CH 
C 
C 
CH3 
6 x CH3 
3 x CH 
CH2 
CH2 
CH2 
3 x CH3 
2 x CH3 
C 
4 x CH 
CH2 
2 x C 
CH3 
2 x CH3 
C 
* Data acquired in d-chloroform at 400 or 100 MHz (for 1H and 13C NMR data, respectively). 
 
  
Chapter Five Third-Generation Approach to a Substrate for Macrolactamisation  
 
 
124 
 
5.4. Synthesis of Fragment C and its Cadiot-Chodkiewicz Coupling with 
Compound 5.30 
5.4.1. Two Possible Means for Deploying the Cadiot-Chodkiewicz Coupling Reaction 
With compound 5.30 in hand, attention turned to the preparation of fragment C required 
for the Cadiot-Chodkiewicz coupling reaction. Two possibilities (Figure 5.8) were envisioned 
for effecting this pivotal step. In the first, fragment C would embody a bromo-alkyne moiety 
as seen in compound 5.31 and this would be coupled with the terminal alkyne 5.32 derived 
from precursor 5.30, or, second, the diyne would be accessed from trienyne 5.33 and bromo-
alkyne 5.34. Attempts to prepare these polyenes from the aldehydes 4.36 or 4.18, themselves 
readily generated from (S)-Roche ester (see Schemes 4.12 and 4.8), were undertaken as 
detailed in the following sections. 
 
Figure 5.8.  Two Possible Pairs of Fragment C-type Coupling Partners 5.31 and 5.33 to be Used in the 
Cadiot-Chodkiewicz Coupling Reaction. 
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5.4.2. Preparation of the Bromo-Alkyne Variant of Fragment C 
It was thought that compound 5.31 could be obtained from the corresponding alcohol 
via a Mitsunobu reaction using N-(4-methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 as the 
nucleophile which had been exploited earlier in the preparation of compound 4.40 (see Section 
4.3). To such ends, subjection of aldehyde 4.36 (Scheme 5.12) obtained, as detailed in Chapter 
Four, in 9 steps from (S)-Roche ester 4.16, to a Ramirez olefination reaction143 with the ylide 
generated from carbon tetrabromide and triphenylphosphine gave the 1,1-dibromoalkene 5.35 
in 62% yield. TBAF-mediated dehydrobromination of product 5.35 provided the desired 
bromoalkyne-containing primary alcohol 5.36 in 84% yield. This transformation, first reported 
by Mori,144 probably proceeds via the anti-elimination pathway shown (see inset, Scheme 512). 
Unfortunately, compound 5.36 was extremely unstable and a complex mixture of products was 
observed on attempting to engage it in a Mitsunobu reaction with sulfonamide 4.28. 
 
Scheme 5.12.  Reagents and Conditions (i) CBr4, PPh3, DCM, 0 to 18 °C, 30 min; (ii) TBAF, THF, 18 °C, 6 h; 
(iii) DIAD, PPh3, THF, 18 °C, 16 h. 
Given the difficulties described immediately above the new approach shown in Scheme 
5.13 was pursued. The last stage in the preparation of target 5.31 would involve the relevant 
conversion of aldehyde 5.37 that could be obtained through a Stille cross-coupling reaction 
between alkenyl iodide 5.38 and stannane 5.39.  
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Scheme 5.13.  Revised Retrosynthetic Analysis of Target 5.31. 
The left-hand side of fragment C (viz. the alkenyl iodide part) could be prepared from 
commercially available (S)-Roche ester 4.16 via the readily available aldehyde 4.18 as shown 
in Scheme 5.14. A Takai olefination reaction was used to convert this aldehyde into the 
corresponding alkenyl iodide 5.40145 (80%) which was itself submitted to a TBAF-mediated 
desilylation reaction to generate the alcohol 5.41146 (88%). With this last compound in hand, 
its Mitsunobu reaction with N-(4-methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 was 
performed and this led to the sulfonamide 5.38 in 90% yield.  
 
Scheme 5.14.  Reagents and Conditions (i) CrCl2, CHI3, THF, 18 °C, 16 h; (ii) TBAF, THF, 18 °C, 2 h; (iii) 
DIAD, PPh3, THF, 18 °C, 16 h. 
The known stannylated dienal 5.39 embodying the right hand side of fragment C was 
synthesised from the Zincke aldehyde 5.43 as shown in Scheme 5.15.147 Thus, heating a 
mixture of 3-methylpyridine and 2,4-dinitrochlorobenzene in acetone to 60 °C for thirty hours 
afforded the pyridinium or Zincke salt 5.42 (90%) which had a striking purple color. This salt 
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was heated under reflux with an excess of dimethylamine in ethanol and after the cooled 
reaction mixture was treated with sodium hydroxide the bifunctional Zincke aldehyde 5.43 was 
obtained in 96% yield. The electrophilic character of this Zincke aldehyde, as emphasised in 
the resonance structure 5.43a, provided the “means” by which it could be converted into 
stannane 5.39 which was obtained in 60% yield. Cross-coupling of this compound with alkenyl 
iodide 5.38 under Fürstner’s conditions18 provided the desired product 5.37 in 87% yield. 
 
Scheme 5.15.  Reagents and Conditions (i) acetone, 60 °C, 30 h; (ii) Me2NH, ethanol, 78 °C, 1 h, then 4 M 
NaOH; (iii) LDA, Bu3SnH, THF, then CH3COCl, 0 to 18 °C; (iv) Pd(PPh3)4, PPh3, [Ph2PO2][NBu4], DMF, 18 °C, 
30 min. 
The spectral data obtained on trienal 5.37 indicated a successful union of the two 
coupling partners. The 1H NMR spectrum displays four one-proton doublet of doublets arising 
from the trans-alkenyl protons, namely those located on C20 to C23. The characteristic peaks 
for the aldehyde, PMB- and nosyl- group protons were also assigned largely on the basis of 
their distinctive chemical shifts. The 13C NMR spectrum exhibits, as expected, twenty-five 
distinct carbon resonances (see Figure 5.9, Figure 5.10 and Table 5.3). 
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Figure 5.9.  400 MHz 1H NMR Spectrum of Trienal 5.37 (recorded in d-chloroform). 
 
 
Figure 5.10.  100 MHz 13C NMR Spectrum of Trienal 5.37 (recorded in d-chloroform). 
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Table 5.3.  Assignment of 1H and 13C NMR Data for Trienal 5.37*. 
C/H δH mult (J in Hz) δC  
 
18 
19 
20 
21 
22 
23 
24 
25-Ha 
25-Hb 
27 
28 
-Nosyl 
 
 
-PMB 
9.44 
 
6.81 
6.51 
6.40 
6.07 
5.63 
2.50  
3.23 
3.18 
1.85 
0.91  
7.97, 7.74–7.57 
 
 
7.12, 6.81 
4.45 
3.78 
s 
 
partially obscured d 
dd (14.8, 11.1) 
dd (14.8, 10.5) 
dd (15.2, 10.5) 
dd (15.2, 8.2) 
 hept (6.7)  
ABX (14.6, 8.3) 
ABX (14.6, 7.0)  
s 
d (6.7) 
d (7.7), complex m 
 
 
d (8.6) 
ABq (15.4) 
s 
 
194.7 
137.5 
142.3 
126.4 
141.2 
130.6 
148.6 
36.0 
52.7 
 
17.6 
9.6 
133.5, 131.7, 
131.2, 124.4 
148.0, 134.0 
129.9, 114.2 
51.3 
55.4 
159.6, 127.1 
CHO 
C 
CH 
CH 
CH 
CH 
CH 
CH 
CH2 
 
CH3 
CH3 
4 x CH 
 
2 x C 
4 x CH 
CH2 
CH3 
2 x C 
* Data acquired in d-chloroform at 400 or 100 MHz (for 1H and 13C NMR data, respectively). 
Treatment of aldehyde 5.37 with the ylide generated from carbon tetrabromide and 
triphenylphosphine (Scheme 5.16) gave the expected 1,1-dibromo tetraene 5.44 (92%). While 
dehydrobromination of product 5.44 with tetra-n-butylammonium fluoride did appear to lead 
to bromo-alkyne 5.31 this proved to be an exceptionally unstable material that rapidly 
decomposed on being dissolved in, for example, deuterated acetone. Accordingly, little useful 
spectroscopic data could be acquired on this compound and it was of no value from a synthetic 
point-of-view. 
 
Scheme 5.16.  Reagents and Conditions (i) CBr4, PPh3, DCM, 0 to 18 °C, 30 min; (ii) TBAF, THF, 18 °C, 6 h. 
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5.4.3. Preparation of the Terminal-Alkyne-Containing Fragment C 
The instability of bromo-trienyne 5.31 prompted the development of a synthesis of its 
non-brominated counterpart 5.33 (Scheme 5.17). Thus, it was expected that a Horner-
Wadsworth-Emmons olefination reaction involving aldehyde 4.14 [available in six steps from 
(S)-Roche ester 4.16, see Section 4.3.2] and phosphonate 5.46 would deliver the trienyne 5.45 
that could be converted into the sulfonamide 5.33 via sequential Mitsunobu and desilylation 
reactions.  
  
Scheme 5.17.  Retrosynthesis Analysis of Trienyne 5.33. 
The first step in the proposed synthesis started with stannylcupration, using a high-order 
cuprate, of 2-butynol (Scheme 5.18) in the presence of methanol to obtain the 
thermodynamically favored E-configured alkenyl stannane 5.47 in 93% yield.148 The use of a 
higher order cuprate [(Bu3Sn)2CuCNLi2] is presumed to have given, in the initial step of the 
reaction, two regioisomeric intermediates I1 and I2 that result from a reversible cis-addition 
reaction. Hydrolysis of these cuprate residues provided the corresponding tin derivatives. The 
protic solvent methanol serves to methanolyse the alkenyl-copper adduct and drives the 
equilibrium toward the desired product. Under thermodynamic conditions (achieved at −10 
°C), only the E-isomer was obtained.  
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Scheme 5.18.  Reagents and Conditions (i) CuCN, n-BuLi, n-Bu3SnH, MeOH, −78 to −10 °C, 2 h. 
The alkenyl stannane 5.47 obtained as described above was treated with molecular 
iodine (Scheme 5.19) to furnish the corresponding iodide 5.48149 in quantitative yield and this 
was submitted to a Sonogashira coupling reaction with ethynyltrimethylsilane to deliver the 
known alcohol 5.49 (82%).150 This alcohol could be converted into the corresponding bromide 
on treatment with carbon tetrabromide and triphenyl phosphine and heating of this product in 
neat triethyl phosphite (so as to effect a Michaelis-Arbuzov reaction) then gave the 
phosphonate 5.46 in 95% yield over the two steps. A Horner-Wadsworth-Emmons reaction 
between this phosphonate and aldehyde 4.14 using lithium bis(trimethylsilyl)amide as a base 
then gave, after global-deprotection (using tetra-n-butylammonium fluoride), the product 
alcohol 5.50 (60% over two steps). A Mitsunobu reaction between this last compound and N-
(4-methoxybenzyl)-2-nitrobenzenesulfonamide (4.28) then provided the desired sulfonamide, 
5.33 (70%), that embodies the Northern Hemisphere of lactam 5.1. Reaction of this 
sulfonamide with 4-chlorothiophenol and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) resulted 
in cleavage of the nosyl group and generation of the N-protected amine 5.51 that was obtained 
in 76% yield. 
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Scheme 5.19.  Reagents and Conditions (i) iodine, THF, −78 to 18 °C, 0.5h; (ii) HC≡CTMS, Pd(Ph3P)4, PPh3, 
CuI, DIPEA, DMF, 18 °C, 16 h; (iii) CBr4, PPh3, DCM, 0 to 18 °C, 2 h; (iv) triethylphosphite, 110 °C, 2h; (v) 
LiHMDS, THF, −78 to 18 °C, 4 h; (vi) TBAF, THF, 18 °C, 2 h; (vii) DIAD, PPh3, THF, 18 °C, 16 h; (viii) 4-
chlorothiophenol, DBU, THF, 18 °C, 4 h. 
 
5.4.4. Cadiot-Chodkiewicz Coupling Reactions 
With the terminal alkyne-containing form of fragment C in hand, a Cadiot-
Chodkiewicz coupling reaction with the corresponding bromo-alkyne partner was pursued. In 
order to obtain this brominated coupling partner, the TIPS-capped alkyne 5.30 was desilylated 
in situ with silver fluoride (Scheme 5.20) and this was followed by treatment of the resulting 
terminal alkyne with N-bromosuccinimide.151 By such means the bromo-alkyne 5.34 was 
obtained in 66% yield. Cadiot-Chodkiewicz coupling of compounds 5.34 and 5.33 was 
performed according to a literature152 procedure using copper(I) chloride, n-butylamine and 
hydroxylamine hydrochloride. The reaction was monitored by thin layer chromatography 
which showed the disappearance of the two starting materials and the formation a single new 
and chromatographically less mobile product. The 1H NMR spectrum of the isolated material 
suggested the presence of more than one product, although the expected molecular-associated 
ion [at m/z 1156 (M+Na)+] was observed as the base peak in ESI mass spectrum. An accurate 
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mass measurement on this species established the molecular formula of the product to be 
C62H76
23NaO14SSi, as expected for the desired product 5.52. However, this material proved far 
too intractable for further development in the present context. 
 
Scheme 5.20.  Reagents and Conditions (i) NBS, AgF, acetonitrile, 18 °C, 4 h; (ii) CuCl, NH2OH.HCl, n-
BuNH2, MeOH, Et2O, 0 °C, 30 min.      
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5.6. Conclusion 
The union of fragments A and B using Fürstner’s modification of the Stille cross-
coupling reaction proceeded effectively at room temperature to give, in good yield, the key 
compound 5.30 (Figure 5.11) that embodies the Southern Hemisphere of macrolactam 5.1. 
The terminal alkyne 5.33, representing the Northern Hemisphere of macrolactam 5.1 was also 
prepared. However, these key units could not be linked in a Cadiot-Chodkiewicz coupling 
reaction. Therefore, a simpler or model macrolactone was designed so as to study the 
amenability of such scaffolds to engage in the pivotal transannular [2+2]-cycloaddition 
reaction. Details of the relevant studies are presented in the following Chapter. 
 
Figure 5.11.  The Advanced Intermediates 5.30 and 5.33 Prepared as Potential Precursors to Macrolactam 
5.1. 
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6.1. The Macrolactone Model and its Retrosynthetic Analysis 
Due to the instability of the polyenyne 5.52 described in the preceding Chapter, the 
synthesis of macrolactone 6.1 was sought as a substrate with which to test the pivotal 
transannular [2+2]-photocycloaddition reaction. If successful, this would provide a model, 6.2, 
of the Eastern Hemisphere of tripartilactam (Scheme 6.1). In this plan, the required substrate, 
6.1, for [2+2]-photocycloaddition reaction was expected to be delivered through a two-fold 
semi-reduction of the precursor diyne unit within macrolactone 6.1. The anticipated 
photoproduct 6.2 could also serve as a potential precursor to the natural product itself through 
elaboration of its Western Hemisphere. 
 
Scheme 6.1.  Identification of Macrolactone 6.2 as a Model Substrate for the Transannular [2+2]-
Cycloaddition Reaction. 
A convergent strategy for the synthesis of macrolactone 6.1 was devised exploiting, as 
much as possible, the already established protocols used in the assembly of fragments A, B and 
C (Scheme 6.2). Thus, it was anticipated that a Horner-Wadsworth-Emmons olefination could 
be employed to connect phosphonate A and fragment B, the latter itself being derived from 
compound 5.25 that was obtained as described earlier.j Two possibilities were considered for 
assembling fragment C. Either a thermally-induced ester forming process followed by an 
intramolecular Glaser type coupling reaction could be used or a Cadiot-Chodkiewicz coupling 
                                                 
j The preparation of this compound is described in Section 5.3.3. 
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process could be engaged to establish the diyne linkage and this would then be followed by a 
thermally-induced lactonisation reaction to complete the macrocyclic ring.  
 
Scheme 6.2.  Key Building Blocks (Fragments) Targetted fot the Assembly of Macrolactone 6.1. 
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6.2. Connection of Fragments A and B 
Scheme 6.3 shows the synthetic route used to assemble the Southern part of 
macrolactone 6.1. Thus, the synthesis started with compound 5.25 (obtained earlier as a mixture 
of epimers at C8), that was itself prepared from D-ribose in a ten-step sequence described in 
Section 5.3.3. The terminal alkyne of this substrate was first deprotonated using iso-
propylmagnesium chloride as a base and the acetylide anion thus formed condensed with 
paraformaldehyde to deliver propargylic alcohol 6.3 in 88% yield. Treatment of this alcohol 
with a solution of sodium bis(2-methoxyethoxy)aluminium hydride (Red-AlTM) provided, after 
protic work-up, the desired trans-allylic alcohol 6.4 in 93% yield. This trans-hydroalumination 
reaction required the use of two equivalents of Red-AlTM, the first being involved in 
coordination, through aluminium, to both a triple bond and a hydroxyl group and thus allowing 
the nucleophilic attack of a second hydride (from the second Red-AlTM molecule) as depicted 
in 6.3a. Oxidation of the resulting allylic alcohol with manganese dioxide then furnished the 
unsaturated aldehyde 6.5 in 89% yield. A Horner-Wadsworth-Emmons olefination reaction 
between this epimeric mixture of aldehydes and phosphonate 3.3k [using lithium 
bis(trimethylsilyl)amide as a base] finally provided the targeted compound 6.6 in 94% yield 
albeit as an inseparable mixture of epimers.  
 
Scheme 6.3.  Reagents and Conditions (i) i-PrMgCl, (CHO)n, THF, 18 °C, 16 h; (ii) Red-Al, 0 °C, 30 min; (iii) 
MnO2, DCM, 18 °C, 4 h; (iv) LiHMDS, THF, −78 to 18 °C, 2 h. 
                                                 
k The preparation of this compound is described in Section 3.3.1.  
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6.3. Preparation and Attachment of Fragment C and Attempts to Effect a 
Macrocyclisation Reaction 
6.3.1. Preparation of Fragment C 
As mentioned earlier, there were two options for the assembly of fragment C and for 
macrocyclisation. The macrolactone 6.1 could, in principle, be obtained through either a 
thermally-induced lactonisation process or an intramolecular cross-coupling reaction to form 
the diyne linkage. Both of these options were investigated experimentally and the outcomes 
are presented in the following sections. Scheme 6.4 illustrates the preparation of the relevant 
alcohol-containing fragment employed in exploring both two options. Thus, the readily 
prepared aldehyde 4.14 [available in six steps from (S)-Roche ester]l was reacted with the ylide 
generated from carbon tetrabromide and triphenylphosphine and the gem-dibromodiene 6.7 
thus obtained in 92% yield. This dibromo-compound was exposed to either tetra-n-
butylammonium fluoride to furnish the desilylated bromo-alkyne 6.8 (96%) or lithium 
bis(trimethylsilyl)amide to deliver the alcohol protected bromo-alkyne 6.9 (83%). On the other 
hand, alcohol 5.41 [obtained in a five-step sequence from (S)-Roche ester]m was submitted to 
a Sonogashira coupling reaction with ethynyltrimethylsilane to give alcohol 6.10 (56%). 
 
Scheme 6.4.  Reagents and Conditions (i) CBr4, PPh3, DCM, 0 to 18 °C, 30 min; (ii) TBAF, THF, 18 °C, 6 h; 
(iii) LiHMDS, THF, 18 °C, 3 h; (iv) Pd(PPh3)2Cl2, CuI, Et3N, THF, 18 °C, 16 h. 
                                                 
l The preparation of this compound is described in Section 4.3.2. 
m The preparation of this compound is described in Section 5.4.2. 
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6.3.2. Macrocyclisation via a Thermally-Induced Lactonisation Process 
In order to perform a thermally-induced lactonisation, the alcohols mentioned above 
needed to be connected to compound 6.6 via an intermolecular acetylene cross-coupling 
reaction. To this end, an epimeric mixture (at C8) of TIPS-capped alkyne 6.6 was first exposed 
to tetra-n-butylammonium fluoride and the desilylated and single epimeric form of product 
6.11 was isolated in 63% yield after flash column chromatography (Scheme 6.5).  
 
Scheme 6.5.  Reagents and Conditions (i) TBAF, THF, 18 °C, 2 h. 
Extensive analysis of the 1H NMR and 13C NMR spectra derived from this desilylation 
product led to the assignment of the illustrated structure for compound 6.11. Various relevant 
assignments of the observed resonances are given in Figure 6.1 and Figure 6.2.  
 
 
Figure 6.1.  400 MHz 1H NMR Spectrum of Compound 6.11 (recorded in d6-acetone). 
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Figure 6.2.  100 MHz 13C NMR Spectrum of Compound 6.11 (recorded in d6-acetone). 
The Cadiot-Chodkiewicz coupling of alkyne 6.11 (Scheme 6.6) with the unprotected 
alcohol 6.8 was conducted using the procedures employed earlier [using copper(I) chloride, n-
butylamine and hydroxylamine hydrochloride as presented in Section 5.4.4] and gave product 
6.12 but this proved to be unstable as evidenced by the complexities of the derived 1H NMR 
spectrum. Accordingly, the silylated alcohol 6.9 was examined as a possibly more suitable 
building block. By the simple means shown in Scheme 6.6, product 6.13 was obtained in 64% 
yield. However, while the preliminary spectroscopic data obtained on this material were in 
complete accord with the assigned structure as efforts were made to purify it then it began to 
engage in a transannular Diels-Alder cycloaddition reaction and thus providing, presumably 
after aromatisation of the intermediate dihydroaromatic compound, 6.13a, the observed 
product 6.14. 
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Scheme 6.6.  Reagents and Conditions (i) CuCl, NH2OH.HCl, n-BuNH2, MeOH, Et2O, 0 to 18 °C, 30 min; (ii) 
TBAF, THF, 18 °C, 2 h. 
The 1H NMR spectrum of compound 6.14 (Figure 6.3) displays only three signals in 
the olefinic region including a characteristic singlet for C2-H at δ 6.03 as well as two mutually 
coupled resonances at δ 5.94 (J = 16.0 Hz) and δ 6.49 (J = 16.0 and 7.7 Hz) that were assigned 
to C16-H and C17-H, respectively. The resonance appearing at δ 7.75 was attributed to the two 
protons attached to the newly established aromatic ring, namely C5-H and C6-H. The 13C NMR 
spectrum (Figure 6.4) also shows the additional six aromatic resonances, the assignments of 
which were assisted through the use of DEPT experiments. The ESI mass spectrum displayed 
a molecular-associated ion at m/z 981 and accurate mass measurement on this species 
established that it had the expected molecular formula, viz C56H70
23NaO10Si2. 
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Figure 6.3.  400 MHz 1H NMR Spectrum of Arene 6.14 (recorded in d6-acetone). 
 
Figure 6.4.  100 MHz 13C NMR Spectrum of Arene 6.14 (recorded in d6-acetone). 
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6.3.3. Attempts to Effect Macrocyclisation via an Intramolecular Cross-Coupling 
Reaction 
As discussed earlier (see Section 3.3.1), thermolysis of 1,3-dioxinone-containing 
compounds normally induces the loss of acetone so as to generate an acylketene that can be 
trapped by added nucleophiles.125 Consistent with such expectations, heating equivalent 
quantities of compound 6.6 (as a mixture of epimers at C-10) and alcohol 6.10 (Scheme 6.7) 
to 120 °C in anhydrous toluene furnished the desired ester 6.15 in 71% yield. Although only 
the major epimer was isolated, the minor one was also being formed as evidenced by thin layer 
chromatographic analysis. Owing to the small scale of reaction, this minor isomer was not 
isolated. Careful maintenance of the anhydrous conditions was crucial to the success of this 
transformation as this prevented the transient acylketene reacting with adventitious water.  
 
Scheme 6.7.  Reagents and Conditions (i) toluene, 120 °C, 4 h. 
The 1H NMR spectrum of compound 6.15 is shown in Figure 6.5 and clearly reveals 
the existence of a 3:1 mixture of both the enol, 6.15e, and keto, 6.15k, tautomeric forms of this 
esterification product. The major component gives rise to two singlets, at δ 11.71 and 5.09 that 
correspond to the OH and C2-H protons, respectively, for the enol form while a singlet at δ 
3.61 arises from the C2-methylene protons of the minor or keto component. The spectrum also 
displays four distinct resonances arising from the protons of the two conjugated trans-double 
bonds of enol 6.15e. These are a doublet for C4-H at δ 5.94 (J = 15.2 Hz) which shows a mutual 
coupling with C5-H at 7.06 [that appears as a doublet of doublets (J = 15.2 and 11.1 Hz)]. This 
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proton is also coupled with C6-H which appears at δ 6.46 as another doublet of doublets (J = 
15.4 and 11.1 Hz). The resonance due to C7-H appears at δ 6.03 (J = 15.4 and 7.6 Hz). Evidence 
for the successful attachment of fragment C follows from the appearance of two additional 
signals in the olefinic region at δ 6.14 (dd, J = 16.0 and 7.7 Hz) and 5.58 (dd, J = 16.0 and 1.2 
Hz). These are attributed to C17- and 16-H, respectively. The resonance due to C18-H appears 
at δ 2.62. An essentially equivalent set of signals with the same pattern was also observed for 
the minor or keto form, 6.15k. 
 
Figure 6.5. 400 MHz 1H NMR Spectrum of 6.15e and 6.15k (recorded in d-chloroform). 
TBAF-mediated deprotection of the silyl-capped alkyne residue within substrate 6.15 
(Scheme 6.8) furnished the desired diyne 6.16 (85%) that was to serve as the substrate for 
intramolecular cross-coupling reaction to create the macrocyclic ring. The Glaser-Hay 
oxidative coupling protocol was the first one examined, under high dilution conditions, and 
employed copper(I) chloride and the bidentate complexing ligand tetramethylethylenediamine 
(TMEDA) in dichloromethane. However, no coupling took place in a reaction flask open to the 
air at ambient temperatures while decomposition was observed at 40 °C under an oxygen 
atmosphere. A literature survey suggested that such intramolecular couplings of terminal 
diynes often requires heating (to above 80 °C) in basic media (eg. using pyridine as solvent) in 
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order to proceed. Such conditions could not be successfully applied to the rather sensitive 
substrate 6.16 without the outset of rapid decomposition.153  
 
Scheme 6.8.  Reagents and Conditions (i) TBAF, THF, 18 °C, 2 h; (ii) CuCl, TMEDA, O2, DCM. 
In effort to effect the desired intramolecular cross-coupling reaction, one of the two 
terminal alkynes was replaced by a notionally more reactive bromo-alkyne. Thus, alcohol 6.8, 
instead of congener 6.10, (Scheme 6.9) was used in the thermally-induced nucleophilic 
addition reaction with compound 6.6 so as to generate ester 6.18. Once again, only the major 
epimer was isolated, this time in 72% yield. TBAF-mediated desilylation of compound 6.18 
furnished the desired terminal alkyne 6.19 in 85% yield. Its intramolecular cross-coupling 
reaction was then attempted under either Sonogashira conditions or using the protocol recently 
reported by Lei.154 Disappointingly, both sets of conditions failed to produce the 20-membered 
macrolactone 6.17. Only decomposition was observed in each instance. 
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Scheme 6.9. Reagents and Conditions (i) toluene, 120 °C, 4 h; (ii) TBAF, THF, 18 °C, 2 h; (iii) Pd(PPh3)2Cl2, 
CuI, i-Pr2NH, THF, 18 °C, 16 h; or Pd(OAc)2, CuI, TBAB, i-Pr2NH, 70 °C, 16 h. 
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6.4. Conclusion 
A synthetic pathway leading to the advanced intermediates 6.6 and 6.11, which embody 
the Southern region of model macrolactone 6.1, has been established. Two means for 
introducing the corresponding enyne alcohols that, in principle, could allow for a 
macrocyclisation reaction to take place were investigated. The first involving an intermolecular 
Cadiot-Chodkiewicz coupling reaction between compound 6.11 and silyl ether 6.9 failed to 
deliver useful products in that treatment of the resulting intermediate with tetra-n-
butylammonium fluoride resulted in the formation of the aromatised product 6.14 (Figure 6.6). 
The second pathway, employing a thermally-induced nucleophilic addition of either alcohol 
6.10 or 6.8 to the 1,3-dioxinone-containing compound 6.6 followed by desilylation delivered 
the desired ester 6.16 and 6.19, respectively, in good yield. Despite their lack of participation 
in intramolecular Csp-Csp Glaser-Hay or Cadiot-Chodkiewicz coupling reactions, the 
acquisition of these compounds demonstrated the capacity of the 1,3-dioxinone moiety to 
participate in desired β-keto-ester forming processes. 
 
Figure 6.6.  Undesired compound 6.14 and Advanced Intermediates for Assembling Macrolactone 6.1.  
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6.5. Future Research 
The undesired intramolecular Diels-Alder (IMDA) reaction occurring between the 
diyne linkage and the conjugated double bond within intermediate 6.13 could be prevented by 
a protection-deprotection strategy involving complexation of the alkyne residues as dicobalt-
hexacarbonyl complex A155 that can eventually be “liberated” by different oxidizing agents 
[such as ceric ammonium nitrate (CAN), or a tertiary amine oxide] or reducing agents (such as 
ethylenediamine).156 As shown in Scheme 6.10, for example, treatment of diyne 6.13 with 
dicobalt-octacarbonyl, Co2(CO)8, would deliver the complex 6.20. The 20-membered 
macrolactone 6.21 would arise through a thermally-induced macrocyclisation between the 
liberated alcohol and the dioxinone moiety. Decomplexation of compound 6.21 would then 
reveal the acetylene linkage that would deliver the likely delicate Z,Z-diene through a 
stereoselective semi-reduction effected by using hydrogenation in the presence of either Rieke 
zinc157 or Lindlar catalyst.158  
 
Scheme 6.10.  Protection-Deprotection Strategy Leading to Macrolactone 6.13. 
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7.1. General Experimental Procedures 
Starting materials and reagents were generally available from Sigma-Aldrich, Merck, 
TCI and/or AK Scientific and were used as supplied or, occasionally, recrystallised or distilled. 
Drying agents and other inorganic salts were purchased from the AJAX, BDH or Unilab 
Chemical Companies. Tetrahydrofuran, dichloromethane, N,N-dimethylformamide, diethyl 
ether, hexane and toluene were dried using a Glass Contour solvent purification system that is 
based upon a technology originally described by Grubbs et al.159 
All reaction mixtures were manipulated under a nitrogen atmosphere using standard 
Schlenk techniques and, unless otherwise specified, stirred magnetically. Deoxygenated 
solutions were obtained by bubbling nitrogen through the relevant solution for at least 15 min. 
Ambient temperature was assumed to be ca. 18 °C. Temperatures higher than ambient were 
attained using thermostated oil baths. To attain temperatures lower than ambient, a cooled, 
water-circulating bath (0 to 10 °C) or relevant cryostats [ice/water, 0 °C; ice/saturated aqueous 
ammonium chloride, −15 °C; dry-ice/acetonitrile, −40 °C; dry-ice/ethylene glycol:ethanol 
(1:1), −50 °C; dry-ice/acetone, −78 °C] were used. 
Ozonolysis reactions were performed using a Model 500 Fischer portable ozone-
generator with the luteinizing power and flow rate adjusted to 80 V and 50 L/h, respectively. 
Analytical thin layer chromatography (TLC) was performed on aluminum-backed 0.2 
mm thick silica gel 60 F254 plates as supplied by Merck. Eluted plates were visualised using a 
254 nm UV lamp and/or by treatment with a suitable dip followed by heating. These dips 
included: a) potassium permanganate : potassium carbonate : 5% sodium hydroxide aqueous 
solution : water (3g : 20g : 5 mL : 300mL); b) anisaldehyde : sulfuric acid (conc.) : ethanol (3 
mL : 4.5 mL : 200 mL); c) phosphomolybdic acid : cerium sulfate : sulfuric acid (conc.) : water 
(15g : 2.5g : 15 mL : 485 mL); d) vanillin : sulfuric acid (conc.) : ethanol : water (18g : 3 mL : 
285 mL : 15 mL). Flash chromatographic separations were carried out following protocols 
defined by Still et al.160 with silica gel 60 (40–63 μm) as the stationary phase and using the 
AR- or HPLC-grade solvents indicated. 
Unless otherwise specified, proton (1H) and carbon (13C) NMR spectra were recorded 
at 18 °C in base-filtered CDCl3 on a Varian spectrometer operating at 400 MHz for proton and 
100 MHz for carbon nuclei. For 1H NMR spectra, signals arising from the residual protio-forms 
of the solvent were used as the internal standards. Chemical shifts are recorded as δ values in 
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parts per million (ppm). 1H NMR data are recorded as follows: chemical shift (δ) [multiplicity, 
coupling constant(s) J (Hz), relative integral] where multiplicity is defined as: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, m = multiplet or combinations of the above. The 
signal due to residual CHCl3 appearing at δH 7.26 and the central resonance of the CDCl3 
“triplet” appearing at δC 77.0 were used to reference 1H and proton-decoupled 13C NMR 
spectra, respectively. For 13C NMR spectra, the data are given as: chemical shift (δ), 
(protonicity), where protonicity is defined as: C = quaternary; CH = methane; CH2 = methylene; 
CH3 = methyl. The assignments of signals observed in proton and carbon NMR spectra were 
assisted by conducting complementary connectivity and/or proximity experiments. 
Connectivity experiments used included the homonuclear (1H/1H) correlation spectroscopy 
(COSY) and/or heteronuclear (1H/13C) correlation spectroscopy [heteronuclear multiple 
quantum coherence (HMQC) and/or heteronuclear multiple-bond correlation (HMQC)]. 
Infrared spectra (νmax) were recorded on a Perkin–Elmer 1800 Series FTIR 
Spectrometer. Samples were analysed by IR spectroscopy (νmax) as thin films on KBr plates. 
Samples for attenuated total reflectance (ATR) IR spectra were prepared by allowing a CDCl3 
solution of these to evaporate on the sampling plate before the spectrum was acquired. 
Mass spectrometry was performed by the Australian National University’s Mass 
Spectrometric Services Unit located in the Research School of Chemistry, Canberra, Australia. 
Low-resolution ESI mass spectra were recorded on a single-quadrupole liquid 
chromatograph−mass spectrometer, while high-resolution measurements were conducted on a 
time-of-flight instrument. Low- and high-resolution electron impact (EI) mass spectra were 
recorded on a magnetic-sector machine. 
Optical rotations were measured between 17 to 20 °C with a Perkin-Elmer 241 
polarimeter at the sodium-D line (λ = 589 nm) and the concentrations (c) (g/100 mL) indicated 
using spectroscopic grade chloroform (CHCl3) as solvent. The measurements were carried out 
in a cell with a path length (l) of 1 dm. Specific rotations [α]D were calculated using the equation 
[α]D = 100.α/(c.l) and are given in 10−1.deg.cm2.g−1. 
Melting points were recorded on an Optimelt automated melting point system and are 
uncorrected. 
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7.2 Experimental Procedures Related to Work Described in Chapter Two 
(3aR,4R,5S,7aS)-4-Bromo-7-chloro-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-5-ol (2.9) 
 
A magnetically stirred solution of compound 2.3 (11.10 g, 75.73 mmol) in 
tetrahydrofuran/water (200 ml of a 4:1 v/v mixture) was cooled to 0 °C and then treated, in 
portions over 10 min, with N-bromosuccinimide (16.03 g, 90.06 mmol). The ensuing mixture 
was warmed to 18 °C, stirred at this temperature for 4 h then treated with sodium thiosulfate 
(6.00 g). Stirring was continued for a further 30 min then sodium chloride (6.00 g) was added 
and the separated aqueous layer was extracted with diethyl ether (3 x 60 mL). The combined 
organic phases were then dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The resulting light-yellow oil was dissolved in 2,2-dimethoxypropane (150 
mL) and the solution thus obtained treated with p-toluenesulfonic acid (1.43 g, 7.50 mmol). 
The mixture so-formed was stirred at 18 °C for 2 h then quenched with sodium hydrogen 
carbonate (50 mL of a saturated aqueous solution) and extracted with ethyl acetate (3 x 100 
mL). The combined organic phases were dried over magnesium sulfate, filtered and 
concentrated under reduced pressure and the light-yellow oil so formed subjected to flash 
chromatography (silica, 20:80  25:75 v/v diethyl ether/hexane gradient elution). 
Concentration of the appropriate fractions (Rf = 0.4 in 25:75 v/v diethyl ether/hexane) afforded 
compound 2.9107 (16.62 g, 78%) as a clear, colourless foam. 
1H NMR (400 MHz, CDCl3) δ 6.02 (d, J = 3.9 Hz, 1H), 4.53–4.47 (complex m, 2H), 4.26 (br 
t, J = 4.5 Hz, 1H), 4.10 (t, J = 6.0 Hz, 1H), 3.28 (br s, 1H), 1.43 (s, 3H), 1.33 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 131.9 (C), 128.0 (CH), 111.9 (C), 77.9 (CH), 75.1 (CH), 70.0 
(CH), 50.3 (CH), 27.9 (CH3), 26.2 (CH3); 
IR (KBr) νmax 3468, 2987, 2934, 1958, 1649, 1455, 1383, 1220, 1161, 1064, 1012, 980, 919, 
866, 807 cm−1; 
MS (EI, +70 eV) m/z 271, 269 and 267 [(M−CH3•)+, 100, 80 and 22%], 209 and 207 (43 and 
33), 131 (63), 128 (40); 
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HRMS (EI, +70 eV) Found: (M−CH3•)+ 266.9417, C9H1279Br35ClO3 requires 266.9424; 
Specific rotation [α]25D = −1.3 (c 1.0, CHCl3). 
These data matched those reported previously.107  
 
(3aS,5aS,6aS,6bS)-4-Chloro-2,2-dimethyl-3a,5a,6a,6b-tetrahydrooxireno[2',3':3,4]benzo 
[1,2-d][1,3]dioxole (2.10)  
 
A magnetically stirred solution of bromohydrin 2.9 (8.30 g, 29.27 mmol) in 
tetrahydrofuran (90 mL) maintained under nitrogen was cooled to 0 °C then treated with 
sodium hydride (1.75 g of 60% w/w dispersion in mineral oil, 43.75 mmol). After 1 h, the 
reaction mixture was filtered through a pad of CeliteTM and the filtrate concentrated under 
reduced pressure to give pale-yellow oil. Subjection of this material to flash chromatography 
(silica, 20:80 v/v diethyl ether/hexane elution) and concentration of the appropriate fractions 
(Rf = 0.4 in 25:75 v/v diethyl ether/hexane) afforded compound 2.10
107 (5.10 g, 86%) as a 
colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.41 (d, J = 4.3 Hz, 1H), 4.60 (dd, J = 6.8 and 1.7 Hz, 1H), 4.54 
(dd, J = 6.8 and 2.7 Hz, 1H), 3.64–3.61 (complex m, 1H), 3.50 (t, J = 4.1 Hz, 1H), 1.54 (s, 3H), 
1.41 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 135.7 (C), 125.9 (CH), 109.2 (C), 75.6 (CH), 74.1 (CH), 54.8 
(CH), 49.9 (CH), 27.3 (CH3), 25.5 (CH3); 
IR (KBr) νmax 2986, 2935, 1958, 1648, 1455, 1429, 1371, 1246, 1213, 1162, 1078, 1062, 1003, 
979, 873, 815 cm−1; 
MS (ESI, +ve) m/z 227 and 225 [(M+Na)+, 35 and 100%]; 
HRMS (ESI, +ve) Found: (M+H)+ 203.0475, C9H12
35ClO3 requires 203.0475; 
Melting point 88–89 °C; 
Specific rotation [α]25D = −91.3 (c 1.0, CHCl3). 
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These data matched those reported previously.107  
 
(3aS,4S,7aS)-7-Chloro-2,2-dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-4-ol (2.11) 
 
A magnetically stirred solution of epoxide 2.10 (4.27 g, 21.07 mmol) in diethyl ether 
(30 mL) was cooled to −78 °C then treated, dropwise, with di-iso-butylaluminium hydride 
(31.6 mL of a 1.0 M solution in hexane, 31.60 mmol). After addition was complete, the reaction 
mixture was warmed to 0 °C and stirred at this temperature for 2 h then treated with tartaric 
acid (60 mL of a 1.0 M aqueous solution) and stirring continued at 18 °C for a further 30 min. 
The separated aqueous layer was extracted with diethyl ether (3 x 100 mL) and the combined 
organic phases were then washed with brine (1 x 100 mL) before being dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The resulting light-yellow oil was 
subjected to flash chromatography (silica, 30:70 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded compound 2.11 (3.90 g, 90%) as 
a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 5.83 (dd, J = 5.9 and 3.0 Hz, 1H), 4.56 (m, 1H), 4.46 (dd, J = 
5.6 and 2.5 Hz, 1H), 3.95 (m, 1H), 2.46–2.32 (complex m, 2H), 2.06 (br s, 1H), 1.45 (s, 3H), 
1.43 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 131.4 (C), 124.2 (CH), 110.8 (C), 77.4 (CH), 77.0 (CH), 67.1 
(CH), 29.9 (CH2), 27.5 (CH3), 26.6 (CH3); 
IR (KBr) νmax 3436, 2986, 2934, 1650, 1372, 1227, 1163, 1085, 1049, 1034, 981, 922, 864, 
811 cm−1; 
MS (ESI, +ve) m/z 229 and 227 [(M+Na)+, 33 and 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 227.0449, C9H13
35Cl23NaO3 requires 227.0451; 
Melting point 112–114 °C; 
Specific rotation [α]25D = +29.8 (c 0.8, CHCl3). 
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tert-Butyl(((3aR,4S,7aS)-7-chloro-2,2-dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-
4-yl)oxy)dimethylsilane (2.12) 
 
A magnetically stirred solution of alcohol 2.11 (3.89 g, 19.01 mmol) in N,N-
dimethylformamide (30 mL) maintained at 20 °C was treated, sequentially, with tert-
butyldimethylsilyl chloride (3.99 g, 26.47 mmol) then imidazole (2.40 g, 35.25 mmol). The 
ensuing mixture was stirred for 2 h then quenched with water (1 x 50 mL) and extracted with 
diethyl ether (3 x 100 mL). The combined organic phases were washed with hydrochloric acid 
(1 x 100 mL of a 1.0 M aqueous solution) and brine (1 x 100 mL) then dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The ensuing light-yellow oil was 
subjected to flash chromatography (silica, 10:90 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.8) gave compound 2.12 (5.79 g, 98%) as a 
clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.78 (dd, J = 6.7 and 2.0 Hz, 1H), 4.48 (dd, J = 5.1 and 2.7 Hz, 
1H), 4.32 (m, 1H), 3.96 (ddd, J = 10.2, 5.3 and 2.0 Hz, 1H), 2.52 (m, 1H), 2.17 (dt, J = 12.1 
and 5.8 Hz, 1H), 1.43 (s, 3H), 1.41 (s, 3H), 0.90 (d, J = 0.6 Hz, 9H), 0.10 (s, 3H), 0.9 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 131.6 (C), 124.6 (CH), 110.9 (C), 78.3 (CH), 77.5 (CH), 68.4 
(CH), 30.0 (CH2), 27.7 (CH3), 26.9 (CH3), 26.1 (3 x CH3), 18.6 (C), −4.3 (CH3), −4.5 (CH3); 
IR (KBr) νmax 3401, 2987, 2954, 2931, 2888, 2858, 1647, 1472, 1382, 1371, 1253, 1237, 1170, 
1120, 1065, 1039, 990, 936, 925, 837, 813 cm−1; 
MS (ESI, +ve) m/z 341 [(M + Na)+, 100%], 261 (10); 
HRMS (ESI, +ve) Found: (M+Na)+ 341.1316, C15H27
35Cl23NaO3Si requires 341.1316; 
Specific rotation [α]25D = −5.1 (c 0.9, CHCl3). 
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Methyl (4S,5R)-5-((S)-1-((tert-Butyldimethylsilyl)oxy)-3-oxopropyl)-2,2-dimethyl-1,3-
dioxolane-4-carboxylate (2.13) 
 
A magnetically stirred solution of alkene 2.12 (4.89 g, 15.33 mmol) in 
dichloromethane/methanol (125 mL of a 4:1 v/v mixture) was treated with pyridine (6.1 mL, 
85.90 mmol) then cooled to −78 °C and ozone bubbled through it until a dark-blue colour 
persisted (ca. 30 min). At this point triphenylphosphine (4.92 g, 18.76 mmol) was added to the 
reaction mixture which was then warmed to 18 °C and kept at this temperature for 1 h before 
being concentrated under reduced pressure. The resulting light-yellow oil was subjected to 
flash chromatography (silica, 20:80 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.4 in 25:75 v/v ethyl acetate/hexane) afforded compound 2.13 (4.55 
g, 86%) as a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 9.80 (s, CHO), 4.60 (d, J = 7.1 Hz, 1H), 4.54 (m, 1H), 4.34 (dd, 
J = 7.0 and 3.9 Hz, 1H), 3.74 (s, 3H), 2.77–2.65 (complex m, 2H), 1.59 (s, 3H), 1.36 (s, 3H), 
0.85 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 200.6 (CHO), 170.5 (CO), 110.9 (C), 81.3 (CH), 75.1 (CH), 
66.2 (CH), 52.3 (CH3), 48.0 (CH2), 26.5 (CH3), 26.0 (3 x CH3), 25.5 (CH3), 18.3 (C), −4.3 
(CH3), −4.5 (CH3); 
IR (KBr) νmax 2953, 2929, 2855, 2739, 1751, 1721, 1472, 1436, 1384, 1373, 1344, 1253, 1208, 
1141, 1094, 1046, 1005, 966, 948, 864, 838, 809 cm−1; 
MS (ESI, +ve) m/z 401 [(M+CH3OH+Na)
+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 369.1708, C16H30
23NaO6Si requires 369.1709; 
Melting point 94–95 °C; 
Specific rotation [α]25D = −29.8 (c = 0.8, CHCl3). 
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Methyl (4S,5R)-5-((1S,3R)-1-((tert-Butyldimethylsilyl)oxy)-3-hydroxypent-4-yn-1-yl)-2,2-
dimethyl-1,3-dioxolane-4-carboxylate (2.14α) and Methyl (4S,5R)-5-((1S,3S)-1-((tert-
Butyldimethylsilyl)oxy)-3-hydroxypent-4-yn-1-yl)-2,2-dimethyl-1,3-dioxolane-4-
carboxylate (2.14β) 
 
A magnetically stirred solution of aldehyde 2.13 (1.77 g, 5.14 mmol) in diethyl ether 
(80 mL) maintained under nitrogen at −78 °C was treated with ethynylmagnesium bromide 
(30.8 mL of an 0.5 M solution in tetrahydrofuran, 15.40 mmol) and the ensuing mixture was 
stirred at −15 °C for a further 1 h then quenched with ammonium chloride (50 mL of a saturated 
aqueous solution). The separated aqueous layer was extracted with diethyl ether (3 x 100 mL) 
and the combined organic phases were then washed with brine (1 x 100 mL) before being dried 
over magnesium sulfate, filtered and concentrated under reduced pressure. The ensuing light-
yellow residue was subjected to flash chromatography (silica, 20:25:55 v/v/v ethyl 
acetate/dichloromethane/hexane elution) and thus affording two fractions, A and B. 
Concentration of fraction A (Rf = 0.4) gave compound 2.14β (770 mg, 40%) as a 
colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 4.59 (d, J = 7.2 Hz, 1H), 4.49 (d, J = 8.6 Hz, 1H), 4.34 (dd, J = 
7.2 and 2.9 Hz, 1H), 4.29–4.23 (complex m, 1H), 3.71 (s, 3H), 2.44 (d, J = 2.1 Hz, 1H), 2.39 
(s, 1H), 2.07 (ddd, J = 14.6, 7.9 and 3.6 Hz, 1H), 1.79 (ddd, J = 14.6, 9.1 and 4.0 Hz, 1H), 1.61 
(s, 3H), 1.36 (s, 3H), 0.86 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 170.5 (CO), 110.7 (C), 85.1 (C), 81.5 (CH), 74.9 (CH), 73.1 
(CH), 68.1 (CH), 59.2 (CH), 52.2 (CH3), 40.9 (CH2), 26.5 (CH3), 26.1 (3 x CH3), 25.4 (CH3), 
18.4 (C), −4.1 (CH3), −4.5 (CH3); 
IR (KBr) νmax 3474, 3309, 2953, 2932, 2888, 2857, 1762, 1472, 1463, 1437, 1381, 1323, 1251, 
1209, 1138, 1092, 1004, 959, 868, 837, 780 cm−1; 
MS (ESI, +ve) m/z 411 [(M+K)+, 100%], 395 [(M+Na)+, 12]; 
HRMS (ESI, +ve) Found: (M+Na)+ 395.1869, C18H32
23NaO6Si requires 395.1866; 
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Melting point 72–74 °C; 
Specific rotation [α]25D = +12.8 (c 1.0, CHCl3). 
Concentration of fraction B (Rf = 0.3) gave compound 2.14α (1.05 g, 55%) as a clear, 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.60 (d, J = 6.9 Hz, 1H), 4.56 (dd, J = 6.6 and 2.1 Hz, 1H), 4.37 
(dd, J = 6.9 and 3.8 Hz, 1H), 4.26 (ddd, J = 6.4, 5.5 and 3.8 Hz, 1H), 3.73 (s, 3H), 2.50 (d, J = 
2.1 Hz, 1H), 2.21-2.12 (complex m, 1H), 1.93 (ddd, J = 14.2, 6.4 and 5.5 Hz, 1H), 1.61 (s, 3H), 
1.36 (s, 3H), 0.87 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H) (signal due to hydroxyl group proton not 
observed); 
13C NMR (100 MHz, CDCl3) δ 170.7 (CO), 110.6 (C), 84.6 (C), 81.4 (CH), 75.1 (CH), 73.7 
(CH), 68.3 (CH), 59.9 (CH), 52.2 (CH3), 41.5 (CH2), 26.6 (CH3), 26.1 (3 x CH3), 25.6 (CH3), 
18.4 (C), −4.2 (CH3), −4.4 (CH3); 
IR (KBr) νmax 3472, 3309, 2953, 2932, 2889, 2857, 1762, 1472, 1463, 1437, 1382, 1317, 1251, 
1208, 1138, 1092, 1031, 987, 959, 872, 837 cm−1; 
MS (ESI, +ve) m/z 411 [(M+K)+, 100%], 395 [(M+Na)+, 17]; 
HRMS (ESI, +ve) Found: (M+Na)+ 395.1867, C18H32
23NaO6Si requires 395.1866; 
Specific rotation [α]25D = + 22.3 (c 0.7, CHCl3). 
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Methyl (4S,5R)-5-((1S,3R)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)- 
pent-4-yn-1-yl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (2.17α) 
 
A magnetically stirred solution of alcohol 2.14α (860 mg, 2.31 mmol) in 
dichloromethane (30 mL) was treated with 2-(4-methoxybenzyloxy)-4-methylquinoline (1.23 
g, 4.62 mmol) and (+)-10-camphorsulfonic acid (54 mg, 0.23 mmol) and the ensuing mixture 
heated at 40 °C for 16 h. The cooled reaction mixture was concentrated under reduced pressure 
and the residue thus obtained subjected to flash chromatography (silica, 30:70 v/v diethyl 
ether/hexane elution) to afford, after concentration of the relevant fractions (Rf = 0.4), 
compound 2.17α (1.02 g, 90%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.3 Hz, 2H), 6.84 (d, J = 8.3 Hz, 2H), 4.71 (d, J = 
11.5 Hz, 1H), 4.49 (d, J = 6.7 Hz, 1H), 4.43 (d, J = 11.5 Hz, 1H), 4.29 (t, J = 6.5 Hz, 2H), 4.17 
(t, J = 6.5 Hz, 1H), 3.77 (d, J = 0.5 Hz, 3H), 3.67 (s, 3H), 2.50 (d, J = 0.9 Hz, 1H), 2.17–2.07 
(complex m, 1H), 2.03–1.92 (complex m, 1H), 1.59 (s, 3H), 1.30 (s, 3H), 0.80 (d, J = 0.4 Hz, 
9H), 0.04 (s, 3H), 0.02 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 170.8 (CO), 159.5 (CH), 129.8 (2 x CH), 129.7 (C), 114.0 (2 
x CH), 110.3 (C), 82.5 (C), 81.5 (CH), 75.0 (CH), 74.5 (CH), 70.3 (CH2), 67.8 (CH), 65.5 
(CH), 55.4 (CH3), 51.9 (CH3), 39.3 (CH2), 26.7 (CH3), 26.1 (3 x CH3), 25.6 (CH3), 18.4 (C), 
−4.1 (CH3), −4.7 (CH3); 
IR (KBr) νmax 2933, 2857, 1763, 1612, 15145, 1249, 1093, 836 cm−1; 
MS (ESI, +ve) m/z 531 [(M+K)+, 100%]; 515 [(M+Na)+, 5]; 
HRMS (ESI, +ve) Found: (M+K)+ 531.2181, C26H40
39KO7Si requires 531.2180; (M+Na)
+ 
515.2442, C26H40
23NaO7Si requires 515.2441; 
Specific rotation [α]25D = +95.5 (c 0.9, CHCl3). 
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Methyl (4S,5R)-5-((1S,3S)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)- 
pent-4-yn-1-yl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (2.17β) 
 
Reaction of alcohol 2.14β with 2-(4-methoxybenzyloxy)-4-methylquinoline and (+)-
10-camphorsulfonic acid in the same manner as described immediately above for the 
conversion 2.14α  2.17α afforded a light-yellow oil on work-up. Subjection of this material 
to flash chromatography (silica, 30:70 v/v diethyl ether/hexane elution) afforded, after 
concentration of the relevant fractions (Rf = 0.4), compound 2.17β (83%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 4.73 (d, J = 
10.9 Hz, 1H), 4.52 (d, J = 7.1 Hz, 1H), 4.34 (d, J = 10.9 Hz, 1H), 4.31 (dd, J = 7.1 and 2.4 Hz, 
1H), 4.25–4.17 (complex m, 2H), 3.78 (s, 3H), 3.59 (s, 3H), 2.48 (d, J = 1.4 Hz, 1H), 2.04 
(complex m, 2H), 1.60 (s, 3H), 1.32 (s, 3H), 0.84 (s, 9H), 0.05 (s, 3H), 0.01 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 170.7 (CO), 159.5 (CH), 130.0 (2 x CH), 129.9 (C), 113.9 (2 
x CH), 110.4 (C), 83.0 (C), 81.7 (CH), 74.5 (CH), 74.3 (CH), 70.5 (CH2), 67.5 (CH), 65.2 
(CH), 55.5 (CH3), 52.0 (CH3), 40.2 (CH2), 26.6 (CH3), 26.2 (3 x CH3), 25.6 (CH3), 18.5 (C), 
−4.0 (CH3), −4.7 (CH3); 
IR (KBr) νmax 2953, 2857, 1763, 1515, 1250, 1204, 1092, 1036, 836, 779 cm−1; 
MS (ESI, +ve) m/z 531 [(M+K)+, 100%]; 515 [(M+Na)+, 10]; 
HRMS (ESI, +ve) Found: (M+K)+ 531.2183, C26H40
39KO7Si requires 531.2180; (M+Na)
+ 
515.2449, C26H40
23NaO7Si requires 515.2441; 
Specific rotation [α]25D = −21.8 (c 0.7, CHCl3). 
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Methyl (4S,5R)-5-((1S,3R)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy) 
hexa-4,5-dien-1-yl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (2.18α) 
 
A magnetically stirred solution of compound 2.17α (304 mg, 0.62 mmol), 
paraformaldehyde (53.5 mg, 1.85 mmol), di-iso-propylamine (130 μL, 0.93 mmol) and copper 
iodide (58.8 mg, 0.31 mmol) in 1,4-dioxane (10 mL) was heated to 100 °C for 24 h. The cooled 
reaction mixture was filtered through a pad of Celite™ and the filtrate treated with ammonium 
chloride (10 mL of a saturated aqueous solution) then water (20 mL). The ensuing mixture was 
extracted with dichloromethane (3 x 30 mL) and the combined organic phases were then 
washed with brine (1 x 30 mL) before being dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The ensuing light-yellow oil was subjected to flash 
chromatography (silica, 15:85 v/v of diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.5 in 30:70 v/v diethyl ether/hexane) gave compound 2.18α (244 
mg, 78%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.22 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H), 5.02 (dd, J = 
14.7 and 6.6 Hz, 1H), 4.90–4.71 (complex m, 2H), 4.57 (d, J = 11.6 Hz, 1H), 4.47 (d, J = 6.7 
Hz, 1H), 4.32 (d, J = 11.6 Hz, 1H), 4.23–4.13 (complex m, 2H), 3.98 (dd, J = 14.4 and 7.0 Hz, 
1H), 3.77 (s, 3H), 3.67 (s, 3H), 1.96 (complex m, 2H), 1.59 (s, 3H), 1.27 (s, 3H), 0.82 (s, 9H), 
0.03 (s, 3H), 0.01 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 209.2 (C), 170.9 (CO), 159.3 (CH), 130.6 (C), 129.7 (2 x CH), 
114.0 (2 x CH), 110.3 (C), 91.5 (CH), 81.2 (CH), 76.2 (CH), 74.6 (CH2), 74.1 (CH), 69.8 
(CH2), 67.7 (CH), 55.4 (CH3), 51.9 (CH3), 40.4 (CH2), 26.7 (CH3), 26.2 (3 x CH3), 25.7 (CH3), 
18.5 (C), −4.1 (CH3), −4.5 (CH3); 
IR (KBr) νmax 2952, 2931, 2857, 1954, 1765, 1736, 1613, 1513, 1249, 1201, 1093, 1038, 837, 
779 cm−1; 
Mass spectrum (ESI, +ve) m/z 545 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: [M+K]+ 545.2335, C27H42
39KO7Si requires 543.2337; 
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Specific rotation [α]25D = +32.5 (c 0.7, CHCl3). 
 
Methyl (4S,5R)-5-((1S,3S)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy) 
hexa-4,5-dien-1-yl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (2.18β) 
 
Reaction of alcohol 2.17β with paraformaldehyde in the presence of di-iso-propylamine 
and copper iodide in the same manner as described immediately above for the conversion 2.17α 
 2.17α afforded a light-yellow oil on work-up. Subjection of this material to flash 
chromatography (silica, 15:85 v/v diethyl ether/hexane elution) afforded, after concentration of 
the relevant fractions (Rf = 0.5 in 30:70 in v/v diethyl ether/hexane), compound 2.18β (86%) as 
a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.3 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.08 (dd, J = 
14.7 and 6.6 Hz, 1H), 4.89–4.75 (complex m, 2H), 4.59 (d, J = 11.0 Hz, 1H), 4.52 (d, J = 7.1 
Hz, 1H), 4.33 (dd, J = 7.1 and 2.5 Hz, 1H), 4.27 (d, J = 11.0 Hz, 1H), 4.25–4.20 (m, 1H), 4.03 
(dd, J = 13.0 and 8.1 Hz, 1H), 3.79 (s, 3H), 3.60 (s, 3H), 1.98–1.82 (complex m, 2H), 1.62 (s, 
3H), 1.33 (s, 3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.03 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 208.8 (C), 170.9 (CO), 159.4 (CH), 130.7 (C), 129.8 (2 x CH), 
113.9 (2 x CH), 110.2 (C), 91.9 (CH), 81.9 (CH), 76.1 (CH), 74.9 (CH2), 74.5 (CH), 70.0 
(CH2), 68.1 (CH), 55.5 (CH3), 51.9 (CH3), 40.6 (CH2), 26.7 (CH3), 26.2 (3 x CH3), 25.6 (CH3), 
18.5 (C), −3.9 (CH3), −4.6 (CH3); 
IR (KBr) νmax 2952, 2932, 2856, 1954, 1764, 1613, 1514, 1249, 1203, 1092, 1036, 836 cm−1; 
MS (ESI, +ve) m/z 529 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 529.2583, C27H42
23NaO7Si requires 529.2598; 
Specific Rotation [α]25D = +9.3 (c 0.8, CHCl3). 
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(4S,5R)-5-((1S,3R)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)pent-4-yn-
1-yl)-N-methoxy-N,2,2-trimethyl-1,3-dioxolane-4-carboxamide (2.20α) 
 
A magnetically stirred solution of methyl ester 2.18α (344 mg, 0.68 mmol) and N,O-
dimethylhydroxylamine hydrochloride (267 mg, 2.73 mmol) in dry tetrahydrofuran (10 mL) 
maintained under nitrogen was cooled to −15 °C then treated, dropwise over 20 min via syringe 
pump, with iso-propylmagnesium chloride (2.0 mL of a 2.0 M solution in tetrahydrofuran, 4.00 
mmol). The ensuing mixture was stirred at −15 °C for 1 h then quenched with ammonium 
chloride (5 mL of a saturated aqueous solution) and the separated aqueous phase extracted with 
ethyl acetate (3 x 20 mL). The combined organic phases were dried over magnesium sulfate 
then filtered and concentrated under reduced pressure and the resulting light-yellow oil 
subjected to flash chromatography (silica, 70:30 v/v diethyl ether/hexane elution). 
Concentration of the relevant fractions (Rf = 0.2) afforded compound 2.20α (314 mg, 86%) as 
a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.5 Hz, 2H), 6.80 (d, J = 8.5 Hz, 2H), 5.01–4.90 
(complex m, 1H), 4.83 (d, J = 7.8 Hz, 1H), 4.78 (dd, J = 10.9 and 6.7 Hz, 1H), 4.64 (dd, J = 
10.9 and 6.5 Hz, 1H), 4.53 (d, J = 11.7 Hz, 1H), 4.43 (dd, J = 7.8 and 1.8 Hz, 1H), 4.31 (d, J = 
11.7 Hz, 1H), 3.96 (m, 1H), 3.75 (s, 3H), 3.72 (s, 1H), 3.69 (s, 3H), 3.15 (s, 3H), 2.03–1.89 
(complex m, 1H), 1.73–1.62 (complex m, 1H), 1.55 (s, 3H), 1.32 (s, 3H), 0.78 (s, 9H), −0.01 
(s, 3H), −0.07 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 209.7 (C), 169.1 (CO), 159.1 (C), 131.0 (C), 129.5 (2 x CH), 
113.8 (2 x CH), 110.0 (C), 91.8 (CH), 81.5 (CH), 75.3 (CH), 74.9 (CH2), 74.4 (CH), 69.4 
(CH2), 69.3 (CH), 61.2 (CH3), 55.4 (CH3), 38.9 (CH2), 32.3 (CH3), 26.4 (CH3), 26.1 (3 x CH3), 
25.0 (CH3), 18.2 (C), −4.0 (CH3), −4.4 (CH3); 
IR (KBr) νmax 2934, 2856, 1953, 1687, 1612, 1513, 1381, 1249, 1210, 1102, 1070, 993, 836 
776 cm−1; 
MS (ESI, +ve) m/z 558 [(M+Na)+, 100%]; 
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HRMS (ESI, +ve) Found: (M+Na)+ 558.2875, C28H45
23NaNO7Si requires 558.2863; 
Melting point 137.5–138.4 °C; 
Specific rotation [α]25D = −22.1 (c 2.0, CHCl3).  
 
(4S,5R)-5-((1S,3S)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)pent-4-yn-
1-yl)-N-methoxy-N,2,2-trimethyl-1,3-dioxolane-4-carboxamide (2.20β) 
 
Reaction of ester 2.18β with N,O-dimethylhydroxylamine hydrochloride and iso-
propylmagnesium chloride in the same manner as described immediately above for the 
conversion 2.18α  2.20α afforded a light-yellow oil on work-up. Subjection of this material 
to flash chromatography (silica, 70:30 v/v diethyl ether/hexane elution) afforded, after 
concentration of the relevant fractions (Rf = 0.2), compound 2.20β (77%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.5 Hz, 2H), 6.83 (d, J = 8.5 Hz, 2H), 5.08 (m, 1H), 
4.84 (d, J = 8.0 Hz, 1H), 4.80–4.70 (complex m, 2H), 4.57 (d, J = 10.8 Hz, 1H), 4.51 (d, J = 
8.0 Hz, 1H), 4.17(d, J = 10.8 Hz, 1H), 4.05 (complex m, 2H), 3.79 (s, 3H), 3.63 (s, 3H), 2.82 
(s, 3H), 1.73 (complex m, 2H), 1.60 (s, 3H), 1.37 (s, 3H), 0.90 (s, 9H), 0.06 (s, 6H); 
13C NMR (100 MHz, CDCl3) δ 208.8 (C), 169.7 (CO), 159.1 (C), 131.4 (C), 129.8 (2 x CH), 
113.6 (2 x CH), 109.8 (C), 92.3 (CH), 82.2 (CH), 75.6 (CH), 74.8 (CH2), 74.5 (CH), 69.7 
(CH2), 68.1 (CH), 61.0 (CH3), 55.5 (CH3), 38.6 (CH2), 32.5 (CH3), 26.4 (CH3), 26.2 (3 x CH3), 
24.9 (CH3), 18.4 (C), −4.1 (CH3), −4.3 (CH3); 
IR (KBr) νmax 2935, 2856, 1954, 1693, 1514, 1249, 1072, 995, 836 cm−1; 
MS (ESI, +ve) m/z 558 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 558.2863, C28H45
23NaNO7Si requires 558.2863; 
Melting point 78.4–79.3 °C; 
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Specific rotation [α]25D = −56.5 (c 1.0, CHCl3). 
 
1-((4S,5R)-5-((1S,3R)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)pent-4-
yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-one (2.5α) 
 
A magnetically stirred solution of Weinreb amide 2.20α (100 mg, 0.18 mmol) in dry 
tetrahydrofuran (2 mL) maintained at −78 °C under a nitrogen atmosphere was treated with 
vinylmagnesium bromide (0.93 mL of a 1.0 M solution in tetrahydrofuran, 0.93 mmol). After 
1 h, the reaction mixture was quenched with ammonium chloride (5 mL of a saturated aqueous 
solution). The separated aqueous layer was extracted with diethyl ether (3 x 5 mL) and the 
combined organic phases were washed with brine (1 x 10 mL) before being dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The resulting light-
yellow oil was subjected to flash chromatography (silica, 15:85 to 50:50 v/v of diethyl 
ether/hexane elution) and two fractions, A and B, thereby obtained. 
Concentration of fraction A (Rf = 0.6 in 30:70 v/v diethyl ether/hexane) gave compound 
2.5α (20 mg, 21%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.24 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 6.83–6.75 
(partially obscured d, J = 17.4 and 10.5 Hz, 1H), 6.25 (d, J = 17.4 Hz, 1H), 5.65 (d, J = 10.5 
Hz, 1H), 4.97 (q, J = 7.0 Hz, 1H), 4.84 (dd, J = 11.0 and 7.0 Hz, 1H), 4.78 (dd, J = 11.0 and 
7.0 Hz, 1H), 4.57 (d, J = 11.6 Hz, 1H), 4.54 (d, J = 8.2 Hz, 1H) 4.40 (dd, J = 8.2 and 3.1 Hz, 
1H), 4.33 (d, J = 11.6 Hz, 1H), 4.12 (m, 1H), 3.98 (q, J = 7.0 Hz 1H), 3.79 (s, 3H), 1.94 (dt, J 
= 13.1 and 7.0 Hz, 1H), 1.78 (dt, J = 13.1 and 7.0 Hz, 1H), 1.59 (s, 3H), 1.30 (s, 3H), 0.81 (s, 
9H), 0.03 (s, 3H), 0.00 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 209.3 (C), 198.2 (CO), 159.3 (C), 133.3 (CH2), 130.6 (C), 
129.7 (2 x CH), 127.9 (CH), 113.9 (2 x CH), 109.7 (C), 91.3 (CH), 82.2 (CH), 80.4 (CH), 76.1 
(CH), 74.3 (CH2), 69.7 (CH2), 68.3 (CH), 55.5 (CH3), 40.0 (CH2), 26.5 (CH3), 26.2 (3 x CH3), 
24.6 (CH3), 18.4 (C), −3.8 (CH3), −4.3 (CH3); 
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IR (KBr) νmax 2930, 2856, 1953, 1698, 1612, 1513, 1249, 1211, 1172, 1070, 836 cm−1; 
MS (ESI, +ve) m/z 541 [(M+K)+, 100%];  
HRMS (ESI, +ve) Found: [M+K]+ 541.2388, C28H42
39KO6Si requires 541.2388; 
Specific rotation [α]25D = +48.2 (c 0.5, CHCl3). 
Concentration of fraction B (Rf = 0.6 in 50:50 v/v diethyl ether/hexane) gave compound 
2.21α (60 mg, 57%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 5.00 (dd, J = 
14.4 and 6.8 Hz, 1H), 4.90–4.73 (complex m, 2H), 4.57 (d, J = 11.6 Hz, 1H), 4.37–4.26 
(complex m, 3H), 4.19 (m, 1H), 3.94 (m, 1H), 3.78 (s, 3H), 3.46 (s, 3H), 3.10–2.68 (complex 
m, 4H), 2.55 (s, 3H), 1.98–1.80 (complex m, 2H), 1.59 (s, 3H), 1.27 (s, 3H), 0.84 (s, 9H), 0.07 
(s, 3H), 0.03 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 210.1 (C), 209.2 (CO), 159.3 (C), 130.5 (C), 129.7 (2 x CH), 
113.9 (2 x CH), 109.2 (C), 91.3 (CH), 81.7 (CH), 80.7 (CH), 76.2 (CH), 74.1 (CH2), 69.7 
(CH2), 68.2 (CH), 60.1 (CH3), 55.4 (CH3), 55.0 (CH2), 45.4 (CH3), 39.9 (CH2), 38.7 (CH2), 
26.5 (CH3), 26.3 (3 x CH3), 24.6 (CH3), 18.6 (C), –3.9 (CH3), –4.5 (CH3); 
IR (KBr) νmax 2934, 2856, 1954, 1714, 1613, 1513, 1381, 1250, 1059, 836 cm−1; 
MS (ESI, +ve) m/z 586 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 586.3173, C30H49
23NaNO7Si requires 586.3176; 
Specific rotation [α]25D = +27.6 (c 1.0, CHCl3). 
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1-((4S,5R)-5-((1S,3S)-1-((tert-Butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)pent-4-
yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-one (2.5β) 
 
A magnetically stirred solution of Weinreb amide 2.20β (210 mg, 0.39 mmol) in dry 
tetrahydrofuran (5 mL) maintained at −78 °C under a nitrogen atmosphere was treated with 
vinylmagnesium bromide (1.96 mL of a 1.0 M solution in tetrahydrofuran, 1.96 mmol). After 
1 h, the reaction mixture was poured into hydrochloric acid (10 mL of a 1.0 M aqueous 
solution). The separated aqueous layer was extracted with diethyl ether (3 x 20 mL) and the 
combined organic phases were washed with brine (1 x 20 mL) before being dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The light-yellow oil thus 
obtained was purified by flash chromatography (silica, 15:85  50:50 v/v of diethyl 
ether/hexane elution) to afford two fractions, A and B. 
Concentration of fraction A (Rf = 0.6 in 30:70 v/v diethyl ether/hexane) gave compound 
2.5β (140 mg, 71%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.24 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 6.78 (dd, J = 
17.4 and 10.6 Hz, 1H), 6.19 (dd, J = 17.4 and 1.1 Hz, 1H), 5.58 (dd, J = 10.6 and 1.1 Hz, 1H), 
5.06 (q, J = 6.7 Hz, 1H), 4.83 (dd, J = 11.0 and 6.7 Hz, 1H), 4.78 (dd, J = 11.0 and 6.7 Hz, 1H), 
4.57 (partially obscured d, J = 8.1 Hz, 1H), 4.56 (partially obscured d, J = 11.2 Hz, 1H), 4.47 
(dd, J = 8.1 and 2.5 Hz, 1H), 4.26 (d, J = 11.2 Hz, 1H), 4.16 (m, 1H), 3.99 (m, 1H), 3.79 (s, 
3H), 1.98–1.74 (complex m, 2H), 1.61 (s, 3H), 1.34 (s, 3H), 0.82 (s, 9H), 0.04 (s, 3H), 0.00 (s, 
3H); 
13C NMR (100 MHz, CDCl3) δ 208.8 (C), 198.4 (CO), 159.3 (C), 133.4 (CH2), 130.8 (C), 
129.6 (2 x CH), 127.6 (CH), 113.9 (2 x CH), 109.6 (C), 91.8 (CH), 83.1 (CH), 80.3 (CH), 76.1 
(CH), 75.0 (CH2), 69.8 (CH2), 68.9 (CH), 55.5 (CH3), 40.8 (CH2), 26.5 (CH3), 26.3 (3 x CH3), 
24.7 (CH3), 18.5 (C), −3.6 (CH3), −4.6 (CH3); 
IR (KBr) νmax 2931, 2856, 1953, 1698, 1613, 1514, 1382, 1248, 1212, 1071, 1037, 835 cm−1; 
MS (ESI, +ve) m/z 525 [(M+Na)+, 100%]; 
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HRMS (ESI, +ve) Found: (M+Na)+ 525.2649. C28H42
23NaO6Si requires 525.2648; 
Specific rotation [α]25D = −19.2 (c 0.7, CHCl3). 
Concentration of fraction B (Rf = 0.6 in 50:50 v/v diethyl ether/hexane) gave compound 
2.21β (30 mg, 14%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.3 Hz, 2H), 6.85 (d, J = 8.3 Hz, 2H), 5.05 (m, 1H), 
4.79 (complex m, 2H), 4.56 (d, J = 11.1 Hz, 1H), 4.40 (s, 2H), 4.26 (d, J = 11.1 Hz, 1H), 4.15 
(m, 1H), 3.97 (m, 1H), 3.78 (s, 3H), 3.44 (s, 3H), 3.02 (m, 1H), 2.84–2.65 (complex m, 3H), 
2.50 (s, 3H), 2.02–1.72 (complex m, 2H), 1.59 (s, 3H), 1.31 (s, 3H), 0.84 (s, 9H), 0.06 (s, 3H), 
0.01 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 210.1 (C), 208.8 (CO), 159.3 (C), 130.7 (C), 129.6 (2 x CH), 
113.9 (2 x CH), 109.3 (C), 91.8 (CH), 82.9 (CH), 80.8 (CH), 76.1 (CH), 75.1 (CH2), 69.9 
(CH2), 69.0 (CH), 60.1 (CH3), 55.4 (CH3), 55.0 (CH2), 45.3 (CH3), 40.7 (CH2), 38.6 (CH2), 
26.5 (CH3), 26.3 (3 x CH3), 24.8 (CH3), 18.62 (C), −3.68 (CH3), −4.74 (CH3); 
IR (KBr) νmax 2934, 2856, 1954, 1714, 1613, 1514, 1464, 1381, 1302, 1250, 1212, 1172, 1072, 
1048, 836 cm−1; 
MS (ESI, +ve) m/z 564 [(M+H)+, 100%]; 
HRMS (ESI, +ve) Found: (M+H)+ 564.3345, C30H50NO7Si requires 564.3357; 
Specific rotation [α]25D = −26.5 (c 0.5, CHCl3). 
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Methyl (4S,5R)-5-((S)-1-((tert-Butyldimethylsilyl)oxy)but-3-en-1-yl)-2,2-dimethyl-1,3-
dioxolane-4-carboxylate (2.22) 
 
A magnetically stirred solution of methyltriphenylphosphonium bromide (10.31 g, 28.9 
mmol) in dry tetrahydrofuran (60 mL) maintained at 0 °C under a nitrogen atmosphere was 
treated with lithium bis(trimethylsilyl)amide (28.9 mL of a 1.0 M solution in tetrahydrofuran, 
28.90 mmol). The resulting yellow mixture was allowed to warm to 20 °C, maintained at this 
temperature for 1 h then re-cooled to 0 °C and treated, via cannula, with a solution of aldehyde 
2.13 (4.00 g, 11.54 mmol) in dry tetrahydrofuran (180 mL). The ensuing mixture was then 
warmed to 20 °C, stirred at this temperature for 2 h before being quenched with ammonium 
chloride (100 mL of a saturated aqueous solution) and then diluted with water (1 x 100 mL). 
The resulting mixture was extracted with diethyl ether (3 x 150 mL) and the combined organic 
phases were washed with water (1 x 100 mL) and brine (1 x 100 mL) before being dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The resulting light-
yellow oil was subjected to flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.5 in 10:90 v/v diethyl ether/hexane) 
afforded compound 2.22 (3.02 g, 76%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.88–5.76 (complex m, 1H), 5.16–5.04 (complex m, 2H), 4.52 
(d, J = 6.6 Hz, 1H), 4.25 (dd, J = 6.6 and 4.2 Hz, 1H), 4.07 (m, 1H), 3.70 (s, 3H), 2.44 (complex 
m, 2H), 1.61 (s, 3H), 1.34 (s, 3H), 0.87 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 171.0 (CO), 134.4 (CH), 117.9 (CH2), 110.3 (C), 80.5 (CH), 
74.9 (CH), 70.4 (CH), 52.0 (CH3), 38.6 (CH2), 26.8 (CH3), 26.1 (3 x CH3), 25.8 (CH3), 18.5 
(C), −4.2 (CH3), −4.5 (CH3); 
IR (KBr) νmax 2953, 2929, 2857, 1766, 1641, 1472, 1436, 1384, 1370, 1249, 1199, 1094, 999, 
957, 915, 870, 837 cm−1; 
MS (ESI, +ve) m/z 345 [(M+H)+, 100%]; 
HRMS (ESI, +ve) Found: (M+H)+ 345.2097, C17H33O5Si requires 345.2097; 
Specific rotation [α]25D = +41.6 (c 1.0, CHCl3). 
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(4S,5R)-5-((S)-1-((tert-Butyldimethylsilyl)oxy)but-3-en-1-yl)-N-methoxy-N,2,2-trimethyl-
1,3-dioxolane-4-carboxamide (2.23) 
 
A magnetically stirred solution of methyl ester 2.22 (1.11 g, 3.22 mmol) and N,O-
dimethylhydroxylamine hydrochloride (940 mg, 9.66 mmol) in dry tetrahydrofuran (25 mL) 
maintained at −15 °C under a nitrogen atmosphere was treated, dropwise over 20 min via 
syringe pump, with iso-propylmagnesium chloride (3.7 mL of a 2.0 M solution in 
tetrahydrofuran, 7.40 mmol). The resulting mixture was stirred at −15 °C for 1 h then quenched 
with ammonium chloride (25 mL of a saturated aqueous solution) before being diluted with 
water (1 x 10 mL). The resulting mixture was extracted with ethyl acetate (3 x 40 mL) and the 
combined organic phases were dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The resulting light-yellow oil was subjected to flash chromatography (silica, 
25:75 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.3 
in 25:75) afforded compound 2.23 (1.10 g, 92%) as a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 5.86–5.74 (complex m, 1H), 5.06–4.97 (complex m, 2H), 4.88 
(d, J = 7.0 Hz, 1H), 4.34 (dd, J = 6.9 and 4.4 Hz, 1H), 3.96–3.90 (complex m, 1H), 3.70 (s, 
3H), 3.15 (s, 3H), 2.35–2.20 (complex m, 2H), 1.52 (s, 3H), 1.34 (s, 3H), 0.84 (s, 9H), 0.01 (s, 
3H), −0.02 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 169.8 (CO), 135.4 (CH), 117.3 (CH2), 110.1 (C), 80.8 (CH), 
73.5 (CH), 71.4 (CH), 61.4 (OCH3), 37.4 (CH2), 32.4 (NCH3), 26.6 (CH3), 26.1 (3 x CH3), 25.3 
(CH3), 18.3 (C), −4.0 (CH3), −4.5 (CH3); 
IR (KBr) νmax 2955, 2936, 2891, 2857, 1694, 1674, 1472, 1463, 1437, 1381, 1251, 1214, 
1169, 1101, 1079, 1042, 1017, 995, 938, 913, 868, 835 cm−1; 
MS (ESI, +ve) m/z 396 [(M+Na)+, 100%], 375 (10); 
HRMS (ESI, +ve) Found: [M+Na]+ 396.2183, C18H35N
23NaO5Si requires 396.2182; 
Melting point 72–73 °C; 
 Specific rotation [α]25D = –7.5 (c 0.7, CHCl3). 
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(3aS,9S,9aR,Z)-9-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-5,8,9,9a-
tetrahydrocycloocta[d][1,3]dioxol-4(3aH)-one (2.25) 
 
A magnetically stirred solution of Weinreb amide 2.23 (1.10 g, 2.95 mmol) in dry 
tetrahydrofuran (30 mL) maintained at −78 °C under a nitrogen atmosphere was treated with 
allylmagnesium bromide (7.4 mL of a 1.0 M solution in diethyl ether, 7.40 mmol) and after 1 
h, the reaction mixture was quenched with ammonium chloride (50 mL of a saturated aqueous 
solution). The separated aqueous layer was extracted with diethyl ether (3 x 50 mL) and the 
combined organic phase washed with water (1 x 50 mL) and brine (1 x 50 mL) before being 
dried over magnesium sulfate, filtered and concentrated under reduced pressure to give the 
light-yellow oil presumed to contain diene 2.24. A magnetically stirred solution of this material 
in dry dichloromethane (1000 mL) maintained at 20 °C was treated, via cannula, with a solution 
of Grubbs’ second-generation catalyst (130 mg, 0.155 mmol) in dichloromethane (20 mL). The 
ensuing mixture was heated at reflux for 2 h then cooled and concentrated under reduced 
pressure. Subjection of this residue to flash chromatography (silica, 15:85 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.5 with 25:75 v/v 
ethyl acetate/hexane) then gave cyclooctenone 2.25 (750 mg, 78%) as a colourless, crystalline 
solid. 
1H NMR (400 MHz, CDCl3) δ 6.02 (m, 1H), 5.86–5.72 (complex m, 1H), 4.58 (d, J = 8.4 Hz, 
1H), 4.43 (m, 1H), 4.30 (d, J = 8.4 Hz, 1H), 3.55 (ddt, J = 18.3, 7.0 and 1.8 Hz, 1H), 2.96 (dd, 
J = 18.3 and 8.1 Hz, 1H), 2.59 (ddd, J = 17.0, 8.6 and 6.7 Hz, 1H), 2.31 (m, 1H), 1.55 (s, 3H), 
1.31 (s, 3H), 0.86 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 204.5 (CO), 133.1 (CH), 125.2 (CH), 108.1 (C), 81.2 (CH), 
81.2 (CH), 72.8 (CH), 41.2 (CH2), 34.3 (CH2), 26.4 (CH3), 26.0 (3 x CH3), 24.0 (CH3), 18.3 
(C), −4.7(5) (CH3), −4.8(4) (CH3); 
IR (KBr) νmax 2952, 2930, 2857, 1729, 1472, 1463, 1381, 1255, 1215, 1120, 1081, 1036, 958, 
876, 837 cm−1; 
MS (ESI, +ve) m/z 349 [(M+Na)+, 100%]; 
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HRMS (ESI, +ve) Found: [M+Na]+ 349.1812, C17H30
23NaO4Si requires 349.1811; 
Melting point 59–61 °C; 
Specific rotation [α]25D = +108.1 (c 1.0, CHCl3). 
 
(3aR,9S,9aR,Z)-9-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-5,8,9,9a-
tetrahydrocycloocta[d][1,3]dioxol-4(3aH)-one (2.27) 
 
A magnetically stirred solution of compound 2.25 (65 mg, 0.20 mmol) in 
methanol/water (6 mL of a 2:1 v/v mixture) was treated with lithium hydroxide (0.4 mL of a 
1.0 M aqueous solution, 0.40 mmol). The ensuing mixture was stirred at 18 °C for 2 h then 
treated successively with hydrochloric acid (0.4 mL of a 1.0 M aqueous solution) and brine (5 
mL) before being extracted with ethyl acetate (3 x 20 mL). The combined organic phases were 
dried over magnesium sulfate, filtered and concentrated under reduced pressure and the light-
yellow oil thus obtained subjected to flash chromatography (silica, 25:75 v/v of ethyl 
acetate/hexane elution). Concentration of the appropriate fractions (Rf = 0.7) afforded 
compound 2.27 (58 mg, 90%) as a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 5.85 (m, 1H), 5.72 (m, 1H), 5.12 (d, J = 8.2 Hz, 1H), 4.31 (dt, 
J = 7.6 and 2.0 Hz, 1H), 4.11 (dd, J = 8.2 and 2.0 Hz, 1H), 3.25 (ddd, J = 15.0, 8.5 and 1.0 Hz, 
1H), 3.14 (dd, J = 15.0 and 7.6 Hz, 1H), 2.55 (m, 1H), 2.45 (m, 1H), 1.43 (s, 3H), 1.30 (s, 3H), 
0.88 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 205.2 (CO), 130.5 (CH), 124.3 (CH), 109.9 (C), 82.1 (CH), 
79.1 (CH), 67.7 (CH), 40.4 (CH2), 32.2 (CH2), 26.6 (CH3), 26.0 (3 x CH3), 25.3 (CH3), 18.4 
(C), −4.3 (CH3), −4.8 (CH3); 
IR (KBr) νmax 2988, 2953, 2936, 2889, 2856, 1726, 1472, 1460, 1382, 1362, 1256, 1210, 1153, 
1120, 1072, 998, 932, 914, 836 cm−1; 
MS (ESI, +ve) m/z 675 [(2M+Na]+, 100%], 349 [(M+Na]+, 72]; 
HRMS (ESI, +ve) Found: (M+Na)+ 349.1799, C17H30
23NaO4Si requires 349.1811; 
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Melting point 75–77 °C; 
Specific rotation [α]25D = −10.8 (c 0.5, CHCl3). 
 
(3aS,5aS,6aR,8S,8aR)-8-((tert-Butyldimethylsilyl)oxy)-2,2-dimethylhexahydrooxireno-
[2',3':5,6]cycloocta[1,2-d][1,3]dioxol-4(3aH)-one (2.30) 
 
A 100 mL round-bottomed flask was charged with the alkene 2.25 (480 mg, 1.47 mmol) 
and a stirring bar then cooled to 0 °C. Freshly prepared dimethyldioxirane (29.4 mL of a 0.06 
M solution in acetone, 1.76 mmol) was added to the flask and the reaction mixture was then 
allowed to warm to 18 °C, maintained at this temperature for 16 h then concentrated under 
reduced pressure. The ensuing light-yellow oil was subjected to flash chromatography (silica, 
50:50 v/v diethyl ether/hexane elution). Concentration of the appropriate fractions (Rf = 0.4) 
afforded compound 2.30 (378 mg, 75%) as a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 4.55 (complex m, 2H), 3.98 (br s, 1H), 3.30 (m, 1H), 3.20 (m, 
1H), 2.82 (complex m, 2H), 2.45 (brd, J = 16.0 Hz, 1H), 1.85 (ddd, J = 16.0, 8.7 and 3.8 Hz, 
1H), 1.61 (s, 3H), 1.37 (s, 3H), 0.86 (s, 9H), 0.06(5) (s, 3H), 0.06 (1) (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 205.7 (CO), 110.2 (C), 82.3 (CH), 81.9 (CH), 69.0 (CH), 52.6 
(CH), 51.5 (CH), 38.5 (CH2), 33.9 (CH2), 26.2 (CH3), 25.9 (3 x CH3), 24.1 (CH3), 18.3 (C), 
–4.61 (2 x CH3); 
IR (KBr) νmax 2930, 2858, 2895, 1725, 1472, 1463, 1382, 1258, 1212, 1166, 1124, 1102, 1075, 
1031, 1003, 953, 914, 877, 837 cm−1; 
MS (ESI, +ve) m/z 365 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: [M+Na]+ 365.1763, C17H30
23NaO5Si requires 365.1760; 
Melting point 96–98 °C; 
Specific rotation [α]25D = +43.5 (c 0.4, CHCl3). 
  
Chapter Seven Experimental Procedures Related to Work Described in Chapter Two 
 
 
177 
 
(3aS,4R,7R,9S,9aR)-9-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-7,8,9,9a-tetrahydro-
4,7-epoxycycloocta[d][1,3]dioxol-4(3aH)-ol (2.31b) 
 
A magnetically stirred solution of epoxide 2.30 (64 mg, 0.19 mmol) in dichloromethane 
(2 mL) maintained at 18 °C was treated with 1,8-diazabicyclo[5.4.0]undec-7-ene (56 μL, 0.37 
mmol) and the ensuing mixture stirred for 6 h at this temperature then concentrated under 
reduced pressure. The yellow oil thus obtained was subjected to flash chromatography (silica, 
25:75 v/v ethyl acetate/hexane elution) to afford, after concentration of the relevant fractions  
(Rf = 0.3 in 25:75 v/v ethyl acetate/hexane elution), compound 2.31b (58 mg, 91%) as a 
colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.17 (dd, J = 5.9 and 1.9 Hz, 1H), 5.81 (dd, J = 5.9 and 1.1 Hz, 
1H), 5.04–4.93 (complex m, 1H), 4.38 (br s, 1H), 4.29 (dd, J = 6.1 and 1.1 Hz, 1H), 4.07 (ddd, 
J = 11.1, 4.0 and 1.6 Hz, 1H), 3.91 (d, J = 6.1, 1H), 2.52 (m, 1H), 1.65 (ddd, J = 13.9, 4.0 and 
2.2 Hz, 1H), 1.59 (s, 3H), 1.40 (s, 3H), 0.88 (s, 9H), 0.06 (s, 6H); 
13C NMR (100 MHz, CDCl3) δ 135.9 (CH), 129.7 (CH), 108.9 (C), 107.9 (C), 81.0 (CH), 80.5 
(CH), 77.8 (CH), 67.7 (CH), 36.2 (CH2), 26.9 (CH3), 26.1 (3 x CH3), 25.8 (CH3), 18.5 (C), 
−4.2 (CH3), −4.6 (CH3); 
IR (KBr) νmax 3502, 2931, 2856, 1471, 1403, 1380, 1324, 1290, 1248, 1222, 1168, 1099, 1075, 
1037, 1014, 991, 922, 880, 836 cm−1; 
MS (ESI, +ve) m/z 365 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 365.1761, C17H30
23NaO5Si requires 365.1760; 
Melting point 89–90 °C; 
Specific rotation [α]25D = –20 (c 1.1, CHCl3). 
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(3aR,4S,6R,9aS,Z)-4-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-9-oxo-3a,4,5,6,9,9a-
hexahydrocycloocta[d][1,3]dioxol-6-yl Cinnamate (2.32) and (3aS,4S,7R,9S,9aR)-9-((tert-
Butyldimethylsilyl)oxy)-2,2-dimethyl-7,8,9,9a-tetrahydro-4,7-epoxycycloocta[d][1,3]-
dioxol-4(3aH)-yl Cinnamate (2.33) 
 
A magnetically stirred solution of lactol 2.31b (41 mg, 0.12 mmol), pyridine (48μL, 
0.59 mmol) and cinnamoyl chloride (82 μL, 0.59 mmol) in dichloromethane (5 mL) maintained 
under nitrogen was treated with 4-(N,N-dimethylamino)pyridine (73 mg, 0.59 mmol). The 
ensuing mixture was heated at 40 °C for 48 h then cooled and treated with ammonium chloride 
(5 mL of a saturated aqueous solution). The separated aqueous phase was extracted with 
dichloromethane (3 x 5 mL) and the combined organic phases were then dried over magnesium 
sulfate before being filtered and concentrated under reduced pressure. The light-yellow oil thus 
obtained was subjected to flash chromatography (silica, 15:85 v/v ethyl acetate/hexane elution) 
and so affording two fractions, A and B. 
Concentration of fraction A (Rf = 0.6 in 25:75 v/v ethyl acetate/hexane) gave compound 
2.33 (10 mg, 19%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 16.0 Hz, 1H), 7.55–7.48 (complex m, 2H), 7.41–
7.33 (complex m, 3H), 6.49 (d, J = 16.0 Hz, 1H), 6.44 (dd, J = 6.0 and 1.1 Hz, 1H), 6.26 (dd, 
J = 6.0 and 1.7 Hz, 1H), 5.10 (br s, 1H), 4.69 (d, J = 6.0 Hz, 1H), 4.29 (d, J = 6.0 Hz, 1H), 4.05 
(m, 1H), 2.60 (m, 1H), 1.71 (m, 1H), 1.58 (s, 3H), 1.36 (s, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 
(s, 3H); 
13C NMR (100 MHz, CDCl3) δ 165.0 (CO), 145.7 (CH), 135.7 (CH), 134.6 (C), 130.6 (CH), 
129.1 (2 x CH), 128.3(8) (2 x CH), 128.3(6) (CH), 118.3 (CH), 114.2 (C), 109.0 (C), 81.4 
(CH), 80.8 (CH), 75.7 (CH), 67.6 (CH), 35.9 (CH2), 26.7 (CH3), 26.1 (3 x CH3), 26.0 (CH3), 
18.6 (C), −4.3 (CH3), −4.6 (CH3); 
IR (KBr) νmax 2929, 2857, 1710, 1637, 1450, 1381, 1331, 1250, 1204, 1159, 1103, 1056, 1039, 
926, 883 cm−1; 
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MS (ESI, +ve) m/z 495 [(M+Na)+, 100%], 474 (8); 
HRMS (ESI, +ve) Found: (M+Na)+ 495.2173, C26H36
23NaO6Si requires 495.2179; 
Specific rotation [α]25D = −73.8 (c 0. 7, CHCl3). 
Concentration of fraction B (Rf = 0.5 in 25:75 v/v ethyl acetate/hexane) gave compound 
2.32 (35 mg, 68%) as a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 16.0 Hz, 1H), 7.55 (complex m, 2H), 7.41 (complex 
m, 3H), 6.45 (d, J = 16.0 Hz, 1H), 6.34 (m, 1H), 6.09 (m, 1H), 6.00 (m, 1H), 4.99 (d, J = 7.4 
Hz, 1H), 4.65 (dd, J = 7.5 and 1.6 Hz, 1H), 4.49 (m, 1H), 2.26 (m, 1H), 2.06 (m, 1H), 1.63 (s, 
3H), 1.45 (s, 3H), 0.84 (s, 9H), 0.04 (s, 3H), 0.01 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 194.8 (CO), 166.2 (CO), 146.2 (CH), 142.2 (CH), 134.3 (C), 
131.9 (CH), 130.9 (CH), 129.2 (2 x CH), 128.4 (2 x CH), 117.4 (CH), 109.7 (C), 81.1 (CH), 
80.5 (CH), 70.6 (CH), 67.5 (CH), 38.0 (CH2), 27.0 (CH3), 26.0 (CH3), 25.9 (3 x CH3), 18.3 
(C), −4.7 (CH3), −5.1 (CH3); 
IR (KBr) νmax 2929, 2856, 1713, 1692, 1636, 1450, 1381, 1309, 1253, 1203, 1166, 1127, 1089, 
1052, 1024, 991, 937 cm−1; 
MS (ESI, +ve) m/z 511 [(M+K)+, 100%], 495 [(M+Na)+, 22]; 
HRMS (ESI, +ve) Found: [M+Na]+ 495.2175, C26H36
23NaO6Si requires 495.2179; 
Melting point 139–140 °C; 
Specific rotation [α]25D = −35 (c 0.3, CHCl3). 
 
(3aR,4S,6R,9aS,Z)-4-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-9-oxo-3a,4,5,6,9,9a-
hexahydrocycloocta[d][1,3]dioxol-6-yl Acetate (2.36) 
 
A magnetically stirred solution of epoxide 2.30 (294 mg, 0.86 mmol) in 
dichloromethane (10 mL) maintained at 18 °C was treated with 1,8-diazabicyclo[5.4.0]undec-
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7-ene (258 μL, 1.72 mmol) and the ensuing mixture stirred at this temperature for 6 h then 
filtered through a pad of TLC-grade silica gel and the filtrate concentrated under reduced 
pressure. The resulting white solid (presumed to be lactol 2.31b) was dissolved in dry 
dichloromethane (10 mL) and the ensuing solution treated with acetic anhydride (162 μL, 1.72 
mmol), pyridine (207 μL, 2.57 mmol) and 4-(N,N-dimethylamino)pyridine (104 mg, 0.86 
mmol). The reaction mixture was heated at 40 °C for 24 h before being cooled then quenched 
with ammonium chloride (10 mL of a saturated aqueous solution). The separated aqueous 
phase was extracted with dichloromethane (3 x 10 mL) and the combined organic phases were 
then dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
resulting light-yellow was subjected to flash chromatography (silica, 30:70 v/v diethyl 
ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.4 in 50:50 v/v 
diethyl ether/hexane) gave compound 2.36 (280.0 mg, 85%) as a colourless, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.24 (dd, J = 12.9 and 5.9 Hz, 1H), 6.05 (dd, J = 12.9 and 2.2 
Hz, 1H), 5.87 (m, 1H), 4.93 (d, J = 7.4 Hz, 1H), 4.60 (dd, J = 7.4 and 1.7 Hz, 1H), 4.45 (m, 
1H), 2.16 (dt, J = 13.8 and 5.1 Hz, 1H), 2.10 (s, 3H), 1.97 (m, 1H), 1.61 (s, 3H), 1.44 (s, 3H), 
0.81 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 194.7 (CO), 170.3 (CO), 142.1 (CH), 131.9 (CH), 109.7 (C), 
81.1 (CH), 80.5 (CH), 70.5 (CH), 67.5 (CH), 37.9 (CH2), 27.0 (CH3), 26.0 (CH3), 25.8 (3 x 
CH3), 21.3 (CH3), 18.3 (C), −4.7 (CH3), −5.1 (CH3); 
IR (KBr) νmax 2930, 2857, 1743, 1692, 1472, 1371, 1224, 1165, 1128, 1108, 1079, 1052, 1031, 
991, 945, 838 cm−1; 
MS (ESI, +ve) m/z 423 [(M+K)+, 100%], 407 [(M+Na)+, 9], 385 [(M+H)+, 13]; 
HRMS (ESI, +ve) Found: [M+Na]+ 407.1874, C19H32
23NaO6Si requires 407.1866; 
Melting point 114–116 °C; 
Specific rotation [α]25D = +11.7 (c 1.5, CHCl3). 
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O-((3aR,4S,6R,9aS,Z)-4-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-9-oxo-3a,4,5,6,9,9a-
hexahydrocycloocta[d][1,3]dioxol-6-yl) O-Phenyl Carbonothioate (2.37) 
 
A magnetically stirred solution of epoxide 2.30 (75 mg, 0.22 mmol) in dichloromethane 
(5 mL) maintained at 18 °C was treated with 1,8-diazabicyclo[5.4.0]undec-7-ene (66 μL, 0.44 
mmol) and the ensuing mixture stirred at this temperature for 6 h before being filtered through 
a pad of TLC-grade silica gel and the filtrate concentrated under reduced pressure. The white 
solid thus obtained was dissolved in dry dichloromethane (5 mL) and the resulting solution 
treated with phenyl thionocarbonate (59 mg, 0.44 mmol), pyridine (53 μL, 0.65 mmol) and 4-
(N,N-dimethylamino)pyridine (27 mg, 0.22 mmol). The ensuing mixture was heated at 40 °C 
for 48 h then cooled, quenched with ammonium chloride (5 mL of a saturated aqueous solution) 
and extracted with dichloromethane (3 x 5 mL). The combined organic phases were dried over 
magnesium sulfate, filtered and concentrated under reduced pressure and the light-yellow oil 
so-formed subjected to flash chromatography (silica, dichloromethane elution). Concentration 
of the relevant fractions (Rf = 0.7) then afforded compound 2.37 (37 mg, 35%) as a clear, 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.44 (t, J = 7.8 Hz, 2H), 7.32 (t, J = 7.4 Hz, 1H), 7.10 (d, J = 
8.1 Hz, 2H), 6.39 (complex m, 2H), 6.13 (d, J = 10.9 Hz, 1H), 4.97 (d, J = 7.4 Hz, 1H), 4.63 
(d, J = 7.4 Hz, 1H), 4.53 (d, J = 4.8 Hz, 1H), 2.45 (m, 1H), 2.18 (m, 1H), 1.63 (s, 3H), 1.44 (s, 
3H), 0.83 (s, 9H), 0.05 (s, 3H), 0.01 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 194.4 (CO), 194.2 (CS), 153.4 (C), 140.6 (CH), 132.2 (CH), 
129.9 (2 x CH), 127.1 (CH), 121.9 (2 x CH), 109.8 (C), 81.1 (CH), 80.6 (CH), 80.5 (CH), 67.3 
(CH), 37.2 (CH2), 27.0 (CH3), 26.0 (CH3), 25.8 (3 x CH3), 18.3 (C), −4.7 (CH3), −5.1 (CH3); 
IR (KBr) νmax 2929, 2856, 1692, 1490, 1290, 1255, 1217, 1124, 1079, 1051, 1019, 1003, 938, 
853, 838 cm−1; 
MS (ESI, +ve) m/z 479 [(M+H)+, 60%], 325 (100); 
HRMS (ESI, +ve) Found: [M+Na]+ 501.1743, C24H34
23NaO6SSi requires 501.1743; 
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Specific rotation [α]25D = −39.8 (c 0.5, CHCl3). 
 
(3aS,9S,9aR,Z)-9-((tert-Butyldimethylsilyl)oxy)-2,2-dimethyl-5-methylene-5,8,9,9a-
tetrahydrocycloocta[d][1,3]dioxol-4(3aH)-one (2.40) 
 
A tube suitable for placement in a microwave reactor was charged with the alkene 2.25 
(10 mg, 0.03 mmol), triethylamine (43 μL, 0.31 mmol) and dichloromethane (1 mL). The 
resulting yellow solution was immediately subjected to microwave irradiation (100 W, internal 
pressure of 200 psi) at 100 °C for 4 h then cooled and filtered through a pad of Celite™. The 
filtrate was concentrated under reduced pressure and the yellow oil thus obtained subjected to 
flash chromatography (silica, 10:90 v/v ethyl acetate/hexane elution). Concentration of the 
relevant fractions (Rf = 0.6 in 25:75 v/v ethyl acetate/hexane) afforded compound 2.40 (9 mg, 
87%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 6.22 (m, 1H), 6.17 (br s, 1H), 5.67–5.59 (complex m, 1H), 5.23 
(s, 1H), 4.77 (d, J = 7.3 Hz, 1H), 4.37 (m, 1H), 4.33 (dd, J = 7.3 and 1.6 Hz, 1H), 2.64–2.39 
(complex m, 2H), 1.68 (s, 3H), 1.36 (s, 3H), 0.79 (s, 9H), 0.01 (s, 3H), −0.02 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 194.4 (CO), 142.9 (C), 129.0 (CH), 125.8 (CH), 125.5 (CH2), 
109.4 (C), 82.6 (CH), 79.7 (CH), 68.7 (CH), 35.9 (CH2), 26.8 (CH3), 26.1 (CH3), 25.9 (3 x 
CH3), 18.4 (C), −4.8 (CH3), −5.2 (CH3); 
IR (KBr) νmax 2930, 2896, 2856, 1713, 1581, 1472, 1378, 1244, 1220, 1164, 1133, 1090, 1068, 
1025, 968, 941, 837 cm−1; 
MS (ESI, +ve) m/z 377 [(M+K)+, 100%], 361 [(M+Na)+, 20]; 
HRMS (ESI, +ve) Found: [M+Na]+ 361.1811, C18H30
23NaO4Si requires 361.1811; 
Specific rotation [α]25D = +85.7 (c 0.7, CHCl3). 
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2-((4-Methoxybenzyl)oxy)-4-methylquinoline (2.16) 
 
A magnetically stirred mixture of 4-methoxybenzyl alcohol (8.4 mL, 67.56 mmol), 2-
chlorolepidine (10.00 g, 56.30 mmol), finely ground potassium hydroxide (12.60 g, 0.22 mol) 
and 18-crown-6 (0.74 g, 2.80 mmol) in toluene (100 mL) was heated at reflux for 2 h with 
azeotropic removal of water (Dean-Stark trap). The reaction mixture was then cooled to 18 °C 
and partitioned between ethyl acetate (150 mL) and water (100 mL). The organic phase was 
washed with brine (1 x 100 mL) before being dried over magnesium sulfate then filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 10:90 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.4) afforded compound 2.16
110 (15.00 g, 95%) as a white, 
crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.4, 2H), 7.63 (t, J = 7.6, 1H), 7.46 (d, J = 8.6, 2H), 7.40 (t, 
J = 7.6, 1H), 6.92 (d, J = 8.6, 2H), 6.80 (s, 1H), 5.47 (s, 2H), 3.82 (s, 3H), 2.61 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 162.0 (C), 159.6 (C), 147.0 (C), 146.7 (C), 130.3 (2 x CH), 
129.8 (C), 129.5 (CH), 128.0 (CH), 125.7 (C), 124.0 (CH), 123.9 (CH), 114.1 (2 x CH), 113.5 
(CH), 67.4 (CH2), 55.5 (CH3), 18.9 (CH3); 
IR (KBr) νmax 1612, 1573, 1514, 1470, 1396, 1329, 1247, 1174, 1038, 1019 cm−1; 
MS (ESI, +ve) m/z 302 [(M+Na)+, 10%], 121 [(C8H9O)
+, 100]; 
HRMS (ESI, +ve) Found: (M+H)+ 280.1339, C18H18NO2Si2 requires 280.1338. 
These data matched those reported previously.110 
 
 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Three 
 
 
184 
 
7.3 Experimental Procedures Related to Work Described in Chapter Three 
6-(Chloromethyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (3.6) 
 
A magnetically stirred solution of di-iso-propylamine (2.8 mL, 19.70 mmol) in 
tetrahydrofuran (50 mL) was treated, at −78 °C, with n-butyl lithium (12.7 mL of a 1.5 M 
solution in hexane, 18.99 mmol). The ensuing mixture was stirred for 30 min then 2,2-
dimethyl-(4H)-1,3-dioxin-4-one 3.5 (2.0 mL, 14.07 mmol) was added dropwise over 5 min. 
The resulting mixture was stirred for another 5 min then the reaction temperature was gradually 
increased to −50 °C. A solution of hexachloroethane (5.83 g, 24.62 mmol) in tetrahydrofuran 
(10 mL) was then added dropwise over 1 h via syringe pump. After stirring for another 10 min, 
the reaction mixture was diluted with diethyl ether (40 mL) then quenched with ammonium 
chloride (50 mL of a saturated aqueous solution). The separated aqueous layer was extracted 
with diethyl ether (3 x 50 mL) and the combined organic phases were washed with brine (1 x 
100 mL) before being dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The ensuing light-yellow residue was subjected to flash chromatography (silica, 
30:70 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.4) 
afforded compound 3.6126 (1.81 g, 73%) as a light-yellow liquid.  
1H NMR (400 MHz, CDCl3) δ 5.51 (s, 1H), 3.99 (s, 2H), 1.67 (s, 6H); 
13C NMR (100 MHz, CDCl3) δ 164.6 (C), 160.5 (C), 107.6 (C), 95.67 (CH), 41.1 (CH2), 24.9 
(2 x CH3). 
These data matched those reported previously.126 The following additional data were acquired 
on this compound. 
IR (ATR) νmax 3000, 1726, 1640, 1391, 1376, 1272, 1201, 1014, 902 cm−1; 
MS (ESI, +ve) m/z 121 and 119 [(M–(CH3)2CO+H)+, 35 and 100%], 179 and 177 [(M+H)+, 
1.7 and 5]; 
HRMS (ESI, +ve) Found: (M+H)+ 177.0316, C7H10
35ClO3 requires 177.0318. (M+H)
+ 
179.0287, C7H10
37ClO3 requires 179.0289. 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Three 
 
 
185 
 
Diethyl ((2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)phosphonate (3.3) 
 
A magnetically stirred solution of sodium hydride (93 mg of 60% w/w dispersion in 
mineral oil, 2.31 mmol) in tetrahydrofuran (5 mL) and N,N-dimethylformamide (0.5 mL) was 
treated, at 18 °C, with diethyl phosphite (0.27 mL, 1.95 mmol). The ensuing mixture was stirred 
for 10 min and the resulting suspension then cooled to 0 °C. The reaction mixture thus formed 
was then treated, dropwise over 10 min with a solution of chloride 3.6 (314 mg, 1.78 mmol) in 
tetrahydrofuran (1 mL). After stirring for 15 min at 0 °C, the reaction temperature was 
gradually increased to 18 °C and stirring continued for a further 30 min. The reaction mixture 
was then filtered through a pad of CeliteTM and the filter cake was washed with ethyl acetate 
(15 mL). The combined filtrates were concentrated under reduced pressure and the residue thus 
obtained was subjected to flash chromatography (silica, ethyl acetate elution). Concentration 
of the appropriate fractions (Rf = 0.1) afforded the phosphonate 3.3
126 (478 mg, 96%) as a clear, 
colourless liquid. 
1H NMR (400 MHz, CDCl3) δ 5.33 (d, J = 3.6 Hz, 1H), 4.09 (dq, J = 14.2 and 7.1 Hz, 4H), 
2.75 (d, J = 22.1 Hz, 2H), 1.65 (s, 6H), 1.29 (t, J = 7.1 Hz, 6H); 
13C NMR (100 MHz, CDCl3) δ 163.1 (d, J = 9.9 Hz, C), 160.6 (d, J = 2.6 Hz, C), 107.2 (C), 
96.2 (d, J = 8.0 Hz, CH), 62.7 (CH2), 62.7 (CH2), 32.5 (d, J = 137.6 Hz, CH2), 25.0 (2 x CH3), 
16.5 (CH3), 16.4 (CH3). 
These data matched those reported previously.126 The following additional data were acquired 
on this compound. 
IR (KBr) νmax 2988, 1728, 1633, 1376, 1269, 1204, 1023, 970 cm−1; 
MS (ESI, +ve) m/z 301 [(M+Na)+, 20%], 243 [(M–2 x C2H5+Na)+, 60], 221 [(M–2 x C2H5+H)+, 
100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 301.0818, C11H19
23NaO6 requires 301.0817. 
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(E)-3-Iodo-2-methylacrylic Acid (3.9) 
 
A vigorously magnetically stirred solution of sodium hydride (2.75 g of 60% w/w 
dispersion in mineral oil, 68.88 mmol) in dry diethyl ether (100 mL) was treated, over 30 min, 
with a solution of diethyl methylmalonate (10.0 mL, 57.40 mmol) in diethyl ether (20 mL). 
The resulting slurry was heated at 35 ºC for 2.5 h before iodoform (22.60 g, 57.41 mmol) was 
added in one portion. Stirring was continued at 35 °C for another 20 h then the reaction mixture 
was cooled to 0 °C and the excess sodium hydride was quenched with hydrochloric acid (20 
mL of a 1.0 M aqueous solution) (CAUTION: evolution of hydrogen gas). After stirring for 20 
min, the aqueous phase was extracted with diethyl ether (3 x 20 mL) and the combined organic 
phases were washed with brine (1 x 50 mL) then dried over magnesium sulfate and 
concentrated under reduced pressure. The residue was diluted with pentane (50 mL) and the 
precipitated iodoform was removed by filtration. The filtrate was concentrated under reduced 
pressure and the residue dissolved in ethanol (120 mL) then treated with a solution of potassium 
hydroxide (12.88 g, 0.23 mol) in water (40 mL). The ensuing mixture was then heated to 100 °C 
for 16 h and after cooling and evaporation of all volatile materials, the residue was dissolved 
in potassium carbonate (100 mL of a 10% aqueous solution). The basic solution was carefully 
acidified with concentrated hydrochloric acid at 0 °C then extracted with dichloromethane (4 
x 100 mL). The combined organic phases were washed with brine (1 x 100 mL) then dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 20:80 v/v ethyl acetate/hexane + 0.5% acetic 
acid elution) and concentration of the appropriate fractions (Rf = 0.3) afforded the acid 3.9
127 
(9.61 g, 79%) as a pale-yellow solid. 
1H NMR (400 MHz, CDCl3) δ 12.17 (s, 1H), 8.03 (d, J = 1.0 Hz, 1H), 2.06 (d, J = 1.0 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 169.5 (C), 139.2 (C), 102.3 (CH), 20.0 (CH3); 
IR (KBr) νmax 3080, 2981, 2699, 2597, 2519, 1690, 1594, 1412, 1302, 1239, 1108, 992 cm−1; 
MS (EI, +ve, 70 eV) m/z 212 (M+•, 100%); 
HRMS (EI, +ve, 70 eV) Found: M+• 211.9334, C4H5
127IO2 requires 211.9334; 
Melting point 45–46 °C. 
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These data matched those reported previously.127  
 
(E)-3-Iodo-2-methylprop-2-en-1-ol (3.10) 
 
A magnetically stirred suspension of lithium aluminium hydride (207 mg, 5.18 mmol) 
in diethyl ether (10 mL) maintained at 0 °C was treated, over 1 h via syringe pump, with a 
solution of acid 3.9 (1.00 g, 4.71 mmol) in diethyl ether (5 mL). The ensuing mixture was then 
stirred for an additional 1 h at 0 °C before being warmed to 18 °C and maintained at this 
temperature for a further 3 h. The reaction mixture was then cooled to 0 °C and the excess 
lithium aluminium hydride was quenched by the dropwise addition of ethyl acetate then tartaric 
acid (10 mL of a 1.0 M aqueous solution) (CAUTION: evolution of hydrogen gas). The 
reaction mixture was warmed to 18 °C and stirred for a further 30 min until two clear layers 
were formed. The separated aqueous layer was extracted with diethyl ether (3 x 10 mL) and 
the combined organic phases were then washed with potassium carbonate (10 mL of a 10% 
aqueous solution) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
30:70 v/v diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) 
afforded compound 3.10127 (838 mg, 90%) as a clear, pale-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.22 (d, J = 0.9 Hz, 1H), 4.05 (s, 2H), 2.90 (s, 1H), 1.80 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 147.2 (C), 77.4 (CH), 67.0 (CH2), 21.5 (CH3); 
IR (KBr) νmax 3307, 2914, 2852, 1621, 1444, 1377, 1276, 1068, 1012, 775, 666 cm−1; 
MS (EI, +ve, 70 eV) m/z 198 (M+•, 45%), 165 (47), 71 (100); 
HRMS (EI, +ve, 70 eV) Found: M+• 197.9542, C4H7
127IO requires 197.9542. 
These data matched those reported previously.127 
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(E)-3-Iodo-2-methylacrylaldehyde (3.4) 
 
A vigorously magnetically stirred solution of alcohol 3.10 (500 mg, 2.52 mmol) in 
dichloromethane (10 mL) was treated, in two equal portions, with manganese dioxide (2.19 g, 
25.25 mmol). A mildly exothermic reaction ensued. After 4 h, the reaction mixture was filtered 
through a pad of flame-dried then cooled CeliteTM and the pad rinsed with dichloromethane (3 
x 20 mL). The combined filtrates were evaporated to give the aldehyde 3.4127 (430 mg, 87%) 
as a clear, pink oil (Rf = 0.5 in 20:80 v/v diethyl ether/hexane). This material was used, without 
purification, in the next step of the reaction sequence. 
1H NMR (400 MHz, CDCl3) δ 9.52 (s, CHO), 7.80 (d, J = 1.2 Hz, 1H), 7.80 (d, J = 1.1 Hz, 
3H); 
13C NMR (100 MHz, CDCl3) δ 189.6 (C), 151.0 (C), 109.6 (CH), 16.6 (CH3); 
IR (KBr) νmax 2919, 2849, 1686, 1593, 1374, 1292, 1045, 1011, 829 cm−1; 
MS (EI, +ve, 70 eV) m/z 196 (M+•, 100%); 
HRMS (EI, +ve, 70 eV) Found: M+• 195.9380, C4H5
127IO requires 195.9385; 
These data matched those reported previously.127 
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6-((1E,3E)-4-Iodo-3-methylbuta-1,3-dien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one (3.2) 
 
A magnetically stirred solution of sodium hydride (83 mg of 60% w/w dispersion in 
mineral oil, 2.08 mmol) in tetrahydrofuran (5 mL) was treated, at 0 °C, with diethyl 
phosphonate 3.3 (580 mg, 2.08 mmol). The ensuing reaction was warmed to 18 °C and stirred 
at this temperature for another 30 min. The resulting suspension was cooled to −78 °C then 
treated, dropwise over 10 min, with a solution of aldehyde 3.4 (429 mg, 2.19 mmol) in 
tetrahydrofuran (5 mL). After stirring for another 15 min, the reaction mixture was warmed to 
18 °C and stirring continued at this temperature for a further 1 h. The reaction mixture was then 
diluted with ethyl acetate (10 mL) and quenched with water (15 mL). The separated aqueous 
layer was extracted with ethyl acetate (3 x 20 mL) and the combined organic phases were 
washed with brine (1 x 30 mL) before being dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The ensuing light-yellow residue was subjected to flash 
chromatography (silica, 30:70 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded compound 3.2 (510 mg, 76%) as an ivory to light-
yellow crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.97 (d, J = 15.5 Hz, 1H), 6.85 (s, 1H), 6.05 (d, J = 15.5 Hz, 
1H), 5.39 (s, 1H), 2.00 (s, 3H), 1.70 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 163.3 (C), 161.8 (C), 144.3 (C), 137.8 (CH), 120.1 (CH), 106.6 
(C), 95.8 (CH), 92.6 (CH), 25.2 (2 x CH3), −19.8 (CH3); 
IR (KBr) νmax 2998, 1714, 1629, 1560, 1391, 1377, 1275, 1204, 1026, 974, 904 cm−1; 
MS (ESI, +ve) m/z 384 [(M+Na+CH3CN)
+, 40%], 375 [(M+Na+CH3OH)
+, 50], 343 [(M+Na)+, 
100];  
HRMS (ESI, +ve) Found: (M+Na)+ 342.9807, C11H13
127I23NaO3 requires 342.9807. (M+H)
+ 
320.9998, C11H14IO3 requires 320.9988;  
Melting point 129–131 °C. 
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(3aS,4S,5R,7aS)-7-Chloro-4-hydroxy-2,2-dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]-
dioxol-5-yl Acetate (3.12) 
 
A magnetically stirred solution of epoxide 2.10 (4.00 g, 20.00 mmol) in acetic acid (25 
mL) was treated with phosphoric acid (0.08 mL). After stirring at 18 °C for 4 h, the reaction 
mixture was diluted with ethyl acetate (50 mL) then quenched with ammonium chloride (100 
mL). The separated aqueous layer was extracted with ethyl acetate (3 x 50 mL) and the 
combined organic phases were then dried over magnesium sulfate, filtered, and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash chromatography 
(silica, 50:50 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions 
(Rf = 0.4) provided the alcohol 3.12 (3.80 g, 73%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 6.10 (d, J = 2.1 Hz, 1H), 5.88–5.82 (m, 1H), 4.89 (complex m, 2H), 
4.20 (m, 1H), 2.96 (br s, 1H), 2.46 (s, 3H), 1.76 (s, 3H), 1.73 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 171.3 (CO), 133.8 (C), 124.8 (CH), 111.2 (C), 76.6 (2 x CH), 
71.9 (CH), 71.0 (CH), 27.6 (CH3), 26.5 (CH3), 21.2 (CH3); 
IR (ATR) νmax 3458, 2988, 2937, 1743, 1372, 1222, 1038, 865 cm−1;  
MS (ESI, +ve) m/z 287 and 285 [(M+Na)+, 35 and 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 287.0476, C11H15
37Cl23NaO5 requires 287.0476. (M+Na)
+ 
285.0506, C11H15
35Cl23NaO5 requires 285.0506; 
Specific rotation [α]25D = −87.4 (c 1.2, CHCl3). 
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(3aS,4S,5R,7aS)-5-Acetoxy-7-chloro-2,2-dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]-
dioxol-4-yl Pivalate (3.13) 
 
A magnetically stirred solution of alcohol 3.12 (3.70 g, 14.08 mmol), triethylamine (3.9 
mL, 28.17 mmol) and 4-(N,N-dimethylamino)pyridine (172 mg, 1.40 mmol) in 
dichloromethane (70 mL) maintained at 0 °C under a nitrogen atmosphere was treated with 
pivaloyl chloride (2.6 mL, 21.13 mmol). The ensuing mixture was allowed to warm to 18 °C 
then stirred at this temperature for 16 h before being poured into ammonium chloride (100 mL 
of a saturated aqueous solution). The separted aqueous layer was extracted with dicloromethane 
(3 x 50 mL) and the combined organic phases were then washed with brine (1 x 100 mL) before 
being dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 10:90 v/v diethyl 
ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) afforded the 
desired compound 3.13 (4.00 g, 82%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.78 (partially obscured s, 1H), 5.76 (partially obscured m, 1H), 
5.11 (dd, J = 8.5 and 2.3 Hz, 1H), 4.59 (dd, J = 4.9 and 1.7 Hz, 1H), 4.50 (dd, J = 4.9 and 2.3 
Hz, 1H), 2.04 (s, 3H), 1.43 (s, 3H), 1.36 (s, 3H), 1.21 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 178.1 (CO), 170.2 (CO), 134.0 (C), 124.7 (CH), 111.5 (C), 
76.7 (CH), 74.6 (CH), 70.9 (CH), 68.5 (CH), 39.1 (C), 27.7 (CH3), 27.1 (3 x CH3), 26.6 (CH3), 
21.0 (CH3); 
IR (KBr) νmax 2984, 2937, 1751, 1734, 1481, 1372, 1224, 1150, 1040, 865 cm−1;  
MS (ESI, +ve) m/z 387 and 385 [(M+K)+, 35 and 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 387.0789, C16H23
37Cl39KO6 requires 387.0791. (M+K)
+ 
385.0818, C16H23
35Cl39KO6 requires 385.0820; 
Specific rotation [α]25D = −136.1 (c 0.8, CHCl3).  
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(4S,5S)-Methyl 5-((1S,2R,E)-2-Acetoxy-4-iodo-1-(pivaloyloxy)but-3-en-1-yl)-2,2-
dimethyl-1,3-dioxolane-4-carboxylate (3.15) 
 
A magnetically stirred solution of alkene 3.13 (1.00 g, 2.9 mmol) in 
dichloromethane/methanol (50 mL of a 4:1 v/v mixture) was treated with pyridine (1.1 mL, 
14.40 mmol) then cooled to −78 °C and ozone then bubbled through it until a dark-blue colour 
persisted (ca. 30 min). At this point triphenylphosphine (0.92 g, 3.50 mmol) was added to the 
reaction mixture which was warmed to 18 °C and kept at this temperature for 1 h before being 
concentrated under reduced pressure. The resulting light-yellow oil was filtered through a short 
pad of TLC-grade silica gel that was washed with diethyl ether/hexane (100 mL of a 2:3 v/v 
mixture). The combined filtrates were concentrated and dried under high vacuum and the 
residue thus obtained, and containing aldehyde 3.14, was immediately subjected to the next 
step of the reaction sequence.  
A solution of chromium chloride (1.97 g, 16.02 mmol), dispensed in a glove box, in dry 
tetrahydrofuran (25 mL) maintained at 18 ºC under an argon atmosphere was slowly treated, 
via cannula, with a solution of aldehyde 3.14 (1.00 g, 2.67 mmol) and iodoform (2.31 g, 5.87 
mmol) in dry tetrahydrofuran (25 mL). The ensuing mixture was stirred for 16 h then filtered 
through a pad of CeliteTM. Water/diethyl ether (60 mL of a 1:1 v/v mixture) was added to the 
filtrate and the separated aqueous layer was extracted with diethyl ether (3 x 50 mL). The 
combined organic extracts were dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
30:70 v/v diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.5) 
afforded the alkenyl iodide 3.15 (0.65 g, 45%) as a white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.46–6.30 (complex m, 2H), 5.58 (dd, J = 4.4 and 3.5 Hz, 1H), 
5.11 (dd, J = 8.8 and 3.5 Hz, 1H), 4.57 (d, J = 6.4 Hz, 1H), 4.46 (dd, J = 8.8 and 6.4 Hz, 1H), 
3.68 (s, 3H), 2.11 (s, 3H), 1.60 (s, 3H), 1.35 (s, 3H), 1.20 (s, 9H); 
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13C NMR (100 MHz, CDCl3) δ 176.8 (CO), 170.0 (CO), 169.3 (CO), 139.8 (CH), 111.7 (C), 
80.2 (CH), 76.2 (CH), 75.5 (CH), 74.5 (CH), 69.8 (CH), 52.7 (CH3), 39.1 (C), 27.2 (3 x CH), 
26.8 (CH3), 25.7 (CH3), 20.8 (CH3); 
IR (KBr) νmax 2979, 1743, 1372, 1226, 1138, 1094, 940, 865 cm−1; 
MS (ESI, +ve) m/z 537 [(M+K)+, 40%], 521 [(M+Na)+, 100]; 
HRMS (ESI, +ve) Found: [M+Na]+ 521.0649, C18H27
127I23NaO8 requires 521.0648; 
Melting point 77–78 °C; 
Specific rotation [α]25D = +9.1 (c 2.3, CHCl3). 
 
(1S,2R,E)-1-((4S,5S)-5-Carbamoyl-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxy-4-iodobut 
-3-en-1-yl Pivalate (3.16) 
 
A magnetically stirred solution of acetate 3.15 (50 mg, 0.10 mmol) in methanol (2 mL) 
was treated with ammonia (0.17 mL of a 35% aqueous solution, 1.50 mmol). After 4 h, the 
reaction mixure was concentrated under reduced pressure and the residue dissolved in ethyl 
acetate (5 mL). The resulting solution was washed with ammonium chloride (5 mL of a 
saturated solution) and the separated aqueous layer extracted with ethyl acetate (3 x 5 mL). The 
combined organic phases were dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
30:25:45 v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded the alcohol 3.16 (40 mg, 87%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 6.76 (br s, 1H), 6.71 (dd, J = 14.6 and 7.3 Hz, 1H), 6.50 (d, J = 
14.6 Hz, 1H), 6.23 (br s, 1H), 5.34 (dd, J = 7.3 and 1.3 Hz, 1H), 4.68 (d, J = 3.1 Hz, 1H), 4.58 
(d, J = 7.4 Hz, 1H), 4.38 (dd, J = 9.3 and 7.4 Hz, 1H), 3.66 (d, J = 9.3 Hz, 1H), 1.50 (s, 3H), 
1.29 (s, 3H), 1.20 (s, 9H); 
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13C NMR (100 MHz, CDCl3) δ 177.4 (CO), 174.8 (CO), 140.9 (CH), 110.8 (C), 81.9 (CH), 
77.0 (CH), 76.7 (CH), 74.7 (CH), 71.2 (CH), 39.2 (C), 27.3 (3 x CH3), 27.1 (CH3), 24.6 (CH3); 
IR (KBr) νmax 3471, 3342, 2981, 2934, 1730, 1676, 1479, 1371, 1280, 1218, 1152, 1071 cm−1; 
MS (ESI, +ve) m/z 464 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 464.0547, C15H24
127I23NaO6 requires 464.0546. 
 
(3aS,6R,7S,7aS)-6-((E)-2-iodovinyl)-2,2-dimethyl-4-oxotetrahydro-4H-[1,3]dioxolo[4,5-
c]pyran-7-yl pivalate (3.17) 
 
A magnetically stirred solution of acetate 3.15 (200 mg, 0.40 mmol) in tetrahydrofuran 
(5 mL) was treated with magnesium methoxide (0.62 mL of a 10% solution in methanol, 0.60 
mmol). After 4 h, the reaction mixture was diluted with diethyl ether (5 mL) then quenched 
with ammonium chloride (5 mL of a saturated aqueous solution). The separted aqueous layer 
was extracted with diethyl ether (3 x 5 mL) and the combined organic phases were dried over 
magnesium sulfate, then filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 30:70 v/v diethyl ether/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.3) afforded the lactone 3.17 (120 mg, 
70%) as an ivory-colored solid. 
1H NMR (400 MHz, CDCl3) δ 6.72 (d, J = 14.7 Hz, 1H), 6.57 (dd, J = 14.7 and 7.5 Hz, 1H), 
5.37 (dd, J = 7.5 and 2.2 Hz, 1H), 4.69 (d, J = 5.8 Hz, 1H), 4.65 (d, J = 2.2 Hz, 1H), 4.58 (d, J 
= 5.8 Hz, 1H), 1.46 (s, 3H), 1.38 (s, 3H), 1.20 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 176.7 (CO), 173.1 (CO), 138.2 (CH), 114.1 (C), 84.7 CH), 
82.5 (CH), 77.4 (CH), 74.9 (CH), 74.2 (CH), 39.1 (C), 27.1 (3 X CH3), 26.7 (CH3), 
25.7(CH3); 
IR (KBr) νmax 2981, 1791, 1738, 1610, 1480, 1376, 1275, 1175, 1132, 1086, 947 cm−1; 
MS (ESI, +ve) m/z 495 [(M+CH3OH+K)
+, 80%], 479 [(M+CH3OH+Na)
+, 100]; 
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HRMS (ESI, +ve) Found: (M+Na)+ 447.0282, C15H21
127I23NaO6 requires 447.0281; 
Melting point 98.5–99.5 °C; 
Specific rotation [α]25D = −55.7 (c 1.1, CHCl3). 
 
(3aS,6R,7S,7aS)-6-((E)-2-iodovinyl)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-
c]pyran-4,7-diol (3.18) 
 
A magnetically stirred solution of lactone 3.17 (40 mg, 0.09 mmol) in dichloromethane 
(5 mL) was cooled to −78 °C then treated, dropwise, with di-iso-butylaluminium hydride (0.11 
mL of a 1.0 M solution in hexane, 0.11 mmol). After addition was complete, the reaction 
mixture was stirred for 30 min then treated with tartaric acid (5 mL of a 1.0 M aqueous solution) 
and stirring continued at 18 °C for a further 30 min. The separated aqueous layer was extracted 
with dichloromethane (3 x 5 mL) and the combined organic phases were then washed with 
brine (1 x 10 mL) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
20:25:55 v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded lactol 3.18 (25 mg, 77%) as a white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ (major isomer) 1 6.65 (dd, J = 14.6 and 5.9 Hz, 1H), 6.48 (d, J 
= 14.6 Hz, 1H), 5.44 (s, 1H), 4.84 (d, J = 5.9 Hz, 1H), 4.59 (d, J = 5.9 Hz, 1H), 4.35 (d, J = 3.0 
Hz, 1H), 4.19–4.14 (m, 1H), 3.57 (s, 2H), 1.48 (s, 3H), 1.32 (s, 3H); δ (minor isomer) 6.68 (dd, 
J = 14.6, 6.4 Hz, 1H), 6.54 (d, J = 14.6 Hz, 1H), 5.42 (d, J = 4.1 Hz, 1H), 4.72 (dd, J = 6.4 and 
2.1 Hz, 1H), 4.63 (dd, J = 6.6 and 4.1 Hz, 1H), 4.12 (m, 1H), 4.07 (m, 1H), 3.57 (s, 2H), 1.56 
(s, 3H), 1.39 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ (major isomer) 144.7 (CH), 112.6 (C), 103.2 (CH), 89.6 (CH), 
86.5 (CH), 82.2 (CH), 79.6 (CH), 74.6 (CH), 26.5 (CH3), 24.9 (CH3); δ (minor isomer)143.9 
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(CH), 114.5 (C), 97.5 (CH), 82.9 (CH), 81.4 (CH), 80.7 (CH), 79.4 (CH), 75.0 (CH), 26.4 
(CH3), 24.9 (CH3). 
IR (KBr) νmax 3351, 2985, 2939, 1609, 1374, 1209, 1158, 1059, 951, 859 cm−1; 
MS (ESI, +ve) m/z 365 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 364.9871, C10H15
127I23Na O5 requires 364.9862; 
Melting point 46.5–47.5 °C. 
 
(3aS,4S,5R,7aS)-7-Chloro-5-((4-methoxybenzyl)oxy)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-4-ol (3.19) 
 
A magnetically stirred solution of epoxide 2.10 (1.00 g, 4.93 mmol) and p-
methoxybenzyl alcohol (2.45 mL, 19.74 mmol) in dichloromethane (25 mL) was treated with 
copper(II) tetrafluoroborate (117 mg, 0.49 mmol) and the ensuing mixture stirred at 18 °C for 
6 h then quenched with ammonium chloride (20 mL of a saturated solution). The separated 
aqueous phase was extracted with diethyl ether (3 x 20 mL) and the combined organic phases 
were dried over magnesium sulfate, then filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 20:80 v/v diethyl 
ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.1) afforded 
compound 3.19 (1.20 g, 71%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.23 (m, 2H), 6.85 (m, 2H), 5.91 (d, J = 1.9 Hz, 1H), 4.56 (ABq, 
∆ δAB = 0.11, JAB = 11.2 Hz, 2H), 4.47 (m, 2H), 4.18 (dt, J = 8.2 and 1.9 Hz, 1H), 3.78 (d, J = 
2.3 Hz, 1H), 3.76 (s, 3H), 1.37 (s, 3H), 1.36 (s, 3H) (signal due to hydroxyl group proton not 
observed); 
13C NMR (100 MHz, CDCl3) δ 159.6 (C), 132.6 (C), 129.8 (C), 129.7 (2 x CH), 125.8 (CH), 
114.2 (2 x CH), 110.9 (C), 76.8 (CH), 76.4 (CH), 76.3 (CH), 72.2 (CH2), 71.6 (CH), 55.4 
(CH3), 27.5 (CH3), 26.4 (CH3); 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Three 
 
 
197 
 
IR (KBr) νmax 3462, 2987, 2934, 1613, 1514, 1371, 1248, 1174, 1102, 1042, 866 cm−1; 
MS (ESI, +ve) m/z 381 and 379 [(M+K)+, 35 and 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 381.0692, C17H21
37Cl39KO5 requires 381.0685. (M+K)
+ 
379.0715, C17H21
35Cl39KO5 requires 379.0715; 
Specific rotation [α]25D = −68.4 (c 1.2, CHCl3). 
 
tert-Butyl(((3aR,4S,5R,7aS)-7-chloro-5-((4-methoxybenzyl)oxy)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-4-yl)oxy)dimethylsilane (3.20) 
 
A magnetically stirred solution of alcohol 3.19 (1.00 g, 2.94 mmol) in N,N-
dimethylformamide (15 mL) maintained at 18 °C was treated, sequentially, with tert-
butyldimethylsilyl chloride (0.66 g, 4.41 mmol) then imidazole (0.40 g, 5.88 mmol). The 
ensuing mixture was stirred for 2 h then diluted with diethyl ether (30 mL) and quenched with 
water (30 mL). The separated aqueous layer was extracted with diethyl ether (3 x 50 mL) and 
the combined organic phases were then washed with hydrochloric acid (50 mL of a 1.0 M 
aqueous solution), water (1 x 50 mL) and brine (1 x 50 mL) before being dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) gave compound 3.20 (1.30 g, 97%) as a 
white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 5.84 (d, J = 
1.5 Hz, 1H), 4.62 (ABq, ∆ δAB = 0.07, JAB = 11.2 Hz, 2H), 4.47 (dd, J = 4.8 and 1.5 Hz, 1H), 
4.38 (dd, J = 4.8 and 2.2 Hz, 1H), 4.21 (d, J = 8.1 Hz, 1H), 3.87 (dd, J = 8.1 and 2.2 Hz, 1H), 
3.80 (s, 3H), 1.42 (s, 3H), 1.39 (s, 3H), 0.94 (s, 9H), 0.13 (s, 6H); 
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13C NMR (100 MHz, CDCl3) δ 159.3 (C), 131.8 (C), 130.3 (C), 129.5 (2 x CH), 126.9 (CH), 
113.9 (2 x CH), 110.7 (C), 77.9 (CH), 76.9 (CH), 76.6 (CH), 73.2 (CH), 73.1 (CH2), 55.4 
(CH3), 27.7 (CH3), 26.4 (CH3), 26.0 (3 x CH3), 18.4 (C), −4.09 (CH3), −4.74 (CH3); 
IR (KBr) νmax 2931, 2889, 2857, 1613, 1514, 1463, 1382, 1249, 1135, 1097, 1046, 838 cm−1; 
MS (ESI, +ve) m/z 479 and 477 [(M+Na)+, 35 and 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 479.1810, C23H35
37Cl23NaO5Si requires 479.1811. 
(M+Na)+ 477.1840, C23H35
35Cl23NaO5Si requires 477.1840; 
Melting point 81–82 °C; 
Specific rotation [α]25D = −46.3 (c 1.1, CHCl3). 
 
(3aR,4S,5R,7aS)-4-((tert-Butyldimethylsilyl)oxy)-7-chloro-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-5-yl Acetate (3.22) 
 
A magnetically stirred solution of alcohol 3.12 (2.00 g, 7.61 mmol) in N,N-
dimethylformamide (25 mL) maintained at 18 °C was treated, sequentially, with tert-
butyldimethylsilyl chloride (1.72 g, 11.4 mmol) then imidazole (1.04 g, 1.52 mmol). The 
ensuing mixture was stirred for 2 h then diluted with diethyl ether (30 mL) and quenched with 
water (1 x 30 mL). The aqueous layer was extracted with diethyl ether (3 x 50 mL) and the 
combined organic phases were then washed with hydrochloric acid (1 x 50 mL of a 1.0 M 
aqueous solution), water (1 x 50 mL) and brine (1 x 50 mL) before being dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 10:90 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.4) gave compound 3.22 (2.70 g, 94%) as a 
white, crystalline solid. 
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1H NMR (400 MHz, CDCl3) δ 5.74 (d, J = 2.0 Hz, 1H), 5.53 (dt, J = 8.4 and 2.0 Hz, 1H), 4.50 
(dd, J = 4.9 and 2.0 Hz, 1H), 4.38 (dd, J = 4.9 and 2.4 Hz, 1H), 3.95 (dd, J = 8.4 and 2.4 Hz, 
1H), 2.08 (s, 3H), 1.43 (s, 3H), 1.38 (s, 3H), 0.90 (s, 9H), 0.12 (s, 3H), 0.09 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 170.2 (CO), 133.4 (C), 125.2 (CH), 111.0 (C), 77.6 (CH), 76.8 
(CH), 71.8 (CH), 71.3 (CH), 27.7 (CH3), 26.5 (CH3), 25.8 (3 X CH3), 21.2 (CH3), 18.2 (C), 
−4.4 (CH3), −4.6 (CH3); 
IR (KBr) νmax 2982, 2931, 2889, 2858, 1748, 1372, 1224, 1137, 1102, 1046, 838 cm−1; 
MS (ESI, +ve) m/z 401 and 399 [(M+Na)+ 35 and 100%)+; 
HRMS (ESI, +ve) Found: (M+Na)+ 401.1333, C17H29
37Cl23NaO5Si requires 401.1341. 
(M+Na)+ 399.1368, C17H29
35Cl23NaO5Si requires 399.1371. (M+H)
+ 379.1522, 
C17H30
37ClO5Si requires 379.1522. (M+H)
+ 377.1553, C17H30
35ClO5Si requires 377.1551; 
Melting point 43–44 °C; 
Specific rotation [α]25D = −95.6 (c 1.0, CHCl3). 
 
(4S,5R)-Methyl 5-((1S,2R,E)-2-Acetoxy-1-((tert-butyldimethylsilyl)oxy)-4-iodobut-3-en-
1-yl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (3.24) 
 
A magnetically stirred solution of alkene 3.22 (1.00 g, 2.65 mmol) in 
dichloromethane/methanol (50 mL of a 4:1 v/v mixture) was treated with pyridine (1.1 mL, 
13.25 mmol) then cooled to −78 °C and ozone bubbled through it until a dark-blue colour 
persisted (ca. 30 min). At this point triphenylphosphine (0.85 g, 3.18 mmol) was added to the 
reaction mixture which was then warmed to 18 °C and kept at this temperature for 1 h before 
being concentrated under reduced pressure. The resulting light-yellow oil was filtered through 
a short pad of TLC-grade silica that was washed with diethyl ether/hexane (100 mL of a 2:3 
v/v mixture). The combined filtrates were concentrated and dried under high vacuum and the 
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residue thus obtained, and containing aldehyde 3.23, immediately used in the next step of the 
reaction sequence.  
A solution of chromium chloride (1.64 g, 13.35 mmol), dispensed in a glove box, in dry 
tetrahydrofuran (25 mL) and dry N,N-dimethylformamide (1.0 mL) maintained at 18 ºC under 
an argon atmosphere was slowly treated, via cannula, with a solution of aldehyde 3.23 (0.90 g, 
2.22 mmol) and iodoform (1.93 g, 4.89 mmol) in dry tetrahydrofuran (25 mL). The ensuing 
mixture was stirred for 16 h then filtered through a pad of CeliteTM. Water/diethyl ether (60 mL 
of a 1:1 v/v mixture) was added to the filtrate and the separated aqueous layer was extracted 
with diethyl ether (3 x 50 mL). The combined organic extracts were dried over magnesium 
sulfate, then filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 20:80 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.4) afforded the alkenyl iodide 3.24 (780 mg, 
55%) as a light-yellow, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.68 (d, J = 14.6, 1H), 6.49 (dd, J = 14.6 and 8.0, 1H), 5.60 (t, 
J = 8.0, 1H), 4.41 (d, J = 6.5, 1H), 4.26 (dd, J = 8.0 and 3.0, 1H), 4.17 (dd, J = 6.5 and 3.0, 
1H), 3.71 (s, 3H), 2.07 (s, 3H), 1.63 (s, 3H), 1.36 (s, 3H), 0.86 (s, 9H), 0.09 (s, 3H), 0.07 (s, 
3H); 
13C NMR (100 MHz, CDCl3) δ 170.4 (CO), 169.8 (CO), 140.4 (CH), 110.3 (C), 83.8 (CH), 
78.6 (CH), 76.5 (CH), 73.6 (CH), 71.6 (CH), 52.1 (CH3), 26.7 (CH3), 26.0 (3 x CH3), 25.9 
(CH3), 21.5 (CH3), 18.5 (C), −3.9 (CH3), −4.6 (CH3); 
IR (KBr) νmax 2932, 2857, 1766, 1745, 1609, 1473, 1371, 1227, 1145, 1096, 838 cm−1; 
MS (ESI, +ve) m/z 567 [(M+K)+, 100%], 551 [(M+Na)+, 100]; 
HRMS (ESI, +ve) Found: (M+K)+ 567.0679, C19H33
127I39KO7Si requires 567.0677. (M+Na)
+ 
551.0939, C19H33
127I23Na O7Si requires 551.0938; 
Melting point 49–50 °C; 
Specific rotation [α]25D = +36.9 (c 0.8, CHCl3). 
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(3aS,6R,7S,7aR)-7-((tert-Butyldimethylsilyl)oxy)-6-((E)-2-iodovinyl)-2,2-dimethyltetra- 
hydro-4H-[1,3]dioxolo[4,5-c]pyran-4-one (3.25) 
 
A magnetically stirred solution of acetate 3.24 (330 mg, 0.62 mmol) in tetrahydrofuran 
(10 mL) was treated with magnesium methoxide (2.6 mL of a 10% solution in methanol, 2.46 
mmol). After 4 h, the reaction mixture was diluted with diethyl ether (10 mL) then quenched 
with ammonium chloride (10 mL of a saturated solution). The aqueous layer was extracted 
with diethyl ether (3 x 10 mL) and the combined organic phases were dried over magnesium 
sulfate, then filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 20:80 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.4) afforded the lactone 3.25 (250 mg, 88%) 
as a white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 6.60 (dd, J = 14.7 and 7.2 Hz, 1H), 6.51 (d, J = 14.7 Hz, 1H), 
4.68 (d, J = 5.8 Hz, 1H), 4.62 (d, J = 5.8 Hz, 1H), 4.47 (s, 1H), 4.30 (d, J = 7.2 Hz, 1H), 1.45 
(s, 3H), 1.37 (s, 3H), 0.88 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 173.8 (CO), 143.6 (CH), 113.6 (C), 84.7 (CH), 81.0 (CH), 
77.9 (CH), 75.4 (CH), 75.3 (CH), 26.9 (CH3), 25.9 (3 x CH3), 25.8 (CH3), 18.2 (C), −4.1 
(CH3), −4.6 (CH3); 
IR (KBr) νmax 2955, 2931, 2858, 1787, 1609, 1472, 1376, 1256, 1175, 1100, 942, 838 cm–1; 
MS (ESI, +ve) m/z 493 [(M+K)+, 15%], 477 [(M+Na)+, 40], 472 [(M−CO2+Na+K)+, 100], 397 
[(M−(CH3)2CO+H)+, 40]; 
HRMS (ESI, +ve) Found: (M+K)+ 493.0313, C16H27
127I39KO5Si requires 567.0677. (M+Na)
+ 
477.0572, C16H27
127I23NaO5Si requires 477.0570; 
Melting point 90–92 °C; 
Specific rotation [α]25D = −71.9 (c 1.7, CHCl3). 
  
Chapter Seven Experimental Procedures Related to Work Described in Chapter Three 
 
 
202 
 
(3aS,6R,7S,7aR)-7-((tert-Butyldimethylsilyl)oxy)-6-((E)-2-iodovinyl)-2,2-dimethyltetra- 
hydro-4H-[1,3]dioxolo[4,5-c]pyran-4-ol (3.26) 
 
A magnetically stirred solution of lactone 3.25 (60.mg, 0.13 mmol) in dichloromethane 
(5 mL) was cooled to −78 °C then treated dropwise with di-iso-butylaluminium hydride (0.14 
mL of a 1.0 M solution in hexane, 0.14 mmol). After addition was complete, the reaction 
mixture was stirred at this temperature for 30 min then treated with tartaric acid (5 mL of a 1.0 
M aqueous solution) and stirring continued at 18 °C for a further 30 min. The separated aqueous 
layer was extracted with dichloromethane (3 x 5 mL) and the combined organic phases were 
then washed with brine (1 x 10 mL) before being dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The resulting residue was subjected to flash 
chromatography (silica, 7.5:20:72.5 v/v/v ethyl acetate/dichloromethane/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.2) afforded lactol 3.26 (55 mg, 91%) as a 
white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ (major isomer) 6.69 (dd, J = 14.8 and 8.0 Hz, 1H), 6.43 (d, J = 
14.8, 1H), 5.31 (d, J = 11.4 Hz, 1H), 4.67 (d, J = 5.9 Hz, 1H), 4.64 (br s, 1H), 4.51 (d, J = 5.9 
Hz, 1H), 4.27 (d, J = 5.9 Hz, 1H), 4.23 (dd, J = 8.0 and 2.0 Hz, 1H), 1.46 (s, 3H), 1.31 (s, 3H), 
0.92 (s, 9H), 0.16 (s, 3H), 0.12 (s, 3H); δ (minor isomer) 6.68 (dd, J = 14.6 and 7.5 Hz, 1H), 
6.30 (d, J = 14.6, 1H), 5.47 (br s, 1H), 4.67 (partially obscured m, 1H), 4.54 (dd, J = 6.3 and 
4.0 Hz, 1H), 4.15 (dd, J = 7.5 and 1.8 Hz, 1H), 4.07 (d, J = 1.8 Hz, 1H), 3.90 (br s, 1H), 1.53 
(s, 3H), 1.37 (s, 3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ (major isomer) 145.5 (CH), 112.5 (C), 103.9 (CH), 89.9 (CH), 
87.4 (CH), 82.1 (CH), 79.8 (CH), 76.9 (CH), 26.7 (CH3), 25.9 (3 x CH3), 25.3 (CH3), 18.4 (C), 
−4.08 (CH3), −4.7 (CH3); δ (minor isomer) 145.3 (CH), 113.3 (C), 98.4 (CH), 84.1 (CH), 82.0 
(CH), 79.3 (CH), 79.1 (CH), 77.4 (CH), 26.4 (CH3), 26.0 (3 x CH3), 24.9 (CH3), 18.2 (C), −4.1 
(CH3), −4.73 (CH3); 
IR (KBr) νmax 3415, 2934, 2859, 1608, 1471, 1382, 1258, 1160, 1074, 836 cm−1; 
MS (ESI, +ve) m/z 520 [(M+Na+CH3CN)
+, 100%], 479 [(M+Na)+, 65], 495 [(M+K)+, 20]; 
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HRMS (ESI, +ve) Found: (M+K)+ 495.0467, C16H29
127I39KO5 requires 495.0466. (M+Na)
+ 
479.0727, C16H29
127I23NaO5 requires 479.2727; 
Melting point 66–68 °C.
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7.4 Experimental Procedures Related to Work Described in Chapter Four 
(3aS,6aS)-2,2-Dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol (4.3) 
 
A magnetically stirred solution of D-ribose (5.00 g, 33.30 mmol) in acetone (120 mL) 
was cooled to 0 °C and then treated dropwise with sulfuric acid (0.10 mL of a 98% aqueous 
solution). The resulting mixture was warmed to 18 °C and stirred at this temperature for 5 h 
(or until thin layer chromatographic analysis showed complete consumption of starting 
material). The reaction mixture was treated with sodium hydrogen carbonate (2.00 g) then 
filtered through a pad of CeliteTM. The filter cake was washed with acetone (100 mL) and the 
combined filtrates concentrated under reduced pressure. The residue thus obtained was 
dissolved in methanol (100 mL) and the resulting solution cooled to 0 °C then sodium 
borohydride (2.52 g, 66.61 mmol) was added in portions. The ensuing mixture was warmed to 
18 °C and stirring continued for 16 h then the solvent was removed under reduced pressure. 
The residue thus obtained was dissolved in tert-butanol/water (100 mL of a 3:2 v/v mixture) 
then sodium periodide (28.49 g, 133.21 mmol) was added at 0 ºC. The resulting mixture was 
stirred at 18 °C for 16 h then diethyl ether (100 mL) was added and the pH adjusted to 7 by 
addition of sodium hydrogen carbonate (saturated aqueous solution). The solid was filtered off 
and the aqueous layer extracted with diethyl ether (3 x 50 mL). The combined organic phases 
were dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 40:60  50:50 v/v diethyl 
ether/hexane gradient elution) and concentration of the appropriate fractions (Rf = 0.3 in 40:60 
v/v diethyl ether/hexane) afforded compound 4.3133b,c (4.00 g, 75%) as a clear, colourless oil 
and as an inseparable (16:84) mixture of α/β isomers. 
1H NMR (400 MHz, CDCl3) δ (α-isomer) 4.97 (d, J = 3.5 Hz, 1H), 4.74 (dd, J = 6.2 and 3.8 
Hz, 1H), 4.47 (dd, J = 6.2 and 3.6 Hz, 1H), 3.95 (d, J = 11.1, 1H), 3.52 (dd, J = 11.0 and 3.7 
Hz, 1H), 3.26 (br s, 1H), 1.52 (s, 3H), 1.35 (s, 3H); δ (β-isomer) 5.39 (s, 1H), 4.81 (dd, J = 5.8 
and 3.6 Hz, 1H), 4.54 (d, J = 5.9 Hz, 1H), 4.04 (dd, J = 10.4 and 3.5 Hz, 1H), 3.99 (d, J = 10.4 
Hz, 1H), 3.26 (br s, 1H), 1.44 (s, 3H), 1.29 (s, 3H); 
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13C NMR (100 MHz, CDCl3) δ (α-isomer) 113.6 (C), 97.6 (CH), 79.7 (CH), 78.4 (CH), 67.8 
(CH2), 26.1 (CH3), 25.0 (CH3); δ (β-isomer) 112.5 (C), 101.9 (CH), 85.3 (CH), 80.1 (CH), 72.0 
(CH2), 26.3 (CH3), 24.9 (CH3);  
IR (KBr) νmax 3433, 2945, 1458, 1383, 1330, 1210, 1160, 1075, 983, 907, 855 cm−1; 
MS (EI, +ve, 70 eV) m/z 145 [(M−CH3•)+, 75%], 85 (50), 59 (100); 
HRMS (EI, +ve, 70 eV) Found: (M−CH3•)+ 145.0502, C7H12O4 requires 145.0501. 
These data matched those reported previously.133b,c 
 
(R)-1-((4R,5S)-5-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-yn-1-ol (4.4) 
 
A magnetically stirred solution of lactol 4.3 (2.93 g, 18.30 mmol) in tetrahydrofuran 
(50 mL) maintained at 0 °C under a nitrogen atmosphere was treated with 1-
propynylmagnesium bromide (109.8 mL of an 0.5 M solution in tetrahydrofuran, 54.90 mmol). 
The ensuing mixture was allowed to stir at this temperature for 1 h then poured into ammonium 
chlodride (100 mL of a saturated aqueous solution). The separated aqueous layer was extracted 
with ethyl acetate (3 x 50 mL) and the combined organic phases were then washed with brine 
(1 x 100 mL) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The ensuing light-yellow residue was subjected to flash chromatography 
(silica, 50:50 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions 
(Rf = 0.3) afforded compound 4.4 (3.50 g, 95%) as a clear, colourless oil. 
1H NMR (400 MHz, CD3OD) δ 4.40 (dq, J = 6.7 and 2.2 Hz, 1H), 4.30 (td, J = 6.5 and 4.8 Hz, 
1H), 4.13 (dd, J = 6.7 and 6.5 Hz, 1H), 3.88 (ABX, JAB = 11.7 Hz, JAX = 4.8 Hz, 1H), 3.77 
(ABX, JAB = 11.7 Hz, JBX = 6.5 Hz, 1H), 1.87 (d, J = 2.2 Hz, 3H), 1.48 (s, 3H), 1.38 (s, 3H) 
(signal due to hydroxyl group protons not observed); 
13C NMR (100 MHz, CD3OD) δ 110.6 (C), 83.2 (C), 81.6 (CH), 80.2 (CH), 80.1 (C), 63.0 
(CH), 62.3 (CH2), 28.7 (CH3), 26.3 (CH3), 4.1 (CH3); 
IR (KBr) νmax 3384, 2985, 2936, 2234, 1453, 1382, 1218, 1166, 1077, 1043, 859 cm−1; 
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MS (ESI, +ve) m/z 239 [(M+K)+, 100%], 223 [(M+Na)+, 40]; 
HRMS (ESI, +ve) Found: (M+K)+ 239.0686, C10H16
39KO4 requires 239.0686. (M+Na)
+ 
223.0946, C10H16
23NaO4 requires 223.0946; 
Specific rotation [α]25D = +20.6 (c 1.0, CHCl3). 
 
((4S,5R)-5-((R)-1-Hydroxybut-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 
Pivaloate (4.5) 
 
A magnetically stirred solution of diol 4.4 (3.18 g, 15.88 mmol), triethylamine (5.5 mL, 
39.70 mmol) and 4-(N,N-dimethylamino)pyridine (194 mg, 1.58 mmol) in dichloromethane 
(100 mL) maintained at −78 °C under a nitrogen atmosphere was treated, over 30 min via 
syringe pump, with pivaloyl chloride (2.1 mL, 17.47 mmol). The ensuing mixture was stirred 
for a further 1 h then poured into water (100 mL). The separated aqueous layer was extracted 
with dichloromethane (3 x 50 mL) and the combined organic phases were then washed with 
brine (1 x 100 mL) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
20:80 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) 
afforded compound 4.5 (3.70 g, 83%) as a clear, colourless oil.  
1H NMR (400 MHz, CDCl3) δ 4.52 (ABX, JAB = 11.5 Hz, JAX = 4.6 Hz, 1H), 4.46 (m, 1H), 
4.39 (td, J = 6.4 and 4.6 Hz, 1H), 4.29 (ABX, JAB = 11.2 Hz, JBX = 6.7 Hz, 1H), 4.19 (t, J = 5.8 
Hz, 1H), 2.55 (s, OH), 1.86 (d, J = 1.2 Hz, 3H), 1.50 (s, 3H), 1.37 (s, 3H), 1.21 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 178.4 (CO), 109.4 (C), 83.3 (C), 79.3 (CH), 77.5 (C), 75.3 
(CH), 62.9 (CH), 61.8 (CH2), 38.9 (C), 27.6 (CH3), 29.3 (3 x CH3), 25.4 (CH3), 3.9 (CH3); 
IR (KBr) νmax 3462, 2980, 2938, 2237, 1733, 1481, 1382, 1284, 1218, 1150, 1081, 1035, 869 
cm−1; 
MS (ESI, +ve) m/z 323 [(M+K)+, 100%]; 
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HRMS (ESI, +ve) Found: (M+K)+ 323.1261, C15H24
39KO5 requires 323.1261. (M+Na)
+ 
307.1522, C15H24
23NaO5 requires 307.1521. (M+H)
+ 285.1702, C15H25O5 requires 285.1702; 
Specific rotation [α]25D = +1.6 (c 0.6, CHCl3). 
 
((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)methyl Pivaloate (4.6) 
 
A magnetically stirred solution of alcohol 4.5 (3.60 g, 12.66 mmol) in N,N-
dimethylformamide (30 mL) maintained at 18 °C was treated, sequentially, with tert-
butyldimethylsilyl chloride (2.86 g, 18.99 mmol) then imidazole (2.15 g, 31.65 mmol). The 
ensuing mixture was stirred for 2 h then diluted with diethyl ether (100 mL) and quenched with 
water (100 mL). The separated aqueous layer was extracted with diethyl ether (3 x 100 mL) 
and the combined organic phases were washed with hydrochloric acid (1 x 100 mL of a 1.0 M 
aqueous solution), water (1 x 100 mL) and brine (1 x 100 mL) then dried over magnesium 
sulfate before being filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 7.5:92.5 v/v diethyl ether/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.3) gave compound 4.6 (4.20 g, 
83%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.49 (m, 2H), 4.33 (m, 1H), 4.19 (dd, J = 11.8 and 8.2 Hz, 1H), 
4.11 (t, J = 6.3 Hz, 1H), 1.83 (d, J = 2.1 Hz, 3H), 1.45 (s, 3H), 1.34 (s, 3H), 1.21 (s, 9H), 0.88 
(s, 9H), 0.14 (s, 3H), 0.11 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 178.6 (CO), 109.1 (C), 82.9 (C), 79.7 (CH), 78.2 (C), 75.9 
(CH), 64.1 (CH), 62.5 (CH2), 38.9 (C), 27.8 (CH3), 27.4 (3 x CH3), 26.0 (3 x CH3), 25.6 (CH3), 
18.3 (C), 3.9 (CH3), −4.0 (CH3), −4.7 (CH3); 
IR (KBr) νmax 3524, 2959, 2932, 2859, 2298, 2230, 1732, 1481, 1381, 1283, 1253, 1155, 1083, 
1033, 838 cm−1; 
MS (ESI, +ve) m/z 437 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 437.2126, C21H38
39KO5Si requires 437.2126; 
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Specific rotation [α]25D = −35.8 (c 1.2, CHCl3). 
 
((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)methanol (4.7) 
 
A magnetically stirred solution of pivaloate 4.6 (2.00 g, 5.02 mmol) in dichloromethane 
(50 mL) was cooled to −78 °C then treated, dropwise, with di-iso-butylaluminium hydride 
(10.0 mL of a 1.0 M solution in hexane, 10.00 mmol). After addition was complete, the reaction 
mixture was stirred for 30 min then treated with tartaric acid (60 mL of a 1.0 M aqueous 
solution) and stirring continued at 18 °C for a further 30 min. The separated aqueous layer was 
extracted with dichloromethane (3 x 50 mL) and the combined organic phases were then 
washed with brine (1 x 100 mL) before being dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The resulting light-yellow oil was subjected to flash 
chromatography (silica, 20:80 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded compound 4.7 (1.55 g, 98%) as a clear, colourless oil. 
1H NMR (400 MHz, CD3OD) δ 4.59 (m, 1H), 4.31 (ddd, J = 8.5, 6.5 and 3.2 Hz, 1H), 4.14 
(dd, J = 6.5 and 5.5 Hz, 1H), 3.95 (ABX, JAB = 11.8, JAX = 3.2 Hz, 1H), 3.80 (ABX, JAB = 11.8 
Hz, JBX = 8.0, 1H), 1.86 (d, J = 2.2 Hz, 3H), 1.49 (s, 3H), 1.38 (s, 3H), 0.96 (s, 9H), 0.21 (s, 
3H), 0.18 (s, 3H) (signal due to hydroxyl group proton not observed); 
13C NMR (100 MHz, CD3OD) δ 109.7 (C), 83.6 (C), 80.9 (CH), 79.9 (CH), 78.9 (C), 63.7 
(CH2), 62.5 (CH), 27.9 (CH3), 26.3 (3 x CH3), 25.5 (CH3), 19.0 (C), 3.2 (CH3), −4.1 (CH3), 
−4.7 (CH3); 
IR (KBr) νmax 3497, 2931, 2858, 2231, 1472, 1380, 1252, 1148, 1075, 838 cm−1; 
MS (ESI, +ve) m/z 353 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 353.1551, C16H30
39KO4Si requires 353.1550; 
Specific rotation [α]25D = −28.6 (c 0.8, CHCl3). 
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1-((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-
dioxolan-4-yl)prop-2-yn-1-ol (4.8) 
 
A magnetically stirred solution of oxalyl chloride (0.86 mL, 10.03 mmol) in 
dichloromethane (40 mL) was treated, at −78 °C, with dimethyl sulfoxide (1.8 mL, 25.08 
mmol). The ensuing mixture was stirred for 10 min then treated with a solution of alcohol 4.7 
(1.55 g, 4.93 mmol) in dichloromethane (10 mL). The resulting mixture was stirred −78 °C for 
another 1 h then treated with triethylamine (4.9 mL, 35.12 mmol) before being warmed to 0 °C 
and stirred for 1 h then quenched with water (100 mL). The separated aqueous layer was 
extracted with dichloromethane (3 x 50 mL). The combined organic phases were washed with 
brine (1 x 100 mL) then dried over magnesium sulfate, filtered, concentrated under reduced 
pressure to afford the anticipated aldehyde (1.30 g, 84%) as a clear, colorless oil. This material 
was immediately used without purification in the next step of the reaction sequence.  
A magnetically stirred solution of the aldehyde (390 mg, 1.25 mmol), formed as 
described above, in tetrahydrofuran (10 mL) maintained at −15 °C under a nitrogen atmosphere 
was treated with ethynylmagnesium bromide (6.2 mL of an 0.5 M solution in tetrahydrofuran, 
3.12 mmol). The ensuing mixture was stirred for a further 1 h then poured into ammonium 
chloride (10 mL of a saturated aqueous solution). The separated aqueous layer was extracted 
with ethyl acetate (3 x 10 mL) and the combined organic phases were then washed with brine 
(1 x 10 mL) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The ensuing light-yellow residue was subjected to flash chromatography 
(silica, 15:85 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions 
(Rf = 0.2) afforded compound 4.8 (392 mg, 93%) as a clear, colourless oil and as an inseparable 
(23:77) mixture of α/β epimers.  
1H NMR (400 MHz, CDCl3) δ (α-epimer) 4.79 (m, 1H), 4.59 (dd, J = 7.9 and 2.2 Hz, 1H), 
4.23 (d, J = 5.4, 1H), 4.17 (t, J = 5.4 Hz, 1H), 3.82 (s, OH), 2.48 (d, J = 2.2 Hz, 1H), 1.84 (d, J 
= 2.2 Hz, 3H), 1.48 (s, 3H), 1.38 (s, 3H), 0.91 (s, 9H), 0.19 (s, 3H), 0.18 (s, 3H); (β-epimer) 
4.90 (m, 1H), 4.85 (m, 1H), 4.29 (dd, J = 6.8 and 1.8 Hz, 1H), 4.22 (dd, J = 6.9 and 5.5 Hz, 
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1H), 3.64 (s, OH), 2.45 (d, J = 2.3 Hz, 1H), 1.84 (d, J = 2.2 Hz, 3H), 1.57 (s, 3H), 1.40 (s, 3H), 
0.91 (s, 9H), 0.18 (s, 3H), 0.17 (s, 3H);  
13C NMR (100 MHz, CDCl3) δ (α-epimer) 109.2 (C), 83.8 (C), 82.9 (C), 79.7 (CH), 79.6 (CH), 
77.3 (C), 73.7 (CH), 62.5 (CH), 61.6 (CH), 27.9 (CH3), 25.9 (3 x CH3), 25.8 (CH3), 18.4 (C), 
3.9 (CH3), −4.3 (CH3), −4.6 (CH3); (β-epimer) 109.6 (C), 83.7 (C), 83.1 (C), 79.8 (CH), 79.4 
(CH), 77.1 (C), 72.8 (CH), 62.0 (CH), 61.2 (CH), 26.6 (CH3), 25.9 (3 x CH3), 25.3 (CH3), 18.5 
(C), 3.8 (CH3), −4.3 (CH3), −4.8 (CH3);  
IR (KBr) νmax 3447, 3310, 2930, 2858, 2232, 2114, 1472, 1382, 1252, 1215, 1066, 838 cm−1; 
MS (ESI, +ve) m/z 377 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 377.1550, C18H30
39KO4Si requires 377.1550. 
 
(R,E)-1-((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-
dioxolan-4-yl)-3-(tributylstannyl)prop-2-en-1-ol (4.9) 
 
A magnetically stirred solution of bis(triphenylphosphine)palladium(II) dichloride (10 
mg, 0.014 mmol) and compound 4.8 (100 mg, 0.25 mmol) in dry dichloromethane (5 mL) 
maintained at 0 °C under an argon atmosphere was treated, dropwise over 2 min, with tri-n-
butyltin hydride (95 mg, 0.35 mmol). The ensuing mixture was stirred for 10 min then warmed 
to 18 ºC and maintained at this temperature for a further 30 min. The ensuing mixture was 
concentrated under reduced pressure and the residue thus obtained subjected to flash 
chromatography (silica which was pre-deactivated with 1% triethylamine in hexane, 10:90 v/v 
diethylether/hexane elution). Concentration of the appropriate fractions (Rf = 0.2) afforded the 
compound 4.9 (80 mg, 43%) as a clear, colourless oil.  
1H NMR (400 MHz, CDCl3) δ 6.22 (d, J = 19.1 Hz, 1H), 6.09 (dd, J = 19.1 and 5.1 Hz, 1H), 
4.78 (m, 1H), 4.54 (m, 1H), 4.15 (m, 2H), 3.16 (d, J = 5.1 Hz, 1H), 1.83 (d, J = 2.2 Hz, 3H), 
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1.51 (s, 3H), 1.50–1.41 (complex m, 6H), 1.34 (s, 3H), 1.32–1.23 (complex m, 6H), 0.97–0.77 
(complex m, 24H), 0.17 (s, 3H), 0.15 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 148.2 (CH), 129.2 (CH), 108.6 (C), 83.2 (C), 80.3 (CH), 79.8 
(CH), 78.6 (C), 72.4 (CH), 62.8 (CH), 29.3 (3 x CH2), 27.5 (3 x CH3), 26.9 (CH3), 26.1 (3 x 
CH3), 25.1 (CH3), 18.5 (C), 13.9 (3 x CH3), 9.7 (3 x CH2), 3.9 (CH3), −4.1 (CH3), −4.6 (CH3); 
IR (KBr) νmax 3482, 2956, 2928, 2856, 2232, 1463, 1378, 1250, 1213, 1147, 1071, 837 cm−1; 
MS (ESI, +ve) m/z 669 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 669.2764, C30H58
39KO4Si
120Sn requires 669.2763. [M+H]+ 
631.3201, C30H59O4Si
120Sn requires 631.3205; 
Specific rotation [α]25D = −22.4 (c 1.3, CHCl3). 
 
6-((R,1E,3E,5E)-7-((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-7-hydroxy-3-methylhepta-1,3,5-trien-1-yl)-2,2-dimethyl-4H-
1,3-dioxin-4-one (4.10) 
 
A two-neck round bottom flask equipped with a condenser and a rubber septum was 
charged with stannane 4.9 (45 mg, 0.07 mmol), alkenyl iodine 3.2 (23 mg, 0.07 mmol), 
tetrakis(triphenylphosphine)palladium(0) (8 mg, 0.01 mmol), triphenylphosphine (5 mg, 0.01 
mmol), lithium chloride (18 mg, 0.43 mmol) and copper iodide (68 mg, 0.36 mmol). The flask 
was evacuated at low pressure then filled with argon. The reaction mixture was dissolved in 
degassed N,N-dimethylformamide (2 mL) and the resulting solution heated to 40 ºC for 16 h. 
After cooling, potassium fluoride (5 mL of a 10% aqueous solution) was added and the reaction 
mixture stirred at 18 ºC for 30 min before being filtered and the filtrate extracted with ethyl 
acetate (3 x 10 mL). The combined organic phases were washed with brine (1 x 10 mL) then 
dried over magnesium sulfate, filtered and concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica, 10:30:60 v/v/v ethyl 
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acetate/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 
0.2) afforded compound 4.10 (20 mg, 52%) as a clear, yellow oil.  
1H NMR (400 MHz, CDCl3) δ 6.95 (d, J = 15.5 Hz, 1H), 6.70 (ddd, J = 15.0, 11.4 and 1.2 Hz, 
1H), 6.36 (d, J = 11.4 Hz, 1H), 6.02 (dd, J = 15.0 and 5.8 Hz, 1H), 5.95 (d, J = 15.5 Hz, 1H), 
5.30 (s, 1H), 4.82 (m, 1H), 4.73 (m, 1H), 4.17 (m, 1H), 4.14 (m, 1H), 3.63 (br s, OH), 1.89 (s, 
3H), 1.84 (d, J = 2.2 Hz, 3H), 1.71 (s, 6H), 1.52 (s, 3H), 1.35 (s, 3H), 0.91 (s, 9H), 0.18 (s, 3H), 
0.16 (s, 3H); 
13C NMR (100 MHz, CDCl3) 164.0 (C), 162.3 (C), 142.6 (CH), 138.4 (CH), 138.0 (CH), 133.8 
(C), 126.9 (CH), 118.7 (CH), 109.0 (C), 106.4 (C), 94.3 (CH), 83.4 (C), 80.1 (CH), 79.5 (CH), 
77.3 (C), 69.8 (CH), 62.3 (CH), 26.7 (CH3), 26.0 (3 x CH3), 25.3 (CH3), 25.2 (2 x CH3), 18.5 
(C), 12.7 (CH3), 3.9 (CH3), −4.3 (CH3), −4.8 (CH3); 
IR (KBr) νmax 3450, 2930, 2858, 2237, 1723, 1613, 1383, 1273, 1250, 1208, 1147, 1068, 1024, 
901, 838 cm−1; 
MS (ESI, +ve) m/z 571 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 571.2497, C29H44
39KO7Si requires 571.2493. (M+Na)
+ 
555.2757, C29H44
23NaO7Si requires 555.2754. (M+H)
+ 533.2937, C29H45O7Si requires 
533.2935; 
Specific rotation [α]25D = −39.9 (c 0.8, CHCl3). 
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(S)-Methyl 3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropanoate (4.17) 
 
A magnetically stirred solution of methyl (S)-3-hydroxy-2-methylpropionate (5.00 g, 
42.32 mmol) in dry N,N-dimethylformamide (50 mL) maintained at 0 °C was treated, 
sequentially, with tert-butyldiphenylsilyl chloride (12.11 g, 46.56 mmol) then imidazole (3.17 
g, 46.56 mmol). The resulting solution was warmed to 18 °C and stirred at this temperature for 
16 h then diluted with diethyl ether (100 mL) and quenched by the addition of water (50 mL). 
The separated aqueous layer was extracted with diethyl ether (3 x 75 mL) and the combined 
organic phases were then washed with brine (1 x 100 mL) before being dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.2) afforded compound 4.17
136 (14.90 g, 99%) 
as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.69–7.67 (complex m, 4H), 7.46–7.38 (complex m, 6H), 3.86 
(ABX, JAB = 9.7, JAX = 6.9 Hz, 1H), 3.75 (ABX, JAB = 9.7, JBX = 5.8 Hz, 1H), 3.70 (s, 3H), 
2.74 (m, 1H), 1.18 (d, J = 7.0 Hz, 3H), 1.06 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 175.5 (CO), 135.8 (4 x CH), 133.7 (C), 133.6 (C), 129.8 (2 x 
CH), 127.8 (4 x CH), 66.1 (CH2), 51.7 (CH3), 42.6 (CH), 26.9 (3 x CH3), 19.4 (C), 13.7 (CH3); 
IR (KBr) νmax 3071, 2933, 2858, 1741, 1472, 1428, 1199, 1112, 823, 702 cm−1; 
MS (ESI, +ve) m/z 379 [(M+Na)+, 100%], 279 [(M−C6H5)+, 55]; 
HRMS (ESI, +ve) Found: (M+Na)+ 379.1706, C21H28
23NaO3Si requires 379.1705. (M+H)
+ 
357.1898, C21H29O3Si requires 357.1886;  
Specific rotation [α]25D = +16.7 (c 1.8, CHCl3). 
These data matched those reported previously.136  
Chapter Seven Experimental Procedures Related to Work Described in Chapter Four 
 
 
214 
 
(S)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropanal (4.18), and (R)-3-((tert-
Butyldiphenylsilyl)oxy)-2-methylpropan-1-ol (4.18b)  
 
A magnetically stirred solution of ester 4.17 (1.00 g, 2.80 mmol) in dry hexane (20 mL) 
maintained at −78 °C under a nitrogen atmosphere was treated, dropwise, with di-iso-
butylaluminium hydride (3.1 mL of 1.0 M solution in hexane, 3.10 mmol). The ensuing mixture 
was stirred at −78 °C for 1 h then quenched with tartaric acid (20 mL of a 1.0 M aqueous 
solution) and stirring continued at 18 °C for further 30 min. The separated aqueous layer was 
extracted with diethyl ether (3 x 20 mL) then the combined organic phases were dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 5:95 to 20:80 v/v diethyl ether/hexane elution) 
to afford two fractions, A and B. 
Concentration of fraction A (Rf = 0.2 in 5:95 v/v diethyl ether/hexane) afforded 
compound 4.18136(750 mg, 82%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 9.79 (s, CHO), 7.68–7.66 (complex m, 4H), 7.48–7.39 (complex 
m, 6H), 3.90 (m, 2H), 2.60 (m, 1H), 1.12 (d, J = 7.0 Hz, 3H), 1.07 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 204.6 (CHO), 135.8 (4 x CH), 133.4 (2 x C), 130.0 (2 x CH), 
128.0 (4 x CH), 64.3 (CH2), 49.0 (CH), 27.0 (3 x CH3), 19.4 (C), 10.5 (CH3); 
IR (KBr) νmax 3071, 2932, 2858, 1737, 1472, 1428, 1112, 823, 702 cm−1; 
MS (ESI, +ve) m/z 381 [(M+CH3OH+Na)
+, 50%], 365 [(M+K)+, 100];  
HRMS (ESI, +ve) Found: (M+Na)+ 349.1602, C20H26
23NaO3Si requires 349.1600; 
Specific rotation [α]25D = +20.9 (c 1.1, CHCl3). 
Concentration of fraction B (Rf = 0.2 in 20:80 v/v diethyl ether/hexane) afforded 
compound 4.18b136 (100 mg, 11%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.69–7.67 (complex m, 4H), 7.47–7.39 (complex m, 6H), 3.74 
(ABX, JAB = 10.0, JAX = 4.5 Hz 1H), 3.68 (d, J = 6.0 Hz, 2H), 3.61 (ABX, JAB = 10.0, JBX = 7.7 
Hz, 1H), 2.36 (s, 1H), 2.00 (m, 1H), 1.07 (s, 9H), 0.84 (d, J = 6.9 Hz, 3H); 
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13C NMR (100 MHz, CDCl3) δ 135.8 (2 x CH), 135.7 (2 x CH), 133.4 (C), 133.3 (C), 130.0 
(2 x CH), 128.0 (4 x CH), 68.9 (CH2), 68.0 (CH2), 37.5 (CH), 27.0 (3 x CH3), 19.4 (C), 13.4 
(CH3); 
IR (KBr) νmax 3368, 3071, 2930, 2858, 1472, 1427, 1112, 823, 701 cm−1; 
MS (ESI, +ve) m/z 351 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 351.1758, C20H28
23NaO2Si requires 351.1756. (M+H)
+ 
329.1937, C20H29O2Si requires 329.1937; 
Specific rotation [α]25D = +6.0 (c 1.3, CHCl3). 
These data matched those reported previously.136 
 
Aldehyde 4.18 can also be prepared by the following procedure: 
 
A magnetically stirred solution of ester 4.17 (1.00 g, 2.80 mmol) in dry diethyl ether 
(30 mL) containing dry methanol (0.17 mL, 4.21 mmol) maintained at 0 °C was carefully 
treated with lithium borohydride (92 mg, 4.21 mmol). After 15 min, the reaction mixture was 
warmed to 18 °C and stirred for 1 h before being cooled to 0 °C and slowly quenched with 
ammonium chloride (20 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (3 x 20 mL) and the combined organic phases were dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The alcohol 4.18b was 
used without further purification in the next step of the reaction sequence. 
A magnetically stirred solution of oxalyl chloride (325 µL, 6.04 mmol) in 
dichloromethane (25 mL) was treated, at −78 °C, with dimethyl sulfoxide (590 µL, 8.31 mmol). 
The ensuing mixture was stirred for 10 min then treated with a solution of alcohol 4.18b, 
formed as described above, in dichloromethane (15 mL). The resulting mixture was stirred at 
−78 °C for another 1 h then treated with triethylamine (2.3 mL, 16.16 mmol) before being 
warmed to 0 °C, stirred for 1 h then quenched with water (30 mL). The separated aqueous layer 
was extracted with dichloromethane (3 x 30 mL) and the combined organic phases were then 
washed with brine (1 x 50 mL) before being dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
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chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded aldehyde 4.18 (890 mg, 97%) as a clear, colorless oil. 
This material was identical, in all respects, with that obtained by the first method.  
 
(R,E)-Ethyl 5-((tert-Butyldiphenylsilyl)oxy)-4-methylpent-2-enoate (4.20) 
 
A magnetically stirred solution of anhydrous lithium chloride (370 mg, 8.73 mmol) in 
dry acetonitrile (80 mL) was treated, at 18 °C, with triethyl phosphonoacetate (1.73 mL, 8.73 
mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1.2 mL, 8.15 mmol). A mildly exothermic 
reaction followed and a clear solution obtained after ca.15 min. After 30 min, a solution of 
aldehyde 4.18 (1.90 g, 5.82 mmol) in acetonitrile (40 mL) was added and the reaction mixture 
was stirred for a further 16 h. The ensuing mixture was diluted with diethyl ether (50 mL) then 
quenched with ammonium chloride (50 mL of a saturated aqueous solution). The separated 
aqueous layer was extracted with diethyl ether (3 x 30 mL) and the combined organic phases 
were washed with brine (1 x 50 mL) before being dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 4.20
137 (1.95 g, 88%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.66–7.64 (complex m, 4H), 7.45–7.37 (complex m, 6H), 6.97 
(dd, J = 15.8 and 7.2 Hz 1H), 5.84 (d, J = 15.8 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.62–3.55 
(complex m, 2H), 2.57 (m, 1H), 1.30 (t, J = 7.1 Hz, 3H), 1.08 (d, J = 6.8 Hz, 3H), 1.06 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 166.9 (CO), 151.5 (CH), 135.8(1) (2 x CH), 135.8(0) (2 x CH), 
133.7(8) (C), 133.7(4) (C), 129.9 (2 x CH), 127.9 (4 x CH), 121.3 (CH), 67.8 (CH2), 60.4 
(CH2), 39.3 (CH), 27.0 (3 x CH3), 19.4 (C), 15.8 (CH3), 14.5 (CH3); 
IR (KBr) νmax 3068, 2960, 2932, 2858, 1720, 1654, 1428, 1268, 1112, 823, 702 cm–1; 
MS (ESI, +ve) m/z 419 [(M+Na)+, 100%]; 
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HRMS (ESI, +ve) Found: (2M+Na)+ 815.4146, C48H64
23Na O6Si2 requires 815.4139. (M+Na)
+ 
419.2020, C24H32
23Na O3Si requires 419.2018; 
Specific rotation [α]25D = +3.1 (c 1.1, CHCl3). 
These data matched those reported previously.137 
 
(R,E)-5-((tert-Butyldiphenylsilyl)oxy)-4-methylpent-2-en-1-ol (4.21) 
 
A magnetically stirred solution of ester 4.20 (1.50 g, 3.92 mmol) in dry hexane (40 mL) 
maintained at −78 °C under a nitrogen atmosphere was treated with di-iso-butylaluminium 
hydride (8.6 mL of 1.0 M solution in hexane, 8.60 mmol). The ensuing mixture was stirred at 
−78 °C for 2 h then quenched with tartaric acid (40 mL of a 1.0 M aqueous solution). The 
resulting mixture was stirred for 1 h and the separated aqueous layer extracted with diethyl 
ether (2 x 50 mL). The combined organic phases were dried over magnesium sulfate, filtered 
and concentrated under reduced pressure and the residue thus obtained was subjected to flash 
chromatography (silica, 30:70 v/v diethyl ether/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 4.21
137 (1.37 g, 99%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.68–7.65 (complex m, 4H), 7.45–7.36 (complex m, 6H), 5.69–
5.59 (complex m, 2H), 4.07 (d, J = 4.9 Hz, 2H), 3.58 (ABX, JAB = 9.8, JAX = 6.3 Hz, 1H), 3.52 
(ABX, JAB = 9.8, JBX = 6.6 Hz, 1H), 2.42 (m, 1H), 1.36 (br s, OH), 1.07 (s. 9H), 1.05 (d, J = 
6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 135.8 (4 x CH), 135.7 (CH), 134.1 (2 x C), 129.8 (2 x CH), 
128.9 (CH), 127.8 (4 x CH), 68.7 (CH2), 64.1 (CH2), 39.1 (CH), 27.1 (3 x CH3), 19.5 (C), 16.6 
(CH3); 
IR (KBr) νmax 3336, 3071, 2959, 2931, 2858, 1427, 1111, 701 cm−1; 
MS (ESI, +ve) m/z 377 [(M+Na)+, 100%]; 
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HRMS (ESI, +ve) Found: (M+K)+ 393.1652, C22H30
39KO2Si requires 393.1652. (M+Na)
+ 
377.1915, C22H30
23NaO2Si requires 377.1913. (M+H)
+ 355.2093, C22H31O2Si requires 
3355.2093; 
Specific rotation [α]25D = +3.2 (c 1.5, CHCl3). 
These data matched those reported previously.137 
 
(R,E)-5-((tert-Butyldiphenylsilyl)oxy)-4-methylpent-2-enal (4.14) 
 
A magnetically stirred solution of alcohol 4.21 (1.37 g, 3.96 mmol) in dichloromethane 
(40 mL) was treated, in two portions, with manganese dioxide (6.37 g, 46.37 mmol). A slightly 
exothermic reaction was took place. The ensuing mixture was stirred for 3 h then filtered 
through a pad of CeliteTM and the pad rinsed with dichloromethane (2 x 30 mL). The combined 
filtrates were concentrated under reduced pressure and the residue thus obtained was subjected 
to flash chromatography (silica, 30:70 v/v diethyl ether/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.5) afforded aldehyde 4.14
137 (1.20 g, 91%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 9.49 (d, J = 7.8 Hz, CHO), 7.66–7.64 (complex m, 4H), 7.46–
7.37 (complex m, 6H), 6.83 (dd, J = 15.8 and 6.9 Hz, 1H), 6.14 (ddd, J = 15.8, 7.8 and 1.3 Hz, 
1H), 3.69 (ABX, JAB = 9.9, JAX = 5.7 Hz, 1H), 3.63 (ABX, JAB = 9.9, JBX = 6.7 Hz, 1H), 2.69 
(m, 1H), 1.11 (d, J = 6.8 Hz, 3H), 1.07 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 194.4 (CHO), 161.2 (CH), 135.7(9) (2 x CH), 135.7(7) (2 x 
CH), 133.5(8) (C), 133.5(5) (C), 132.6 (CH), 130.0 (2 x CH), 127.9 (4 x CH), 67.5 (CH2), 39.8 
(CH), 27.0 (3 x CH3), 19.5 (C), 15.6 (CH3); 
IR (KBr) νmax 3071, 2960, 2931, 2858, 1693, 1427, 1111, 702 cm−1; 
MS (ESI, +ve) m/z 375 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 375.1756, C22H28
23NaO2Si requires 375.1756; 
Specific rotation [α]25D = +12.3 (c 1.9, CHCl3). 
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These data matched those reported previously.137 
 
(E)-4-Methoxy-3-methyl-4-oxobut-2-enoic Acid (4.23) 
 
A magnetically stirred solution of 2-bromopropionate 4.22 (10.00 g, 59.88 mmol) in 
acetonitrile (120 mL) was treated with triphenylphosphine (15.70 g, 59.88 mmol). After stirring 
at 65 °C for 16 h, the reaction mixture was cooled to 0 °C then treated with a solution of di-
iso-propylethylamine (9.39 mL, 53.89 mmol) and glyoxylic acid monohydrate (4.96 g, 53.89 
mmol) in acetonitrile (40 mL). The solution thus formed was stirred for a further 2 h then 
warmed to 18 °C and stirred at this temperature for 16 h. The solvent was removed under 
reduced pressure and the residue dissolved in ethyl acetate (50 mL). The solution thus obtained 
was extracted with sodium hydrogen carbonate (3 x 50 mL of a saturated aqueous solution) 
and the combined aqueous phases were acidified to pH 1–2 with hydrochloric acid (cont.) then 
extracted with ethyl acetate (3 x 100 mL). The combined organic phases were concentrated 
under reduced pressure then filtered through a pad of TLC-grade silica gel that was washed 
with ethyl acetate. The combined filtrates were evaporated under reduced pressure to afford 
compound 4.23138 (6.40 g, 82%) as a white, crystalline solid (Rf = 0.1 in 50:50 v/v ethyl 
acetate/hexane). 
1H NMR [400 MHz, (CD3)2CO] δ 6.73 (m, 1H), 3.79 (s, 3H), 2.24 (d, J = 1.6 Hz, 3H) (signal 
due to the acid proton not observed); 
13C NMR [100 MHz, (CD3)2CO] δ 168.0 (CO), 167.0 (CO), 144.1 (C), 127.4 (CH), 52.8 (CH3), 
14.3 (CH3). 
These data matched those reported previously.138 The following additional data were acquired 
on this compound. 
IR (KBr) νmax 3006, 2960, 1723, 1699, 1645, 1436, 1241, 1121, 905 cm−1; 
MS (ESI, −ve) m/z 99 [(M−COOH−H)−, 100%], 143 [(M−H)−, 50]; 
HRMS (ESI, −ve) Found: (M−H)− 143.0344, C6H7O4 requires 143.0344; 
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Melting point 76–77 °C. 
 
(E)-Methyl 4-Hydroxy-2-methylbut-2-enoate (4.24) 
 
A magnetically stirred solution of acid 4.23 (6.17 g, 42.81 mmol) in dry tetrahydrofuran 
(90 mL) maintained at −15 °C was treated, dropwise, with borane-tetrahydrofuran complex 
(47.1 mL of 1.0 M solution in tetrahydrofuran, 47.10 mmol). The ensuing mixture was warmed 
to 18 °C and stirred at this temperature for 16 h then treated, dropwise, with water (50 mL) and 
potassium carbonate (10.00 g). The separated aqueous layer was extracted with diethyl ether (3 
x 50 mL) and the combined organic phases were then dried over magnesium sulfate before 
being filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 60:40 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded compound 4.24
138 (4.00 g, 72%) 
as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 6.80 (td, J = 6.0, 1.3 Hz, 1H), 4.33 (dd, J = 6.0 and 0.8 Hz, 2H), 
3.73 (s, 3H), 2.21 (s, OH), 1.82 (d, J = 1.3 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 168.4 (CO), 140.6 (CH), 128.5 (C), 59.8 (CH2), 52.1 (CH3), 
12.9 (CH3); 
IR (KBr) νmax 3420, 2954, 1716, 1653, 1645, 1438, 1266, 1131, 730 cm−1; 
These data matched those reported previously.138 
 
(E)-Methyl 4-Bromo-2-methylbut-2-enoate (4.25) 
 
A magnetically stirred solution of alcohol 4.24 (3.10 g, 23.82 mmol) and carbon 
tetrabromide (9.48 g, 28.58 mmol) in dry dichloromethane (100 mL) maintained at 0 °C was 
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treated, in one portion, with triphenylphosphine (7.50 g, 28.58 mmol). The ensuing mixture 
was warmed to 18 °C and treated with methanol (0.3 mL). After a further 30 min, the solvent 
was removed by evaporation and the residue filtered through a pad of TLC-grade silica gel that 
was eluted with diethyl ether/pentane (100 mL of a 3:7 v/v mixture). The combined filtrates 
were concentrated under reduced pressure and the residue thus obtained was subjected to flash 
chromatography (silica, 5:95 v/v diethyl ether/pentane elution). Concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 4.25
138 (3.70 g, 80%) as a clear, colourless 
liquid. 
1H NMR (400 MHz, CDCl3) δ 6.93 (m, 1H), 4.03 (d, J = 8.5 Hz, 2H), 3.77 (s, 3H), 1.92 (d, J 
= 1.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 167.9 (CO), 135.3 (CH), 132.1 (C), 52.1 (CH3), 26.1 (CH2), 
12.4 (CH3); 
IR (KBr) νmax 2952, 1718, 1647, 1436, 1268, 1194, 1104, 749 cm−1; 
These data matched those reported previously.138 
 
(E)-Methyl 4-(Diethoxyphosphoryl)-2-methylbut-2-enoate (4.15) 
 
A magnetically stirred solution of bromide 4.25 (2.80 g, 14.50 mmol) and 
triethylphosphite (3.73 g, 21.76 mmol) was heated to 110 °C for 2 h. The cooled reaction 
mixture was concentrated under reduced pressure and the residue thus obtained subjected to 
flash chromatography (silica, 70:30 v/v ethyl acetate/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 4.15
139 (3.50 g, 96%) as a clear, colourless 
liquid. 
1H NMR (400 MHz, CDCl3) δ 6.69 (m, 1H), 4.09–4.02 (complex m, 4H), 3.69 (s, 3H), 2.69 
(dd, J = 23.4 and 8.2 Hz, 2H), 1.83 (d, J = 3.7 Hz, 3H), 1.27 (t, J = 7.1 Hz, 6H); 
IR (KBr) νmax 3469, 2985, 1716, 1651, 1438, 1254, 1166, 1050, 1026, 966 cm−1. 
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These data matched those reported previously.139 The following additional data were acquired 
on this compound. 
13C NMR (100 MHz, CDCl3) δ 167.8 (d, J = 3.4 Hz, CO), 131.7 (d, J = 13.8 Hz, C), 130.5 (d, 
J = 11.3 Hz, CH), 62.3(3) (CH2), 62.3(2) (CH2), 52.0 (CH3), 27.7 (d, J = 140.0 Hz, CH2–PO), 
16.5(5) (CH3), 16.5(0) (CH3), 12.7 (d, J = 2.5 Hz, CH3); 
31P NMR (162 MHz, CDCl3) δ 25.4 (PO); 
MS (ESI, +ve) m/z 273 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 273.0868, C10H19
23NaO5P requires 273.0868. (M+H)
+ 
251.1048, C10H20O5P requires 251.1048.  
 
(R,2E,4E,6E)-Methyl 9-((tert-Butyldiphenylsilyl)oxy)-2,8-dimethylnona-2,4,6-trienoate 
(4.13) 
 
A magnetically stirred solution of phosphonate 4.15 (1.76 g, 7.06 mmol) in dry 
tetrahydrofuran (30 mL) maintained at 0 °C under a nitrogen atmosphere was treated with n-
butyllithium (4.5 mL of 1.5 M solution in tetrahydrofuran, 6.70 mmol). The ensuing mixture 
was stirred at 0 °C for 10 min then cooled to –78 °C and treated with a solution of aldehyde 
4.14 (1.24 g, 3.53 mmol) in tetrahydrofuran (30 mL). The resulting mixture was stirred at −78 
°C for 30 min then warmed to 18 °C and stirred for a further 3.5 h. The reaction was quenched 
with ammonium chloride (50 mL of a saturated aqueous solution) and the aqueous layer 
extracted with diethyl ether (3 x 50 mL). The combined organic phases were dried over 
magnesium sulfate, then filtered and concentrated under reduced pressure and the residue thus 
obtained was subjected to flash chromatography (silica, 4:96 v/v diethylether/hexane elution). 
Concentration of the appropriate fractions (Rf = 0.2) afforded compound 4.13 (1.27 g, 80%) as 
a clear, colourless oil and as an inseparable (94:6) mixture of E/Z isomers. 
1H NMR (400 MHz, CDCl3) δ (E-isomer) 7.68–7.65 (complex m, 4H), 7.45–7.36 (complex 
m, 6H), 7.22 (dd, J = 11.0 and 1.4 Hz, 1H), 6.50 (dd, J = 14.8 and 10.2 Hz, 1H), 6.40 (dd, J = 
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14.8 and 11.0 Hz, 1H), 6.21 (dd, J = 15.3 and 10.2 Hz, 1H), 5.85 (dd, J = 15.3 and 7.4 Hz, 1H), 
3.77 (s, 3H), 3.61–3.53 (complex m, 2H), 2.51 (m, 1H), 1.96 (s, 3H), 1.08 (d, J = 5.6 Hz, 3H), 
1.07 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (E-isomer) 169.1 (CO), 141.8 (CH), 140.1 (CH), 138.8 (CH), 
135.8(4) (2 x CH), 135.8(2) (2 x CH), 134.0 (C), 133.9(8) (C), 130.1 (CH), 129.8 (2 x CH), 
127.8 (4 x CH), 126.3 (CH), 126.2 (C), 68.5 (CH2), 52.0 (CH3), 39.8 (CH), 27.1 (3 x CH3), 
19.5 (C), 16.5 (CH3), 12.9 (CH3); 
IR (KBr) νmax 2955, 2858, 1707, 1614, 1428, 1235, 1111, 701 cm−1; 
MS (ESI, +ve) m/z 471 [(M+Na)+, 100%], 449 [(M+H)+, 20]; 
HRMS (ESI, +ve) Found: (M+Na)+ 471.2331, C28H36
23NaO3Si requires 471.2331. (M+H)
+ 
449.2525, C28H37O3Si requires 449.2513; 
Specific rotation [α]25D = +2.6 (c 0.9, CHCl3). 
 
(R,2E,4E,6E)-Methyl 9-Hydroxy-2,8-dimethylnona-2,4,6-trienoate (4.26) 
 
A magnetically stirred solution of silyl ether 4.13 (1.02 g, 2.27 mmol) in 
tetrahydrofuran (25 mL) was treated with tetra-n-butylammonium fluoride (4.6 mL of a 1.0 M 
solution in tetrahydrofuran, 4.60 mmol). After 2 h, the reaction mixture was quenched with 
ammonium chloride (25 mL of a saturated aqueous solution) and the separated aqueous layer 
was extracted with diethyl ether (3 x 25 mL). The combined organic phases were then dried 
over magnesium sulfate before being filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 50:50 v/v diethyl 
ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) afforded alcohol 
4.26 (400 mg, 84%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.19 (dd, J = 10.6 and 1.5 Hz, 1H), 6.50 (dd, J = 14.7 and 9.6 
Hz, 1H), 6.44 (dd, J = 14.7 and 10.6 Hz, 1H), 6.28 (dd, J = 15.3 and 9.6 Hz, 1H), 5.79 (dd, J = 
15.3 and 7.7 Hz, 1H), 3.75 (s, 3H), 3.56 (ABX, JAB = 10.5, JAX = 5.7 Hz, 1H), 3.49 (ABX, JAB 
= 10.5, JAX = 7.3 Hz, 1H), 2.47 (m, 1H), 1.94 (d, J = 1.5 Hz, 3H), 1.64 (s, OH), 1.05 (d, J = 6.8 
Hz, 3H); 
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13C NMR (100 MHz, CDCl3) δ 169.0 (CO), 140.7 (CH), 139.4 (CH), 138.5 (CH), 131.0 (CH), 
126.8 (CH), 126.6 (C), 67.3 (CH2), 51.9 (CH3), 40.0 (CH), 16.3 (CH3), 12.8 (CH3); 
IR (KBr) νmax 3419, 2953, 2873, 1705, 1613, 1436, 1253, 1109, 992 cm−1; 
MS (ESI, +ve) m/z 265.4 [(M+CH3OH+Na)
+, 50%], 233 [(M+Na)+, 70], 186 (100); 
HRMS (ESI, +ve) Found: (M+Na)+ 233.1155, C12H18
23NaO3 requires 233.1154; 
Specific rotation [α]25D = +17.8 (c 0.9, CHCl3). 
 
(R,2E,4E,6E)-Methyl 9-(1,3-Dioxoisoindolin-2-yl)-2,8-dimethylnona-2,4,6-trienoate 
(4.27) 
 
A magnetically stirred solution of alcohol 4.26 (100 mg, 0.47 mmol) and phthalimide 
(140 mg, 0.95 mmol) in tetrahydrofuran (2 mL) maintained at 0 °C was treated, sequentially, 
with triphenylphosphine (187 mg, 0.71 mmol) then di-iso-propyl azodicarboxylate (0.17 mL, 
0.86 mmol). The ensuing mixture was warmed to 18 °C and stirred at this temperature for 16 
h, then concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 5:30:65 v/v/v diethyl ether/dichloromethane/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded phtalimide 4.27 (140 mg, 87%) 
as a white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 7.82 (dd, J = 5.4 and 3.1 Hz, 2H), 7.69 (dd, J = 5.4 and 3.1 Hz, 
2H), 7.13 (d, J = 11.4 Hz, 1H), 6.42 (dd, J = 14.8 and 10.5 Hz, 1H), 6.30 (dd, J = 14.8 and 11.4 
Hz, 1H), 6.13 (dd, J = 15.1 and 10.5 Hz, 1H), 5.76 (dd, J = 15.1 and 8.4 Hz, 1H), 3.73 (s, 3H), 
3.65 (ABX, JAB = 13.6, JAX = 8.4 Hz, 1H), 3.60 (ABX, JAB = 13.6, JBX = 7.0 Hz, 1H), 2.81 
(hept, J = 7.0 Hz, 1H), 1.88 (s, 3H), 1.09 (d, J = 7.0 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 168.9 (CO), 168.5 (2 x CO), 140.3 (CH), 139.2 (CH), 138.4 
(CH), 134.1 (2 x CH), 132.1 (2 x C), 130.9 (CH), 126.8 (CH), 126.6 (C), 123.4 (2 x CH), 51.9 
(CH3), 43.5 (CH2), 37.1 (CH), 18.1 (CH3), 12.8 (CH3); 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Four 
 
 
225 
 
IR (KBr) νmax 3468, 2952, 1773, 1713, 1614, 1434, 1396, 1352, 1282, 1244, 1101, 1046, 993, 
917 cm−1; 
MS (ESI, +ve) m/z 394 [(M+CH3OH+Na)
+, 95%], 362 [(M+Na)+, 100];  
HRMS (ESI, +ve) Found: (M+Na)+ 362.1369, C20H21N
23NaO4 requires 362.1368; 
Melting point 84–85 °C; 
Specific rotation [α]25D  = +87.9 (c 1.2, CHCl3). 
 
(R)-Methyl 3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropanoate (4.30) 
 
A magnetically stirred solution of methyl (R)-3-hydroxy-2-methylpropionate (1.00 g, 
8.46 mmol) in dry N,N-dimethylformamide (10 mL) maintained at 0 °C was treated, 
sequentially, with tert-butyldiphenylsilyl chloride (2.42 g, 9.31 mmol) then imidazole (634 mg, 
9.31 mmol). The resulting solution was warmed to 18 °C and stirred at this temperature for 16 
h then diluted with diethyl ether (20 mL) before being quenched by addition of water (30 mL). 
The separated aqueous layer was extracted with diethyl ether (3 x 25 mL) and the combined 
organic phases were washed with brine (1 x 30 mL), then dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 4.30
141 (2.90 g, 96%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.70–7.68 (complex m, 4H), 7.45–7.39 (complex m, 6H), 3.87 
(ABX, JAB = 9.7, JAX = 6.9 Hz, 1H), 3.76 (ABX, JAB = 9.7, JBX = 5.8 Hz, 1H), 3.71 (s, 3H), 
2.75 (hept, J = 7.0 Hz, 1H), 1.19 (d, J = 7.1 Hz, 3H), 1.07 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 175.5 (CO), 135.8 (4 x CH), 133.7 (C), 133.6 (C), 129.8 (2 x 
CH), 127.8 (4 x CH), 66.1 (CH2), 51.7 (CH3), 42.6 (CH), 26.9 (3 x CH3), 19.4 (C), 13.7 (CH3); 
IR (KBr) νmax 3071, 2932, 2858, 1741, 1472, 1428, 1199, 1112, 823, 702 cm−1; 
MS (ESI, +ve) m/z 379 [(M+Na)+, 100%], 279 [(M−C6H5)+, 100]; 
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HRMS (ESI, +ve) Found: (M+Na)+ 379.1707, C21H28
23NaO3Si requires 379.1705. (M+H)
+ 
357.1887, C21H29O3Si requires 357.1886,  
Specific rotation [α]25D = −16.7 (c 1.5, CHCl3). 
These data matched those reported previously.141 
 
(S)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropan-1-ol (4.31) 
 
A magnetically stirred solution of methyl ester 4.30 (1.30 g, 3.64 mmol) in dry diethyl 
ether (30 mL) containing dry methanol (0.22 mL, 5.47 mmol) maintained at 0 °C was carefully 
treated with lithium borohydride (120 mg, 5.47 mmol). After 15 min, the reaction mixture was 
warmed to 18 °C and stirred for 2 h before being cooled to 0 °C then slowly quenched with 
ammonium chloride (30 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (3 x 20 mL) and the combined organic phases were washed with 
brine (1 x 30 mL) then dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 40:60 v/v 
diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) afforded 
alcohol 4.31141 (1.19 g, 99%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.70–7.68 (complex m, 4H), 7.47–7.38 (complex m, 6H), 3.74 
(ABX, JAB = 10.1, JAX = 4.5 Hz, 1H), 3.68 (complex m, 2H), 3.61 (ABX, JAB = 10.1, JBX = 7.7 
Hz, 1H), 2.48 (s, OH), 2.01 (m, 1H), 1.07 (s, 9H), 0.84 (d, J = 7.0 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 135.7(2) (2 x CH), 135.7(0) (2 x CH), 133.3(0) (C), 133.2(8) 
(C), 129.9 (2 x CH), 127.9 (4 x CH), 68.8 (CH2), 67.8 (CH2), 37.5 (CH), 26.9 (3 x CH3), 19.3 
(C), 13.3 (CH3); 
IR (KBr) νmax 3351, 3071, 2958, 2930, 2858, 1589, 1472, 1427, 1390, 1361, 1112, 1039, 823, 
740, 701 cm−1; 
MS (ESI, +ve) m/z 392 [(M+CH3CN+Na)
+, 30%], 351 [(M+Na)+, 100],  
HRMS (ESI, +ve) Found: (M+Na)+ 351.1758, C20H28
23NaO2Si requires 351.1756. (M+H)
+ 
329.1935, C20H29O2Si requires 329.1937; 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Four 
 
 
227 
 
Specific rotation [α]25D = +5.3 (c 1.9, CHCl3). 
These data matched those reported previously.141 
 
(S)-N-(3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropyl)-N-(4-methoxybenzyl)-2-
nitrobenzenesulfonamide (4.32) 
 
A magnetically stirred solution of alcohol 4.31 (1.05 g, 3.19 mmol) and N-(4-
methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 (1.55 g, 4.79 mmol) in tetrahydrofuran (50 
mL) maintained at 0 °C was treated, sequentially, with triphenylphosphine (1.09 g, 4.15 mmol) 
then di-iso-propyl azodicarboxylate (0.84 mL, 4.15 mmol). The ensuing mixture was warmed 
to 18 °C and stirred at this temperature for 16 h, before being concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 3:30:67 
v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the appropriate 
fractions (Rf = 0.3) afforded compound 4.32 (1.95 g, 96%) as a clear, colourless oil.  
1H NMR (400 MHz, CDCl3) δ 7.94 (dd, J = 7.8 and 1.2 Hz, 1H), 7.65–7.49 (complex m, 7H), 
7.47–7.33 (complex m, 6H), 7.13 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz, 2H), 4.43 (ABq, 
∆δAB= 0.07, JAB =15.5 Hz, 2H), 3.77 (s, 3H), 3.37 (ABX, JAB = 10.1, JAX = 5.9 Hz, 1H), 3.31 
(ABX, JAB = 14.5, JAX = 5.6 Hz, 1H), 3.27 (ABX, JAB = 10.1, JBX = 6.1 Hz, 1H), 3.17 (ABX, 
JAB = 14.5, JBX = 9.0 Hz, 1H), 1.91 (m, 1H), 0.99 (s, 9H), 0.74 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 159.4 (C), 147.9 (C), 135.6(9) (2 x CH), 135.6(7) (2 x CH), 
134.1 (C), 133.5(8) (C), 133.5(6) (C), 133.3 (CH), 131.6 (CH), 131.2 (CH), 129.8(0) (3 x CH), 
129.7(8) (CH), 127.7(9) (2 x CH), 127.7(7) (2 x CH), 127.5 (C), 124.3 (CH), 114.1 (2 x CH), 
66.7 (CH2), 55.4 (CH3), 50.7 (CH2), 50.2 (CH2), 33.9 (CH), 26.9 (3 x CH3), 19.3 (C), 14.5 
(CH3); 
IR (KBr) νmax 2931, 2857, 1588, 1544, 1513, 1462, 1427, 1370, 1251, 1159, 1112, 1034, 703 
cm−1; 
MS (ESI, +ve) m/z 671 [(M+K)+, 100%]; 
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HRMS (ESI, +ve) Found: (M+K)+ 671.2017, C34H40
39KN2O6SSi requires 671.2013; 
Specific rotation [α]25D = +18.9 (c 0.9, CHCl3). 
 
(S)-N-(3-Hydroxy-2-methylpropyl)-N-(4-methoxybenzyl)-2-nitrobenzenesulfonamide 
(4.33) 
 
A magnetically stirred solution of silyl ether 4.32 (1.95 g, 3.08 mmol) in 
tetrahydrofuran (50 mL) was treated with tetra-n-butylammonium fluoride (4.6 mL of 1.0 M 
solution in tetrahydrofuran, 4.62 mmol). After 2 h, the reaction mixture was quenched with 
ammonium chloride (50 mL of a saturated aqueous solution) and the separated aqueous layer 
was extracted with diethyl ether (3 x 50 mL). The combined organic phases were then dried 
over magnesium sulfate before being filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 40:30:30 v/v/v ethyl 
acetate/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 
0.2) afforded alcohol 4.33 (1.10 g, 90%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 7.8 and 1.2 Hz, 1H), 7.73–7.62 (complex m, 3H), 
7.15 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 4.46 (ABq, ∆δAB= 0.14, JAB =15.2 Hz, 2H), 
3.79 (s, 3H), 3.58 (ABX, JAB = 11.4, JAX = 4.1 Hz, 1H), 3.44 (ABX, JAB = 14.7, JAX = 9.1 Hz, 
1H), 3.37 (ABX, JAB = 11.4, JAX = 4.2 Hz, 1H), 3.01 (ABX, JAB = 14.7, JAX = 6.2 Hz, 1H), 
1.93 (s, OH), 1.89–1.66 (complex m, 1H), 0.82 (d, J = 6.9 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 159.5 (C), 148.0 (C), 133.6 (CH), 133.5 (C), 131.8 (CH), 130.8 
(CH), 129.9 (2 x CH), 127.4 (C), 124.4 (CH), 114.2 (2 x CH), 63.9 (CH2), 55.4 (CH3), 51.8 
(CH2), 50.7 (CH2), 33.8 (CH), 14.5 (CH3); 
IR (KBr) νmax 3557, 2933, 1612, 1544, 1513, 1463, 1371, 1248, 1162, 1032, 911, 778 cm−1; 
MS (ESI, +ve) m/z 417 [(M+Na)+, 100%], 395 [(M+H)+, 25]; 
HRMS (ESI, +ve) Found: (M+Na)+ 417.1103, C18H22N2
23NaO6S requires 417.1096; 
Specific rotation [α]25D = −7.1 (c 1.4, CHCl3). 
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(S)-N-(4-Methoxybenzyl)-N-(2-methyl-3-oxopropyl)-2-nitrobenzenesulfonamide (4.34) 
 
A magnetically stirred solution of alcohol 4.33 (1.50 g, 3.80 mmol) in dichloromethane 
(50 mL) maintained at 0 ºC was treated with the Dess-Martin periodinane (2.26 g, 5.32 mmol) 
and pyridine (1.4 mL, 17.11 mmol). The ensuing mixture was warmed to 18 ºC and stirred for 
3 h then quenched by addition of a mixture of sodium thiosulfate (25 mL of a 10% aqueous 
solution) and sodium hydrogen carbonate (25 mL of a saturated aqueous solution). The 
resulting slurry was filtered through CeliteTM and the separated aqueous layer associated with 
the filtrate was extracted with diethyl ether (3 x 50 mL). The combined organic phases were 
washed with brine (1 x 50 mL) then dried over magnesium sulfate, filtered and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash chromatography 
(silica, 20:25:55 v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded aldehyde 4.34 (1.25 g, 84%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 9.47 (d, J = 1.7 Hz, CHO), 7.96 (m, 1H), 7.73–7.63 (complex 
m, 3H), 7.15 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 4.44 (s, 2H), 3.78 (s, 3H), 3.61 
(ABX, JAB = 15.0, JAX = 7.3 Hz, 1H), 3.29 (ABX, JAB = 15.0, JAX = 6.9 Hz, 1H), 2.54 (m, 1H), 
0.96 (d, J = 7.3 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 202.8 (CO), 159.6 (C), 148.1 (C), 133.8 (CH), 133.5 (C), 131.8 
(CH), 130.8 (CH), 129.9 (2 x CH), 127.4 (C), 124.4 (CH), 114.2 (2 x CH), 55.4 (CH3), 52.0 
(CH2), 47.9 (CH2), 45.4 (CH), 12.0 (CH3); 
IR (KBr) νmax 3096, 2936, 2838, 1724, 1612, 1544, 1513, 1458, 1372, 1250, 1164, 1031, 851, 
777 cm−1; 
MS (ESI, +ve) m/z 447 [(M+CH3OH+Na)
+, 100%], 393 [(M+H)+, 20]; 
HRMS (ESI, +ve) Found: (M+Na)+ 415.0941, C18H20N2
23NaO6S requires 415.0940. (M+H)
+ 
393.1121, C18H21N2O6S requires 393.1120; 
Specific rotation [α]25D = +1.5 (c 1.6, CHCl3).  
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(R,2E,4E,6E)-9-((tert-Butyldiphenylsilyl)oxy)-2,8-dimethylnona-2,4,6-trienal (4.36) 
 
A magnetically stirred solution of ester 4.13 (659 mg, 1.47mmol) in dry hexane (20 
mL) maintained at −78 °C was treated with di-iso-butylaluminium hydride (3.3 mL of 1.0 M 
solution in hexane, 3.30 mmol). The ensuing reaction mixture was stirred for 2 h then quenched 
with tartaric acid (20 mL of a 1 M aqueous solution) and stirring was continued for a further 1 
h. The separated aqueous layer was extracted with diethyl ether (3 x 30 mL) and the combined 
organic phases were then dried over magnesium sulfate before being filtered and concentrated 
under reduced pressure. The residue thus obtained was dissolved in dichloromethane (20 mL) 
and the solution thus formed was treated, in three portions, with manganese dioxide (2.94 g, 
21.39 mmol). A slightly exothermic reaction occured. The ensuing mixture was stirred for 3 h 
then filtered through a pad of CeliteTM that was rinsed with dichloromethane (3 x 20 mL). The 
combined filtrates were concentrated under reduced pressure and the residue thus obtained was 
subjected to flash chromatography (silica, 10:90 v/v diethyl ether/hexane). Concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 4.36 (500 mg, 81%) as a clear, colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 9.46 (s, 1H), 7.68–7.66 (complex m, 4H), 7.52–7.31 (complex 
m, 6H), 6.87 (dd, J = 10.8, 1.1 Hz, 1H), 6.62 (partially obscured d, J = 14.8 and 9.9 Hz, 1H), 
6.57 (partially obscured d, J = 14.8 and 10.8 Hz, 1H), 6.25 (dd, J = 15.3 and 9.9 Hz, 1H), 5.97 
(dd, J = 15.3 and 7.4 Hz, 1H), 3.59 (d, J = 6.2 Hz, 2H), 2.54 (m, 1H), 1.87 (s, 3H), 1.09 (d, J = 
6.5 Hz, 3H), 1.08 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 194.8 (CO), 149.0 (CH), 143.8 (CH), 142.0 (CH), 137.1 (C), 
135.7(4) (2 x CH), 135.7(3) (2 x CH), 133.8(6) (C), 133.8(4) (C), 129.9 (CH), 129.8 (2 x CH), 
127.8 (4 x CH), 125.8 (CH), 68.3 (CH2), 39.9 (CH), 27.0 (3 x CH3), 19.4 (C), 16.3 (CH3), 9.6 
(CH3); 
IR (KBr) νmax 2930, 2857, 1679, 1611, 1427, 1190, 1112, 998, 702 cm−1; 
MS (ESI, +ve) m/z 457 [(M+K)+, 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 457.1967, C27H34
39KO2Si requires 457.1965; 
Specific rotation [α]25D = +3.5 (c 1.4, CHCl3). 
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tert-Butyl(((R,3E,5E,7E,9Z)-2,8-dimethyltrideca-3,5,7,9-tetraen-11-yn-1-yl)oxy)diphenyl 
lsilane (4.38) 
 
A magnetically stirred solution of sulfone 4.37 (360 mg, 1.43 mmol) in tetrahydrofuran 
(10 mL) maintained at −55 °C was treated, dropwise, with potassium bis(trimethylsilyl)amide 
(2.87 mL of an 0.5 M solution in toluene, 1.43 mmol). The resulting dark-red solution was 
stirred at this temperature for 30 min then slowly treated with a solution of aldehyde 4.36 (200 
mg, 0.47 mmol) in tetrahydrofuran (5 mL). The ensuing mixture was stirred at −55 °C for a 
further 16 h then warmed to 18 ºC for 1 h before being diluted with diethyl ether (15 mL) and 
washed with water (20 mL). The separated aqueous layer was extracted with diethyl ether (3 x 
15 mL) and the combined organic phases were washed with brine (1 x 20 mL) then dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 2:98 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.4) afforded compound 4.38 (95 mg, 44%) as 
a clear, yellow oil and as an inseparable (85:15) mixture of 16Z/16E isomers containing starting 
material (40 mg, 20% recovery).  
1H NMR (400 MHz, CDCl3) δ (Z-isomer) 7.69–7.67 (complex m, 4H), 7.49–7.33 (complex m, 
6H), 6.52–6.40 (complex m, 1H), 6.33–6.09 (complex m, 4H), 5.72 (dd, J = 14.5 and 7.4 Hz, 
1H), 5.39 (dq, J = 11.8 and 2.8 Hz, 1H), 3.60 (ABX, JAB = 9.7, JAX = 6.2 Hz, 1H), 3.54 (ABX, 
JAB = 9.7, JBX = 6.6 Hz, 1H), 2.50 (m, 1H), 2.23 (s, 3H), 2.02 (d, J = 2.8 Hz, 3H), 1.08(2) (d, J 
= 6.7, 3H), 1.08(1) (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (Z-isomer) 142.1 (CH), 138.3 (CH), 135.9 (C), 135.7(8) (2 x 
CH), 135.7(7) (2 x CH), 134.8 (CH), 134.0(3) (C), 134.0(1) (C), 133.7 (CH), 130.6 (CH), 129.7 
(2 x CH), 127.7 (4 x CH), 127.4 (CH), 106.4 (CH), 93.0 (C), 79.4 (C), 68.6 (CH), 39.7 (CH), 
27.0 (3 x CH3), 19.5 (C), 16.6 (CH3), 15.1 (CH3), 4.9 (CH3); 
IR (KBr) νmax 3025, 2958, 2857, 1958, 1471, 1427, 1112, 1082, 986, 701 cm−1; 
MS (ESI, +ve) m/z 493 [(M+K)+, 100%], 477 [(M+Na)+, 20]; 
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HRMS (ESI, +ve) Found: (M+K)+ 493.2336, C31H38
39KOSi requires 493.2329; 
Specific rotation [α]25D = −2.0 (c 1.0, CHCl3). 
 
(R,3E,5E,7E,9Z)-2,8-Dimethyltrideca-3,5,7,9-tetraen-11-yn-1-ol (4.39) 
 
A magnetically stirred solution of silyl ether 4.38 (130 mg, 0.29 mmol) in 
tetrahydrofuran (5 mL) was treated with tetra-n-butylammonium fluoride (0.58 mL of a 1.0 M 
solution in tetrahydrofuran, 0.58 mmol). After 2 h, the reaction mixture was quenched with 
ammonium chloride (5 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (3 x 5 mL) and the combined organic phases were then dried over 
magnesium sulfate before being filtered and concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica, 40:60 v/v diethyl ether/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.2) afforded alcohol 4.39 (55 mg, 
89%) as a clear, yellow oil and as an inseparable (72:25) mixture of 16Z/16E isomers.  
1H NMR (400 MHz, CDCl3) δ (Z-isomer) 6.49 (m, 1H), 6.33–6.19 (complex m, 3H), 6.13 (d, 
J = 11.9 Hz, 1H), 5.63 (m, 1H), 5.37 (dq, J = 11.9 and 2.8 Hz, 1H), 3.53 (ABX, JAB = 10.5, JAX 
= 5.7 Hz, 1H), 3.45 (ABX, JAB = 10.5, JBX =7.5 Hz, 1H), 2.44 (hept, J = 6.8 Hz, 1H), 2.20 (s, 
3H), 2.00 (d, J = 2.8 Hz, 3H), 1.46 (s, OH), 1.04 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ (Z-isomer) 141.9 (CH), 137.2 (CH), 136.4 (C), 134.1 (CH), 
133.3 (CH), 131.9 (CH), 128.2 (CH), 106.7 (CH), 93.2 (C), 79.4 (C), 67.5 (CH2), 40.2 (CH), 
16.5 (CH3), 15.1 (CH3), 4.9 (CH3); 
IR (KBr) νmax 3351, 3024, 2958, 2914, 2871, 1956, 1439, 1376, 1030, 987 cm−1; 
MS (EI, +ve, 70 eV) m/z 216 (M+•, 100%), 185 (50), 157 (75), 142 (60). 128 (50); 
HRMS (EI, +ve, 70 eV) Found: M+• 216.1515, C15H20O requires 215.1514; 
Specific rotation [α]25D = +11.7 (c 2.3, CHCl3). 
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N-((R,3E,5E,7E,9Z)-2,8-Dimethyltrideca-3,5,7,9-tetraen-11-yn-1-yl)-N-(4-
methoxybenzyl)-2-nitrobenzenesulfonamide (4.40) 
 
A magnetically stirred solution of alcohol 4.39 (18 mg, 0.08 mmol) and N-(4-
methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 (54 mg, 0.17 mmol) in tetrahydrofuran (2 
mL) maintained at 0 °C was treated, sequentially, with triphenylphosphine (33 mg, 0.12 mmol) 
then di-iso-propyl azodicarboxylate (0.03 mL, 0.15 mmol). The ensuing mixture was warmed 
to 18 °C and stirred at this temperature for 16 h then concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 10:25:65 v/v/v ethyl 
acetate/dichloromethane/hexane) and concentration of the appropriate fractions (Rf = 0.4 in 
20:25:55 v/v/v ethyl acetate/dichloromethane/hexane) afforded compound 4.40 (35 mg, 66%) 
as a clear, yellow oil and as an inseparable (60:40) mixture of 16Z/16E isomers.  
1H NMR (400 MHz, CDCl3) δ (Z-isomer) 7.98 (d, J = 7.9 Hz, 1H), 7.73–7.57 (m, 3H), 7.15 
(d, J = 8.6 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.37 (partially obscured d, J = 11.8 Hz, 1H), 6.35 
(partially obscured m, 1H), 6.14 (dd, J = 11.7 and 6.0 Hz, 1H), 6.01–5.92 (complex m, 2H), 
5.38 (dq, J = 11.8 and 2.8 Hz, 1H), 5.31 (dd, J = 14.1 and 8.2 Hz, 1H), 4.57 (d, J = 15.4 Hz, 
1H), 4.41 (dd, J = 15.4 and 3.4 Hz, 1H), 3.79 (s, 3H), 3.16 (d, J = 7.6 Hz, 2H), 2.47 (m, 1H), 
2.19 (s, 3H), 2.01 (d, J = 2.7 Hz, 3H), 0.87 (d, J = 6.7 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ (Z-isomer) 159.5 (C), 147.9 (C), 141.8 (CH), 137.0 (CH), 136.5 
(C), 134.0 (C), 133.3 (CH), 133.2 (CH), 131.7 (CH), 131.4 (CH), 131.2 (CH), 129.9 (2 x CH), 
128.1 (CH), 128.0 (C), 127.3 (CH), 124.5 (CH), 114.2 (2 x CH), 106.8 (CH), 93.3 (C), 79.4 
(C), 55.4 (CH3), 52.5 (CH2), 50.1 (CH2), 35.6 (CH), 17.9 (CH3), 15.1 (CH3), 4.9 (CH3); 
IR (KBr) νmax 2960, 2916, 1612, 1543, 1513, 1455, 1440, 1371, 1303, 1248, 1162, 1125, 1030, 
989 cm−1; 
MS (ESI, +ve) m/z 543 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 543.1936, C29H32N2
23NaO5S requires 543.1930; 
Specific rotation [α]25D = −2.9 (c 1.7, CHCl3). 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Four 
 
 
234 
 
N-(4-Methoxybenzyl)-2-nitrobenzenesulfonamide (4.28) 
 
A magnetically stirred solution of 4-methoxybenzylamine (2.00 g, 15.31 mmol) in 
dichloromethane (100 mL) was treated with triethylamine (3.2 mL, 22.96 mmol). The ensuing 
mixture was cooled to 0 °C and treated with 2-nitrobenzenesulfonyl chloride (3.73 g, 16.84 
mmol). After 5 min, the reaction mixture was warmed to 18 °C, stirred at this temperature for 
1 h then quenched with hydrochloric acid (100 mL of a 1.0 M aqueous solution). The separated 
aqueous layer was extracted with dichloromethane (3 x 50 mL) and the combined organic 
phases were washed with brine (1 x 50 mL) then dried over magnesium sulfate, filtered, and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 40:60 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.4) afforded compound 4.28
140 (4.70 g, 95%) as a white, crystalline 
solid. 
1H NMR [400 MHz, (CD3)2CO] δ 7.95 (dd, J = 7.8 and 1.5 Hz, 1H), 7.89 (dd, J = 7.8 and 1.4 
Hz, 1H), 7.83 (td, J = 7.7 and 1.5 Hz, 1H), 7.75 (td, J = 7.7 and 1.4 Hz, 1H), 7.21 (d, J = 8.7 
Hz, 2H), 7.07 (s, 1H), 6.77 (d, J = 8.7 Hz, 2H), 4.29 (s, 2H), 3.74 (s, 3H); 
13C NMR [100 MHz, (CD3)2CO] δ 160.1 (C), 148.9 (C), 134.9 (C), 134.5 (CH), 133.3 (CH), 
131.3 (CH), 130.1 (2 x CH), 129.9 (C), 125.5 (CH), 114.5 (2 x CH), 55.5 (CH3), 47.5 (CH2); 
IR (KBr) νmax 3304, 1609, 1537, 1510, 1404, 1362, 1333, 1244, 1154, 1028, 835, 783 cm−1; 
MS (ESI, +ve) m/z 345 [(M+Na)+, 100%], 340 [(M+NH4)
+, 30]; 
HRMS (ESI, +ve) Found: (M+Na)+ 345.0523, C14H14
23NaN2O5S requires 345.0521; 
Melting point 120 °C. 
These data matched those reported previously.140 
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2-(But-2-yn-1-ylsulfonyl)benzo[d]thiazole (1.78)  
 
A magnetically stirred solution of 2-butynol (1.00g, 14.27 mmol) and tetra-n-butyl 
ammonium iodide (527 mg, 1.42 mmol), in toluene (20 mL) maintained at 0 oC was treated, 
sequentially, with sodium hydroxide (35 mL of a 2.0 M aqueous solution) then, dropwise, with 
a solution of p-toluenesulfonyl chloride (2.85 g, 14.98 mmol) in toluene (5 mL). The ensuing 
mixture was warmed to 18 °C and stirring was continued at this temperature for 3 h. 
2-Mercaptobenzothiazole (2.58 g, 15.41 mmol) was then added to the reaction mixture in one 
portion. After another 2 h, the separated aqueous layer was extracted with ethyl acetate (3 x 25 
mL) and the combined organic phases were washed with water (1 x 50 mL) then dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.2) afforded sulfide 1.78a
86,87 (2.30 g, 73%) 
as a white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 8.1 Hz, 1H), 7.76 (d, J = 8.1 Hz, 1H), 7.43 (m, 1H), 
7.31 (m, 1H), 4.10 (q, J = 2.5 Hz, 2H), 1.83 (t, J = 2.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 165.6 (C), 153.2 (C), 135.5 (C), 126.2 (CH), 124.5(CH), 121.8 
(CH), 121.1 (CH), 80.8 (C), 73.2 (C), 22.6 (CH2), 3.9 (CH3);  
IR (KBr) νmax 3061, 2916, 2236, 1456, 1427, 1309, 1238, 1077, 1001 cm−1. 
These data matched those reported previously.86,87 
 
A magnetically stirred solution of sulfide 1.78a (1.00 g, 4.55 mmol) in ethanol (25 mL) 
maintained at 0 °C was treated, dropwise, with a pre-mixed solution of ammonium molybdate 
tetrahydrate (2.25 g, 1.82 mmol) and hydrogen peroxide (15.5 mL of a 30% w/w in aqueous 
solution, 0.15 mol). The resulting mixture was slowly warmed to 18 °C and stirred at this 
temperature for 16 h before being diluted with diethyl ether (50 mL) and washed with sodium 
hydrogen carbonate (1 x 20 mL of a saturated aqueous solution). The separated aqueous layer 
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was washed with diethyl ether (2 x 20 mL) and the combined organic phases were dried over 
magnesium sulfate, filtered and concentrated under reduce pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 10:30:60 v/v/v ethyl acetate/dichloromethane 
/hexane) and concentration of the appropriate fractions (Rf = 0.2) afforded sulfone 1.78
86,87 
(2.30 g, 73%) as a light-yellow, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 7.7 Hz, 1H), 8.01 (d, J = 7.7 Hz, 1H), 7.62 (m, 2H), 
4.34 (q, J = 2.5 Hz, 2H), 1.75 (t, J = 2.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 164.3 (C), 152.6 (C), 137.2 (C), 128.2 (CH), 127.8 (CH), 125.6 
(CH), 122.4 (CH), 86.0 (C), 65.1 (C), 47.7 (CH2), 3.8 (CH3). 
These data matched those reported previously.86,87 The following additional data were acquired 
on this compound. 
IR (KBr) νmax 3086, 2903, 2245, 1461, 1339, 1316, 1153, 853 cm−1; 
MS (ESI, +ve) m/z 315 [(M+CH3CN+Na)
+, 95%,], 290 [(M+K)+, 100]; 
HRMS (ESI, +ve) Found: (M+K)+ 289.9713, C11H9
39KNO2S2 requires 289.9712. (M+Na)
+ 
273.9973, C11H9
23NaNO2S2 requires 273.9972. 
 
 
 
Chapter Seven Experimental Procedures Related to Work Described in Chapter Five 
 
 
237 
 
7.5 Experimental Procedures Related to Work Described in Chapter Five 
(R)-1-((4R,5S)-5-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-yn-1-ol (5.2) 
 
A magnetically stirred solution of lactol 4.3 (1.25 g, 7.80 mmol) in tetrahydrofuran (20 
mL) maintained at 0 °C under a nitrogen atmosphere was treated with ethynylmagnesium 
bromide (62.4 mL of an 0.5 M solution in tetrahydrofuran, 31.20 mmol). The ensuing mixture 
was stirred at this temperature for 2 h then poured into ammonium chloride (100 mL of a 
saturated aqueous solution). The separated aqueous layer was extracted with ethyl acetate (3 x 
50 mL) and the combined organic phases were then washed with brine (1 x 100 mL) before 
being dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
light-yellow residue thus obtained was subjected to flash chromatography (silica, 50:50 v/v 
ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) afforded 
compound 5.2 (1.29 g, 89%) as a clear, colourless oil. 
1H NMR (400 MHz, CD3OD) δ 4.45 (dd, J = 7.2 and 2.2 Hz, 1H), 4.33 (td, J = 6.5 and 4.6 Hz, 
1H), 4.17 (dd, J = 7.2 and 6.5 Hz, 1H), 3.91 (ABX, JAB = 11.8, JAX = 4.6 Hz, 1H), 3.80 (ABX, 
JAB = 11.8, JBX = 6.5 Hz, 1H), 2.89 (d, J = 2.2 Hz, 1H), 1.49 (s, 3H), 1.40 (s, 3H) (signal due 
to hydroxyl group protons not observed); 
13C NMR (100 MHz, CD3OD) δ 109.9 (C), 84.0 (C), 80.3 (CH), 79.3 (CH), 74.9 (CH), 61.9 
(CH), 61.3 (CH2), 27.9 (CH3), 25.5 (CH3); 
IR (KBr) νmax 3380, 3285, 2987, 2937, 2109, 1383, 1219, 1166, 1054 cm−1; 
MS (ESI, +ve) m/z 209 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 209.0793, C9H14
23NaO4 requires 209.0790; 
Specific rotation [α]25D = +29.7 (c 1.6, CHCl3). 
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((4S,5R)-5-((R)-1-Hydroxyprop-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 
Pivaloate (5.3) 
 
A magnetically stirred solution of diol 5.2 (1.29 g, 6.92 mmol), triethylamine (2.4 mL, 
17.32 mmol) and 4-(N,N-dimethylamino)pyridine (85 mg, 0.70 mmol) in dichloromethane 
(100 mL) maintained at −78 °C under a nitrogen atmosphere was treated, over 30 min via 
syringe pump,with pivaloyl chloride (0.94 mL, 7.62 mmol). The ensuing mixture was stirred 
at −78 °C for a further 1 h then poured into ammonium chloride (100 mL of a saturated aqueous 
solution). The separated aqueous layer was extracted with dichloromethane (3 x 50 mL) and 
the combined organic phases were then washed with brine (1 x 100 mL) before being dried 
over magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 20:25:55 v/v/v ethyl 
acetate/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 
0.4) afforded the desired compound 5.3 (1.30 g, 69%) as a white, crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 4.50 (ABX, JAB = 11.6, JAX = 4.3 Hz, 1H), 4.48 (dd, J = 6.5 
and 2.1 Hz, 1H), 4.41 (td, J = 6.5 and 4.3 Hz, 1H), 4.28 (ABX, JAB = 11.6, JBX = 6.5 Hz, 1H), 
4.22 (t, J = 6.5 Hz, 1H), 2.73 (s, OH), 2.55 (d, J = 2.1 Hz, 1H), 1.50 (s, 3H), 1.37 (s, 3H), 1.20 
(s, 9H); 
13C NMR (100 MHz, CDCl3) δ 178.4 (CO), 109.5 (C), 82.1 (C), 78.8 (CH), 75.2 (CH), 75.0 
(CH), 62.6 (CH2), 61.6 (CH), 38.9 (C), 27.5 (CH3), 27.3 (3 x CH3), 25.4 (CH3); 
IR (KBr) νmax 3374, 3227, 2974, 2936, 2115, 1726, 1463, 1382, 1219, 1166, 1023, 912 cm−1; 
MS (ESI, +ve) m/z 334 [(M+CH3CN+Na)
+, 100%], 293 [(M+Na) +, 55]; 
HRMS (ESI, +ve) Found: (M+Na) + 293.1365, C14H22
23NaO5 requires 293.1365; 
Melting point 102 °C; 
Specific rotation [α]25D = +3.6 (c 1.2, CHCl3). 
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((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)prop-2-yn-1-yl)-2,2-dimethyl-1,3-
dioxolan-4-yl)methyl Pivalate (5.4) 
 
A magnetically stirred solution of alcohol 5.3 (1.00 g, 3.70 mmol) in N,N-
dimethylformamide (20 mL) maintained at 18 °C was treated, sequentially, with tert-
butyldimethylsilyl chloride (0.84 g, 5.55 mmol) then imidazole (0.63 g, 9.25 mmol). The 
ensuing mixture was stirred for 2 h then diluted with diethyl ether (30 mL) and quenched with 
water (30 mL). The separated aqueous layer was extracted with diethyl ether (3 x 50 mL) and 
the combined organic phases were then washed with hydrochloric acid (1 x 50 mL of a 1.0 M 
aqueous solution), water (1 x 50 mL) and brine (1 x 50 mL) before being dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 10:90 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded compound 5.4 (1.40 g, 98%) as a 
clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.54 (partially obscured dd, J = 6.3 and 2.2 Hz, 1H), 4.52 
(partially obscured dd, J = 11.8 and 2.6 Hz, 1H), 4.37 (ddd, J = 8.1, 6.3 and 2.6 Hz, 1H), 4.20 
(partially obscured dd, J = 11.8 and 8.1 Hz, 1H), 4.18 (partially obscured t, J = 6.3 Hz, 1H), 
2.50 (d, J = 2.2 Hz, 1H), 1.47 (s, 3H), 1.35 (s, 3H), 1.21 (s, 9H), 0.90 (s, 9H), 0.18 (s, 3H), 0.15 
(s, 3H); 
13C NMR (100 MHz, CDCl3) δ 178.5 (CO), 109.2 (C), 82.7 (C), 79.3 (CH), 75.8 (CH), 74.8 
(CH), 63.9 (CH2), 62.2 (CH), 38.9 (C), 27.7 (CH3), 27.3 (3 x CH3), 25.9 (3 x CH3), 25.4 (CH3), 
18.2 (C), −4.1 (CH3), −4.7 (CH3); 
IR (KBr) νmax 3264, 2959, 2933, 2859, 2118, 1732, 1481, 1463, 1382, 1371, 1255, 1158, 1089, 
839, 780 cm−1; 
MS (ESI, +ve) m/z 407 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 407.2231, C20H36
23NaO5Si requires 407.2230. (M+H)
+ 
385.2416, C20H37O5Si requires 385.2410; 
Specific rotation [α]25D = −41.2 (c 1.4, CHCl3). 
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((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-3-(trimethylsilyl)prop-2-yn-1-yl)-2,2-
dimethyl-1,3-dioxolan-4-yl)methyl Pivalate (5.5) 
 
A magnetically stirred solution of terminal alkyne 5.4 (1.40 g, 3.64 mmol) in 
tetrahydrofuran (40 mL) maintained at 0 °C was treated, dropwise, with iso-propylmagnesium 
chloride (3.6 mL of a 2.0 M solution in tetrahydrofuran, 7.28 mmol). After 30 min, the reaction 
mixture was warmed to 18 °C for 10 min then cooled to 0 °C again before being treated with 
trimethylsilyl chloride (0.69 mL, 5.26 mmol). After stirring at this temperature for a further 30 
min, the reaction mixture was warmed to 18 °C for 1 h then quenched with ammonium chloride 
(50 mL of a saturated aqueous solution). The separated aqueous layer was extracted with 
diethyl ether (3 x 50 mL) and the combined organic phases were then washed with brine (1 x 
100 mL) before being dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 5:95 v/v 
diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) afforded 
compound 5.5 (1.50 g, 90%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.55 (partially obscured d, J = 5.2 Hz, 1H), 4.54 (ABX, JAB = 
11.8, JAX = 2.8 Hz, 1H), 4.37 (ddd, J = 8.2, 6.4 and 2.8 Hz, 1H), 4.22 (ABX, JAB = 11.8, JBX = 
8.2 Hz, 1H), 4.16 (dd, J = 6.4 and 5.2 Hz, 1H), 1.46 (s, 3H), 1.35 (s, 3H), 1.22 (s, 9H), 0.91 (s, 
9H), 0.17 (s, 3H), 0.16 (s, 9H), 0.14 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 178.4 (CO), 109.1 (C), 104.2 (C), 91.8 (C), 79.4 (CH), 75.9 
(CH), 64.1 (CH2), 62.9 (CH), 38.9 (C), 27.7 (CH3), 27.4 (3 x CH3), 25.9 (3 x CH3), 25.5 (CH3), 
18.2 (C), −0.22 (3 x CH3), −4.1 (CH3), −4.6 (CH3); 
IR (KBr) νmax 2959, 2933, 2900, 2859, 2176, 1732, 1480, 1463, 1382, 1370, 1251, 1157, 1090, 
842, 779 cm−1; 
MS (ESI, +ve) m/z 479 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 479.2617, C23H44
23NaO5Si2 requires 479.2625; 
Specific rotation [α]25D = −40.0 (c 1.0, CHCl3). 
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((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-3-(trimethylsilyl)prop-2-yn-1-yl)-2,2-
dimethyl-1,3-dioxolan-4-yl)methanol (5.6) 
 
A magnetically stirred solution of pivaloate 5.5 (1.50 g, 3.28 mmol) in hexane (50 mL) 
maintained at −78 °C was treated, dropwise, with di-iso-butylaluminium hydride (6.6 mL of a 
1.0 M solution in hexane, 6.60 mmol). After addition was complete, the reaction mixture was 
stirred for 1 h then treated with tartaric acid (60 mL of a 1.0 M aqueous solution) and stirring 
continued at 18 °C for a further 1 h. The separated aqueous layer was extracted with diethyl 
ether (3 x 50 mL) and the combined organic phases were then washed with brine (1 x 100 mL) 
before being dried over magnesium sulfate, filtered and concentrated under reduced pressure. 
The ensuing light-yellow oil was subjected to flash chromatography (silica, 25:75 v/v diethyl 
ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) afforded 
compound 5.6 (1.15 g, 94%) as a clear, colourless oil. 
1H NMR (400 MHz, CD3OD) δ 4.63 (d, J = 5.2 Hz, 1H), 4.34 (ddd, J = 7.9, 6.6 and 3.4 Hz, 
1H), 4.17 (dd, J = 6.6 and 2.2 Hz, 1H), 3.98 (ABX, JAB = 11.8, JAX = 3.4 Hz, 1H), 3.84 (ABX, 
JAB = 11.8, JBX = 7.9 Hz, 1H), 1.50 (s, 3H), 1.39 (s, 3H), 0.97 (s, 9H), 0.23 (s, 3H), 0.20 (s, 
9H), 0.19 (s, 3H) (signal due to hydroxyl group proton not observed); 
13C NMR (100 MHz, CD3OD) δ 109.8 (C), 105.8 (C), 92.3 (C), 80.6 (CH), 79.8 (CH), 64.2 
(CH2), 62.3 (CH2), 27.8 (CH3), 26.3 (3 x CH3), 25.4 (CH3), 19.0 (C), −0.3 (3 x CH3), −4.0 
(CH3), −4.5 (CH3); 
IR (KBr) νmax 3500, 2958, 2932, 2897, 2859, 2176, 1472, 1380, 1251, 1084, 841, 779 cm−1; 
MS (ESI, +ve) m/z 395 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 395.2051, C18H36
23NaO4Si2 requires 395.2050; 
Specific rotation [α]25D = −27.4 (c 1.2, CHCl3). 
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1-((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-3-(trimethylsilyl)prop-2-yn-1-yl)-2,2-
dimethyl-1,3-dioxolan-4-yl)prop-2-yn-1-ol (5.7) 
 
A magnetically stirred solution of alcohol 5.6 (200 mg, 0.54 mmol) in dichloromethane 
(5 mL) maintained at 0 ºC was treated with the Dess-Martin periodinane (341 mg, 0.80 mmol) 
and pyridine (0.22 mL, 2.68 mmol). The ensuing mixture was warmed to 18 °C and stirred at 
this temperature for 3 h then quenched with sodium thiosulfate (5 mL of a 10% aqueous 
solution) and sodium hydrogen carbonate (5 mL of a saturated aqueous solution). The resulting 
slurry was filtered through CeliteTM and the separated aqueous phase associated with the filtrate 
was extracted with diethyl ether (3 x 5 mL). The combined organic phases were washed with 
brine (1 x 10 mL) then dried over magnesium sulfate before being filtered and concentrated 
under reduced pressure. The residue thus obtained was immediately submitted, without 
purification, to the next step of the reaction sequence. 
A magnetically stirred solution of zinc chloride (0.77 mL of a 1.0 M solution in diethyl 
ether, 0.77 mmol) maintained at 0 °C was treated with ethynylmagnesium bromide (5.2 mL of 
a 0.5 M solution in tetrahydrofuran, 2.60 mmol). The ensuing mixture was cooled to −15 °C 
and treated with a solution of aldehyde (160 mg, 0.43 mmol), formed as described above, in 
tetrahydrofuran (5 mL). After 4 h, the reaction mixture was poured into ammonium chloride 
(10 mL of a saturated aqueous solution) and the separated aqueous layer was extracted with 
diethyl ether (3 x 10 mL). The combined organic phases were then washed with brine (1 x 20 
mL) before being dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The ensuing light-yellow oil was subjected to flash chromatography (silica, 20:80 v/v 
diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.25) afforded 
compound 5.7 (140 mg, 68%) as a clear, colourless oil and as an inseparable (17:83) mixture 
of α/β epimers. 
1H NMR (400 MHz, CDCl3) δ (β-epimer) 4.92 (br s, 1H), 4.85 (d, J = 4.7 Hz, 1H), δ 4.29 (dd, 
J = 6.8 and 1.9 Hz, 1H), 4.25 (dd, J = 6.8 and 4.7 Hz, 1H), 3.63 (br s, OH), 2.45 (d, J = 2.3 Hz, 
1H), 1.57 (s, 3H), 1.39 (s, 3H), 0.92 (s, 9H), 0.19 (s, 3H), 0.18 (s, 3H), 0.16 (s, 9H); 
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13C NMR (100 MHz, CDCl3) δ (β-epimer) 109.7 (C), 102.9 (C), 92.8 (C), 82.7 (C), 79.8 (CH), 
78.9 (CH), 72.8 (CH), 62.2 (CH), 61.1 (CH), 26.5 (CH3), 25.8 (3 x CH3), 25.3 (CH3), 18.4 (C), 
−0.3 (3 x CH3), −4.5 (CH3), −4.9 (CH3); 
IR (KBr) νmax 3467, 3312, 3279, 2957, 2858, 2176, 1472, 1382, 1251, 1215, 1080, 841 cm−1; 
MS (ESI) m/z 419 [(M+Na)+, 100%]; 
HRMS (ESI) Found: (M+Na)+ 419.2054, C20H36
23NaO4Si requires 419.2050. 
 
(R,E)-1-((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-3-(trimethylsilyl)prop-2-yn-1-yl)-
2,2-dimethyl-1,3-dioxolan-4-yl)-3-(tributylstannyl)prop-2-en-1-ol (5.8β) 
 
A magnetically stirred solution of bis(triphenylphosphine)palladium(II) dichloride (10 
mg, 0.02 mmol) and compound 5.7 (119 mg, 0.30 mmol) in dry dichloromethane (5 mL) 
maintained at −78 °C under an argon atmosphere was treated, dropwise over 2 min, with tri-n-
butyltin hydride (0.97 mL, 0.35 mmol). The ensuing mixture was stirred for 30 min then 
warmed to 0 ºC and maintained at this temperature for a further 30 min. After being warmed 
to 18 ºC the reaction mixture was concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica deactivated with 1% triethylamine in 
hexane, 3:97 v/v diethylether/hexane elution) to afford two fractions, A and B. 
Concentration of fraction A (Rf = 0.3) afforded compound 5.8α as a clear, colourless oil 
(24 mg, 12%). 
1H NMR (400 MHz, CDCl3) δ 6.36 (dd, J = 19.2 and 1.2 Hz, 1H), 6.31 (dd, J = 19.2 and 4.7 
Hz, 1H), 4.71 (d, J = 6.5 Hz, 1H), 4.34 (m, 1H), 4.12 (dd, J = 6.5 and 5.2 Hz, 1H), 3.99 (dd, J 
= 9.0 and 5.2 Hz, 1H), 3.37 (d, J = 3.5 Hz, 1H), 1.54 (s, 3H), 1.52–1.46 (complex m, 6H), 1.33 
(s, 3H), 1.31–1.25 (complex m, 6H), 0.93 (s, 9H), 0.91–0.86 (complex m, 15H), 0.24 (s, 3H), 
0.21 (s, 3H), 0.17 (s, 9H); 
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Concentration of fraction B (Rf = 0.2) afforded compound 5.8β as a clear, colourless oil 
(125 mg, 60%)  
1H NMR (400 MHz, CDCl3) δ 6.23 (d, J = 19.2 Hz, 1H), 6.12 (dd, J = 19.2 and 5.5 Hz, 1H), 
4.81 (d, J = 4.7 Hz, 1H), 4.61 (m, 1H), 4.24–4.13 (complex m, 2H), 3.38 (d, J = 4.0 Hz, 1H), 
1.54 (s, 3H), 1.51–1.43 (complex m, 6H), 1.36 (s, 3H), 1.34–1.25 (complex m, 6H), 0.93 (s, 
9H), 0.91–0.86 (complex m, 15H), 0.20 (s, 3H), 0.18 (s, 3H), 0.17 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 148.2 (C), 129.5 (C), 108.8 (C), 103.8 (C), 92.2 (C), 80.6 (CH), 
79.3 (CH), 72.8 (CH), 62.8 (CH), 29.2 (3 x CH2), 27.4 (3 x CH2), 26.7 (CH3), 25.9 (3 x CH3), 
25.2 (CH3), 18.5 (C), 13.9 (3 x CH3), 9.6 (3 x CH2), −0.2 (3 x CH3), −4.4 (CH3), −4.7 (CH3); 
IR (KBr) νmax 3496, 2957, 2929, 2857, 2177, 1464, 1379, 1250, 1214, 1079, 841 cm−1; 
MS (ESI, +ve) m/z 711 [(M+Na)+, 100%]; 597 {[M–(2xC4H9)+Na]+, 50}; 
HRMS (ESI, +ve) Found: (M+Na)+ 711.3279, C32H64
23NaO4Si2
120Sn requires 711.3263; 
Specific rotation [α]25D = −29.5 (c 0.9, CHCl3). 
 
6-((R,1E,3E,5E)-7-((4S,5S)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-3-(trimethylsilyl)prop-
2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-7-hydroxy-3-methylhepta-1,3,5-trien-1-yl)-
2,2-dimethyl-4H-1,3-dioxin-4-one (5.9) 
 
 A two-neck round bottom flask equipped with a condenser and a rubber septum was 
charged with stannane 5.8β (100 mg, 0.14 mmol), alkenyl iodine 3.10 (46 mg, 0.14 mmol), 
tetrakis(triphenylphosphine)palladium(0) (17 mg, 0.01(4) mmol), triphenylphosphine (9 mg, 
0.03 mmol), lithium chloride (37 mg, 0.87 mmol) and cooper iodide (138 mg, 0.73 mmol). The 
flask was evacuated at low pressure then filled with argon. The resulting mixture was dissolved 
in degassed N,N-dimethylformamide (5 mL) and the solution so formed was heated to 40 ºC 
for 16 h. After cooling, potassium fluoride (5 mL of a 10% aqueous solution) was added and 
the reaction mixture was stirred at 18 ºC for 30 min before being filtered and the filtrate then 
extracted with ethyl acetate (3 x 10 mL). The combined organic phases were washed with water 
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(2 x 20 mL) and brine (1 x 10 mL) then dried over magnesium sulfate before being filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 10:30:60 v/v/v ethyl acetate/dichloromethane/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded compound 5.9 (16 mg, 20%) as a 
clear, yellow oil.  
1H NMR (400 MHz, CDCl3) δ 6.97 (d, J = 15.5 Hz, 1H), 6.70 (dd, J = 15.0 and 11.3 Hz, 1H), 
6.38 (d, J = 11.3 Hz, 1H), 6.06 (dd, J = 15.0 and 6.1 Hz, 1H), 5.97 (d, J = 15.5 Hz, 1H), 5.32 
(s, 1H), 4.86 (d, J = 4.6 Hz, 1H), 4.80 (d, J = 5.1 Hz, 1H), 4.24 (dd, J = 6.8 and 5.1 Hz 1H), 
4.16 (d, J = 6.8 Hz, 1H), 3.74 (s, OH), 1.90 (s, 3H), 1.72 (s, 6H), 1.55 (s, 3H), 1.36 (s, 3H), 
0.94 (s, 9H), 0.21 (s, 3H), 0.19 (s, 3H), 0.18 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 163.9 (C), 162.2 (C), 142.5 (CH), 138.2 (CH), 137.9 (CH), 
133.7 (CH), 126.9 (CH), 118.7 (CH), 109.2 (C), 106.4 (C), 103.1 (C), 94.2 (CH), 92.5 (C), 80.3 
(CH), 79.0 (CH), 70.0 (CH), 62.3 (CH), 26.5 (CH3), 25.9 (3 x CH3), 25.3 (CH3), 25.3 (CH3), 
25.2 (CH3), 18.5 (C), 12.5 (CH3), −0.3 (3 x CH3), −4.6 (CH3), −4.9 (CH3); 
IR (KBr) νmax 3467, 2956, 2929, 2858, 1726, 1614, 1383, 1273, 1250, 1210, 1074, 1024, 971, 
842 cm−1; 
MS (ESI, +ve) m/z 613 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: [M+Na]+ 613.2994, C31H50
23NaO7Si requires 613.2993. [M+H]
+ 
591.3179, C31H51O7Si2 requires 591.3173; 
Specific rotation [α]25D = −41.6 (c 0.6, CHCl3). 
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((4S,5R)-2,2-Dimethyl-5-((R)-1-((2-(trimethylsilyl)ethoxy)methoxy)prop-2-yn-1-yl)-1,3-
dioxolan-4-yl)methyl Pivaloate (5.11) 
 
A magnetically stirred solution of alcohol 5.3 (0.65 g, 2.40 mmol), and 4-(N,N-
dimethylamino)pyridine (147 mg, 1.20 mmol) in dichloromethane (20 mL) maintained at 0 °C 
under a nitrogen atmosphere was treated, sequentially, with di-iso-propylethylamine (1.3 mL, 
7.21 mmol) then, dropwise, with 2-(trimethylsilyl)ethoxymethyl chloride (1.3 mL, 7.21 mmol). 
After stirring for a further 30 min, the reaction mixture was heated at reflux for 16 h before 
being cooled to 18 °C and poured into ammonium chloride (20 mL of a saturated aqueous 
solution). The separated aqueous layer was extracted with dichloromethane (3 x 20 mL) and 
the combined organic phases were then washed with brine (1 x 50 mL) before being dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 10:90 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.2) afforded compound 5.11 (800 mg, 83%) 
as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.96 (d, J = 6.9 Hz, 1H), 4.69 (d, J = 6.9 Hz, 1H), 4.50 (partially 
obscured dd, J = 5.9 and 2.1 Hz, 1H), 4.50 (partially obscured ABX, JAB = 11.7 Hz, JAX = 4.2 
Hz, 1H), 4.40 (m, 1H), 4.28 (t, J = 5.9 Hz, 1H), 4.23 (ABX, JAB = 11.7 Hz, JBX = 7.4 Hz, 1H), 
3.71 (td, J = 9.9, 7.0 Hz, 1H), 3.56 (td, J = 9.9, 6.8 Hz, 1H), 2.50 (d, J = 2.1 Hz, 1H), 1.50 (s, 
3H), 1.36 (s, 3H), 1.20 (s, 9H), 0.95–0.90 (complex m, 2H), −0.01 (s, 9H); 
13C NMR (100 MHz, CDCl3) 178.2 (CO), 109.5 (C), 92.5 (CH2), 79.6 (C), 77.9 (CH), 75.9 
(CH), 75.2 (CH), 66.4 (CH2), 65.0 (CH), 62.7 (CH2), 38.8 (C), 27.4 (CH3), 27.3 (3 x CH3), 25.3 
(CH3), 18.2 (CH2), −1.3 (3 x CH3); 
IR (ATR) νmax 3265, 2956, 2895, 1730, 1481, 1371, 1248, 1156, 1022, 834 cm−1; 
MS (ESI, +ve) m/z 423 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 423.2180, C20H36
23NaO6Si requires 423.2179; 
Specific rotation [α]25D = −70.3 (c 1.2, CHCl3). 
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(R)-1-((4R,5S)-5-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(tri-iso-propylsilyl) 
prop-2-yn-1-ol (5.14) 
 
A magnetically stirred solution of iso-propylmagnesium chloride (9.4 mL of a 2.0 M 
solution in tetrahydrofuran, 18.80 mmol) in tetrahydrofuran (5 mL) maintained at 0 °C was 
treated with tri-iso-propylsilylacetylene (4.2 mL, 18.72 mmol). The ensuing mixture was 
stirred for a further 30 min then warmed to 18 °C for 1 h before being cooled to 0 °C and treated 
with a solution of lactol 4.3 (1.00 g, 6.24 mmol) in tetrahydrofuran (10 mL). After 3 h the 
reaction mixture was warmed to 18 ºC and stirred for a further 16 h then treated with 
ammonium chloride (20 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with ethyl acetate (3 x 20 mL) and the combined organic phases were dried over 
magnesium sulfate then filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 20:30:50 v/v/v diethyl 
ether/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) 
afforded compound 5.14 (2.10 g, 98%) as a clear, colourless oil. 
1H NMR (400 MHz, CD3OD) δ 4.49 (d, J = 6.7 Hz, 1H), 4.28 (m, 1H), 4.14 (t, J = 6.7 Hz, 
1H), 3.89 (ABX, JAB = 11.8 Hz, JAX = 4.7 Hz, 1H), 3.79 (ABX, JAB = 11.8 Hz, JBX = 6.7 Hz, 
1H), 1.46 (s, 3H), 1.35 (s, 3H), 1.13–1.07 (complex m, 21H) (signal due to hydroxyl group 
protons not observed); 
13C NMR (100 MHz, CD3OD) δ 109.8 (C), 108.4 (C), 86.8 (C), 80.6 (CH), 79.4 (CH), 62.5 
(CH), 61.5 (CH2), 28.0 (CH3), 25.6 (CH3), 19.0 (6 x CH3), 12.4 (3 x CH); 
IR (KBr) νmax 3368, 2943, 2866, 2173, 1463, 1382, 1245, 1219, 1073, 883 cm−1; 
MS (ESI, +ve) m/z 365 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 365.2125, C18H34O4Si
23Na requires 365.2124; 
Specific rotation [α]25D = +1.9 (c 1.3, CHCl3). 
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((4S,5R)-2,2-Dimethyl-5-((R)-1-(pivaloyloxy)-3-(tri-iso-propylsilyl)prop-2-yn-1-yl)-1,3-
dioxolan-4-yl)methyl Pivalate (5.15), ((4S,5R)-5-((R)-1-Hydroxy-3-(tri-iso-propylsilyl) 
prop-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl Pivalate (5.16), and (R)-1-
((4R,5S)-5-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(tri-iso-propylsilyl)prop-
2-yn-1-yl Pivalate (5.17) 
 
A magnetically stirred solution of diol 5.14 (0.86 g, 2.51 mmol), triethylamine (0.38 
mL, 2.76 mmol) and 4-(N,N-dimethylamino)pyridine (31 mg, 0.25 mmol) in dichloromethane 
(50 mL) maintained at −78 °C was treated with pivaloyl chloride (0.32 mL, 2.63 mmol). The 
ensuing mixture was stirred at −78 °C for a further 1.5 h then poured into ammonium chloride 
(50 mL of a saturated aqueous solution). The separated aqueous layer was extracted with 
dichloromethane (3 x 50 mL) and the combined organic phases were washed with brine (1 x 
100 mL) then dried over magnesium sulfate, filtered and concentrated under reduced pressure. 
The residue thus obtained was subjected to flash chromatography (silica, 20:80 to 30:70 v/v 
diethyl ether/hexane elution) to afford three fractions, A, B, and C. 
Concentration of fraction A (Rf = 0.6 in 20:80 v/v diethyl ether/hexane) afforded 
compound 5.15 (70 mg, 5%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.69 (d, J = 4.4 Hz, 1H), 4.52 (ABX, JAB = 11.6, JAX = 3.2 Hz, 
1H), 4.45 (ddd, J = 8.0, 6.6 and 3.2 Hz, 1H), 4.36 (dd, J = 6.6 and 4.4 Hz, 1H), 4.29 (ABX, JAB 
= 11.6, JBX = 8.0 Hz, 1H), 1.46 (s, 3H), 1.35 (s, 3H), 1.24 (s, 9H), 1.22 (s, 9H), 1.04 (s, 21H); 
13C NMR (100 MHz, CDCl3) δ 178.3 (CO), 176.8 (CO), 109.5 (C), 101.3 (C), 89.4 (C), 77.1 
(CH), 75.7 (CH), 63.8 (CH2), 62.4 (CH), 38.9 (2 x C), 27.6 (CH3), 27.3 (3 x CH3), 27.2 (3 x 
CH3), 25.4 (CH3), 18.6 (6 x CH3), 11.2 (3 x CH); 
IR (ATR) νmax 2960, 2942, 2867, 2180, 1734, 1480, 1462, 1381, 1279, 1131, 882 cm−1; 
MS (ESI, +ve) m/z 533 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 533.3280, C28H50
23NaO6Si requires 533.3274; 
Specific rotation [α]25D = −60.7 (c 1.3, CHCl3). 
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Concentration of fraction B (Rf = 0.4 in 30:70 v/v diethyl ether/hexane) afforded 
compound 5.16 (460 mg, 43%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.51 (t, J = 5.7 Hz, 1H), 4.44 (dd, J = 10.9 and 3.8 Hz, 1H), 
4.37–4.26 (complex m, 2H), 4.18 (t, J = 5.7 Hz, 1H), 2.26 (d, J = 5.7 Hz, OH), 1.44 (s, 3H), 
1.30 (s, 3H), 1.14 (s, 9H), 1.00 (s, 21H); 
13C NMR (100 MHz, CDCl3) δ 178.2 (CO), 109.4 (C), 104.9 (C), 88.7 (C), 79.1 (CH), 75.4 
(CH), 63.0 (CH2), 62.0 (CH), 38.9 (C), 27.6 (CH3), 27.3 (3 x CH3), 25.5 (CH3), 18.7 (6 x CH3), 
11.3 (3 x CH); 
IR (ATR) νmax 3463, 2943, 2866, 2173, 1733, 1481, 1463, 1381, 1284, 1222, 1162, 882 cm−1; 
MS (ESI, +ve) m/z 449 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 449.2702, C23H42
23NaO5Si requires 449.2699; 
Specific rotation [α]25D = −3.7 (c 0.8, CHCl3). 
Concentration of fraction C (Rf = 0.2 in 30:70 v/v diethyl ether/hexane) afforded 
compound 5.17 (460 mg, 43%) as a clear, colourless oil 
1H NMR (400 MHz, CDCl3) δ 5.63 (d, J = 4.5 Hz, 1H), 4.43–4.31 (complex m, 2H), 3.97 (ddd, 
J = 11.9, 8.2 and 3.5 Hz, 1H), 3.86 (ddd, J = 11.9, 7.2 and 4.5 Hz, 1H), 2.00 (dd, J = 8.2 and 
4.5 Hz, OH), 1.47 (s, 3H), 1.37 (s, 3H), 1.22 (s, 9H), 1.05 (s, 21H); 
13C NMR (100 MHz, CDCl3) 176.7 (CO), 109.2 (C), 101.7 (C), 89.2 (C), 78.3 (CH), 77.1 
(CH), 62.7 (CH), 61.8 (CH2), 38.9 (C), 27.6 (CH3), 27.2 (3 x CH3), 25.4 (CH3), 18.6 (6 x CH3), 
11.2 (3 x CH); 
IR (ATR) νmax 3491, 2942, 2866, 2178, 1742, 1463, 1381, 1277, 1138, 1045, 882 cm−1; 
MS (ESI, +ve) m/z 449 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 449.2701, C23H42
23NaO5Si requires 449.2699; 
Specific rotation [α]25D = −62.4 (c 1.2, CHCl3). 
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(R)-1-((4R,5S)-5-((S)-1-Hydroxyprop-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(tri-
iso-propylsilyl)prop-2-yn-1-yl Pivalate (5.18α) and (R)-1-((4R,5S)-5-((R)-1-Hydroxyprop-
2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(tri-iso-propylsilyl)prop-2-yn-1-yl Pivaloate 
(5.18β)  
 
A magnetically stirred solution of alcohol 5.17 (1.00 g, 2.34 mmol) in dichloromethane 
(50 mL) maintained at 0 ºC was treated with the Dess-Martin periodinane (1.99 g, 4.69 mmol) 
and pyridine (0.94 mL, 11.72 mmol). The ensuing mixture was warmed to 18 °C and stirred 
for 3 h then quenched with sodium thiosulfate (25 mL of 10% aqueous solution) and sodium 
hydrogen carbonate (25 mL of a saturated aqueous solution). The resulting slurry was filtered 
through CeliteTM and the separated aqueous layer associated with the filtrate was extracted with 
diethyl ether (3 x 50 mL). The combined organic phases were washed with brine (1 x 50 mL) 
then dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
residue thus obtained was immediately submitted, without purification, to the next step of the 
reaction sequence. 
A magnetically stirred solution of zinc chloride (4.7 mL of 1.0 M solution in diethyl 
ether, 4.70 mmol) maintained at 0 °C was treated with ethynylmagnesium bromide (28.0 mL 
of 0.5 M solution in tetrahydrofuran, 14.00 mmol). The ensuing mixture was cooled to −40 ºC 
and treated with a solution of the aldehyde, formed as described above, in tetrahydrofuran (10 
mL). After 4 h, the reaction mixture was poured into ammonium chloride (50 mL of a saturated 
aqueous solution) and the separated aqueous layer extracted with diethyl ether (3 x 50 mL). 
The combined organic phases were washed with brine (1 x 50 mL) before being dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The resulting light-
yellow oil was subjected to flash chromatography (silica, 20:80 to 30:70 v/v diethyl 
ether/hexane elution) to afford two fractions, A and B. 
Concentration of fraction A (Rf = 0.2(7) in 30:70 v/v diethyl ether/hexane) afforded 
5.18α (0.17 g, 19%) as a clear, colourless oil. 
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1H NMR (400 MHz, CD3OD) δ 5.78 (d, J = 4.6 Hz, 1H), 4.77 (dd, J = 8.2 and 2.1 Hz, 1H), 
4.36 (dd, J = 6.5 and 4.6 Hz, 1H), 4.26 (dd, J = 8.2 and 6.5 Hz, 1H), 2.85 (d, J = 2.1 Hz, 1H), 
1.58 (s, 3H), 1.41 (s, 3H), 1.24 (s, 9H), 1.13–1.10 (complex m, 21H) (signal due to hydroxyl 
group proton not observed); 
13C NMR (100 MHz, CD3OD) δ 178.0 (CO), 110.7 (C), 104.3 (C), 89.2 (C), 84.2 (C), 80.1 
(CH), 78.7 (CH), 74.8 (CH), 64.7 (CH), 61.3 (CH), 39.7 (C), 27.5 (CH3), 27.4 (3 x CH3), 25.23 
(CH3), 19.0 (6 x CH3), 12.4 (3 x CH); 
IR (KBr) νmax 3467, 3313, 3279, 2943, 2867, 2175, 1740, 1463, 1382, 1280, 1217, 1146, 1047, 
882 cm−1; 
MS (ESI, +ve) m/z 473 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 473.2699, C25H42
23NaO5Si requires 473.2699; 
Specific rotation [α]25D = −51.2 (c 1.6, CHCl3). 
Concentration of fraction B (Rf = 0.3(2) in 30:70 v/v diethyl ether/hexane) afforded 
5.18β (0.56 g, 62%) as a clear, colourless oil. 
1H NMR (400 MHz, CD3OD) δ 5.86 (d, J = 4.4 Hz, 1H), 4.71 (dd, J = 7.2 and 2.2 Hz, 1H), 
4.43–4.29 (complex m, 2H), 3.04 (d, J = 2.2 Hz, 1H), 1.60 (s, 3H), 1.43 (s, 3H), 1.25 (s, 9H), 
1.13–1.11 (complex m, 21H) (signal due to hydroxyl group proton not observed); 
13C NMR (100 MHz, CD3OD) δ 178.0 (CO), 110.8 (C), 104.2 (C), 89.4 (C), 82.9 (C), 81.1 
(CH), 78.4 (CH), 76.4 (CH), 64.9 (CH), 61.2 (CH), 39.7 (C), 27.5 (CH3), 27.4 (3 x CH3), 25.3 
(CH3), 19.0 (6 x CH3), 12.3 (3 x CH); 
IR (ATR) νmax 3475, 3313, 3271, 2942, 2866, 2183, 1738, 1462, 1382, 1216, 1120, 1047, 880 
cm−1; 
MS (ESI, +ve) m/z 473 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 473.2694, C25H42
23NaO5Si requires 473.2699. (M+H)
+ 
451.2882, C25H43O5Si requires 451.2880; 
Specific rotation [α]25D = −23.8 (c 1.3, CHCl3).  
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(R)-1-((4R,5S)-5-((R,E)-1-Hydroxy-3-(tributylstannyl)allyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)-3-(tri-iso-propylsilyl)prop-2-yn-1-yl Pivalate (5.20β) 
 
A magnetically stirred solution of bis(triphenylphosphine)palladium(II) dichloride (33 
mg, 0.05 mmol) and terminal alkyne 5.18β (430 mg, 0.95 mmol) in dry dichloromethane (20 
mL) maintained at −78 ºC under an argon atmosphere was treated, dropwise over 2 min, with 
tri-n-butyltin hydride (0.39 mL, 1.43 mmol). The ensuing mixture was stirred at −78 ºC for 30 
min then warmed to 0 ºC and maintained at this temperature for a further 30 min. After being 
warmed to 18 ºC, the reaction mixture was concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica deactivated with 1% triethylamine 
in hexane, 10:90 v/v diethyl ether/hexane elution) to afford two fractions, A and B. 
Concentration of fraction A (Rf = 0.5) afforded compound 5.21β (100 mg, 14%) as a 
clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.90 (s, JH-Sn= 64.2 Hz, 1H), 5.70 (d, J = 5.4 Hz, 1H), 5.35 (s, 
JH-Sn= 31.3 Hz, 1H), 4.54 (dd, J = 5.6 and 4.0 Hz, JH-Sn= 22.0 Hz, 1H), 4.27 (dd, J = 6.6 and 
5.4 Hz, 1H), 4.19 (dd, J = 6.6 and 4.0 Hz, 1H), 2.43 (d, J = 5.6 Hz, OH), 1.56 (s, 3H), 1.50–
1.43 (complex m, 6H), 1.37 (s, 3H), 1.35–1.26 (complex m, 6H), 1.21 (s, 9H), 1.07–1.05 
(complex m, 21H), 0.94–0.86 (complex m, 15H); 
13C NMR (100 MHz, CDCl3) δ 176.5 (CO), 156.8 (C), 126.4 (CH2), 109.0 (C), 102.6 (C), 88.6 
(C), 79.8 (CH), 77.6 (CH), 75.6 (CH), 63.9 (CH), 38.9 (C), 29.2 (3 x CH2), 27.6 (3 x CH2), 
27.1 (3 x CH3), 26.9 (CH3), 25.1 (CH3), 18.7 (6 x CH3), 13.8 (3 x CH3), 11.3 (3 x CH), 10.6 (3 
x CH2). 
Concentration of fraction B (Rf = 0.3) afforded compound 5.20β (450 mg, 63%) as a 
clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 6.38 (d, J = 19.1 Hz, JH-Sn= 33.4 Hz, 1H), 6.04 (dd, J = 19.1 
and 5.7 Hz, JH-Sn= 31.0 Hz, 1H), 5.67 (d, J = 6.0 Hz, 1H), 4.41 (m, 1H), 4.27 (t, J = 6.0 Hz, 
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1H), 4.15 (dd, J = 6.0 and 5.0 Hz, 1H), 2.35 (d, J = 5.0 Hz, OH), 1.56 (s, 3H), 1.52–1.44 
(complex m, 6H), 1.37 (s, 3H), 1.34–1.25 (complex m, 6H), 1.21 (s, 9H), 1.06 (br s, 21H), 
0.92–0.85 (complex m, 15H); 
13C NMR (100 MHz, CDCl3) δ 176.4 (CO), 146.4 (CH), 132.3 (CH), 109.2 (C), 102.5 (C), 
88.6 (C), 79.8 (CH), 77.3 (CH), 72.3 (CH), 63.6 (CH), 38.9 (C), 29.2 (3 x CH2), 27.4 (3 x CH2), 
27.1 (3 x CH3), 27.1 (CH3), 25.3 (CH3), 18.7 (6 x CH3), 13.8 (3 x CH3), 11.3 (3 x CH), 9.6 (3 
x CH2); 
IR (ATR) νmax 3516, 2956, 2926, 2866, 1739, 1463, 1376, 1276, 1215, 1139, 1071, 1045, 881, 
677 cm−1; 
MS (ESI, +ve) m/z 765 [(M+Na)+, 45%], 743 [(M+H)+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 765.3913, C37H70
23NaO5Si
120Sn requires 765.3912. 
(M+H)+ 743.4093, C37H71O5Si
120Sn requires 743.4093; 
Specific rotation [α]25D = −2.0 (c 1.0, CHCl3). 
 
(R)-1-((4R,5S)-5-((S,E)-1-Hydroxy-3-(tributylstannyl)allyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)-3-(tri-iso-propylsilyl)prop-2-yn-1-yl Pivalate (5.20α) 
 
Reaction of terminal alkyne 5.18α with bis(triphenylphosphine)palladium(II) 
dichloride and tri-n-butyltin hydride in the same manner as described immediately above for 
the conversion 5.18β  5.20β afforded a dark-yellow oil on work-up. Subjection of this 
material to flash chromatography (silica, 10:90 v/v diethyl ether/hexane elution) afforded two 
fractions, A and B. 
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Concentration of fraction A (Rf = 0.4) afforded compound 5.21α (15%) as a clear, 
colourless oil.  
1H NMR (400 MHz, CDCl3) δ 5.92 (s, JH-Sn= 65.0 Hz, 1H), 5.81 (d, J = 3.6 Hz, 1H), 5.35 (s, 
JH-Sn= 31.5 Hz, 1H), 4.64 (dd, J = 9.3 and 3.2 Hz, JH-Sn= 24.4 Hz, 1H), 4.34 (dd, J = 6.2 and 
3.6 Hz, 1H), 4.02 (dd, J = 9.3 and 6.2 Hz, 1H), 2.31 (d, J = 3.2 Hz, OH), 1.53–1.51 (complex 
m, 9H), 1.33–1.26 (complex m, 9H), 1.23 (s, 9H), 1.06 (s, 21H), 0.95–0.86 (complex m, 15H); 
13C NMR (100 MHz, CDCl3) δ 176.8 (CO), 155.8 (C), 127.1 (CH2), 109.4 (C), 103.1 (C), 89.2 
(C), 79.3 (CH), 78.3 (CH), 76.3 (CH), 64.5 (CH), 38.9 (C), 29.2 (3 x CH2), 27.6 (3 x CH2), 
27.2 (CH3), 27.2 (3 x CH3), 25.2 (CH3), 18.7 (6 x CH3), 13.8 (3 x CH3), 11.3 (3 x CH), 10.5 (3 
x CH2). 
Concentration of fraction B (Rf = 0.2) afforded compound 5.20α (75%) as a clear, 
colourless oil.  
1H NMR (400 MHz, CDCl3) δ 6.33 (d, J = 19.2 Hz, JH-Sn= 35.2 Hz, 1H), 6.11 (dd, J = 19.2 
and 4.7 Hz, JH-Sn= 30.8 Hz, 1H), 5.80 (d, J = 3.7 Hz, 1H), 4.55 (dt, J = 8.8 and 4.7 Hz, 1H), 
4.32 (dd, J = 6.0 and 3.7 Hz, 1H), 4.01 (dd, J = 8.8 and 6.0 Hz, 1H), 2.14 (d, J = 4.7 Hz, 1H), 
1.58–1.42 (complex m, 9H), 1.35–1.26 (complex m, 9H), 1.22 (s, 9H), 1.06 (s, 21H), 0.92–
0.86 (complex m, 15H); 
13C NMR (100 MHz, CDCl3) δ 176.4 (CO), 146.4 (CH), 132.3 (CH), 109.2 (C), 102.5 (C), 
88.6 (C), 79.8 (CH), 77.3 (CH), 72.3 (CH), 63.6 (CH), 38.9 (C), 29.2 (3 x CH2), 27.4 (3 x CH2), 
27.1 (3 x CH3), 27.1 (CH3), 25.3 (CH3), 18.7 (6 x CH3), 13.8 (3 x CH3), 11.3 (3 x CH), 9.6 (3 
x CH2); 
IR (ATR) νmax 3512, 2957, 2927, 2867, 1741, 1721, 1464, 1379, 1281, 1214, 1147, 1071, 881, 
678 cm−1; 
MS (ESI, +ve) m/z 765 [(M+Na)+, 40%], 743 [(M+H)+, 25], 56 (C4H8
+, 100); 
HRMS (ESI, +ve) Found: (M+Na)+ 765.3914, C37H70
23NaO5Si
120Sn requires 765.3912; 
Specific rotation [α]25D = −36.4 (c 1.6, CHCl3). 
  
Chapter Seven Experimental Procedures Related to Work Described in Chapter Five 
 
 
255 
 
(R)-1-((4R,5S)-5-((R,2E,4E,6E)-7-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-1-hydroxy-5-
methylhepta-2,4,6-trien-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(tri-iso-propylsilyl)prop-
2-yn-1-yl Pivaloate (5.22) 
 
A Schlenk flask was charged with tetra-n-butylammonium diphenylphosphinate (369 
mg, 0.80 mmol) that was melted then cooled to ambient temperature (twice) under high 
vacuum. Thereafter, tetrakis(triphenylphosphine)palladium(0) (33 mg, 0.03 mmol), 
triphenylphosphine (19 mg, 0.06 mmol) and copper thiophene-2-carboxylate (153 mg, 0.80 
mmol) were introduced under an argon atmosphere, followed by addition of a degassed 
solution of stannane 5.20β (425 mg, 0.57 mmol) and alkenyl iodide 3.2 (165 mg, 0.52 mmol) 
in N,N-dimethylformamide (10 mL). After 30 min, the reaction mixture was diluted with 
diethyl ether (10 mL) then quenched with water (10 mL) and filtered through a short pad of 
CeliteTM. The separated aqueous layer was extracted with diethyl ether (3 x 20 mL) and the 
combined organic phases were then washed with water (2 x 20 mL) and brine (1 x 20 mL) 
before being dried over magnesium sulfate, filtered and concentrated under reduced pressure. 
The resulting light-yellow oil was subjected to flash chromatography (silica, 10:30:60 v/v/v 
ethyl acetate/dichloromethane/hexane elution) and concentration of the appropriate fractions 
(Rf = 0.2) afforded compound 5.22 (310 mg, 93%) as a clear, light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.96 (d, J = 15.5 Hz, 1H), 6.77 (dd, J = 15.0 and 11.4 Hz, 1H), 
6.34 (d, J = 11.3 Hz, 1H), 5.99 (d, J = 15.5 Hz, 1H), 5.96 (dd, J = 15.0 and 5.9 Hz, 1H), 5.67 
(d, J = 5.8 Hz, 1H), 5.33 (s, 1H), 4.58 (m, 1H), 4.32 (t, J = 5.8 Hz, 1H), 4.11 (t, J = 5.8 Hz, 
1H), 2.64 (d, J = 3.8 Hz, OH), 1.91 (s, 3H), 1.71 (s, 6H), 1.55 (s, 3H), 1.38 (s, 3H), 1.20 (s, 
9H), 1.05 (s, 21H); 
13C NMR (100 MHz, CDCl3) δ 176.4 (CO), 163.7 (C), 162.1 (CO), 142.2 (CH), 137.0 (CH), 
135.8 (CH), 134.7 (C), 128.3 (CH), 119.2 (CH), 109.4 (C), 106.4 (C), 101.9 (C), 94.5 (CH), 
89.2 (C), 79.8 (CH), 77.2 (CH), 69.5 (CH), 63.0 (CH), 38.9 (C), 27.1 (CH3), 27.0 (3 x CH3), 
25.3 (CH3), 25.2 (2 x CH3), 18.6 (6 x CH3), 12.6 (CH3), 11.2 (3 x CH); 
IR (ATR) νmax 3445, 2960, 2943, 2866, 1724, 1613, 1382, 1273, 1248, 1138, 1025, 972 cm−1; 
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MS (ESI, +ve) m/z 667 [(M+Na)+, 100%], 645 [(M+H)+, 80], 627 [(M−H2O+H)+, 50]; 
HRMS (ESI, +ve) Found: [M+Na]+ 667.3646, C36H56
23NaO8Si requires 667.3642. [M+H]
+ 
645.3829, C36H57O8Si requires 645.3823; 
Specific rotation [α]25D = +27.7 (c 1.1, CHCl3). 
 
(1R)-1-((4R,5S)-5-(1-((4-Methoxybenzyl)oxy)prop-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)-3-(tri-iso-propylsilyl)prop-2-yn-1-yl Pivalate (5.23) 
 
A magnetically stirred solution of alcohol 5.18 (1.00 g, 2.22 mmol) in dichloromethane 
(50 mL) was treated with 2-(4-methoxybenzyloxy)-4-methylquinoline (1.23 g, 4.44 mmol) and 
(+)-10-camphorsulfonic acid (258 mg, 0.23 mmol) and the ensuing mixture was heated at 40 
°C for 16 h. The cooled reaction mixture was concentrated under reduced pressure and the 
residue thus obtained was subjected to flash chromatography (silica, 15:85 v/v diethyl 
ether/hexane elution) to afford, after concentration of the relevant fractions (Rf = 0.3 in 30:70 
v/v diethyl ether/hexane), compound 5.23 (0.95 g, 75%) as a clear, colourless oil and as an 
inseparable (25:75) mixture of α/β epimers. A small fraction of an earlier eluting fraction 
containing a single epimer was used for characterisation.  
1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.73 (d, J = 
3.8 Hz, 1H), 4.74 (d, J = 10.5 Hz, 1H), 4.60 (dt, J = 6.2 and 2.0 Hz, 1H), 4.52 (d, J = 10.5 Hz, 
1H), 4.29–4.24 (complex m, 2H), 3.80 (s, 3H), 2.57 (d, J = 2.0 Hz, 1H), 1.56 (s, 3H), 1.39 (s, 
3H), 1.16 (s, 9H), 1.06–1.04 (complex m, 21H); 
13C NMR (100 MHz, CDCl3) δ 176.4 (C), 159.6 (C), 130.7 (2 x CH), 129.0 (C), 114.0 (2 x 
CH), 109.8 (C), 102.6 (C), 88.7 (C), 80.5 (C), 77.6 (CH), 77.4 (CH), 75.5 (CH), 70.6 (CH2), 
67.2 (CH), 63.1 (CH), 55.4 (CH3), 38.7 (C), 27.3 (CH3), 27.0 (3 x CH3), 25.3 (CH3), 18.7 (6 x 
CH3), 11.3 (3 x CH); 
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IR (ATR) νmax 3274, 2942, 2866, 2178, 1737, 1612, 1515, 1463, 1318, 1250, 1144, 1071, 881 
cm−1; 
MS (ESI, +ve) m/z 593 [(M+Na)+, 85%], 588 [(M+NH4)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 593.3266, C33H50
23NaO6Si requires 593.3274; 
Specific rotation [α]25D = +8.4 (c 1.4, CHCl3). 
 
(1R)-1-((4R,5S)-5-(1-((4-Methoxybenzyl)oxy)prop-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)-3-(tri-iso-propylsilyl)prop-2-yn-1-ol (5.24) 
 
A magnetically stirred solution of pivaloate 5.23 (500 mg, 0.87 mmol) in hexane (20 
mL) maintained at −78 °C was treated, dropwise, with di-iso-butylaluminium hydride (1.8 mL 
of a 1.0 M solution in hexane, 1.80 mmol). After addition was complete, the reaction mixture 
was stirred for 30 min then treated with tartaric acid (20 mL of a 1.0 M aqueous solution) and 
stirring continued at 18 °C for a further 1h. The separated aqueous layer was extracted with 
diethyl ether (3 x 20 mL) and the combined organic phases were then washed with brine (1 x 
20 mL) before being dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 30:70 v/v 
diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) afforded 
compound 5.24 (390 mg, 91%) as a clear, colourless oil and as an inseparable (25:75) mixture 
of α/β epimers. 
1H NMR (400 MHz, CDCl3) δ (α-epimer) 7.30 (partially obscured d, J = 8.6 Hz, 2H), 6.86 
(partially obscured d, J = 8.6 Hz, 2H), 4.80 (partially obscured d, J = 10.7 Hz, 1H), 4.52 
(partially obscured d, J = 10.7 Hz, 1H), 4.49–4.43 (complex m, 2H), 4.26 (m, 2H), 3.80 (s, 3H), 
3.12 (d, J = 5.3 Hz, OH), 2.61 (d, J = 2.0 Hz, 1H), 1.48 (s, 3H), 1.36 (s, 3H), 1.07 (complex 
partially obscured m, 21H); δ (β-epimer) 7.30 (partially obscured d, J = 8.6 Hz, 2H), 6.86 
(partially obscured d, J = 8.6 Hz, 2H), 4.91 (t, J = 6.3 Hz, 1H), 4.80 (partially obscured d, J = 
10.7 Hz, 1H), 4.65 (dd, J = 4.6 and 2.2 Hz, 1H), 4.52 (partially obscured d, J = 10.7 Hz, 1H), 
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4.39–4.32 (complex m, 2H), 3.79 (s, 3H), 3.57 (d, J = 6.4 Hz, OH), 2.63 (d, J = 2.2 Hz, 1H), 
1.54 (s, 3H), 1.36 (s, 3H), 1.07 (complex partially obscured m, 21H); 
 13C NMR (100 MHz, CDCl3) δ (α-epimer)159.9 (C), 130.5 (2 x CH), 128.2 (C), 114.2 (2 x 
CH), 109.6 (C), 105.8 (C), 87.6 (C), 80.3 (CH), 80.2 (C), 77.4 (CH), 75.8 (CH), 70.8 (CH2), 
67.4 (CH), 61.5 (CH), 55.3 (CH3), 27.6 (CH3), 25.3 (CH3), 18.7 (6 x CH3), 11.3 (3 x CH); δ 
(β-epimer) δ 159.8 (C), 130.3 (2 x CH), 128.5 (C), 114.0 (2 x CH), 109.8 (C), 106.1 (C), 87.5 
(C), 79.9 (CH), 79.1 (C), 78.2 (CH), 76.9 (CH), 71.1 (CH2), 67.6 (CH), 61.6 (CH), 55.3 (CH3), 
26.7 (CH3), 25.3 (CH3), 18.7 (6 x CH3), 11.3 (3 x CH); 
IR (ATR) νmax 3451, 3274, 2941, 2865, 2172, 1612, 1514, 1463, 1381, 1248, 1066, 881 cm−1; 
MS (ESI, +ve) m/z 509 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 509.2692, C28H42
23NaO5Si requires 509.2699. 
 
((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yn-8-
yl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl Pivaloate (5.26) 
 
A magnetically stirred solution of alcohol 5.16 (1.58 g, 3.70 mmol), and 4-(N,N-
dimethylamino)pyridine (226 mg, 1.85 mmol) in dichloromethane (30 mL) maintained at 0 °C 
was treated, sequentially, with di-iso-propylethylamine (3.9 mL, 22.23 mmol) then, dropwise, 
with 2-(trimethylsilyl)ethoxymethyl chloride (3.3 mL, 18.5 mmol). After stirring for a further 
30 min, the ensuing mixture was heated at reflux for 16 h before being cooled to 18 °C and 
poured into ammonium chloride (50 mL of a saturated aqueous solution). The separated 
aqueous layer was extracted with dichloromethane (3 x 50 mL) and the combined organic 
phases were washed with brine (1 x 100 mL) before being dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. The residue thus obtained was subjected to 
flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded compound 5.26 (1.90 g, 92%) as a clear, colourless 
oil.  
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1H NMR (400 MHz, CDCl3) δ 5.00 (d, J = 6.9 Hz, 1H), 4.72 (d, J = 6.9 Hz, 1H), 4.61 (d, J = 
4.6 Hz, 1H), 4.50 (dd, J = 11.3 and 4.2 Hz, 1H), 4.40 (td, J = 6.9 and 4.2 Hz, 1H), 4.35–4.25 
(complex m, 2H), 3.74 (td, J = 10.0 and 6.6 Hz, 1H), 3.54 (td, J = 10.0 and 6.6 Hz, 1H), 1.50 
(s, 3H), 1.36 (s, 3H), 1.21 (s, 9H), 1.06 (s, 21H), 0.96–0.91 (complex m, 2H), 0.00 (s, 9H); 
13C NMR (100 MHz, CDCl3) 178.1 (CO), 109.4 (C), 102.7 (C), 92.2 (CH2), 89.7 (C), 78.3 
(CH), 75.3 (CH), 66.2 (CH2), 65.2 (CH), 63.2 (CH2), 38.8 (C), 27.5 (CH3), 27.3 (3 x CH3), 25.4 
(CH3), 18.7 (6 x CH3), 18.2 (CH2), 11.3 (3 x CH), −1.3 (3 x CH3); 
IR (ATR) νmax 2957, 2866, 1732, 1462, 1381, 1248, 1156, 1022, 835 cm−1; 
MS (ESI, +ve) m/z 579 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 579.3512, C29H56
23NaO6Si2 requires 579.3513; 
Specific rotation [α]25D = −73.3 (c 1.2, CHCl3). 
 
((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yn-8-
yl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol (5.27) 
 
 A magnetically stirred solution of pivaloate 5.26 (1.62 g, 2.90 mmol) in hexane (50 mL) 
maintained at −78 °C was treated, dropwise, with di-iso-butylaluminium hydride (5.8 mL of a 
1.0 M solution in hexane, 5.82 mmol). After addition was complete, the reaction mixture was 
stirred for 30 min then treated with tartaric acid (50 mL of a 1.0 M aqueous solution) and 
stirring was continued at 18 °C for a further 1 h. The separated aqueous layer was extracted 
with diethyl ether (3 x 50 mL) and the combined organic phases were then washed with brine 
(1 x 100 mL) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The resulting light-yellow oil was subjected to flash chromatography (silica, 
25:75 v/v diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) 
afforded compound 5.27 (1.3 g, 94%) as a clear, colourless oil. 
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1H NMR (400 MHz, CD3OD) δ 5.02 (d, J = 6.6 Hz, 1H), 4.76 (d, J = 6.6 Hz, 1H), 4.60 (d, J = 
5.5 Hz, 1H), 4.36 (ddd, J = 7.6, 6.6 and 4.1 Hz, 1H), 4.28 (dd, J = 6.6 and 5.5 Hz, 1H), 3.97 
(ABX, JAB = 11.6 Hz, JAX = 4.1 Hz, 1H), 3.83 (partially obscured ABX, JAB = 11.6 Hz, JBX = 
7.6 Hz, 1H), 3.80 (partially obscured m, 1H), 3.65 (td, J = 9.1 and 7.4 Hz, 1H), 1.51 (s, 3H), 
1.38 (s, 3H), 1.14 (s, 3H), 1.13 (s, 18 H), 1.00–0.96 (complex m, 2H), 0.06 (s, 9H) (signal due 
to hydroxyl group proton not observed); 
13C NMR (100 MHz, CD3OD) δ 109.9 (C), 104.8 (C), 93.4 (CH2), 89.9 (C), 79.6 (CH), 79.4 
(CH), 67.2 (CH2), 66.8 (CH), 61.8 (CH2), 27.9 (CH3), 25.5 (CH3), 19.1 (6 x CH3), 18.9 (CH2), 
12.4 (3 x CH), −1.2 (3 x CH3); 
IR (ATR) νmax 3505, 2944, 2866, 2171, 1463, 1381, 1249, 1027, 836 cm−1; 
MS (ESI, +ve) m/z 495 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 495.2936, C24H48
23NaO5Si2 requires 495.2938; 
Specific rotation [α]25D = −76.7 (c 1.2, CHCl3). 
 
1-((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yn-
8-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-yn-1-ol (5.28) 
Method A 
 
A magnetically stirred solution of alcohol 5.27 (647 mg, 1.36 mmol) in 
dichloromethane (30 mL) maintained at 0 ºC was treated with the Dess-Martin periodinane 
(1.16 g, 2.72 mmol) and pyridine (0.55 mL, 6.84 mmol). The ensuing mixture was warmed to 
18 °C and stirred for 3 h then quenched by addition of a mixture of sodium thiosulfate (15 mL 
of a 10% aqueous solution) and sodium hydrogen carbonate (15 mL of a saturated aqueous 
solution). The resulting slurry was filtered through CeliteTM and the separated aqueous layer 
associated with the filtrate was extracted with diethyl ether (3 x 50 mL). The combined organic 
phases were washed with brine (1 x 30 mL) then dried over magnesium sulfate, filtered and 
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concentrated under reduced pressure. The residue thus obtained was immediately submitted, 
without purification, to the next step of the reaction sequence.  
A magnetically stirred solution of zinc chloride (2.55 mL of 1.0 M solution in diethyl 
ether, 2.55 mmol) maintained at 0 °C was treated with ethynylmagnesium bromide (15.3 mL 
of a 0.5 M solution in tetrahydrofuran, 7.65 mmol). The ensuing solution was cooled to −40 ºC 
and treated with a solution of aldehyde, formed as described above, in tetrahydrofuran (10 mL). 
After 4 h, the reaction mixture was poured into ammonium chloride (50 mL of a saturated 
aqueous solution) and the separated aqueous layer was extracted with diethyl ether (3 x 50 mL). 
The combined organic phases were washed with brine (1 x 50 mL) before being dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The resulting light-
yellow oil was subjected to flash chromatography (silica, 20:80 v/v diethyl ether/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.3) gave compound 5.28 (490 mg, 
72% over 2 steps) as a clear, colourless oil and as an inseparable (25:75) mixture of α/β epimers. 
1H NMR (400 MHz, CD3OD) δ (α-epimer) 5.05 (d, J = 6.7 Hz, 1H), 4.92 (d, J = 4.6, 1H), 4.85 
(partially obscured m, 1H), 4.77 (d, J = 6.7 Hz, 1H), 4.37–4.26 (complex partially obscured m, 
2H), 3.89 (partially obscured m, 1H), 3.66 (partially obscured m, 1H), 2.88 (d, J = 2.1 Hz, 1H), 
1.58 (s, 3H), 1.41 (s, 3H), 1.16 (br s, 21H), 0.95–0.89 (complex m, 2H), 0.07 (s, 9H) (signal 
due to hydroxyl group proton not observed); δ (β-epimer)5.04 (d, J = 6.7 Hz, 1H), 4.94 (d, J = 
4.2 Hz, 1H), 4.82 (dd, J = 6.6 and 2.1 Hz, 1H), 4.78 (d, J = 6.7 Hz, 1H), 4.37–4.26 (complex 
partially obscured m, 2H), 3.89 (partially obscured m, 1H), 3.66 (partially obscured m, 1H), 
2.98 (d, J = 2.1 Hz, 1H), 1.58 (s, 3H), 1.42 (s, 3H), 1.15 (br s, 21H), 1.00–0.97 (complex m, 
2H), 0.07 (s, 9H) (signal due to hydroxyl group proton not observed); 
 13C NMR (100 MHz, CD3OD) δ (α-epimer) 110.5 (C), 105.0 (C), 93.0 (CH2), 90.3 (C), 84.4 
(C), 80.3 (CH), 79.7 (CH), 74.9 (CH), 67.0(7) (CH2), 66.5(0) (CH), 61.5 (CH), 27.2(6) (CH3), 
25.1(7) (CH3), 19.1 (6 x CH3), 18.9 (CH2), 12.4 (3 x CH), −1.2 (3 x CH3); δ (β-epimer) 110.6 
(C), 104.8 (C), 93.1 (CH2), 90.5 (C), 83.3 (C), 81.2 (CH), 79.5 (CH), 75.7 (CH), 67.1(5) (CH2), 
66.5(5) (CH), 61.4 (CH), 27.3(0) (CH3), 25.2 (CH3), 19.1 (6 x CH3), 18.9 (CH2), 12.4 (3 x CH), 
−1.2 (3 x CH3); IR (ATR) νmax 3471, 3313, 2944, 2866, 2176, 1463, 1381, 1249, 1025, 835 
cm−1; 
MS (ESI, +ve) m/z 519 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 519.2938, C26H48
23NaO5Si2 requires 519.2938. 
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Method B 
 
A magnetically stirred solution of oxalyl chloride (0.40 mL, 4.65 mmol) in 
dichloromethane (20 mL) maintained at −78 oC was treated with dimethyl sulfoxide (0.60 mL, 
8.46 mmol). The ensuing mixture was stirred for 30 min, then treated with the solution of 
alcohol 5.27 (1.00 g, 2.11 mmol) in dichloromethane (10 mL). The resulting mixture was 
stirred at −78 °C for another 30 min then treated with triethylamine (1.8 mL, 12.69 mmol) 
before being warmed to 0 °C and stirred for 1 h. The reaction mixture was quenched with water 
(50 mL) and the separated aqueous layer was extracted with dichloromethane (3 x 50 mL). The 
combined organic phases were washed with brine (1 x 100 mL) then dried over magnesium 
sulfate, concentrated under reduced pressure. The residue thus obtained was used, without 
purification, in the next step of the reaction sequence. 
A magnetically stirred solution of aldehyde, formed as described above, in 
tetrahydrofuran (50 mL) maintained at −15 °C was treated with ethynylmagnesium bromide 
(8.5 mL of 0.5 M solution in tetrahydrofuran, 4.23 mmol). The ensuing mixture was stirred for 
a further 1 h then poured into ammonium chloride (50 mL of a saturated aqueous solution). 
The separated aqueous layer was extracted with diethyl ether (3 x 50 mL) and the combined 
organic phases were then washed with brine (1 x 50 mL) before being dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The resulting light-yellow oil was 
subjected to flash chromatography (silica, 20:80 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) gave compound 5.28 (1.00 g, 95% over 2 
steps) as a clear, colourless oil and as an inseparable (30:70) mixture of α/β epimers. This 
material was identical, in all respects, with that obtained by method A. 
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(8R)-11,11-Di-iso-propyl-8-((4R,5S)-5-(1-((4-methoxybenzyl)oxy)prop-2-yn-1-yl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yne (5.25) 
Method A 
 
A magnetically stirred solution of alcohol 5.28 (1.00 g, 2.01 mmol) in dry 
tetrahydrofuran (25 mL) maintained at 0 °C was treated with sodium hydride (402 mg of 60% 
w/w dispersion in mineral oil, 10.06 mmol). The ensuing mixture was warmed to 18 °C and 
stirred at this temperature for a further 30 min then treated with p-methoxybenzyl chloride 
(0.57 mL, 5.03 mmol) and tetra-n-butyl ammonium iodide (372 mg, 1.01 mmol). After 16 h, 
the reaction mixture was quenched by dropwise addition of water (until no more gas evolution 
observed) then ammonium chloride (30 mL of a saturated aqueous solution). The separated 
aqueous layer was extracted with diethyl ether (3 x 30 mL) and the combined organic phases 
were then washed with brine (1 x 50 mL) before being dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 15:85 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 5.25 (920 mg, 74%) as a clear, colourless 
oil and as an inseparable (30:70) mixture of α/β epimers.  
1H NMR (400 MHz, CDCl3) δ (α-epimer) 7.32 (partially obscured d, J = 8.6 Hz, 2H), 6.86 
(partially obscured d, J = 8.6 Hz, 2H), 5.02 (d, J = 6.9 Hz, 1H), 4.87 (d, J = 3.8 Hz, 1H), 4.85 
(partially obscured m, 1H), 4.75 (d, J = 11.4 Hz, 1H), 4.72 (d, J = 6.9 Hz, 1H), 4.46 (partially 
obscured m, 1H), 4.39–4.29 (complex partially obscured m, 2H), 3.79 (s, 3H), 3.68 (partially 
obscured m, 1H), 3.51 (partially obscured m, 1H), 2.57 (d, J = 2.0 Hz, 1H), 1.58 (s, 3H), 1.39 
(s, 3H), 1.12–0.98 (complex partially obscured m, 21H), 0.98–0.80 (complex partially obscured 
m, 2H), −0.02 (s, 9H); δ (β-epimer) 7.32 (partially obscured d, J = 8.6 Hz, 2H), 6.86 (partially 
obscured d, J = 8.6 Hz, 2H), 4.97 (d, J = 6.9 Hz, 1H), 4.87 (d, J = 3.8 Hz, 1H), 4.76 (d, J = 11.4 
Hz, 1H), 4.72 (d, J = 6.9 Hz, 1H), 4.63 (dd, J = 8.1 and 2.0 Hz, 1H), 4.57 (d, J = 11.4 Hz, 1H), 
4.49–4.42 (complex partially obscured m, 1H), 4.39–4.29 (complex partially obscured m, 1H), 
3.79 (s, 3H), 3.68 (partially obscured m, 1H), 3.51 (partially obscured m, 1H), 2.56 (d, J = 2.0 
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Hz, 1H), 1.58 (s, 3H), 1.39 (s, 3H), 1.12–0.98 (complex partially obscured m, 21H), 0.98–0.80 
(complex partially obscured m, 2H), 0.01 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (α-epimer)159.6 (C), 130.4 (2 x CH), 129.2 (C), 114.0 (2 x 
CH), 109.8 (C), 103.1 (C), 91.7 (CH2), 90.0 (C), 80.9 (C), 78.6 (CH), 77.3 (CH), 75.12 (CH), 
70.7 (CH2), 67.7 (CH), 65.6 (CH2), 64.8 (CH), 55.3 (CH3), 26.9 (CH3), 24.8 (CH3), 18.7 (6 x 
CH3), 18.2 (CH2), 11.4 (3 x CH), −1.3 (3 x CH3); δ (β-epimer) 159.4 (C), 129.7(1) (2 x CH), 
129.7(0) (C), 113.8 (2 x CH), 110.2 (C), 103.2 (C), 91.9 (CH2), 89.9 (C), 80.1 (C), 78.7 (CH), 
78.5 (CH), 76.3 (CH), 70.7 (CH2), 67.5 (CH), 65.9 (CH2), 65.2 (CH), 55.3 (CH3), 26.9 (CH3), 
25.2 (CH3), 18.7 (6 x CH3), 18.3 (CH2), 11.3 (3 x CH), −1.3 (3 x CH3);  
IR (ATR) νmax 3310, 2943, 2865, 2172, 1613, 1514, 1380, 1248, 1027, 860, 834 cm−1; 
MS (ESI, +ve) m/z 639 [(M+Na)+, 100%], 634 [(M+NH4)
+, 50]; 
HRMS (ESI, +ve) Found: (M+Na)+ 639.3515, C34H56
23NaO6Si2 requires 639.3513. 
Method B 
 
A magnetically stirred solution of alcohol 5.24 (0.90 g, 1.85 mmol), and 4-(N,N-
dimethylamino)pyridine (113 mg, 0.92 mmol) in dichloromethane (20 mL) maintained at 0 °C 
was treated, sequentially, with di-iso-propylethylamine (1.9 mL, 11.09 mmol) then, dropwise, 
with 2-(trimethylsilyl)ethoxymethyl chloride (1.6 mL, 9.25 mmol). After stirring for a further 
30 min, the reaction mixture was heated at reflux for 16 h before being cooled to 18 °C and 
poured into ammonium chloride (30 mL of a saturated aqueous solution). The separated 
aqueous layer was extracted with dichloromethane (3 x 30 mL) and the combined organic 
phases were then washed with brine (1 x 50 mL) before being dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. The residue thus obtained was subjected to 
flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded compound 5.25 (1.00 g, 88%) as a clear, colourless oil 
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and as an inseparable (25:75) mixture of α/β epimers. This material was identical, in all 
respects, with that obtained by method A. 
 
(R)-11,11-Di-iso-propyl-8-((4R,5S)-5-((S,E)-1-((4-methoxybenzyl)oxy)-3-(tributylstan-
nyl)allyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-
yne (5.29α) and (R)-11,11-Di-iso-propyl-8-((4R,5S)-5-((R,E)-1-((4-methoxybenzyl)oxy)-3-
(tributylstannyl)allyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,12-trimethyl-5,7-dioxa-2,11-
disilatridec-9-yne (5.29β) 
 
A magnetically stirred solution of bis(triphenylphosphine)palladium(II) dichloride (20 
mg, 0.028 mmol) and compound 5.25 (350 mg, 0.57 mmol) in dry dichloromethane (15 mL) 
maintained at −78 ºC under an argon atmosphere was treated, dropwise over 2 min, with tri-n-
butyltin hydride (0.33 mL, 1.13 mmol). The ensuing mixture was stirred for 30 min at −78 ºC 
then warmed to 0 ºC and maintained at this temperature for a further 30 min. After being 
warmed to 18 ºC, the reaction mixture was concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica deactivated with 1% triethylamine 
in hexane, 10:90 v/v diethylether/hexane elution) and thus affording two fractions, A and B. 
Concentration of fractions A (Rf = 0.3) afforded 5.29β (270 mg, 52%) as a clear, 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 6.41 (d, J = 
19.2 Hz, JH-Sn= 35.9 Hz, 1H), 6.06 (dd, J = 19.2 and 7.0 Hz, JH-Sn= 29.5 Hz, 1H), 4.94 (d, J = 
6.8 Hz, 1H), 4.71 (d, J = 6.8 Hz, 1H), 4.63 (d, J = 5.0 Hz, 1H), 4.52 (ABq, ∆ δAB = 0.09, JAB = 
11.4 Hz, 2H), 4.27–4.24 (complex m, 2H), 4.19 (m, 1H), 3.79 (s, 3H), 3.67 (td, J = 10.4 and 
6.1 Hz, 1H), 3.53 (td, J = 10.4 and 6.1 Hz, 1H), 1.58 (s, 3H), 1.55–1.47 (complex m, 6H), 1.38 
(s, 3H), 1.36–1.27 (complex m, 6H), 1.10–1.07 (complex m, 21H), 0.94–0.87 (complex m, 
17H), 0.00 (s, 9H); 
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13C NMR (100 MHz, CDCl3) δ 159.0 (C), 144.6 (CH), 135.8 (CH), 131.1 (C), 129.2 (2 x CH), 
113.7 (2 x CH), 109.1 (C), 103.9 (C), 92.0 (CH2), 89.2 (C), 81.2 (CH), 79.6 (CH), 78.3 (CH), 
69.9 (CH2), 66.0 (CH and CH2), 55.3 (CH3), 29.3 (3 x CH2), 27.4 (3 x CH2), 27.0 (CH3), 25.4 
(CH3), 18.8 (6 x CH3), 18.2 (CH2), 13.9 (3 x CH3), 11.4 (3 x CH), 9.7 (3 x CH2), −1.3 (3 x 
CH3); 
IR (ATR) νmax 2955, 2926, 2866, 1614, 1514, 1464, 1377, 1248, 1025, 860, 835 cm−1; 
MS (ESI, +ve) m/z 931 (120Sn) [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 931.4731, C46H84
23NaO6Si2
120Sn requires 931.4726. 
(M+H)+ 909.4905, C46H85O6Si2
120Sn requires 909.4907; 
Specific rotation [α]25D = −21.5 (c 1.7, CHCl3). 
Concentration of fractions B (Rf = 0.2) afforded 5.29α (100 mg, 19%) as a clear, 
colourless oil.  
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 6.43–6.13 (d, 
J = 19.1 Hz, JH-Sn= 35.9 Hz, 1H), 6.02–5.74 (dd, J = 19.1 and 7.0 Hz, JH-Sn= 31.0 Hz, 1H), 5.07 
(d, J = 7.0 Hz, 1H), 4.90 (d, J = 1.9 Hz, 1H), 4.74 (d, J = 7.0 Hz, 1H), 4.45 (partially obscured 
m, 1H), 4.38 (ABq, ∆ δAB = 0.15, JAB = 10.3 Hz, 2H), 4.36 (dd, J = 7.2 and 2.0 Hz, 1H), 4.15 
(dd, J = 9.3 and 7.2 Hz, 1H), 3.78 (s, 3H), 3.69 (ddd, J = 11.5, 10.0 and 5.7 Hz, 1H), 3.50 (ddd, 
J = 11.5, 10.0 and 5.7 Hz, 1H), 1.57–1.50 (complex m, 9H), 1.35–1.30 (complex m, 9H), 1.10 
(br s, 21H), 0.95–0.88 (complex m, 17H), −0.20 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 159.4 (C), 145.8 (CH), 134.1 (CH), 130.2 (C), 130.1 (2 x CH), 
114.0 (2 x CH), 109.2 (C), 103.8 (C), 91.6 (CH2), 89.5 (C), 81.0 (CH), 79.2 (CH), 77.7 (CH), 
69.9 (CH2), 65.5 (CH2), 65.4 (CH), 55.3 (CH3), 29.3 (3 x CH2), 27.3 (3 x CH2), 26.9 (CH3), 
24.9 (CH3), 18.8 (6 x CH3), 18.2 (CH2), 13.9 (3 x CH3), 11.5 (3 x CH), 9.8 (3 x CH2), −1.3 (3 
x CH3); 
IR (ATR) νmax 2954, 2926, 2866, 1613, 1515, 1464, 1378, 1249, 1031, 860, 835 cm−1; 
MS (ESI, +ve) m/z 931 [(M+Na)+, 50%], 926 [(M+NH4)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 931.4709, C46H84
23NaO6Si2
120Sn requires 931.4726; 
Specific rotation [α]25D = −50.5 (c 1.0, CHCl3). 
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6-((R,1E,3E,5E)-7-((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-
disilatridec-9-yn-8-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-7-((4-methoxybenzyl)oxy)-3-
methylhepta-1,3,5-trien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one (5.30) 
 
A Schlenk flask was charged with tetra-n-butylammonium diphenylphosphinate (262 
mg, 0.57 mmol). This was melted then cooled to ambient temperature (twice) under high 
vacuum. Thereafter, tetrakis(triphenylphosphine)palladium(0) (23 mg, 0.02 mmol), copper 
thiophene-2-carboxylate (109 mg, 0.57 mmol) and triphenylphosphine (10.7 mg, 0.04mmol) 
were introduced under an argon atmosphere, followed by addition of a degassed solution of 
stannane 5.29β (370 mg, 0.41 mmol) and alkenyl iodide 3.2 (117 mg, 0.37 mmol) in N,N-
dimethylformamide (10 mL). After 30 min, the reaction mixture was diluted with diethyl ether 
(20 mL) then quenched with water (10 mL) and filtered through a short pad of CeliteTM. The 
separated aqueous layer associated with the filtrate was extracted with diethyl ether (3 x 20 
mL) and the combined organic phases were washed with water (2 x 30) and brine (1 x 20 mL) 
then dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
resulting yellow oil was subjected to flash chromatography (silica, 10:30:60 v/v/v diethyl 
ether/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 0.1) 
afforded compound 5.30 (260 mg, 87%) as a clear, light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.6 Hz, 2H), 6.97 (d, J = 15.5 Hz, 1H), 6.85 (d, J = 
8.6 Hz, 2H), 6.73 (dd, J = 15.2 and 11.3 Hz, 1H), 6.37 (d, J = 11.3 Hz, 1H), 6.03 (d, J = 15.5 
Hz, 1H), 5.91 (dd, J = 15.2 and 7.7 Hz, 1H), 5.35 (s, 1H), 4.95 (d, J = 6.7 Hz, 1H), 4.69 (d, J 
= 6.7 Hz, 1H), 4.63 (d, J = 5.0 Hz, 1H), 4.51 (ABq, ∆ δAB = 0.02, JAB = 11.4 Hz, 2H), 4.45 (t, 
J = 7.7 Hz, 1H), 4.27 (t, J = 6.8 Hz, 1H), 4.19 (dd, J = 6.8 and 5.0 Hz, 1H), 3.79 (s, 3H), 3.60 
(ddd, J = 11.1, 9.9 and 5.8 Hz, 1H), 3.55 (ddd, J = 11.1, 9.9 and 5.8 Hz, 1H), 1.9 1(s, 3H), 1.72 
(s, 3H), 1.71 (s, 3H), 1.58 (s, 3H), 1.38 (s, 3H), 1.12–1.05 (complex m, 21H), 0.89–0.73 
(complex m, 2H), −0.04 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 163.6 (C), 162.0 (C), 159.2 (C), 141.9 (CH), 136.6 (CH), 135.1 
(C), 134.2 (CH), 130.7 (C), 130.5 (CH), 129.2 (2 x CH), 119.6 (CH), 113.8 (2 x CH), 109.4 
(C), 106.4 (C), 103.4 (C), 94.7 (CH), 91.9 (CH2), 89.8 (C), 79.7 (CH), 78.2 (CH), 78.0 (CH), 
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70.6 (CH2), 66.0 (CH2), 65.4 (CH), 55.3 (CH3), 27.0 (CH3), 25.3 (CH3), 25.2 (2 x CH3), 18.7 
(6 x CH3), 18.2 (CH2), 12.6 (CH3), 11.3 (3 x CH), −1.3 (3 x CH3); 
IR (ATR) νmax 2944, 2865, 1725, 1613, 1514, 1380, 1248, 1024, 836 cm−1; 
MS (ESI, +ve) m/z 833 [(M+Na)+, 50%], 828 [(M+NH4)
+, 70], 811 [(M+H)+, 65], 82 
[C3H8O+Na)
+, 90], 55 [(CH3OH+Na)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 833.4465, C45H70
23NaO9Si2 requires 833.4456. (M+H)
+ 
811.4634, C45H71O9Si2 requires 811.4637; 
Specific rotation [α]25D = +38.0 (c 1.1, CHCl3). 
 
6-((R,1E,3E,5E)-7-((4S,5R)-5-((R)-3-Bromo-1-((2-(trimethylsilyl)ethoxy)methoxy)prop-
2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-7-((4-methoxybenzyl)oxy)-3-methylhepta-
1,3,5-trien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one (5.34) 
 
A magnetically stirred solution of alkyne 5.30 (58 mg, 0.07 mmol) in acetonitrile (3 
mL) was treated, sequentially, with N-bromosuccinimide (15 mg, 0.08 mmol) then silver 
fluoride (11 mg, 0.08 mmol). The ensuing mixture was protected from light and stirred for 4 h 
at ambient temperatures then filtered through a pad of CeliteTM that was washed with ether (1 
x 10 mL). The combined filtrates were washed with water (1 x 10 mL) then dried over 
magnesium sulfate and concentrated under reduced pressure. The resulting yellow oil was 
subjected to flash chromatography (silica, 50:50 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.2) afforded compound 5.34 (35 mg, 67%) as 
a clear, light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 8.7 Hz, 2H), 6.97 (d, J = 15.5 Hz, 1H), 6.88 (d, J = 
8.6 Hz, 2H), 6.65 (dd, J = 15.2 and 11.3 Hz, 1H), 6.36 (d, J = 11.3 Hz, 1H), 6.04 (d, J = 15.5 
Hz, 1H), 5.86 (dd, J = 15.2 and 7.1 Hz, 1H), 5.36 (s, 1H), 4.85 (d, J = 6.9 Hz, 1H), 4.65 (d, J 
= 6.9 Hz, 1H), 4.60 (d, J = 11.8 Hz, 1H), 4.52 (d, J = 4.9 Hz, 1H), 4.49 (d, J = 11.8 Hz, 1H), 
4.28 (complex m, 2H), 4.18 (m, 1H), 3.80 (s, 3H), 3.56 (ddd, J = 11.3, 9.7 and 5.8 Hz, 1H), 
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3.49 (ddd, J = 11.3, 9.7 and 5.8 Hz, 1H), 1.93 (s, 3H), 1.73 (s, 3H), 1.72 (s, 3H), 1.58 (s, 3H), 
1.41 (s, 3H), 0.86–0.76 (complex m, 2H), −0.03 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 163.6 (C), 162.1 (C), 159.2 (C), 141.9 (CH), 136.5 (CH), 135.3 
(C), 133.9 (CH), 130.9 (C), 130.3 (CH), 129.3 (2 x CH), 119.8 (CH), 113.9 (2 x CH), 109.9 
(C), 106.5 (C), 94.8 (CH), 92.5 (CH2), 79.5 (CH), 78.4 (CH), 77.4 (CH), 76.6 (C), 70.2 (CH2), 
66.2 (CH), 66.1 (CH2), 55.4 (CH3), 47.7 (C), 26.9 (CH3), 25.5 (CH3), 25.3 (CH3), 25.2 (CH3), 
18.2 (CH2), 12.7 (CH3), −1.3 (3 x CH3); 
IR (ATR) νmax 2992, 2942, 1723, 1612, 1514, 1380, 1248, 1023, 836 cm−1; 
MS (ESI, +ve) m/z 805 and 803 [(M+CH3OH+K)
+, both 40%], 757 and 755 [(M+Na)+, both 
100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 757.2207, C36H49
81Br23NaO9Si requires 757.2206. 
(M+Na)+ 755.2220, C36H49
79Br23NaO9Si requires 755.2227; 
Specific rotation [α]25D = −1.0 (c 1.0, CHCl3). 
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tert-Butyl(((R,3E,5E,7E)-10,10-dibromo-2,8-dimethyldeca-3,5,7,9-tetraen-1-
yl)oxy)diphenylsilane (5.35) 
 
A magnetically stirred solution of carbon tetrabromide (554 mg, 1.67 mmol) in dry 
dichloromethane (10 mL) maintained at 0 °C was treated with triphenylphosphine (877 mg, 
3.34 mmol). After 15 min, the ensuing mixture was slowly treated with a solution of aldehyde 
4.39 (350 mg, 0.84 mmol) in dry dichloromethane (10 mL). The reaction mixture was stirred 
for 15 min then warmed to 18 °C and maintained at this temperature for a further 30 min. The 
reaction solvent was removed by evaporation and the residue was filtered through a pad of 
TLC-grade silica gel that was eluted with diethyl ether/hexane (2 x 30 mL of 1:4 v/v mixture). 
The combined filtrates were concentrated under reduced pressure to give the compound 5.35 
(400 mg, 83%) as a clear, yellow oil (Rf = 0.6 in 5:95 v/v diethyl ether/hexane). This material 
was used, without purification, in the next step of reaction sequence. 
1H NMR (400 MHz, CDCl3) δ 7.68–7.66 (complex m, 4H), 7.45–7.37 (complex m, 6H), 7.05 
(s, 1H), 6.40 (dd, J = 14.3 and 10.6 Hz, 1H), 6.32 (dd, J = 14.3 and 10.0 Hz, 1H), 6.26 (d, J = 
10.6 Hz, 1H), 6.17 (dd, J = 15.2 and 10.0 Hz, 1H), 5.77 (dd, J = 15.2 and 7.4 Hz, 1H), 3.59 
(ABX, JAB = 9.7, JAX = 6.3 Hz, 1H), 3.54 (ABX, JAB = 9.7, JBX = 6.6 Hz, 1H), 2.48 (hept, J = 
6.5 Hz, 1H), 2.08 (s, 3H), 1.08 (s, 9H), 1.07 (d, J = 6.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 140.9 (CH), 139.4 (CH), 136.0 (CH), 135.8 (2 x CH), 135.8 (2 
x CH), 134.7 (CH), 134.0 (C), 134.0 (C), 132.2 (C), 130.4 (CH), 129.7 (2 x CH), 127.7 (4 x 
CH), 126.6 (CH), 85.9 (C), 68.5 (CH2), 39.8 (CH), 27.0 (3 x CH3), 19.5 (C), 16.6 (CH3), 15.6 
(CH3); 
IR (KBr) νmax 3028, 2959, 2930, 2857, 1471, 1427, 1112, 987, 701 cm−1; 
MS (EI, +ve, 70 eV) m/z 519 [(M−HBr+Na)+•, 30%], 517 (60), 515 (30), 239 (35), 199 (80), 
135 (100); 
HRMS (EI, +ve, 70 eV) Found: M+• 576.0692, C28H34
81Br2OSi requires 576.0705. M
+• 
574.0714, C28H34
79Br81BrOSi requires 574.0725. M+• 572.0741, C28H34
79Br2OSi requires 
572.0746; 
Specific rotation [α]25D = +1.6 (c 1.6, CHCl3).  
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(R,3E,5E,7E)-10-Bromo-2,8-dimethyldeca-3,5,7-trien-9-yn-1-ol (5.36) 
 
A magnetically stirred solution of silyl ether 5.35 (350 mg, 0.61 mmol) in 
tetrahydrofuran (10 mL) was treated with tetra-n-butylammonium fluoride (3.3 mL of 1.0 M 
solution in tetrahydrofuran, 3.30 mmol). After 6 h, the reaction mixture was quenched with 
ammonium chloride (10 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (3 x 10 mL) and the combined organic phases were dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 10:30:60 v/v/v diethyl 
ether/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) 
afforded alcohol 5.36 (130 mg, 84%) as a clear, yellow oil. As the compound was found to be 
unstable, only the following data were acquired on it. 
1H NMR (400 MHz, CDCl3) δ 6.48–6.31 (complex m, 2H), 6.31–6.15 (complex m, 2H), 5.68 
(dd, J = 14.5 and 7.9 Hz, 1H), 3.53 (ABX, JAB = 10.5, JAX = 5.6 Hz, 1H), 3.47 (ABX, JAB = 
10.5, JBX = 6.1 Hz, 1H), 2.44 (hept, J = 6.6 Hz, 1H), 2.08 (s, 3H), 1.47 (br s, OH), 1.04 (d, J = 
6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 138.7 (CH), 137.1 (CH), 134.6 (CH), 131.4 (CH), 127.0 (CH), 
118.0 (C), 84.0 (C), 67.4 (CH2), 49.5 (C), 40.0 (CH), 17.4 (CH3), 16.4 (CH3); 
IR (KBr) νmax 3367, 3026, 2960, 2923, 2872, 2175, 1602, 1455, 1382, 1031, 987 cm−1; 
MS (EI, +ve, 70 eV) m/z 254 and 256 (M+•, both 20%), 223 and 225 (both 18%), 199 (100), 
129 (70). 
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(R,E)-tert-Butyl((4-iodo-2-methylbut-3-en-1-yl)oxy)diphenylsilane (5.40) 
 
A magnetically stirred solution of chromium chloride (1.03 g, 8.42 mmol), dispensed 
in a glove box, in dry tetrahydrofuran (20 mL) maintained at 18 ºC under an argon atmosphere 
was slowly treated, via cannula, with a solution of aldehyde 4.20 (500 mg, 1.53 mmol) and 
iodoform (1.50 g, 3.82 mmol) in dry tetrahydrofuran (20 mL). The ensuing mixture was stirred 
for 16 h then filtered through a pad of CeliteTM. Water/diethyl ether (60 mL of a 1:1 v/v mixture) 
was added to the filtrate and the separated aqueous layer was extracted with diethyl ether (3 x 
50 mL). The combined organic phases were dried over magnesium sulfate, then filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 2.5:97.5 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.5) afforded the alkenyl iodide 5.40
145 (470 mg, 68%) as a clear, 
light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.55–7.52 (complex m, 4H), 7.30–7.24 (complex m, 6H), 6.37 
(dd, J = 14.5 and 7.6 Hz, 1H), 5.93 (d, J = 14.5 Hz, 1H), 3.39 (d, J = 6.3 Hz, 2H), 2.29 (hept, 
J = 6.8 Hz, 1H), 0.94 (s, 9H), 0.88 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 149.2 (CH), 135.8 (2 x CH), 135.7 (2 x CH), 133.8 (C), 133.7 
(C), 129.8 (2 x CH), 127.8 (4 x CH), 75.4 (CH), 67.7 (CH2), 43.2 (CH), 27.0 (3 x CH3), 19.4 
(C), 15.7 (CH3); 
IR (ATR) νmax 2959, 2930, 2857, 1471, 1427, 1110, 1084, 823, 738, 699 cm−1; 
MS (ESI, +ve) m/z 473 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 473.0777, C21H27
127I23NaOSi requires 473.0774; 
Specific rotation [α]25D = +10.6 (c 0.8, CHCl3). 
These data matched those reported previously.145 
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(R,E)-4-Iodo-2-methylbut-3-en-1-ol (5.41) 
 
A magnetically stirred solution of silyl ether 5.40 (470 mg, 1.04 mmol) in 
tetrahydrofuran (10 mL) was treated with tetra-n-butylammonium fluoride (1.6 mL of 1.0 M 
solution in tetrahydrofuran, 1.60 mmol). After 2 h, the reaction mixture was quenched with 
ammonium chloride (10 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (3 x 10 mL) and the combined organic phases were dried over 
magnesium sulfate before being filtered and concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica, 30:70 v/v diethyl ether/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.2) afforded alcohol 5.41
146 (195 
mg, 88%) as a clear, light-pink oil. 
1H NMR (400 MHz, CDCl3) δ 6.46 (dd, J = 14.5 and 7.9 Hz, 1H), 6.15 (dd, J = 14.5 and 1.1 
Hz, 1H), 3.50 (ABX, JAB = 10.6, JAX = 5.8, 1H), 3.46 (ABX, JAB = 10.6, JBX = 7.3 Hz, 1H), 
2.40 (hept, J = 6.8 Hz, 1H), 1.57 (br s, OH), 1.02 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 148.6 (CH), 76.1 (CH), 66.6 (CH2), 43.5 (CH), 15.7 (CH3). 
These data matched those reported previously.146 The following additional data were acquired 
on this compound. 
IR (ATR) νmax 3325, 2959, 2927, 2871, 1603, 1455, 1379, 1229, 1181, 1031, 947 cm−1; 
MS (EI, +ve, 70 eV) m/z 212 (M+•, 25%), 199 (50), 181 (95), 85 (82), 55 (100); 
HRMS (EI, +ve, 70 eV) Found: M+• 211.9709, C5H9
127IO requires 211.9698; 
Specific rotation [α]25D = +24.7 (c 0.7, CHCl3). 
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(R,E)-N-(4-Iodo-2-methylbut-3-en-1-yl)-N-(4-methoxybenzyl)-2-
nitrobenzenesulfonamide (5.38) 
 
A magnetically stirred solution of alcohol 5.41 (300 mg, 1.41 mmol) and N-(4-
methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 (730 mg, 2.26 mmol) in tetrahydrofuran (20 
mL) maintained at 0 °C was treated, sequentially, with triphenylphosphine (482 mg, 1.84 
mmol) then di-iso-propyl azodicarboxylate (0.36 mL, 1.84 mmol). The ensuing mixture was 
warmed to 18 °C and stirred at this temperature for 16 h then concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 50:50 v/v 
diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) afforded 
compound 5.38 (660 mg, 90%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 7.6 Hz, 1H), 7.75–7.61 (complex m, 3H), 7.13 (d, 
J = 8.6 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.15 (dd, J = 14.4 and 8.3 Hz, 1H), 5.96 (d, J = 14.4 
Hz, 1H), 4.44 (ABq, ∆ δAB = 0.09, JAB = 15.3 Hz, 2H), 3.79 (s, 3H), 3.15 (d, J = 7.8 Hz, 2H), 
2.41 (hept, J = 6.8 Hz, 1H), 0.86 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 159.5 (C), 148.1 (CH), 148.0 (C), 133.9 (C), 133.7 (CH), 131.9 
(CH), 131.1 (CH), 129.9 (2 x CH), 127.0 (C), 124.6 (CH), 114.3 (2 x CH), 76.5 (CH), 55.4 
(CH3), 51.8 (CH2), 51.3 (CH2), 39.3 (CH), 17.0 (CH3); 
IR (KBr) νmax 2963, 2931, 1611, 1540, 1512, 1455, 1342, 1245, 1160, 1027, 910, 728 cm−1; 
MS (ESI, +ve) m/z 539 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 539.0112, C19H21
127IN2
23NaO5S requires 539.0114; 
Specific rotation [α]25D = +23.7 (c 1.1, CHCl3). 
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1-(2,4-Dinitrophenyl)-3-methylpyridin-1-ium chloride (5.42) 
 
A magnetically stirred solution of 3-methylpyridine (2.00 mL, 20.55 mmol) in acetone 
(20 mL) was treated, in one portion, with 2,4-dinitrochlorobenzene (4.12 g, 20.35 mmol). The 
ensuing mixture was heated to 60 °C for 30 h then the reaction solvent was removed under 
vacuum. The solid associated with the residue was removed by filtration and washed several 
times (hexane) to afford pyridinium salt 5.42147 (5.50 g, 90%) as a purple powder. 
1H NMR [400 MHz, (CD3)2SO] δ 9.32 (s, 1H), 9.24 (d, J = 6.2 Hz, 1H), 9.11 (d, J = 2.6 Hz, 
1H), 8.95 (dd, J = 8.7, 2.6 Hz, 1H), 8.79 (d, J = 8.2 Hz, 1H), 8.40 (d, J = 8.7 Hz, 1H), 8.32 (dd, 
J = 8.2, 6.2 Hz, 1H), 2.59 (s, 3H). 
These data matched those reported previously.147 The following additional data were acquired 
on this compound.  
13C NMR [100 MHz, (CD3)2SO] δ 149.6 (C), 149.5 (CH), 145.7 (CH), 143.7 (CH), 143.4 (C), 
139.4 (CH), 139.1 (C), 132.3 (CH), 130.7 (CH), 127.8 (CH), 122.0 (CH), 18.4 (CH3); 
IR (ATR) νmax 3392, 2916, 1603, 1531, 1342, 1123, 1084, 834, 818 cm−1; 
MS (ESI, +ve) m/z 260 [(M–Cl–)+, 100%], 214 [(M–Cl––NO2)+, 50]; 
HRMS (ESI, +ve) Found: (M–Cl–)+ 260.0672, C12H10N3O4 requires 260.0671; 
Melting point 187–189 °C. 
  
Chapter Seven Experimental Procedures Related to Work Described in Chapter Five 
 
 
276 
 
(2E,4E)-5-(Dimethylamino)-2-methylpenta-2,4-dienal (5.43) 
 
A magnetically stirred solution of pyridinium salt 5.42 (1.00 g, 3.38 mmol) in ethanol 
(20 mL) was treated, dropwise, with dimethylamine (0.95 mL of a 40% w/w solution in water, 
8.46 mmol). The ensuing mixture was heated to 78 °C for 1 h and solvent then removed, under 
reduced pressure from the cooled reaction mixture. The residue thus obtained was dissolved in 
sodium hydroxide (20 mL of a 4 M aqueous solution) and the ensuing solution transferred to a 
separatory funnel containing dichloromethane (20 mL). The separated aqueous layer was 
extracted with dichloromethane (3 x 20 mL) and the combined organic phases were dried over 
magnesium sulfate then filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, diethyl ether elution) and concentration 
of the appropriate fractions (Rf = 0.2) afforded aldehyde 5.43
147 (0.45 g, 96%) as a yellow, 
crystalline solid. 
1H NMR (400 MHz, CDCl3) δ 9.12 (s, 1H), 6.80 (d, J = 12.1 Hz, 1H), 6.73 (d, J = 12.1, Hz, 
1H), 5.20 (t, J = 12.1 Hz, 1H), 2.91 (s, 6H), 1.71 (s, 3H). 
These data matched those reported previously147 The following additional data were acquired 
on this compound. 
13C NMR (100 MHz, CDCl3) δ 192.6 (CO), 153.7 (CH), 151.5 (CH), 125.7 (C), 94.9 (CH), 
40.8 (2 x CH3), 9.1 (CH3); 
IR (ATR) νmax 3467, 2910, 1547, 1375, 1221, 1180, 1102, 998, 817 cm−1; 
MS (ESI, +ve) m/z 162 [(M+Na)+, 100%], 140 [(M+H)+, 95]; 
HRMS (ESI, +ve) Found: (M+H)+ 140.1071, C8H14NO requires 140.1075; 
Melting point 74 °C. 
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(2E,4E)-2-Methyl-5-(tributylstannyl)penta-2,4-dienal (5.39) 
 
A magnetically stirred solution of di-iso-propylamine (0.42 mL, 3.02 mmol) and 
tetrahydrofuran (10 mL) maintained at 0 °C was treated, dropwise, with n-butyllithium (2.60 
mL of a 1.3 M solution in hexane, 2.60 mmol). After 5 min, tri-n-butyltin hydride (0.64 mL, 
2.38 mmol) was introduced, and the ensuing mixture was stirred for a further 10 min before 
being treated, dropwise, with a solution of aldehyde 5.43 (0.30 g, 2.15 mmol) in tetrahydrofuran 
(2 mL). The reaction mixture was then warmed to 18 °C and treated with acetyl chloride (0.46 
mL, 6.46 mmol). After stirring for 10 min, sodium hydrogen carbonate (20 mL of a saturated 
aqueous solution) was added to the reaction mixture and stirring was continued for a further 15 
min. The separated aqueous layer was extracted with dichloromethane (3 x 20 mL) and the 
combined organic phases were dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
3:97 v/v diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.4) 
afforded the title compound 5.39147 (500 mg, 60%) as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 9.45 (s, 1H), 7.14-6.90 (complex m, 2H), 6.74 (dd, J = 9.2 and 
0.9 Hz, 1H), 1.88 (s, 3H), 1.62–1.47 (complex m, 6H), 1.42–1.25 (complex m, 6H), 1.08-0.94 
(complex m, 6H), 0.90 (t, J = 7.3 Hz, 9H). 
These data matched those reported previously.147 The following additional data were acquired 
on this compound. 
13C NMR (100 MHz, CDCl3) δ 195.8 (CO), 150.3 (CH), 149.8 (CH), 141.5 (CH), 135.9 (C), 
29.2 (3 x CH2), 27.4 (3 x CH2), 13.8 (3 x CH3), 9.9 (3 x CH2), 9.6 (CH3); 
IR (ATR) νmax 2955, 2923, 2852, 1675, 1619, 1463, 1395, 1377, 1354, 1237, 1159, 997 cm−1; 
MS (ESI, +ve) m/z 450 [(M+CH3CN+Na)
+, 100%], 441 [(M+CH3OH+Na)
+, 80], 409 
[(M+Na)+, 85], 387 [(M+H)+, 20]; 
HRMS (ESI, +ve) Found: (M+H)+ 387.1711, C18H35O
120Sn requires 387.1710. 
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N-((R,3E,5E,7E)-2,8-Dimethyl-9-oxonona-3,5,7-trien-1-yl)-N-(4-methoxybenzyl)-2-
nitrobenzenesulfonamide (5.37) 
 
A Schlenk flask was charged with tetra-n-butylammonium diphenylphosphinate (593 
mg, 1.29 mmol) that was melted then cooled to ambient temperature (twice) under high 
vacuum. Thereafter, tetrakis(triphenylphosphine)palladium(0) (53 mg, 0.05 mmol), 
triphenylphosphine (25 mg, 0.09 mmol) and copper thiophene-2-carboxylate (246 mg, 1.29 
mmol) were introduced under an argon atmosphere, followed by addition of a degassed 
solution of stannane 5.39 (355 mg, 0.92 mmol) and alkenyl iodide 5.38 (452 mg, 0.87 mmol) 
in N,N-dimethylformamide (10 mL). After 30 min, the reaction mixture was diluted with 
diethyl ether (20 mL) then quenched with water (10 mL) and filtered through a short pad of 
CeliteTM. The separated aqueous layer was extracted with diethyl ether (3 x 20 mL) and the 
combined organic phases were then washed with water (2 x 20) and brine (1 x 20 mL) before 
being dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
resulting light-yellow oil was subjected to flash chromatography (silica, 10:30:60 v/v/v ethyl 
acetate/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 
0.3) afforded compound 5.37 (370 mg, 87%) as a clear, light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 9.44 (s, CHO), 7.97 (d, J = 7.7 Hz, 1H), 7.74–7.57 (complex 
m, 3H), 7.12 (d, J = 8.6 Hz, 2H), 6.81 (partially obscured d, J = 8.6 Hz, 3H), 6.51 (dd, J = 14.8 
and 11.1 Hz, 1H), 6.40 (dd, J = 14.8 and 10.5 Hz, 1H), 6.07 (dd, J = 15.2 and 10.5 Hz, 1H), 
5.63 (dd, J = 15.2 and 8.2 Hz, 1H), 4.45 (ABq, ∆ δAB = 0.07, JAB = 15.4 Hz, 2H), 3.78 (s, 3H), 
3.23 (ABX, JAB = 14.6, JAX = 8.3 Hz, 1H), 3.18 (ABX, JAB = 14.6, JBX = 7.0 Hz, 1H), 2.50 
(hept, J = 6.7 Hz, 1H), 1.85 (s, 3H), 0.91 (d, J = 6.7 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 194.7 (CO), 159.6 (C), 148.6 (CH), 148.0 (C), 142.3 (CH), 
141.2 (CH), 137.5 (C), 134.0 (C), 133.5 (CH), 131.7 (CH), 131.2 (CH), 130.6 (CH), 129.9 (2 
x CH), 127.1 (C), 126.4 (CH), 124.4 (CH), 114.2 (2 x CH), 55.4 (CH3), 52.7 (CH2), 51.3 (CH2), 
36.0 (CH), 17.6 (CH3), 9.6 (CH3); 
IR (KBr) νmax 2970, 2930, 1666, 1610, 1542, 1513, 1352, 1248, 1161, 1004 cm−1; 
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MS (ESI, +ve) m/z 507 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 507.1555, C25H28N2
23NaO6S requires 507.1566; 
Specific rotation [α]25D = +9.4 (c 3.5, CHCl3). 
 
N-((R,3E,5E,7E)-10,10-Dibromo-2,8-dimethyldeca-3,5,7,9-tetraen-1-yl)-N-(4-
methoxybenzyl)-2-nitrobenzenesulfonamide (5.44) 
 
A magnetically stirred solution of carbon tetrabromide (137 mg, 0.41 mmol) in dry 
dichloromethane (5 mL) maintained at 0 °C was treated with triphenyl phosphine (217 mg, 
0.83 mmol). After 15 min, the ensuing mixture was slowly treated with a solution of aldehyde 
5.37 (100 mg, 0.21 mmol) in dry dichloromethane (5 mL). The reaction mixture was stirred for 
15 min then warmed to 18 °C and maintained at this temperature for a further 30 min. The 
reaction solvent was removed by evaporation and the residue thus obtained was filtered through 
a pad of TLC-grade silica gel that was eluted with diethyl ether/hexane (2 x 30 mL of a 1:1 v/v 
mixture). The combined filtrates were concentrated under reduced pressure to give compound 
5.44 (119 mg, 90%) as a clear, light-yellow oil (Rf = 0.3 in 50:50 v/v diethyl ether/hexane). 
This material was used, without purification, in the next step of reaction sequence. 
1H NMR [400 MHz, (CD3)2CO] δ 8.09 (dd, J = 7.8 and 1.2 Hz, 1H), 7.93–7.81 (complex m, 
3H), 7.25 (d, J = 8.7 Hz, 2H), 7.19 (s, 1H), 6.89 (d, J = 8.7 Hz, 2H), 6.42 (dd, J = 13.6 and 11.4 
Hz, 1H), 6.33 (d, J = 11.4 Hz, 1H), 6.15 (dd, J = 13.6 and 10.8 Hz, 1H), 6.06 (dd, J = 14.5 and 
10.4 Hz, 1H), 5.46 (dd, J = 14.5 and 8.3 Hz, 1H), 4.52 (ABq, ∆ δAB = 0.10, JAB = 15.3 Hz, 2H), 
3.79 (s, 3H), 3.23 (ABX, JAB = 14.4, JAX = 8.4 Hz, 1H), 3.18 (ABX, JAB = 14.4, JBX = 7.3 Hz, 
1H), 2.50 (hept, J = 6.7 Hz, 1H), 2.07 (s, 3H), 0.86 (d, J = 6.7 Hz, 3H); 
13C NMR [100 MHz, (CD3)2CO] δ 160.4 (C), 148.9 (C), 141.9 (CH), 139.1 (CH), 136.7 (CH), 
135.8 (CH), 134.9 (CH), 134.2 (C), 133.1 (C), 132.9 (CH), 131.9 (CH), 131.5 (CH), 130.7 (2 
x CH), 128.6 (CH), 127.7 (CH), 125.2 (CH), 114.8 (2 x CH), 85.9 (C), 55.5 (CH3), 53.3 (CH2), 
51.5 (CH2), 36.3 (CH), 17.8 (CH3), 15.5 (CH3); 
IR (KBr) νmax 2962, 2929, 1611, 1542, 1512, 1359, 1248, 1161, 1027, 989, 777 cm−1; 
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MS (ESI, +ve) m/z 663 [(M+Na)+, 40%], 658 [(M+NH4)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 664.9962, C26H28
81Br2N2
23NaO5S requires 664.9942. 
(M+Na)+ 662.9957, C26H28
79Br81Br23NaN2O5S requires 662.9963. (M+Na)
+ 660.9964, 
C26H28
79Br2
23NaN2O5S requires 660.9983; 
Specific rotation [α]25D = +3.5 (c 1.7, CHCl3). 
 
(E)-3-(Tributylstannyl)but-2-en-1-ol (5.47) 
 
A magnetically stirred solution of copper cyanide (2.39 g, 26.70 mmol) in 
tetrahydrofuran (100 mL) maintained at –78 °C was treated with n-butyllithium (35.7 mL of a 
1.5 M solution in hexane, 53.55 mmol). After 5 min, the reaction mixture was warmed to 
−40 °C and stirred for a further 10 min. The by now almost clear solution was cooled to −78 °C 
and tri-n-butyltin hydride (14.3 mL, 53.55 mmol) was added, dropwise, resulting in an 
immediate formation of a turbid yellow solution. Evolution of gas was also observed. After 
stirring for an additional 10 min at −78 °C, the reaction mixture was warmed to −40 °C for 5 
min giving an almost clear golden-yellow solution. The reaction mixture was then re-cooled to 
−78 °C before being treated with methanol (60 mL, 1.47 mol) while maintaining vigorous 
stirring. After a further 10 min, the reaction mixure was warmed to −40 °C and stirring was 
continued for an additional 15 min to afford a clear, red coloured solution. The reaction mixture 
was then treated with 2-butynol (1.00 g, 13.40 mmol) before being warmed to −10 °C and 
stirred at this temperature for 1 h. The reaction mixture was then quenched with methanol (20 
mL), ammonium chloride (40 mL of a saturated solution) and ammonium hydroxide (40 mL 
of a 30% aqueous solution). Stirring was then continued for a further 20 min. The separated 
aqueous layer was extracted with diethyl ether (3 x 100 mL) and the combined organic phases 
were dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 10:90 v/v ethyl 
acetate/hexane with 1% triethylamine elution) and concentration of the appropriate fractions 
(Rf = 0.2) afforded alcohol 5.47
148 (4.50 g, 93%) as a clear, colourless oil. 
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1H NMR (400 MHz, CDCl3) δ 5.74 (ddd, J = 7.8, 4.2 and 1.8 Hz, JH-Sn= 32.9 Hz, 1H), 4.24 (t, 
J = 5.6 Hz, 2H), 1.88 (s, JH-Sn= 22.1 Hz, 3H), 1.54–1.43 (complex m, 6H), 1.30 (dd, J = 14.7 
and 7.3 Hz, 7H), 0.91–0.86 (complex m, 15H); 
13C NMR (100 MHz, CDCl3) δ 142.7 (C), 139.5 (CH), 59.1 (CH2), 29.3 (3 x CH2), 27.6 (3 x 
CH2), 19.6 (CH3), 13.9 (3 x CH2), 9.3 (3 x CH3); 
IR (KBr) νmax 3308, 2956, 2924, 2872, 2853, 1464, 1376, 1059, 1002 cm−1; 
MS (ESI, +ve) m/z 385 [(M+Na)+, 12%], 179 [(M−C12H25O+H)+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 385.1527, C16H34
23NaO120Sn requires 385.1529. 
These data matched those reported previously.148 
 
(E)-3-Iodobut-2-en-1-ol (5.48) 
 
A magnetically stirred solution of alkenyl tin 5.47 (2.00 g, 5.53 mmol) in 
tetrahydrofuran (30 mL) maintained at −78 °C was treated, dropwise over 10 min via an 
addition funnel, with a solution of iodine (1.69 g, 6.64 mmol) in tetrahydrofuran (10 mL). After 
addition was complete, the reaction mixture was warmed to 18 °C and stirrred for a further 30 
min at this temperature then quenched with a mixture of sodium thiosulfate (30 mL of a 
saturated aqueous solution) and sodium bicarbonate (20 mL of a saturated aqueous solution). 
The separated aqueous layer was extracted with diethyl ether (3 x 30 mL) and the combined 
organic phases were treated with potassium fluoride (50 mL of a 10% aqueous solution). The 
resuling mixture was vigorously stirred for 30 min before being filtered through CeliteTM. The 
separated aqueous layer associated with the filtrate was extracted with diethyl ether (3 x 30 
mL) and the combined organic phases were dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 40:60 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded alkenyl iodide 5.48
149 (1.10 g, quant.) as a clear, light-
yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.35 (t, J = 6.9 Hz, 1H), 4.04 (t, J = 6.9 Hz, 2H), 2.53 (s, 1H), 
2.53 (s, 3H); 
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13C NMR (100 MHz, CDCl3) δ 139.8 (CH), 98.5 (C), 59.8 (CH2), 28.2 (CH3); 
IR (KBr) νmax 3304, 2916, 1636, 1424, 1376, 1219, 1099, 1059, 1002 cm−1; 
MS (EI, +ve, 70 eV) m/z 198 [(M+•, 70%], 155 (40), 121 (100); 
HRMS (EI, +ve, 70 eV) Found: M+• 197.9543, C4H7
127IO requires 197.9542. 
These data matched those reported previously.149  
 
(E)-3-Methyl-5-(trimethylsilyl)pent-2-en-4-yn-1-ol (5.49) 
 
A magnetically stirred solution of alkenyl iodide 5.48 (1.00 g, 5.05 mmol), 
tetrakis(triphenylphosphine)palladium(0) (292 mg, 0.25 mmol), triphenylphosphine (132 mg, 
0.50 mmol) and copper iodide (96 mg, 0.50 mmol) in N,N-dimethylformamide (20 mL) 
maintained under an argon atmosphere was treated with diethyl-iso-propylamine (1.8 mL, 
10.10 mmol). The ensuing mixture was cooled to 0 °C, flushed with argon for a further 10 min 
then treated with ethynyltrimethylsilane (1.07 mL, 7.57 mmol). The ensuing mixture was 
warmed to 18 °C and stirred at this temperature for 16 h before being quenched with ammonium 
chloride (20 mL of a saturated aqueous solution). The separated aqueous layer was extracted 
with diethyl ether (3 x 25 mL) and the combined organic phases were then washed with water 
(2 x 25 mL) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
10:30:60 v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded alkyne iodide 5.49
150 (690 mg, 81%) as a clear, 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ 6.03 (td, J = 6.8 and 1.4 Hz, 1H), 4.19 (d, J = 6.8 Hz, 2H), 1.81 
(s, 3H), 1.72 (s, OH), 0.17 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 136.6 (CH), 120.8 (C), 107.5 (C), 92.3 (C), 59.2 (CH2), 17.5 
(CH3), 0.1 (3 x CH3); 
IR (KBr) νmax 3307, 2959, 2145, 1630, 1409, 1377, 1249, 1009, 842 cm−1; 
These data matched those reported previously.150  
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(E)-Diethyl (3-methyl-5-(trimethylsilyl)pent-2-en-4-yn-1-yl)phosphonate (5.46) 
 
A magnetically stirred solution of alcohol 5.49 (750 mg, 4.46 mmol) and carbon 
tetrabromide (1.63 g, 4.90 mmol) in dichloromethane (10 mL) maintained at 0 °C was treated 
with triphenylphosphine (1.29 g, 4.90 mmol). The ensuing mixture was warmed to 18 °C and 
stirring was continued for 2 h. The reaction solvent was removed under reduced pressure and 
the residue thus obtained filtered through a pad of TLC-grade silica gel that was eluted with 
diethyl ether/hexane (30 mL of a 3:7 v/v mixture). The combined filtrates were concentrated 
under reduced pressure to afford the anticipated bromide that was used, without purification, 
in the next step of the reaction sequence. NMR spectral data were recorded on the bromide. 
1H NMR (400 MHz, CDCl3) δ 6.13 (m, 1H), 4.00 (d, J = 8.7 Hz, 2H), 1.87 (d, J = 1.5 Hz, 3H), 
0.18 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 132.5 (CH), 124.3 (C), 106.8 (C), 94.9 (C), 27.4 (CH2), 17.1 
(CH3), 0.04 (3 x CH3)]; 
 The bromide, formed as described above, was treated with triethyl phosphite (0.96 mL, 
5.00 mmol) and the resulting mixture was heated to 110 ºC for 2 h. After cooling to 18 ºC the 
residue was subjected to flash chromatography (silica, ethyl acetate elution) and concentration 
of the appropriate fractions (Rf = 0.4) afforded phosphonate 5.46 (1.10 g, 95%) as a clear, 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.83 (m, 1H), 4.17–3.91 (complex m, 4H), 2.57 (dd, J = 23.1 
and 8.2 Hz, 2H), 1.76 (d, J = 3.6 Hz, 3H), 1.26 (t, J = 7.1 Hz, 6H), 0.11 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 126.8 (d, J = 12.3 Hz, CH), 122.3 (d, J = 15.6 Hz, C), 107.4 
(d, J = 5.9 Hz, C), 91.9 (d, J = 2.8 Hz, C), 62.1(7) (CH2), 62.1(0) (CH2), 27.3 (d, J = 141.0 
Hz, CH2–PO), 17.5 (d, J = 2.6 Hz, CH3), 16.5(8) (CH3), 16.5(2) (CH3), 0.1 (3 x CH3); 
31P NMR (162 MHz, CDCl3) δ 26.2 (PO); 
IR (KBr) νmax 3468, 2961, 2904, 2146, 1444, 1392, 1250, 1163, 1050, 1027, 964, 842 cm−1; 
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MS (ESI, +ve) m/z 311 [(M+Na)+, 100%], 289 [(M+H)+, 30]; 
HRMS (ESI, +ve) Found: (M+Na)+ 311.1211, C13H25
23NaO3PSi requires 311.1208. (M+H)
+ 
289.1389, C13H26O3PSi requires 289.1389. 
 
(R,3E,5E,7E)-2,8-Dimethyldeca-3,5,7-trien-9-yn-1-ol (5.50) 
 
A magnetically stirred solution of phosphonate 5.46 (736 mg, 2.55 mmol) in dry 
tetrahydrofuran (20 mL) maintained at –78 °C under a nitrogen atmosphere was treated with 
lithium bis(trimethylsilyl)amide (2.38 mL of a 1.0 M solution in tetrahydrofuran, 2.38 mmol). 
The ensuing mixture was stirred at this temperature for 1 h then treated with a solution of 
aldehyde 4.14 (600 mg, 1.70 mmol) in dry tetrahydrofuran (10 mL). After 30 min, the reaction 
mixture was warmed to 18 °C, stirred at this temperature for a further 3.5 h then quenched with 
ammonium chloride (50 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (2 x 30 mL) and the combined organic phases were dried over 
magnesium sulfate then filtered and concentrated under reduced pressure. The residue thus 
obtained was dissolved in tetrahydrofuran (20 mL) and the resulting solution was treated with 
tetra-n-butylammonium fluoride (2.9 mL of a 1.0 M solution in tetrahydrofuran, 2.90 mmol). 
After 2 h the reaction mixture was quenched with ammonium chloride (20 mL of a saturated 
aqueous solution) and the separated aqueous layer extracted with diethyl ether (3 x 20 mL). 
The combined organic phases were dried over magnesium sulfate before being filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 40:60 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded alcohol 5.50 (180 mg, 60%) as a clear, colourless oil 
and as an inseparable (90:10) mixture of E/Z isomers. 
1H NMR (400 MHz, CDCl3) δ 6.46 (dd, J = 11.2 and 1.1 Hz, 1H), 6.37 (dd, J = 13.6 and 11.2 
Hz, 1H), 6.29–6.16 (complex m, 2H), 5.67 (dd, J = 14.4 and 7.9 Hz, 1H), 3.52 (dd, J = 10.5 
and 5.7 Hz, 1H), 3.45 (dd, J = 10.5 and 7.3 Hz, 1H), 2.99 (s, 1H), 2.45 (m, 1H), 1.91 (s, 3H), 
1.54 (s, OH), 1.03 (d, J = 6.8 Hz, 3H). 
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13C NMR (100 MHz, CDCl3) δ 138.6 (CH), 137.2 (CH), 134.6 (CH), 131.3 (CH), 127.0 (CH), 
117.4 (C), 87.7 (C), 77.2 (CH), 67.4 (CH2), 40.0 (CH), 17.5 (CH3), 16.4 (CH3); 
IR (KBr) νmax 3367, 3296, 3027, 2961, 2925, 2873, 2084, 1605, 1454, 1031, 988 cm−1; 
Specific rotation [α]25D = +34.5 (c 1.1, CHCl3). 
 
N-((R,3E,5E,7E)-2,8-Dimethyldeca-3,5,7-trien-9-yn-1-yl)-N-(4-methoxybenzyl)-2-
nitrobenzenesulfonamide (5.33) 
 
A magnetically stirred solution of alcohol 5.50 (120 mg, 0.68 mmol) and N-(4-
methoxybenzyl)-2-nitrobenzenesulfonamide 4.28 (329 mg, 1.02 mmol) in tetrahydrofuran (10 
mL) maintained at 0 °C was treated, sequentially, with triphenylphosphine (232 mg, 0.88 
mmol) then di-iso-propyl azodicarboxylate (0.17 mL, 0.88 mmol). The ensuing mixture was 
warmed to 18 °C and stirred at this temperature for 16 h before being concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
3:30:67 v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) afforded sulfonamide 5.33 (230 mg, 70%) as a clear, light-
yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.97 (m, 1H), 7.73–7.58 (complex m, 3H), 7.14 (d, J = 8.6 Hz, 
2H), 6.82 (d, J = 8.6 Hz, 2H), 6.39 (d, J = 11.6 Hz, 1H), 6.27 (dd, J = 13.8 and 11.6 Hz, 1H), 
6.04–5.88 (complex m, 2H), 5.34 (dd, J = 14.3 and 8.2 Hz, 1H), 4.48 (ABq, ∆ δAB = 0.17, JAB 
= 15.4 Hz, 2H), 3.79 (s, 3H), 3.16 (d, J = 7.6 Hz, 2H), 3.01 (s, 1H), 2.47 (m, 1H), 1.91 (s, 3H), 
0.87 (d, J = 6.7 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 159.5 (C), 147.9 (C), 138.3 (CH), 137.1 (CH), 134.5 (CH), 
134.3 (C), 133.4 (CH), 131.7 (CH), 131.2 (CH), 130.9 (CH), 129.9 (2 x CH), 127.3 (C), 126.9 
(CH), 124.4 (CH), 117.5 (C), 114.2 (2 x CH), 87.7 (C), 77.3 (CH), 55.4 (CH3), 52.4 (CH2), 
50.9 (CH2), 35.6 (CH), 17.8 (CH3), 17.6 (CH3); 
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IR (KBr) νmax 3289, 2930, 2083, 1611, 1543, 1513, 1455, 1371, 1248, 1162, 990 cm−1; 
MS (ESI, +ve) m/z 503 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 503.1619, C26H28N2
23NaO5S requires 503.1617; 
Specific rotation [α]25D = +13.4 (c 1.2, CHCl3). 
 
(R,3E,5E,7E)-N-(4-Methoxybenzyl)-2,8-dimethyldeca-3,5,7-trien-9-yn-1-amine (5.51) 
 
 A magnetically stirred solution of 4-chlorothiophenol (90 mg, 0.62 mmol) in 
tetrahydrofuran (2 mL) was treated with 1,8-diazabicyclo[5.4.0]undec-7-ene (124 µL, 0.62 
mmol). After 15 min, the reaction mixture was treated, dropwise, with a solution of 
sulfonamide 5.33 (150 mg, 0.31 mmol) in tetrahydrofuran (3 mL) and stirring was the 
continued for 4 h before it was concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, ethyl acetate elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded amine 5.51 (70 mg, 76%) as a clear, light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 6.46 (dd, J = 
11.2 and 1.6 Hz, 1H), 6.34 (dd, J = 13.9 and 11.2 Hz, 1H), 6.29–6.11 (complex m, 2H), 5.65 
(dd, J = 14.5 and 7.6 Hz, 1H), 3.80 (s, 3H), 3.72 (d, J = 3.3 Hz, 2H), 2.98 (s, 1H), 2.62–2.40 
(complex m, 3H), 1.91 (s, 3H), 1.03 (d, J = 6.4 Hz, 3H) (signal due to amine proton not 
observed); 
13C NMR (100 MHz, CDCl3) δ 158.9 (C), 140.5 (C), 137.3 (CH), 134.9 (CH), 130.6 (CH), 
129.6 (2 x CH), 126.7 (CH), 117.1 (C), 113.9 (3 x CH), 87.8 (CH), 83.1 (C), 55.4 (CH3), 54.8 
(CH2), 53.2 (CH2), 37.5 (CH), 18.6 (CH3), 17.5 (CH3); 
IR (KBr) νmax 3292, 2953, 2924, 2083, 1610, 1512, 1454, 1300, 1246, 1175, 1036, 989 cm−1; 
MS (ESI, +ve) m/z 296 [(M+H)+, 100%]; 
HRMS (ESI, +ve) Found: (M+H)+ 296.2014, C20H26NO requires 296.2014; 
Specific rotation [α]25D = −6.2 (c 0.6, CHCl3). 
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7.6 Experimental Procedures Related to Work Described in Chapter Six 
4-((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yn-
8-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-((4-methoxybenzyl)oxy)but-2-yn-1-ol (6.3) 
 
A magnetically stirred solution of terminal alkyne 5.25 (930 mg, 1.51 mmol) in 
tetrahydrofuran (50 mL) maintained at 0 °C under a nitrogen atmosphere was treated with iso-
propylmagnesium chloride (1.5 mL of a 2 M solution in tetrahydrofuran, 3.00 mmol). The 
ensuing mixture was stirred for a further 15 min then treated with formaldehyde (181 mg, 6.03 
mmol). The reaction mixture was warmed to 18 °C and stirred at this temperature for 16 h then 
quenched with ammonium chloride (30 mL of a saturated aqueous solution). The separated 
aqueous layer was extracted with diethyl ether (3 x 30 mL) and the combined organic phases 
were then washed with brine (1 x 50 mL) before being dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 40:60 v/v diethyl ether/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 6.3 (858 mg, 88%) as a clear, colourless oil 
and as an inseparable (3:7) mixture of α/β epimers along with recovered starting material (100 
mg, 11%).  
1H NMR (400 MHz, CDCl3) δ (α-epimer) 7.32 (partially obscured d, J = 8.7 Hz, 2H), 6.87 
(partially obscured d, J = 8.7 Hz, 2H), 5.01 (d, J = 6.8 Hz, 1H), 4.86 (d, J = 2.6 Hz, 1H), 4.84 
(partially obscured d, J = 7.8 Hz, 1H), 4.73 (partially obscured d, J = 10.5 Hz, 1H), 4.71 (d, J 
= 6.8 Hz, 1H), 4.46 (partially obscured d, J = 10.5 Hz, 1H), 4.36 (partially obscured d, J = 1.5 
Hz, 2H), 4.38–4.34 (complex partially obscured m, 2H), 3.78 (s, 3H), 3.65 (ddd, J = 11.0, 10.1 
and 5.9 Hz, 1H), 3.49 (ddd, J = 11.0, 10.1 and 5.9 Hz, 1H), 2.17 (partially obscured s, OH), 
1.57 (s, 3H), 1.37 (s, 3H), 1.08–1.03 (complex partially obscured m, 21H), 0.98–0.80 (complex 
partially obscured m, 2H), −0.02 (s, 9H); (β-epimer) 7.30 (partially obscured d, J = 8.7 Hz, 
2H), 6.85 (partially obscured d, J = 8.7 Hz, 2H), 4.97 (d, J = 3.3 Hz, 1H), 4.92 (d, J = 7.0 Hz, 
1H), 4.73 (partially obscured d, J = 7.0 Hz, 1H), 4.72 (partially obscured d, J = 11.5 Hz, 1H), 
4.66 (dt, J = 8.4 and 1.8 Hz, 1H), 4.58 (d, J = 11.5 Hz, 1H), 4.45 (partially obscured d, J = 8.4 
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and 7.1 Hz 1H), 4.36 (partially obscured m, 1H), 4.32 (partially obscured m, 1H), 4.27 (partially 
obscured d, J = 1.7 Hz, 1H), 3.79 (s, 3H), 3.73 (ddd, J = 11.5, 10.1 and 5.9 Hz, 1H), 3.58 (ddd, 
J = 11.5, 10.1 and 5.9 Hz, 1H), 2.17 (partially obscured s, OH), 1.59 (s, 3H), 1.38 (s, 3H), 1.08–
1.03 (complex partially obscured m, 21H), 0.98–0.80 (complex partially obscured m, 2H), 0.01 
(s, 9H);  
13C NMR (100 MHz, CDCl3) δ (α-epimer) 159.5 (C), 130.2 (2 x CH), 129.4 (C), 114.0 (2 x 
CH), 109.7 (C), 103.3 (C), 91.8 (CH2), 89.9 (C), 85.4 (C), 82.7 (C), 78.6 (CH), 77.4 (CH), 70.7 
(CH2), 67.9 (CH), 65.7 (partially obscured, CH2), 64.9 (CH), 55.3 (CH3), 51.3 (CH2), 26.9 
(CH3), 25.0 (CH3), 18.7 (6 x CH3), 18.2 (CH2), 11.4 (3 x CH), −1.3 (3 x CH3); (β-epimer) 159.4 
(C), 129.8 (C), 129.7 (2 x CH), 113.8 (2 x CH), 110.3 (C), 103.2 (C), 92.2 (CH2), 89.9 (C), 
86.9 (C), 81.8 (C), 78.9 (CH), 78.5 (CH), 70.9 (CH2), 67.8 (CH), 66.2 (CH2), 65.7 (partially 
obscured, CH), 55.3 (CH3), 50.9 (CH2), 26.8 (CH3), 25.2 (CH3), 18.8 (6 x CH3), 18.2 (CH2), 
11.3 (3 x CH), −1.4 (3 x CH3);  
IR (ATR) νmax 3452, 2944, 2892, 2865, 2172, 1613, 1514, 1380, 1249, 1027, 835 cm−1; 
MS (ESI, +ve) m/z 669 [(M+Na)+, 100%], 664 [(M+NH4)
+, 25]; 
HRMS (ESI, +ve) Found: (M+Na)+ 669.3619, C35H58
23NaO7Si2 requires 669.3619. 
 
(E)-4-((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-
yn-8-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-((4-methoxybenzyl)oxy)but-2-en-1-ol (6.4) 
 
In a 100 mL flame-dried round bottom flask, a magnetically stirred solution of 
propargylic alcohol 6.3 (858 mg, 1.32 mmol) in dry tetrahydrofuran (50 mL) maintained at 0 
°C under a nitrogen atmosphere was treated, dropwise, with Red-AlTM (sodium bis(2-
methoxyethoxy)aluminium hydride) (0.86 mL of 65% w/w solution in toluene, 2.64 mmol). 
After 30 min, the reaction mixture was quenched by dropwise addition of methanol until no 
further gas evolution occurred then by the addition of tartaric acid (50 mL of a 1.0 M aqueous 
solution). The ensuing mixture was warmed to 18 °C and stirring was continued for an 
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additional 1 h. The separated aqueous layer was extracted with diethyl ether (3 x 50 mL) and 
the combined organic phases were then washed with potassium carbonate (1 x 50 mL of a 10% 
aqueous solution) before being dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
20:30:50 v/v/v ethyl acetate/dichloromethane/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2) afforded compound 6.4 (800 mg, 93%) as a clear, colourless oil 
and as an inseparable (30:70) mixture of α/β epimers. 
1H NMR (400 MHz, CDCl3) δ (α-epimer) 7.32 (partially obscured d, J = 8.7 Hz, 2H), 6.87 
(partially obscured d, J = 8.7 Hz, 2H), 5.94 (partially obscured dt, J = 15.6, 5.3 Hz, 1H), 5.67 
(partially obscured d, J = 15.6 and 7.7 Hz, 1H), 5.07 (d, J = 7.0 Hz, 1H), 4.93 (d, J = 2.0 Hz, 
1H), 4.74 (d, J = 7.0 Hz, 1H), 4.55 (dd, J = 7.8 and 7.6 Hz, 1H), 4.48 (d, J = 10.3 Hz, 1H), 4.38 
(dd, J = 7.2 and 2.0 Hz, 1H), 4.33 (partially obscured d, J = 10.3 Hz, 1H), 4.24 (partially 
obscured d, J = 5.2 and 1.0 Hz, 1H), 4.19–4.13 (complex partially obscured m, 2H), 3.78 (s, 
3H), 3.67 (partially obscured m, 1H), 3.50 (partially obscured m, 1H), 1.77 (partially obscured 
s, OH), 1.55 (s, 3H), 1.33 (s, 3H), 1.10–1.06 (complex partially obscured m, 21H), 0.92–0.82 
(complex partially obscured m, 2H), −0.02 (s, 9H); (β-epimer) 7.30 (partially obscured d, J = 
8.7 Hz, 2H), 6.85 (partially obscured d, J = 8.7 Hz, 2H), 6.00 (dt, J = 15.6, 5.3 Hz, 1H), 5.70 
(partially obscured d, J = 15.6 and 8.0 Hz, 1H), 4.91 (d, J = 6.8 Hz, 1H), 4.71 (d, J = 6.8 Hz, 
1H), 4.68 (d, J = 4.9 Hz, 1H), 4.50 (ABq, ∆ δAB = 0.03, JAB = 11.4 Hz, 2H), 4.32 (d, J = 7.6 
Hz, 1H), 4.27 (partially obscured t, J = 6.6 Hz, 1H), 4.19–4.13 (partially obscured m, 3H), 3.79 
(s, 3H), 3.72–3.63 (partially obscured m, 1H), 3.57–3.44 (partially obscured m, 1H), 1.77 
(partially obscured s, OH), 1.58 (s, 3H), 1.38 (s, 3H), 1.10–1.06 (complex partially obscured 
m, 21H), 0.92–0.82 (complex partially obscured m, 2H), 0.00 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (α-epimer) 159.5 (C), 134.6 (CH), 130.1 (2 x CH), 129.9 (C), 
129.3 (CH), 114.0 (2 x CH), 109.4 (C), 103.6 (C), 91.6 (CH2), 89.7 (C), 79.1 (CH), 77.8 (CH), 
77.6 (CH), 70.0 (CH2), 65.5 (CH2), 65.2 (CH), 63.1 (CH2), 55.3 (CH3), 26.8 (CH3), 24.8 (CH3), 
18.8 (6 x CH3), 18.2 (CH2), 11.4 (3 x CH), −1.3 (3 x CH3); (β-epimer) 159.2 (C), 135.3 (CH), 
130.9 (C), 129.2 (2 x CH), 128.2 (CH), 113.8 (2 x CH), 109.4 (C), 103.5 (C), 92.1 (CH2), 89.5 
(C), 79.7 (CH), 78.3 (CH), 77.8 (CH), 70.3 (CH2), 66.3 (CH2), 65.7 (CH), 63.0 (CH2), 55.4 
(CH3), 26.9 (CH3), 25.4 (CH3), 18.7 (6 x CH3), 18.3 (CH2), 11.3 (3 x CH), −1.3 (3 x CH3);  
IR (ATR) νmax 3446, 2945, 2866, 1613, 1514, 1379, 1249, 1030, 835 cm−1; 
MS (ESI, +ve) m/z 671 [(M+Na)+, 100%]; 
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HRMS (ESI, +ve) Found: (M+Na)+ 671.3775. C35H60
23NaO7Si2 requires 671.3775. 
 
(E)-4-((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-
yn-8-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-((4-methoxybenzyl)oxy)but-2-enal (6.5) 
 
A magnetically stirred solution of alcohol 6.4 (800 mg, 1.23 mmol) in dichloromethane 
(50 mL) was treated, in three portions, with manganese dioxide (1.69 g, 12.32 mmol). A slightly 
exothermic reaction occured. The ensuing mixture was stirred for 4 h at ambient temperatures 
then filtered through a pad of flame-dried Celite™ that was rinsed with dichloromethane (2 x 
30 mL). The combined filtrates were concentrated under reduced pressure and the residue thus 
obtained was subjected to flash chromatography (silica, 20:80 v/v ethyl acetate/hexane elution). 
Concentration of the appropriate fractions (Rf = 0.6) afforded aldehyde 6.5 (710 mg, 89%) as 
a clear, colourless oil and as an inseparable (30:70) mixture of α/β epimers. 
1H NMR [400 MHz, (CD3)2CO] δ (α-epimer) 9.68 (d, J = 7.7 Hz, 1H), 7.34 (partially obscured 
d, J = 8.5 Hz, 2H), 6.96 (dd, J = 15.8 and 6.4 Hz, 1H), 6.90 (partially obscured d, J = 8.5 Hz, 
2H), 6.25 (dd, J = 15.8 and 7.7 Hz, 1H), 5.02 (d, J = 6.5 Hz, 1H), 4.96 (d, J = 2.7 Hz, 1H), 4.84 
(partially obscured m, 1H), 4.74 (d, J = 6.7 Hz, 1H), 4.51 (ABq, ∆ δAB = 0.04, JAB = 10.3 Hz, 
2H), 4.43 (dd, J = 6.9 and 2.7 Hz, 1H), 4.25 (partially obscured m, 1H), 3.80 (s, 3H), 3.73 
(partially obscured m, 1H), 3.60 (partially obscured m, 1H), 1.50 (s, 3H), 1.31 (s, 3H), 1.14–
1.10 (complex partially obscured m, 21H), 0.92–0.82 (complex partially obscured m, 2H), 
−0.01 (s, 9H); (β-epimer) 9.65 (d, J = 7.9 Hz, 1H), 7.34 (partially obscured d, J = 8.5 Hz, 2H), 
7.08 (dd, J = 15.8 and 5.7 Hz, 1H), 6.90 (partially obscured d, J = 8.5 Hz, 2H), 6.33 (ddd, J = 
15.8, 7.9 and 1.1 Hz, 1H), 5.02 (d, J = 6.5 Hz, 1H), 4.80 (d, J = 6.5 Hz, 1H), 4.79 (d, J = 8.1 
Hz, 1H), 4.58 (s, 2H), 4.53 (partially obscured m, 1H), 4.31 (dd, J = 8.1 and 5.8 Hz, 1H), 4.25 
(partially obscured m, 1H), 3.79 (s, 3H), 3.73 (partially obscured m, 1H), 3.60 (partially 
obscured m, 1H), 1.48 (s, 3H), 1.34 (s, 3H), 1.14–1.10 (complex partially obscured m, 21H), 
0.92–0.82 (complex partially obscured m, 2H), −0.01 (s, 9H);  
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13C NMR [100 MHz, (CD3)2CO] δ (α-epimer) 193.7 (CO), 160.5 (C), 154.9 (CH), 134.8 (CH), 
130.7 (2 x CH), 130.3 (C), 114.6 (2 x CH), 109.8 (C), 105.1 (C), 92.4 (CH2), 89.8 (C), 79.6 
(CH), 78.4 (CH), 77.3 (CH), 71.6 (CH2), 66.1 (CH2), 65.8 (CH), 55.5 (CH3), 27.3 (CH3), 25.0 
(CH3), 19.1 (6 x CH3), 18.6 (CH2), 12.0 (3 x CH), −1.3 (3 x CH3); (β-epimer) 193.8 (CO), 
160.2 (C), 154.7 (CH), 134.3 (CH), 131.2 (C), 129.7 (2 x CH), 114.5 (2 x CH), 109.8 (C), 105.4 
(C), 93.7 (CH2), 88.7 (C), 80.1 (CH), 78.9 (CH), 77.7 (CH), 71.8 (CH2), 67.2 (CH2), 66.7 (CH), 
55.5 (CH3), 27.3 (CH3), 25.9 (CH3), 19.1 (6 x CH3), 18.9 (CH2), 11.9 (3 x CH), −1.2 (3 x CH3);  
IR (ATR) νmax 2944, 2866, 2171, 1695, 1514, 1248, 1026, 835 cm−1; 
MS (ESI, +ve) m/z 701 [(M+CH3OH+Na)
+, 70%], 669 [(M+Na)+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 669.3602, C35H58
23NaO7Si2 requires 669.3619. 
 
6-((1E,3E)-5-((4S,5R)-5-((R)-11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-
disilatridec-9-yn-8-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)-5-((4-methoxybenzyl)oxy)penta-
1,3-dien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one (6.6) 
 
A magnetically stirred solution of phosphonate 3.3 (458 mg, 1.65 mmol) in dry 
tetrahydrofuran (30 mL) maintained at −78 °C under a nitrogen atmosphere was treated with 
lithium bis(trimethylsilyl)amide (1.54 mL of 1.0 M solution in tetrahydrofuran, 1.54 mmol). 
The ensuing mixture was stirred at −78 °C for 1 h then treated with a solution of aldehyde 6.5 
(710 mg, 1.10 mmol) in tetrahydrofuran (15 mL). After 30 min, the reaction mixture was 
warmed up to 18 °C and stirred for a further 3.5 h at this temperature then quenched with 
ammonium chloride (50 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (2 x 50 mL) and the combined organic phases were then dried over 
magnesium sulfate before being filtered, concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 40:60 v/v diethyl ether/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.3) gave compound 6.6 (800 mg, 94%) as 
a clear, colourless oil and as an inseparable (30:70) mixture of α/β epimers. 
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1H NMR (400 MHz, CDCl3) δ (α-epimer) 7.27 (partially obscured d, J = 8.6 Hz, 2H), 7.04 (dd, 
J = 15.2 and 11.1 Hz, 1H), 6.85 (partially obscured d, J = 8.6 Hz, 2H), 6.39 (dd, J = 15.4 and 
11.1 Hz, 1H), 6.07–6.00 (complex partially obscured m, 2H), 5.36 (s, 1H), 5.07 (d, J = 7.0 Hz, 
1H), 4.92 (d, J = 2.1 Hz, 1H), 4.73 (partially obscured d, J = 7.0 Hz, 1H), 4.68 (partially 
obscured m, 1H), 4.44 (d, J = 10.2 Hz, 1H), 4.39–4.36 (complex partially obscured m, 2H), 
4.16 (partially obscured m, 1H), 3.79 (partially obscured s, 3H), 3.63 (partially obscured td, J 
= 10.2, 6.1 Hz, 1H), 3.50 (partially obscured td, J = 10.2, 6.1 Hz, 1H), 1.71 (s, 6H), 1.55 (s, 
3H), 1.32 (s, 3H), 1.01 (s, 21H), 0.96–0.76 (complex partially obscured m, 2H), −0.02 (s, 9H); 
(β-epimer) 7.27 (partially obscured d, J = 8.6 Hz, 2H), 6.95 (dd, J = 15.2 and 11.0 Hz, 1H), 
6.85 (partially obscured d, J = 8.6 Hz, 2H), 6.46 (dd, J = 15.4 and 11.0 Hz, 1H), 6.12 (dd, J = 
15.4 and 7.1 Hz, 1H), 6.03 (partially obscured d, J = 15.2 Hz, 1H), 5.34 (s, 1H), 4.95 (d, J = 
6.6 Hz, 1H), 4.72 (d, J = 6.6 Hz, 1H), 4.61 (m, 1H), 4.50 (m, 2H), 4.38 (partially obscured m, 
1H), 4.21–4.18 (complex partially obscured m, 2H), 3.79 (partially obscured s, 3H), 3.63 
(partially obscured td, J = 10.2, 6.1 Hz, 1H), 3.50 (partially obscured td, J = 10.2, 6.1 Hz, 1H), 
1.71 (s, 6H), 1.55 (s, 3H), 1.37 (s, 3H), 1.09 (s, 21H), 0.96–0.76 (complex partially obscured 
m, 2H), −0.02 (s, 9H);  
13C NMR (100 MHz, CDCl3) δ (α-epimer) 163.2 (C), 161.9 (C), 159.6 (C), 139.5 (CH), 137.3 
(CH), 132.0 (CH), 130.1 (2 x CH), 129.4 (C), 123.8 (CH),114.1 (2 x CH), 109.5 (C), 106.5 
(C),103.5 (C), 95.1 (CH), 91.6 (CH2), 90.0 (C), 79.0 (CH), 77.8 (CH), 77.3 (CH), 70.6 (CH2), 
65.6 (CH2), 65.1 (CH), 55.3 (CH3), 26.8 (CH3), 25.3 (CH3),25.1 (CH3), 24.7 (CH3) 18.7 (6 x 
CH3), 18.2 (CH2), 11.4 (3 x CH), −1.3 (3 x CH3); (β-epimer) 163.0 (C), 161.8 (C), 159.2 (C), 
138.1 (CH), 137.0 (CH), 132.0 (CH), 130.5 (C), 129.1 (2 x CH), 124.2 (CH), 113.8 (2 x CH), 
109.5 (C), 106.5 (C), 103.4 (C), 95.3 (CH), 92.2 (CH2), 89.6 (C), 79.8 (CH), 78.2 (CH), 77.3 
(CH), 70.8 (CH2), 66.4 (CH2), 65.7 (CH), 55.3 (CH3), 27.0 (CH3), 25.5 (CH3), 25.3 (CH3), 25.1 
(CH3), 18.7 (6 x CH3), 18.3 (CH2), 11.3 (3 x CH), −1.3 (3 x CH3);  
IR (ATR) νmax 2944, 2865, 2173, 1726, 1628, 1514, 1377, 1248, 1018, 859, 835 cm−1; 
MS (ESI, +ve) m/z 793 [(M+Na)+, 100%], 788 [(M+NH4)
+, 80]; 
HRMS (ESI, +ve) Found: (M+Na)+ 793.4125, C42H66
23NaO9Si2 requires 793.4143. 
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(R,E)-tert-Butyl((6,6-dibromo-2-methylhexa-3,5-dien-1-yl)oxy)diphenylsilane (6.7) 
 
A magnetically stirred solution of carbon tetrabromide (734 mg, 2.21 mmol) in dry 
dichloromethane (15 mL) maintained at 0 °C was treated with triphenylphosphine (1.16 g, 4.42 
mmol). After 15 min, the ensuing mixture was slowly treated with a solution of aldehyde 4.14 
(390 mg, 1.11 mmol) in dichloromethane (15 mL). The ensuing mixture was stirred for 15 min 
then warmed to 18 °C and maintained at this temperature for a further 30 min. The solvent was 
removed under reduced pressure and the residue thus obtained was filtered through a pad of 
TLC-grade silica gel that was eluted with diethyl ether/hexane (2 x 30 mL of a 1:4 v/v mixture). 
The combined filtrates were concentrated under reduced pressure to give compound 6.7 (520 
mg, 92%) as a clear, colourless oil (Rf = 0.7 in 5:95 v/v diethyl ether/hexane). This material 
was used, without purification, in the next step of reaction sequence  
1H NMR (400 MHz, CDCl3) δ 7.67–7.65 (complex m, 4H), 7.49–7.33 (complex m, 6H), 6.88 
(d, J = 10.1 Hz, 1H), 6.12 (ddd, J = 15.4, 10.1 and 1.0 Hz, 1H), 5.84 (dd, J = 15.4 and 7.5 Hz, 
1H), 3.58 (ABX, JAB = 9.9, JAX = 6.2 Hz, 1H), 3.55 (ABX, JAB = 9.9, JBX = 6.4 Hz, 1H), 2.46 
(hept, J = 6.8 Hz, 1H), 1.07 (s, 9H), 1.05 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 141.9 (CH), 137.3 (CH), 135.8 (2 x CH), 135.7 (2 x CH), 133.9 
(CH), 133.8 (CH), 129.8 (2 x CH), 127.8 (4 x CH), 126.9 (CH), 89.1 (C), 68.1 (CH2), 39.9 
(CH), 27.0 (3 x CH3), 19.5 (C), 16.3 (CH3); 
IR (ATR) νmax 3073, 2959, 2930, 2857, 1427, 1112, 701 cm−1; 
MS (ESI, +ve) m/z 549, 547 and 545 [(M+K)+, 50, 100 and 50%, respectively]; 
HRMS (ESI, +ve) Found: (M+K)+ 548.9872, C23H28
81Br2
39KOSi requires 548.9872. (M+K)+ 
546.9888, C23H28
79Br81Br39KOSi requires 546.9893. (M+K)+ 544.9918, C23H28
79Br2
39KOSi 
requires 544.9913; 
Specific rotation [α]25D = −2.0 (c 1.0, CHCl3).  
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(R,E)-6-Bromo-2-methylhex-3-en-5-yn-1-ol (6.8) 
 
A magnetically stirred solution of silyl ether 6.7 (520 mg, 1.04 mmol) in 
tetrahydrofuran (10 mL) was treated with tetra-n-butylammonium fluoride (8.8 mL of a 1.0 M 
solution in tetrahydrofuran, 8.85 mmol). After 6 h, the reaction mixture was quenched with 
ammonium chloride (20 mL of a saturated aqueous solution). The separated aqueous layer was 
extracted with diethyl ether (3 x 20 mL) and the combined organic phases were dried over 
magnesium sulfate then filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 50:50 v/v diethyl ether/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.4) afforded alcohol 6.8 (200 mg, 96%) 
as a clear, colourless oil.  
1H NMR (400 MHz, CDCl3) δ 6.12 (dd, J = 16.0, 7.8 Hz, 1H), 5.54 (dd, J = 16.0, 1.3 Hz, 1H), 
3.52 (ABX, JAB = 10.6, JAX = 5.7 Hz, 1H), 3.47 (ABX, JAB = 10.6, JBX = 7.2 Hz, 1H), 2.43 
(hept, J = 6.8 Hz, 1H), 1.57 (s, OH), 1.02 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 148.2 (CH), 110.3 (CH), 78.6 (C), 66.9 (CH2), 48.7 (C), 40.2 
(CH), 15.9 (CH3); 
IR (ATR) νmax 3336, 2966, 2930, 2874, 1457, 1381, 1032, 957 cm−1; 
MS (EI, +ve, 70 eV) m/z 188 and 190 (M+•, both 20%), 159 and 157 [(M−CH3O•)+, both 30], 
78 (100); 
HRMS (EI, +ve, 70 eV) Found: M+• 189.9816, C7H9
81BrO requires 189.9816. M+• 187.9838, 
C7H9
79BrO requires 187.9837; 
Specific rotation [α]25D = +23 (c 1.5, CHCl3). 
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(R,E)-((6-Bromo-2-methylhex-3-en-5-yn-1-yl)oxy)(tert-butyl)diphenylsilane (6.9) 
 
A magnetically stirred solution of dibromoalkene 6.7 (200 mg, 0.39 mmol) in dry 
tetrahydrofuran (10 mL) maintained at −78 °C was treated with lithium 
bis(trimethylsilyl)amide (0.47 mL of a 1.0 M solution in tetrahydrofuran, 0.47 mmol). After 15 
min, the reaction mixture was warmed to 18 °C and maintained at this temperature for 3 h then 
quenched with ammonium chloride (10 mL of a saturated aqueous solution). The aqueous layer 
was extracted with diethyl ether (2 x 10 mL) and the combined organic phases were dried over 
magnesium sulfate then filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 5:95 v/v diethyl ether/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.7) afforded compound 6.9 (140 mg, 83%) 
as a clear, colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.68–7.66 (complex m, 4H), 7.45–7.39 (complex m, 6H), 6.17 
(dd, J = 16.0 and 7.5 Hz, 1H), 5.49 (d, J = 16.0 Hz, 1H), 3.54 (d, J = 6.3 Hz, 2H), 2.45 (hept, 
J = 6.8 Hz, 1H), 1.08 (s, 9H), 1.03 (d, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 149.0 (CH), 135.8 (2 x CH), 135.7 (2 x CH), 133.8 (2 x C), 
129.8 (2 x CH), 127.8 (4 x CH), 109.2 (CH), 79.0 (C), 67.9 (CH2), 47.9 (C), 40.0 (CH), 27.0 
(3 x CH3), 19.4 (C), 16.0 (CH3); 
IR (ATR) νmax 3071, 2959, 2931, 2858, 1471, 1427, 1109, 701 cm−1; 
MS (ESI, +ve) m/z 467 and 465 [(M+K)+, both 100%]; 
HRMS (ESI, +ve) Found: (M+K)+ 465.0665, C23H27
79Br39KOSi requires 465.0652. (M+K)+ 
467.0644, C23H27
81Br39KOSi requires 467.0631; 
Specific rotation [α]25D = +8.6 (c 1.2, CHCl3). 
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(R,E)-2-Methyl-6-(trimethylsilyl)hex-3-en-5-yn-1-ol (6.10) 
 
A magnetically stirred solution of alkenyl iodide 5.41 (540 mg, 2.55 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (18 mg, 0.02 mmol) and copper iodide (10 mg, 
0.02 mmol) in dry tetrahydrofuran (20 mL) maintained under an argon atmosphere was treated 
with triethylamine (0.71 mL, 5.09 mmol). The resulting solution was cooled to 0 °C and flushed 
with argon for further 10 min then treated with ethynyltrimethylsilane (0.54 mL, 3.82 mmol). 
The ensuing mixture was warmed to 18 °C and stirred at this temperature for 16 h then 
quenched with ammonium chloride (20 mL of a saturated aqueous solution). The separated 
aqueous layer was extracted with diethyl ether (3 x 25 mL) and the combined organic phases 
were dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 10:30:60 v/v/v diethyl 
ether/dichloromethane/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) 
afforded alcohol 6.10 (260 mg, 56%) as a clear, light-brown oil. 
1H NMR (400 MHz, CDCl3) δ 6.12 (dd, J = 16.0 and 7.9 Hz, 1H), 5.60 (d, J = 16.0 Hz, 1H), 
3.57–3.38 (complex m, 2H), 2.43 (hept, J = 6.8 Hz, 1H), 1.42 (s, 1H), 1.02 (d, J = 6.8 Hz, 3H), 
0.18 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 147.6 (CH), 110.9 (CH), 103.7 (C), 93.9 (C), 67.0 (CH2), 40.3 
(CH), 15.9 (CH3), 0.1 (3 x CH3); 
IR (ATR) νmax 3339, 2960, 2874, 2154, 1248, 1033, 842 cm−1; 
MS (ESI, +ve) m/z 205 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 205.1022, C10H18
23NaOSi requires 205.1025; 
Specific rotation [α]25D = +34.6 (c 1.2, CHCl3). 
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6-((R,1E,3E)-5-((4S,5R)-2,2-Dimethyl-5-((R)-1-((2-(trimethylsilyl)ethoxy)methoxy)prop-
2-yn-1-yl)-1,3-dioxolan-4-yl)-5-((4-methoxybenzyl)oxy)penta-1,3-dien-1-yl)-2,2-
dimethyl-4H-1,3-dioxin-4-one (6.11) 
 
A magnetically stirred solution of compound 6.6 (300 mg, 0.39 mmol) in 
tetrahydrofuran (5 mL) was treated with tetra-n-butyl ammonium fluoride (0.77 mL of a 1.0 M 
solution in tetrahydrofuran, 0.77 mmol). After 2 h, the reaction mixture was quenched with 
ammonium chloride (5 mL of a saturated aqueous solution) and the aqueous layer extracted 
with diethyl ether (3 x 5 mL). The combined organic phases were dried over magnesium sulfate 
before being filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 50:50 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded the terminal alkyne 6.11 (150 mg, 
63%) as a clear, yellow oil.  
1H NMR [400 MHz, (CD3)2CO] δ 7.32 (d, J = 8.7 Hz, 2H), 7.08 (dd, J = 15.1 and 11.0 Hz, 
1H), 6.90 (d, J = 8.7 Hz, 2H), 6.57 (dd, J = 15.5 and 11.0 Hz, 1H), 6.29 (d, J = 15.1 Hz, 1H), 
6.24 (dd, J = 15.5 and 7.0 Hz, 1H), 5.43 (s, 1H), 4.92 (d, J = 6.7 Hz, 1H), 4.75 (d, J = 6.7 Hz, 
1H), 4.72 (dd, J = 8.0 and 2.1 Hz, 1H), 4.50 (ABq, ∆ δAB = 0.09, JAB = 11.2 Hz, 2H), 4.33 (dd, 
J = 7.0 and 4.2 Hz, 1H), 4.27 (dd, J = 8.0 and 6.1 Hz, 1H), 4.20 (dd, J = 6.1 and 4.2 Hz, 1H), 
3.79 (s, 3H), 3.73 (td, J = 9.8 and 6.6 Hz, 1H), 3.63 (td, J = 9.8 and 6.6 Hz, 1H), 3.02 (d, J = 
2.1 Hz, 1H), 1.71 (s, 6H), 1.47 (s, 3H), 1.33 (s, 3H), 0.96–0.90 (complex m, 2H), 0.02 (s, 9H); 
13C NMR [100 MHz, (CD3)2CO] δ 163.8 (C), 161.3 (C), 160.0 (C), 139.6 (CH), 137.8 (CH), 
132.3 (CH), 131.5 (C), 129.7 (2 x CH), 124.8 (CH), 114.4 (2 x CH), 109.8 (C), 106.9 (C), 95.9 
(CH), 93.1 (CH2), 81.4 (C), 80.6 (CH), 78.8 (CH), 78.3 (CH), 76.8 (CH), 70.9 (CH2), 67.0 
(CH2), 66.2 (CH), 55.5 (CH3), 27.1 (CH3), 25.9 (CH3), 25.1 (CH3), 25.0 (CH3), 18.6 (CH2), 
−1.2 (3 x CH3). 
IR (ATR) νmax 3264, 2948, 2894, 1724, 1628, 1514, 1379, 1249, 1019, 859, 836 cm−1; 
MS (ESI, +ve) m/z 637 [(M+Na)+, 100%]; 
HRMS (ESI, +ve) Found: (M+Na)+ 637.2808, C33H46
23NaO9Si requires 637.2809; 
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Specific rotation [α]25D = −46.5 (c 1.0, CHCl3). 
 
6-((R,1E,3E)-5-((4S,5R)-2,2-Dimethyl-5-((8R,15R,E)-2,2,15,19,19-pentamethyl-18,18-
diphenyl-5,7,17-trioxa-2,18-disilaicosa-13-en-9,11-diyn-8-yl)-1,3-dioxolan-4-yl)-5-((4-
methoxybenzyl)oxy)penta-1,3-dien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one (6.13) 
 
In a two-neck round bottom flask, a degassed solution of copper iodide in n-butylamine 
(0.5 mL of 30% aqueous solution) was treated with hydroxylamine hydrochloride with the 
result that the original blue color was discharged. The reaction mixture was cooled to 0 oC then 
treated with a solution of alkyne 6.11 (40 mg, 0.06 mmol) in methanol (1 mL). The orange 
alkynide suspension thus formed was treated, dropwise, with a solution of bromoalkyne 6.9 
(42 mg, 0.98 mmol) dissolved in the minimum volume of diethyl ether then warmed to 18 °C. 
More hydroxylamine hydrochloride was added as necessary throughout the reaction so as to 
prevent the solution from turning blue or green. After reaction was complete (ca. 30 min as 
judged by thin layer chromatography) then diethyl ether (5 mL) was added and the resulting 
mixture was washed with ammonium chloride (5mL of a saturated aqueous solution). The 
separated aqueous layer was extracted with diethyl ether (3 x 5 mL) and the combined organic 
phases were dried over magnesium sulfate, filtered, concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 40:60 v/v diethyl 
ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) afforded 
compound 6.13 (40 mg, 64%) as a clear, light-yellow oil. As the compound was found to be 
unstable, only the following data were acquired on it. 
1H NMR [400 MHz, (CD3)2CO] δ 7.70–7.68 (complex m, 4H), 7.48–7.41 (complex m, 6H), 
7.31 (d, J = 8.7 Hz, 2H), 7.08 (dd, J = 15.3 and 11.0 Hz, 1H), 6.90 (d, J = 8.7 Hz, 2H), 6.58 
(dd, J = 15.4 and 11.0 Hz, 1H), 6.40 (dd, J = 16.0 and 7.6 Hz, 1H), 6.30 (d, J = 15.3 Hz, 1H), 
6.23 (dd, J = 15.4 and 7.4 Hz, 1H), 5.72 (d, J = 16.0 Hz, 1H), 5.43 (s, 1H), 4.87 (d, J = 6.8 Hz, 
1H), 4.80 (d, J = 7.4 Hz, 1H), 4.73 (d, J = 6.8 Hz, 1H), 4.51 (ABq, ∆ δAB = 0.10, JAB = 11.3 
Hz, 2H), 4.34–4.26 (complex m, 2H), 4.23 (dd, J = 6.1 and 4.5 Hz, 1H), 3.78 (s, 3H), 3.71–
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3.56 (complex m, 2 x 2H), 2.57 (hept, J = 6.8 Hz, 1H), 1.70 (s, 6H), 1.48 (s, 3H), 1.34 (s, 3H), 
1.05 (d, J = 6.8 Hz, 3H), 1.05 (s, 9H), 0.97–0.87 (complex m, 2H), 0.02 (s, 9H); 
IR (ATR) νmax 2953, 2932, 2859, 1726, 1628, 1514, 1377, 1247, 1006, 1018, 859, 834 cm−1; 
MS (ESI, +ve) m/z 983 [(M+Na)+, 50%], 978 [(M+NH4)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 983.4536, C56H72
23NaO10Si2 requires 983.4562. 
 
6-((3aR,4R,9S,9aS)-5-((R,E)-6-((tert-Butyldiphenylsilyl)oxy)-5-methylhex-3-en-1-yn-1-
yl)-9-((4-methoxybenzyl)oxy)-2,2-dimethyl-4-((2-(trimethylsilyl)ethoxy)methoxy)-
3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxol-6-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 
(6.14) 
 
A magnetically stirred solution of compound 6.13 (20 mg, 0.02 mmol) in toluene (2 
mL) maintained at ambient temperatures was treated with tetra-n-butylammonium fluoride 
(0.08 mL of 1.0 M solution in tetrahydrofuran, 0.08 mmol). After 16 h the reaction mixture 
was quenched with ammonium chloride (2 mL of a saturated aqueous solution) and the 
separated aqueous layer was extracted with diethyl ether (3 x 2 mL). The combined organic 
phases were dried over magnesium sulfate before being filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 
40:60 v/v diethyl ether/hexane elution) and concentration of the appropriate fractions (Rf = 0.4) 
afforded the aromatised compound 6.14 (15 mg, 75%) as a clear, colorless oil.  
1H NMR [400 MHz, (CD3)2CO] δ 7.83–7.61 (complex m, 6H), 7.54–7.34 (complex m, 8H), 
6.94 (d, J = 8.7 Hz, 2H), 6.49 (dd, J = 16.0 and 7.7 Hz, 1H), 6.03 (s, 1H), 5.94 (d, J = 16.0 Hz, 
1H), 5.59 (d, J = 3.8 Hz, 1H), 5.12 (d, J = 6.2 Hz, 1H), 4.89 (ABq, ∆ δAB = 0.19, JAB = 11.4 
Hz, 2H), 4.74 (ABq, ∆ δAB = 0.08, JAB = 6.4 Hz, 2H), 4.43 (dd, J = 8.5 and 6.2 Hz, 1H), 4.32 
(dd, J = 8.5 and 3.8 Hz, 1H), 3.80 (s, 3H), 3.67 (d, J = 6.3 Hz, 2H), 3.59 (td, J = 10.1, 6.7 Hz, 
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1H), 3.40 (td, J = 10.1, 6.7 Hz, 1H), 2.64 (hept, J = 6.8 Hz, 1H), 1.79 (s, 6H), 1.59 (s, 3H), 1.42 
(s, 3H), 1.12 (d, J = 6.8 Hz, 3H), 1.08 (s, 9H), 0.84–0.80 (m, 2H), −0.06 (s, 9H); 
13C NMR [100 MHz, (CD3)2CO] δ 165.5 (C), 161.1 (C), 160.3 (C), 150.2 (CH), 143.0 (C), 
138.4 (C), 136.4 (2 x CH), 136.4 (2 x CH), 134.4 (C), 134.4 (C), 132.8 (C), 131.6 (C), 130.7 
(2 x CH), 130.2 (2 x CH), 129.9 (CH), 128.7 (4 x CH), 125.7 (CH), 122.1 (C), 114.5 (2 x CH), 
111.6 (C), 110.2 (CH), 107.5 (C), 99.2 (C), 96.8 (CH), 94.9 (CH2), 84.7 (C), 80.6 (CH), 79.1 
(CH), 76.5 (CH), 72.9 (CH2), 72.1 (CH), 68.8 (CH2), 65.6 (CH2), 55.5 (CH3), 41.1 (CH), 27.3 
(3 x CH3), 26.9 (CH3), 25.4 (CH3), 25.2 (CH3), 25.1 (CH3), 19.9 (C), 18.7 (CH2), 16.4 (CH3), 
−1.2 (3 x CH3); 
IR (ATR) νmax 2954, 2894, 2859, 1730, 1614, 1514, 1377, 1249, 1207, 1111, 1023, 821 cm−1; 
MS (ESI, +ve) m/z 981 [(M+Na)+, 90%], 976 [(M+NH4)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 981.4415, C56H70
23NaO10Si2 requires 981.4405; 
Specific rotation [α]25D = +66.2 (c 0.8, CHCl3).  
 
(R,E)-2-Methyl-6-(trimethylsilyl)hex-3-en-5-yn-1-yl (R,2Z,4E,6E)-8-((4S,5R)-5-((R)-
11,11-Di-iso-propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yn-8-yl)-2,2-dimethyl-
1,3-dioxolan-4-yl)-3-hydroxy-8-((4-methoxybenzyl)oxy)octa-2,4,6-trienoate (6.15) 
 
A magnetically stirred solution of dioxinone 6.6 (136 mg, 0.18 mmol) and alcohol 6.10 
(48 mg, 0.26 mmol) in dry toluene (5 mL) was heated at 120 °C for 4 h. The ensuing mixture 
was concentrated under reduced pressure and the residue thus obtained subjected to flash 
column chromatography (silica, 20:80 v/v diethyl ether/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.3) afforded the β-epimeric form of compound 6.15 (113 mg, 71%) 
as a clear, colorless oil. 
1H NMR (400 MHz, CDCl3) δ (enol form) 11.71 (s, OH), 7.27 (partially obscured d, J = 8.6 
Hz, 2H), 7.06 (dd, J = 15.2 and 11.1 Hz, 1H), 6.85 (partially obscured d, J = 8.6 Hz, 2H), 6.46 
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(dd, J = 15.4 and 11.1 Hz, 1H), 6.14 (dd, J = 16.0 and 7.7 Hz, 1H), 6.03 (dd, J = 15.4 and 7.6 
Hz, 1H), 5.94 (d, J = 15.2 Hz, 1H), 5.58 (dd, J = 16.0 and 1.2 Hz, 1H), 5.09 (s, 1H), 4 .96 
(partially obscured d, J = 6.7 Hz, 1H), 4.70 (d, J = 6.7 Hz, 1H), 4.61 (d, J = 5.3 Hz, 1H), 4.55–
4.45 (complex partially obscured m, 2H), 4.40 (t, J = 7.3 Hz, 1H), 4.25 (t, J = 6.7 Hz, 1H), 4.18 
(partially obscured m, 1H), 4.03 (partially obscured d, J = 6.6 Hz, 2H), 3.79 (s, 3H), 3.68–3.57 
(complex partially obscured m, 1H), 3.55–3.42 (complex partially obscured m, 1H), 2.62 (hept, 
J = 6.9 Hz, 1H), 1.57 (s, 3H), 1.37 (s, 3H), 1.09–1.05 (complex partially obscured m, 21H), 
1.06 (d, J = 6.9 Hz, 3H), 0.94–0.77 (complex partially obscured m, 2H), 0.18 (s, 9H), −0.01 (s, 
9H); (keto form) 7.27 (partially obscured d, J = 8.6 Hz, 2H), 7.19 (dd, J = 15.5 and 11.0 Hz, 
1H), 6.85 (partially obscured d, J = 8.6 Hz, 2H), 6.51 (partially obscured d, J = 15.4 and 11.0 
Hz, 1H), 6.30 (dd, J = 15.4 and 6.7 Hz, 1H), 6.24 (d, J = 15.5 Hz, 1H), 6.06 (dd, J = 16.0 and 
7.6 Hz, 1H), 5.57 (dd, J = 16.0 and 1.2 Hz, 1H ), 4.94 (partially obscured d, J = 6.7 Hz, 1H), 
4.72 (partially obscured d, J = 6.7 Hz, 1H), 4.63 (partially obscured d, J = 5.3 Hz, 1H), 4.55–
4.45 (complex partially obscured m, 2H), 4.35 (partially obscured m, 1H), 4.20–4.17 (complex 
partially obscured m, 2H), 4.03 (partially obscured d, J = 6.6 Hz, 2H), 3.80 (s, 3H), 3.68–3.57 
(partially obscured m, 1H), 3.61 (s, 2H), 3.55–3.42 (partially obscured m, 1H), 2.62 (hept, J = 
6.9 Hz, 1H), 1.55 (s, 3H), 1.53 (s, 3H), 1.09 (s, 21H), 1.06 (d, J = 6.9 Hz, 3H), 0.94–0.77 
(complex partially obscured m, 2H), 0.18 (s, 9H), −0.02 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (enol form) 172.6 (C), 169.1 (C), 159.2 (C), 146.4 (CH), 136.3 
(CH), 136.0 (CH), 132.9 (CH), 130.6 (C), 129.2 (2 x CH), 126.7 (CH), 113.8 (2 x CH), 110.6 
(CH), 109.5 (C, partially obscured), 103.6 (C), 103.4 (C), 94.2 (C), 92.1 (CH), 92.0 (CH2), 89.7 
(C), 79.7 (CH), 78.3 (CH), 77.6 (CH), 70.7 (CH2), 67.7 (CH2), 66.2 (CH2), 65.5 (CH), 55.4 
(CH3), 36.7 (CH), 27.0 (CH3), 25.4 (CH3), 18.8 (6 x CH3), 18.3 (CH2), 16.4 (CH3), 11.4 (3 x 
CH), 0.07 (3 x CH3), −1.3 (3 x CH3); (keto form) 191.9 (C), 167.3 (C), 159.2 (C), 146.1 (CH), 
143.4 (CH), 141.8 (CH), 131.2 (CH), 130.4 (C), 129.5 (CH), 129.1 (2 x CH), 113.9 (2 x CH), 
110.8 (CH), 109.5 (C, partially obscured),103.5 (2 x C), 94.2 (C), 92.3 (CH2), 89.4 (C), 79.8 
(CH), 78.2 (CH), 77.4 (CH), 71.1 (CH2), 68.7 (CH2), 66.5 (CH2), 65.8 (CH), 55.4 (CH3), 47.3 
(CH2), 36.7 (CH), 27.1 (CH3), 25.6 (CH3), 18.8 (6 x CH3), 18.7 (CH2), 16.3 (CH3), 11.3 (3 x 
CH), 0.07 (3 x CH3), −1.2 (3 x CH3); 
IR (ATR) νmax 2945, 2893, 2866, 2159, 1633, 1580, 1514, 1464, 1419, 1248, 1026, 841 cm−1; 
MS (ESI, +ve) m/z 917 [(M+Na)+, 100%], 913 [(M+NH4)
+, 50]; 
HRMS (ESI, +ve) Found: (M+Na)+ 917.4853, C49H78
23NaO9Si3 requires 917.4851. (M+H)
+ 
895.5055, C49H79O9Si3 requires 895.5032; 
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Specific rotation [α]25D = +31.6 (c 0.9, CHCl3). 
 
(R,E)-2-Methylhex-3-en-5-yn-1-yl(R,2Z,4E,6E)-8-((4S,5R)-2,2-dimethyl-5-((R)-1-((2-
(trimethylsilyl)ethoxy)methoxy)prop-2-yn-1-yl)-1,3-dioxolan-4-yl)-3-hydroxy-8-((4-
methoxybenzyl)oxy)octa-2,4,6-trienoate (6.16) 
 
A magnetically stirred solution of compound 6.15 (57 mg, 0.06 mmol) in 
tetrahydrofuran (2 mL) maintained at ambient temperatures was treated with tetra-n-
butylammonium fluoride (0.16 mL of a 1.0 M solution in tetrahydrofuran, 0.16 mmol). After 
2 h the reaction mixture was quenched with ammonium chloride (5 mL of a saturated aqueous 
solution) and the separated aqueous layer was extracted with diethyl ether (3 x 5 mL). The 
combined organic phases were dried over magnesium sulfate before being filtered and 
concentrated under reduced pressure and the residue thus obtained was subjected to flash 
chromatography (silica, 30:70 v/v diethyl ether/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.3) afforded compound 6.16 (36 mg, 85%) as a clear, light-yellow 
oil. 
1H NMR (400 MHz, CDCl3) δ (enol form) 11.71 (s, OH), 7.27 (partially obscured d, J = 8.6 
Hz, 2H), 7.07 (dd, J = 15.2 and 11.0 Hz, 1H), 6.85 (partially obscured d, J = 8.6 Hz, 2H), 6.42 
(partially obscured d, J = 15.4 and 11.0 Hz, 1H), 6.17 (partially obscured d, J = 16.1 and 7.5 
Hz, 1H), 6.03 (dd, J = 15.4 and 7.4 Hz, 1H), 5.94 (d, J = 15.2 Hz, 1H), 5.53 (ddd, J = 16.1, 2.2 
and 1.3 Hz, 1H), 5.08 (s, 1H), 4.88 (partially obscured d, J = 6.7 Hz, 1H), 4.64 (partially 
obscured d, J = 6.7 Hz, 1H), 4.55 (partially obscured m, 1H), 4.51 (ABq, ∆ δAB = 0.11, JAB = 
11.8 Hz, 2H), 4.29 (partially obscured d, J = 6.8 Hz, 1H), 4.27–4.16 (complex m, 2H), 4.04 (d, 
J = 6.6 Hz, 2H), 3.80 (s, 3H), 3.66–3.56 (complex partially obscured m, 1H), 3.50 (partially 
obscured m, 1H), 2.83 (d, J = 2.2 Hz, 1H), 2.63 (hept, J = 6.9 Hz, 1H), 2.46 (d, J = 2.2 Hz, 
1H), 1.57 (s, 3H), 1.40 (s, 3H), 1.06 (d, J = 6.9 Hz, 3H), 0.92–0.82 (complex partially obscured 
m, 2H), −0.02 (s, 9H); (keto form) 7.27 (partially obscured d, J = 8.6 Hz, 2H), 7.20 (dd, J = 
15.5 and 10.8 Hz, 1H), 6.88 (partially obscured d, J = 8.6 Hz, 2H), 6.48 (partially obscured d, 
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J = 15.4 and 10.8 Hz, 1H), 6.31 (dd, J = 15.4 and 6.8 Hz, 1H), 6.25 (d, J = 15.5 Hz, 1H), 6.12 
(partially obscured d, J = 16.1 and 7.6 Hz, 1H), 5.50 (ddd, J = 16.1, 2.2 and 1.3 Hz, 1H ), 4.87 
(partially obscured d, J = 6.7 Hz, 1H), 4.69 (partially obscured d, J = 6.7 Hz, 1H), 4.59 (dd, J 
= 7.3 and 2.0 Hz, 1H), 4.51 (ABq, ∆ δAB = 0.11, JAB = 11.8 Hz, 2H), 4.30 (partially obscured 
d, J = 6.0 Hz, 1H), 4.27–4.16 (complex m, 2H), 4.03 (d, J = 6.6, 2H), 3.80 (s, 3H), 3.61 
(partially obscured m, 1H), 3.60 (s, 2H), 3.50 (partially obscured m, 1H), 2.83 (d, J = 2.2 Hz, 
1H), 2.63 (hept, J = 6.9 Hz, 1H), 2.50 (d, J = 2.2 Hz, 1H), 1.55 (s, 3H), 1.40 (s, 3H), 1.05 (d, J 
= 6.9 Hz, 3H), 0.92–0.82 (complex partially obscured m, 2H), 0.00 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (enol form) 172.6 (C), 169.1 (C), 159.2 (C), 147.2 (CH), 136.3 
(CH), 136.0 (CH), 132.9 (CH), 130.4 (C), 129.3 (2 x CH), 126.6 (CH), 113.8 (2 x CH), 109.9 
(CH), 109.8 (C), 92.4 (CH2), 91.9 (CH), 82.1 (CH), 80.2 (CH), 79.6 (CH), 78.1 (CH), 77.1 
(CH), 76.9 (CH), 75.9 (CH), 70.3 (CH2), 68.6 (CH2), 66.4 (CH2), 65.2 (CH), 55.4 (CH3), 36.7 
(CH), 26.9 (CH3), 25.6 (CH3), 18.2 (CH2), 16.3 (CH3), −1.4 (3 x CH3); (keto form) 191.9 (C), 
167.2 (C), 159.3 (C), 146.9 (CH), 143.4 (CH), 141.9 (CH), 131.2 (CH), 130.2 (C), 129.5 (CH), 
129.1 (2 x CH), 113.9 (2 x CH), 109.7 (CH), 109.6 (C), 92.7 (CH2), 82.1 (C), 80.3 (CH), 79.7 
(CH), 78.0 (CH), 77.1 (CH), 76.6 (CH), 75.7 (CH), 70.7 (CH2), 67.5 (CH2), 66.6 (CH2), 65.6 
(CH), 55.4 (CH3), 47.3 (CH2), 36.7 (CH), 26.9 (CH3), 25.6 (CH3), 18.2 (CH2), 16.2 (CH3), −1.3 
(3 x CH3); 
IR (ATR) νmax 3288, 2954, 2894, 1741, 1634, 1514, 1420, 1248, 1025, 836 cm−1; 
MS (ESI, +ve) m/z 689 [(M+Na)+, 80%], 684 [(M+NH4)
+, 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 689.3123, C37H50
23NaO9Si requires 689.3122. (M+H)
+ 
667.3302, C37H51O9Si requires 667.3302; 
Specific rotation [α]25D = −21.1 (c 2.3, CHCl3). 
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(R,E)-6-Bromo-2-methylhex-3-en-5-yn-1-yl(R,2Z,4E,6E)-8-((4S,5R)-5-((R)-11,11-di-iso-
propyl-2,2,12-trimethyl-5,7-dioxa-2,11-disilatridec-9-yn-8-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)-3-hydroxy-8-((4-methoxybenzyl)oxy)octa-2,4,6-trienoate (6.18) 
 
A magnetically stirred solution of dioxinone 6.6 (136 mg, 0.18 mmol) and alcohol 6.8 
(100 mg, 0.13 mmol) in dry toluene (5 mL) was heated at 120 °C for 4 h. The ensuing mixture 
was concentrated under reduce pressure and the residue thus obtained subjected to flash column 
chromatography (silica, 30:70 v/v diethyl ether/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.6) afforded the β-epimeric form of compound 6.18 (85 mg, 72%) 
as a clear, light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ (enol form) 11.70 (s, OH), 7.27 (partially obscured d, J = 8.6 
Hz, 2H), 7.07 (dd, J = 15.2, 11.0 Hz, 1H), 6.85 (partially obscured d, J = 8.6 Hz, 2H), 6.45 (dd, 
J = 15.4, 11.0 Hz, 1H), 6.11 (dd, J = 16.0, 7.6 Hz, 1H), 6.04 (dd, J = 15.4, 7.6 Hz, 1H), 5.94 
(d, J = 15.2 Hz, 1H), 5.51 (dd, J = 16.0, 1.1 Hz, 1H), 5.08 (s, 1H), 4 .96 (partially obscured d, 
J = 6.9 Hz, 1H), 4.70 (d, J = 6.9 Hz, 1H), 4.61 (d, J = 5.3 Hz, 1H), 4.53–4.46 (complex partially 
obscured m, 2H), 4.38 (partially obscured m, 1H), 4.25 (t, J = 6.7 Hz, 1H), 4.19 (partially 
obscured m, 1H), 4.03 (partially obscured d, J = 6.6 Hz, 2H), 3.79 (s, 3H), 3.63 (partially 
obscured m, 1H), 3.49 (partially obscured m, 1H), 2.62 (hept, J = 6.9 Hz, 1H), 1.57 (s, 3H), 
1.37 (s, 3H), 1.08 (s, 21H), 1.06 (d, J = 6.9 Hz, 3H), 0.93–0.80 (complex partially obscured m, 
2H), −0.02 (s, 9H); (keto form) 7.27 (partially obscured d, J = 8.6 Hz, 2H), 7.19 (dd, J = 15.5, 
10.8 Hz, 1H), 6.87 (partially obscured d, J = 8.6 Hz, 2H), 6.49 (partially obscured d, J = 15.4, 
10.8 Hz, 1H), 6.31 (dd, J = 15.4, 6.7 Hz, 1H), 6.24 (d, J = 15.5 Hz, 1H), 6.08 (dd, J = 16.0, 7.6 
Hz, 1H), 5.49 (dd, J = 16.0, 1.1 Hz, 1H ), 4.95 (partially obscured d, J = 6.9 Hz, 1H), 4.72 (d, 
J = 6.9 Hz, 1H), 4.62 (d, J = 5.3 Hz, 1H), 4.53–4.46 (complex partially obscured m, 2H), 4.38 
(partially obscured m, 1H), 4.23–4.15 (complex partially obscured m, 2H), 4.03 (partially 
obscured d, J = 6.6 Hz, 2H), 3.80 (s, 3H), 3.63 (partially obscured m, 1H), 3.59 (s, 2H), 3.49 
(partially obscured m, 1H), 2.62 (hept, J = 6.9 Hz, 1H), 1.55 (s, 3H), 1.37 (s, 3H), 1.08 (s, 21H), 
1.04 (d, J = 6.9 Hz, 3H), 0.93–0.80 (complex partially obscured m, 2H), −0.01 (s, 9H); 
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13C NMR (100 MHz, CDCl3) δ (enol form) 172.6 (C), 169.2 (C), 159.2 (C), 147.0 (CH), 136.3 
(CH), 136.1 (CH), 132.9 (CH), 130.6 (C), 129.2 (2 x CH), 126.7 (CH), 113.8 (2 x CH), 110.1 
(CH), 109.5 (C, partially obscured), 103.4 (C), 92.3 (CH), 92.0 (CH2), 89.7 (C), 79.7 (CH), 
78.5 (C), 78.3 (CH), 77.6 (CH), 70.7 (CH2), 68.5 (CH2), 66.2 (CH2), 65.4 (CH), 55.4 (CH3), 
49.0 (C), 36.6 (CH), 27.0 (CH3), 25.4 (CH3), 18.8 (6 x CH3), 18.3 (CH2), 16.3 (CH3), 11.3 (3 
x CH), −1.4 (3 x CH3); (keto form) 191.8 (C), 167.2 (C), 159.2 (C), 146.8 (CH), 143.5 (CH), 
141.8 (CH), 131.2 (CH), 130.4 (C), 129.5 (CH), 129.1 (2 x CH), 113.9 (2 x CH), 110.3 (CH), 
109.5 (C, partially obscured), 103.5 (C), 92.0 (CH2), 89.4 (C), 79.8 (CH), 78.5 (C), 78.2 (CH), 
77.3 (CH), 71.1 (CH2), 67.5 (CH2), 66.6 (CH2), 65.8 (CH), 55.4 (CH3), 49.1 (C), 47.3 (CH2), 
36.7 (CH), 27.1 (CH3), 25.6 (CH3), 18.8 (6 x CH3), 18.3 (CH2), 16.3 (CH3), 11.3 (3 x CH), 
−1.3 (3 x CH3); 
IR (ATR) νmax 2944, 2865, 1743, 1633, 1580, 1514, 1420, 1248, 1026, 835 cm−1; 
MS (ESI, +ve) m/z 925 and 923 [(M+Na)+, both 90%], 920 and 918 [(M+NH4)
+, both 100]; 
HRMS (ESI, +ve) Found: (M+Na)+ 925.3543, C46H69
81Br23NaO9Si2 requires 925.3541. 
(M+Na)+ 923.3568, C46H69
79Br23NaO9Si2 requires 923.3561; 
Specific rotation [α]25D = +16.5 (c 2.7, CHCl3). 
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(R,E)-6-Bromo-2-methylhex-3-en-5-yn-1-yl (R,2Z,4E,6E)-8-((4S,5R)-2,2-Dimethyl-5-((R) 
-1-((2-(trimethylsilyl)ethoxy)methoxy)prop-2-yn-1-yl)-1,3-dioxolan-4-yl)-3-hydroxy-8-
((4-methoxybenzyl)oxy)octa-2,4,6-trienoate (6.19) 
 
A magnetically stirred solution of compound 6.18 (85 mg, 0.09 mmol) in 
tetrahydrofuran (2 mL) maintained at ambient temperatures was treated with tetra-n-
butylammonium fluoride (0.11 mL of 1.0 M solution in tetrahydrofuran, 0.11 mmol). After 2 
h, the reaction mixture was quenched with ammonium chloride (2 mL of a saturated aqueous 
solution) and the separated aqueous layer was extracted with diethyl ether (3 x 2 mL). The 
combined organic phases were dried over magnesium sulfate before being filtered and 
concentrated under reduced pressure and the residue thus obtained was subjected to flash 
chromatography (silica, 10:30:60 v/v/v diethyl ether/dichloromethane/hexane elution). 
Concentration of the appropriate fractions (Rf = 0.4) afforded compound 6.19 (60 mg, 85%) as 
a clear, yellow oil.  
1H NMR (400 MHz, CDCl3) δ (enol form) 11.71 (s, OH), 7.27 (partially obscured d, J = 8.6 
Hz, 2H), 7.07 (dd, J = 15.1 and 11.0 Hz, 1H), 6.87 (partially obscured d, J = 8.6 Hz, 2H), 6.41 
(dd, J = 15.4 and 11.0 Hz, 1H), 6.13 (dd, J = 16.1 and 7.5 Hz, 1H), 6.03 (dd, J = 15.4 and 7.4 
Hz, 1H), 5.95 (d, J = 15.5 Hz, 1H), 5.52 (d, J = 16.1, 1H), 5.08 (s, 1H), 4.89 (partially obscured 
d, J = 6.8 Hz, 1H), 4.68 (d, J = 6.8 Hz, 1H), 4.56 (m, 1H), 4.52 (ABq, ∆ δAB = 0.11, JAB = 11.8 
Hz, 2H), 4.30 (partially obscured m, 1H), 4.26–4.17 (complex m, 2H), 4.05–4.02 (partially 
obscured m, 2H), 3.80 (s, 3H), 3.61 (partially obscured m, 1H), 3.51 (partially obscured m, 
1H), 2.62 (hept, J = 6.9 Hz, 1H), 2.46 (d, J = 1.9 Hz, 1H), 1.58 (s, 3H), 1.40 (partially obscured 
s, 3H), 1.06 (d, J = 6.9 Hz, 3H), 0.92–0.82 (complex partially obscured m, 2H), −0.01 (s, 9H); 
(keto form) 7.27 (partially obscured d, J = 8.6 Hz, 2H), 7.20 (dd, J = 15.5 and 10.8 Hz, 1H), 
6.87 (partially obscured d, J = 8.6 Hz, 2H), 6.47 (partially obscured d, J = 15.5 and 10.8 Hz, 
1H), 6.31 (dd, J = 15.5 and 6.9 Hz, 1H), 6.24 (d, J = 15.5 Hz, 1H), 6.08 (dd, J = 15.9 and 7.3 
Hz, 1H), 5.49 (d, J = 15.9 Hz, 1H), 4.88 (partially obscured d, J = 6.8 Hz, 1H), 4.69 (d, J = 6.8 
Hz, 1H), 4.61 (dd, J = 7.3 and 1.9 Hz, 1H), 4.51 (ABq, ∆ δAB = 0.11, JAB = 11.8 Hz, 2H), 4.30 
(partially obscured m, 1H), 4.26–4.17 (complex m, 2H), 4.05–4.02 (complex partially obscured 
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m, 2H), 3.80 (s, 3H), 3.61 (partially obscured m, 1H), 3.60 (s, 2H), 3.51 (partially obscured m, 
1H), 2.62 (hept, J = 6.9 Hz, 1H), 2.50 (d, J = 1.9 Hz 1H), 1.55 (s, 3H), 1.40 (partially obscured 
s, 3H), 1.04 (d, J = 6.9 Hz, 3H), 0.92–0.82 (complex partially obscured m, 2H), 0.00 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ (enol form) 172.6 (C), 169.2 (C), 159.2 (C), 147.1 (CH), 136.4 
(CH), 136.1 (CH), 132.9 (CH), 130.4 (C), 129.3 (2 x CH), 126.6 (CH), 113.8 (2 x CH), 110.1 
(CH), 109.8 (C), 92.4 (CH2), 91.9 (CH), 80.2 (C), 79.6 (CH), 78.5 (C), 78.1 (CH), 76.6 (CH), 
75.9 (CH), 70.3 (CH2), 68.5 (CH2), 66.4 (CH2), 65.2 (CH), 55.4 (CH3), 49.0 (C), 36.6 (CH), 
26.9 (CH3), 25.6 (CH3), 18.3 (CH2), 16.3 (CH3), −1.3 (3 x CH3); (keto form) 191.8 (C), 167.2 
(C), 159.3 (C), 146.8 (CH), 143.4 (CH), 141.9 (CH), 131.2 (CH), 130.2 (C), 129.5 (CH), 129.1 
(2 x CH), 113.9 (2 x CH), 110.3 (CH), 109.9 (C), 92.7 (CH2), 80.4 (C), 79.7 (CH), 78.5 (C), 
78.0 (CH), 76.8 (CH), 75.7 (CH), 70.7 (CH2), 67.5 (CH2), 66.6 (CH2), 65.5 (CH), 55.4 (CH3), 
49.1 (C), 47.3 (CH2), 36.6 (CH), 26.9 (CH3), 25.7 (CH3), 18.2 (CH2), 16.2 (CH3), −1.2 (3 x 
CH3); 
IR (ATR) νmax 3283, 2954, 2923, 1741, 1633, 1514, 1420, 1248, 1027, 835 cm−1; 
MS (ESI, +ve) m/z 769 and 767 [(M+Na)+, both 100%], 689 [(M−Br+H+Na)+, 80]; 
HRMS (ESI, +ve) Found: (M+Na)+ 769.2219, C37H49
81Br23NaO9Si requires 769.2206. 
(M+Na)+ 767.2225, C37H49
79Br23NaO9Si requires 767.2227; 
Specific rotation [α]25D = −21.8 (c 1.7, CHCl3).
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Appendix One: ORTEPs and X-Ray Crystal Structure Report for Compound 2.11  
 
  
 
  
Structure of molecule one of compound 
2.11 (CCDC No. 956513) with labelling of 
selected atoms. Anisotropic displacement 
ellipsoids display 30% probability levels. 
Hydrogen atoms are drawn as circles with 
small radii.  
 Structure of molecule two of compound 
2.11 (CCDC No. 956513) with labelling 
of selected atoms. Anisotropic 
displacement ellipsoids display 30% 
probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
 
A full X-ray crystallographic report for compound 2.11 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.11.pdf  
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Appendix Two: ORTEPs and X-Ray Crystal Structure Report for Compound 2.13  
 
 
 
Structure of molecule one of compound 
2.13 (CCDC No. 956514) with labelling of 
selected atoms. Anisotropic displacement 
ellipsoids display 30% probability levels. 
Hydrogen atoms are drawn as circles with 
small radii. 
 Structure of molecule one of compound 
2.13 (CCDC No. 956514) with labelling of 
selected atoms. Anisotropic displacement 
ellipsoids display 30% probability levels. 
Hydrogen atoms are drawn as circles with 
small radii. 
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Structure of molecule two of compound 
2.13 (CCDC No. 956514) with labelling 
of selected atoms, showing the dominant 
sites of disordered atoms (Si111, C112–
C117, occupancy 0.742). Anisotropic 
displacement ellipsoids display 30% 
probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
 Structure of molecule two of compound 
2.13 (CCDC No. 956514) with labelling of 
selected atoms, showing the dominant sites 
of disordered atoms (Si111, C112–C117, 
occupancy 0.742). Anisotropic 
displacement ellipsoids display 30% 
probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
 
 
Structure of molecule three of compound 2.13 (CCDC No. 956514) with labelling of selected 
atoms, showing the dominant sites of disordered atoms (Si311, C312–C317, occupancy 0.080). 
Anisotropic displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn 
as circles with small radii. 
 
A full X-ray crystallographic report for compound 2.13 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.13.pdf 
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Appendix Three: ORTEPs and X-Ray Crystal Structure Report for Compound 2.20α  
 
 
Structure of compound 2.20α (CCDC No. 956515) with labelling of selected atoms. 
Anisotropic displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn 
as circles with small radii. 
 
A full X-ray crystallographic report for compound 2.20α (as complied by Anthony C. Willis 
of the Australian National University) is provided in PDF-format on the compact disc found 
on the inside back cover of this thesis.  
X-ray report 2.20α.pdf  
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Appendix Four: ORTEPs and X-Ray Crystal Structure Report for Compound 2.20β  
 
 
 
Structure of compound 2.20β (CCDC No. 956516) with labelling of selected atoms. 
Anisotropic displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn 
as circles with small radii. 
 
A full X-ray crystallographic report for compound 2.20β (as complied by Anthony C. Willis 
of the Australian National University) is provided in PDF-format on the compact disc found 
on the inside back cover of this thesis.  
X-ray report 2.20β.pdf  
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Appendix Five: ORTEPs and X-Ray Crystal Structure Report for Compound 2.25  
 
 
Structure of compound 2.25 (CCDC No. 956517) with labelling of selected atoms. Anisotropic 
displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn as circles 
with small radii. 
 
A full X-ray crystallographic report for compound 2.25 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.25.pdf  
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Appendix Six: ORTEPs and X-Ray Crystal Structure Report for Compound 2.27  
 
 
Structure of compound 2.27 (CCDC No. 956521) with labelling of selected atoms. Anisotropic 
displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn as circles 
with small radii. 
 
A full X-ray crystallographic report for compound 2.27 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.27.pdf  
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Appendix Seven: ORTEPs and X-Ray Crystal Structure Report for Compound 2.30  
 
 
 
Structure of compound 2.30 (CCDC No. 956518) with labelling of selected atoms. Anisotropic 
displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn as circles 
with small radii. 
 
A full X-ray crystallographic report for compound 2.30 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.30.pdf  
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Appendix Eight: ORTEPs and X-Ray Crystal Structure Report for Compound 2.32  
 
 
Structure of compound 2.32 (CCDC No. 956519) with labelling of selected atoms. Anisotropic 
displacement ellipsoids display 30% probability levels. Hydrogen atoms are drawn as circles 
with small radii. 
 
A full X-ray crystallographic report for compound 2.32 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.32.pdf  
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Appendix Nine: ORTEPs and X-Ray Crystal Structure Report for Compound 2.36  
 
  
  
Structure of compound 2.36 (CCDC No. 
956520) with labelling of selected atoms, 
showing the dominant sites of disordered 
atoms (O17, Si18, C19–C24, occupancy 
0.679). Anisotropic displacement ellipsoids 
display 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii. 
 Structure of compound 2.36 (CCDC No. 
956520) with labelling of selected atoms, 
showing the dominant sites of disordered 
atoms (O117, Si118, C119–C124, 
occupancy 0.321). Anisotropic 
displacement ellipsoids display 30% 
probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
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Structure of compound 2.36 (CCDC No. 956520) with labelling of selected atoms, showing 
both sites of each disordered atoms. Anisotropic displacement ellipsoids display 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
 
A full X-ray crystallographic report for compound 2.36 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 2.36.pdf  
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Appendix Ten: ORTEPs and X-Ray Crystal Structure Report for Compound 5.3  
 
 
Structure of compound 5.3 with labelling of selected atoms. Only the major sites of disordered 
atoms are shown (C15, C16, C17, occupancy 0.829). Anisotropic displacement ellipsoids 
display 30% probability levels. Hydrogen atoms are drawn as circles with small radii. 
 
A full X-ray crystallographic report for compound 5.3 (as complied by Anthony C. Willis of 
the Australian National University) is provided in PDF-format on the compact disc found on 
the inside back cover of this thesis.  
X-ray report 5.3.pdf  
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